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by Chien Fat Chau 
 
Targeted and controlled delivery of therapeutic agents on demand is pivotal in 
realising the efficacy of many pharmaceuticals. The design and fabrication of a novel, 
electrically-addressable, porous structure-based drug delivery device for the 
controlled release of therapeutic proteins and peptides, are described in this thesis.  
The initial prototype microdevice design incorporates a porous polysilicon 
(PPSi) structure as a drug reservoir. Two alternative methods were investigated to 
fabricate the PPSi structure: i) the chemical stain etching method; ii) a reactive ion 
etching (RIE) method through a masking template. Random pores, with irregular 
pore shape and size in the micro- to mesoporous regime (< 50 nm), were obtained 
using the stain etching method but this method suffered from poor reproducibility 
and non-uniformity. Two novel RIE approaches were investigated to fabricate 
ordered PPSi structures; two different masking templates were investigated – a 
porous anodic alumina (PAA) and a metal mask with hexagonally arranged holes 
produced by a novel nanosphere lithography (NSL) technique. A quasi-ordered PAA 
template with pore diameters in the region of 50 nm was fabricated but was not 
suitable for the subsequent proposed RIE process. By using the NSL technique, 
quasi-ordered PPSi structures with tapered pore profiles, were obtained. This is the 
first demonstration of the fabrication of PPSi with ordered pores of sizes in the 
macropore range of ~ 370 nm. 
A revised silicon-based prototype microdevice was designed and fabricated. 
The microdevice incorporates a nanostructured, quasi-ordered porous silicon (PSi) as 
a drug reservoir and an integrated heater and temperature sensor as an active 
control mechanism. The PSi structure was fabricated using a modified NSL 
technique and a Bosch-based RIE process. Hexagonally arranged cylindrical pores 
with diameters between ~75 nm and ~120 nm, and depths in the range of ~330 nm 
and 500 nm, were obtained. The novel fabrication techniques investigated here are 
simple and versatile; both p-type and n-type PSi structures have been successfully 
fabricated.  
Proof-of-concept studies, using the revised prototype drug delivery 
microdevices, suggested that the nanostructured PSi would be suitable for the 
passive release of an intermediate-sized (~23 000 Dalton) model protein. It is 
envisaged that the microdevice has the potential to deliver osteoinductive growth 
factors, on demand, to the site of fracture, in a controlled and sustainable manner, as 
a first step to an intelligent therapeutic system for skeletal regeneration. ii 
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1  Introduction 
Chapter  1 
Introduction 
1.1  Background and Motivations 
Fractures, as a result of congenital deformities, trauma or tumour resection, or 
degenerative diseases such as osteoporosis and degenerative disc disease, represent 
a major and growing global public health issue. The socioeconomic burden of 
traumatic or osteoporotic bone fractures is high and likely to rise with the increasing 
elderly population (aged ≥ 65 years) from the current 323 million to 1 555 million by 
the year 2050 [1]. It has been estimated that in 1990 there were 1.66 million hip 
fractures worldwide; this is estimated to increase to 6.26 million in 2050 [1], inline 
with the demographic changes. In the United Kingdom, there are more than 70 000 
hip fractures every year and the number is estimated to increase to 101 000 by the 
year 2020 [2]. Osteoporotic fractures cost the UK £1.7 billion annually [1], while the 
combined health and social care costs of hip fractures alone, in the UK, were 
estimated at £726 million per annum in 2000 [3]. The lifetime risk of any fracture 
was found to be 53.2 % and 20.7 %, among women and men in the UK aged 50 years, 
respectively [4]; hence, one in two women and one in five men over the age of 50 in 
the UK will have an osteoporotic fracture in their remaining lifetime. These numbers 
are greater than the lifetime risk of coronary heart disease (46 % for a 50-year-old 
woman [1]) and substantiate the need for innovative strategies to manage fracture 
incidences. 1.1 Background and Motivations    2 
From the clinical perspective, the treatment of fractures remains a challenge 
in orthopaedic surgery. Fracture healing and bone formation is a complex 
physiological process involving a cascade of cellular events [5, 6]. Even under 
optimum clinical condition, 5 % to 10 % of all fractures (reported cases in the United 
States) progress to delayed union or non-union [7]. These complications often result 
in the patients required a surgical re-intervention. Currently, the primary tissue 
engineering approach to improve impaired healing, accelerate bone regeneration and 
restore skeletal condition includes the utilisation of i) osteoinductive growth factors, 
ii) osteogenic cells (mesenchymal stem cells, osteoprogenitor cells and osteoblasts), 
iii) osteoconductive scaffolds, and the provision of a iv) mechanically stable 
environment; collectively, these four factors are known as the diamond concept in 
facture healing [6]. The utilisation of growth factors from the transforming growth 
factor-β (TGF-β) superfamily, especially the bone morphogenetic proteins (BMPs), is 
the most intensively studied and shows the most promising potential to 
enhancement in skeletal regeneration.  
In 1965, Marshall R. Urist first described the phenomenon of osteoinduction 
or the ability to induce bone formation at an ectopic (non-bone) site [8], following his 
seminal discovery of local de novo bone formation after intramuscular implantation 
of demineralised bone matrix in rabbits [9]. He later ascribed the phenomenon of 
osteoinduction to the presence of a protein in the bone matrix, which he termed bone 
morphogenetic protein [10]. Since then, the biological activity and the clinical 
application of BMPs have been extensively investigated and reviewed [11-17]. Of the 
more than sixteen different human BMPs identified, at the present time, only two 
engineered or recombinant human BMPs (rhBMPs), rhBMP-2 and rhBMP-7, are 
available for clinical use, in restricted orthopaedic indications, based on the positive 
evaluation by a number of large prospective, randomised controlled trials [18-20]. 
The rhBMP-7, also known as osteogenic protein-1 (OP-1), is commercially available 
as OP-1® Implant1 (Stryker Biotech, US) for the treatment of tibial non-union. The 
rhBMP-2 is commercially available as InductOs® (Wyeth, UK) or INFUSE® Bone 
Graft2 (Medtronic Spinal and Biologics, US) in combination with an absorbable 
collagen sponge (ACS) as the carrier. INFUSE® Bone Graft was regulatory approved 
                                                           
1 OP-1® Implant, http://www.stryker.com/en-us/products/Orthobiologicals/Osteoinductive/OP-1/OP-
1Implant/index.htm (last accessed Jul. 2009). 
2 INFUSE® Bone Graft, https://www.infusebonegraft.com/ (last accessed Jul. 2009). 1.1 Background and Motivations    3 
for the treatment of lumber fusion (in combination with LT-CAGE® fusion cage), 
open tibial fractures (with an intermedullary nail fixation), and as an alternative to 
autogenous bone grafts for sinus augmentations and for localised alveolar ridge 
augmentations [15]. 
One of the factors that limit the extended use of BMPs in orthopaedic therapy 
is the dose-dependent of BMPs in the induction of bone formation [14]. The dose of 
BMPs must overcome a threshold level for effective osteoinduction; however, too high 
of a dose beyond this threshold results in rapid osteoinduction that eventually 
results in direct intramembranous ossification. The dose-response curve, of BMPs, 
also becomes steeper in larger animal models due to a relatively rapid systemic 
clearance of BMPs in higher species [14]. The efficacy of BMPs is thus dependent on 
the ability to provide and retain the required level of BMPs, at the rate needed to 
effect the local sculpting of the fracture repair.  
Currently, the predominant delivery system of BMPs, for skeletal 
regeneration, involves incorporation of the BMPs with appropriate biomaterials (or 
carriers) either covalently or non-covalently. Several carrier materials have been 
developed [14, 21-24] and these can be broadly categorised into the following: 
I)  Natural polymer carriers, such as collagen, chitosan and alginate. These 
materials are highly biocompatible, bioresorbable and can be modified 
into many configurations with variable residence time. The 
disadvantages, however, include sourcing and processing of these 
materials, and their possible immunogenicity and disease transmission 
[21]. Thus far, collagen-based carrier is by far the most widely used. 
Collagen formulations include gelatine, demineralised bone matrix and 
fibrillar collagen [21]. The clinically approved carrier, for the delivery of 
rhBMPs, is a type-I bovine collagen, either as an ACS (used with 
INFUSE® Bone Graft and InductOs®) [24] or as a particulate bone-
derived collagen matrix (used with OP-1® Implant) [21]. 
II)  Inorganic materials, such as calcium phosphate cements, calcium 
sulphates cements and bioglass. These materials can be produced in 
various forms and can mimic the natural bony structure. Calcium 1.1 Background and Motivations    4 
phosphate and its variants, such as synthetic hydroxyapatite (crystalline 
calcium phosphate) and tricalcium phosphate, are osteoconductive and 
have been used as bone graft substitutes [25]. However, due to the high 
temperature manufacturing process, the incorporation of BMPs into these 
materials is less effective; commonly this is achieved, post fabrication, by 
adsorption, surface coating or mixing with additional carrier or in 
microspheres [21]. 
III)  Synthetic polymer materials, such as poly(lactic acid) (PLA), poly(glycolic 
acid) (PGA) and their copolymers. These materials are widely used in 
medical implants and drug delivery systems as they are biodegradable 
(via hydrolysis, cellular degradation or enzymatic pathways [8, 21]) and 
biocompatible [8, 22]. The disadvantages of some synthetic polymers are a 
potential decrease in local pH, bulk degradation and adverse host tissue 
reactions that may result from the residual molecules from the 
polymerisation process (such as catalysts and solvents) [8, 21].  
IV)  Composites of the above materials to optimise the benefits of each 
material. For instance, the calcium phosphate can be added to natural 
polymers to enhance their mechanical stability [26]. 
Most of these carrier systems are designed to mimic the porous bone matrix, 
which is the natural delivery system of BMPs. The incorporation of the BMPs in 
these carrier materials is achieved either by encapsulation during the fabrication of 
the carrier materials or by adsorption post fabrication. Hence, the release of BMPs is 
mostly by diffusion and desorption of BMPs, which often accompanied by the bio-
degradable of the carrier materials. The release of BMPs is thus passive and 
dependent upon the physical and chemical interaction between the material, the 
BMPs and the surroundings; when the loading process was performed by post-
fabrication adsorption, the released BMPs typically follow an initial burst profile. 
Although the exact pharmacokinetics of BMPs release required for an optimum bone 
growth remains to be elucidated [8], an active means of controlling the release of the 
BMPs seems to be advantageous. In this way, either a sustained or a pulsatile 
release profile can be potentially achieved, with a precise dosage and frequency, 
during the therapeutic period thus providing an optimum osteoinduction. Advanced 1.1 Background and Motivations    5 
drug delivery systems, which are realised using the microfabrication techniques 
derived from microelectromechanical systems (MEMS), offer the potential of such an 
actively controlled release profile. In addition, these microdevices could be integrated 
with sensors for monitoring the bio-chemical activities at the site of implant or 
measuring the release rate of BMPs. It is envisaged that such a monitoring system 
can provide a timely feedback of the healing rate and thus appropriate dose can be 
adjusted via telemetry. Microfabricated drug delivery devices have been intensively 
investigated and some promising approaches can potentially pave the way for the 
use of certain biopharmaceuticals. Some of the current state-of-the-art 
microfabrication-based drug delivery systems are reviewed in Chapter 2. 
1.1.1  Bone Morphogenetic Protein-2 (BMP-2) 
Bone morphogenetic protein-2 (BMP-2) is one of the multi-functional growth 
factors from the TGF-β superfamily that plays significant roles in the proliferation, 
differentiation and other functions in many cell types. BMP-2, as a potent 
osteoinductive growth factor, is best-known for its ability to induce de novo bone and 
cartilage formation. The mature BMP-2 is a homodimeric protein consisting of two 
114-residues monomers representing the C-terminal sequence of a long precursor 
protein of 396 amino acids [27]. BMP-2 consists of seven cysteine residues, like all 
members of the TGF-β superfamily, with six of the cysteines form the intra-
polypeptide disulfide bonds and one cysteine (Cys78) contributes to an inter-chain 
disulfide bridge, therefore conserving the cystine-knot folding motif [27, 28]. BMP-2 
has a molecular weight of about 26 000 Dalton [27], with dimensions of 7.0 nm x 3.5 
nm x 3.0 nm [28]. The two-dimensional ribbon model of human BMP-2 is depicted in 
Figure   1.1 (a), which identifies the dimeric protein structure as chain A (in cyan) and 
chain B (in green), the inter-polypeptide disulfide bonds (in yellow) and the inter-
chain disulfide bridge (in red). The solvent-accessible surface model, as depicted in 
Figure   1.1 (b), shows an elongated S-shaped molecule of 7 nm in length [29]. The 
recombinant-form of BMP-2, rhBMP-2 showed little reduction in biological activity, 




Figure   1.1: Two dimensional computer-generated (a) ribbon model and (b) solvent-accessible 
surface model of dimeric human BMP-2. Colour scheme: cyan – chain A; green – chain B; yellow – 
disulfide bonds of the cystine-knots between Cys14-79, Cys43-111, Cys47-113; red – inter-chain 
disulfide bridge at Cys78; grey – water molecules (reprinted from [29]). 
1.2  Aims and Scope of Work 
Implantable drug delivery devices, for site-specific, controlled delivery of therapeutic 
agents, especially biopharmaceuticals, have significant potential for a wide range of 
clinical applications. In skeletal regeneration, the delivery of the osteoinductive 
growth factors to the site of fracture, in a controlled and sustainable manner, has 
been regarded as the key factor to improve the efficacy of BMPs. Hence, the aim of 
this research is to create, by microfabrication, novel electrically-addressable drug 
delivery devices, which can be used for the controlled release of proteins and 
peptides. The longer term’s aim, beyond the scope of this thesis, is to demonstrate 
the potential of this technology for the controlled delivery of rhBMP-2 on human 
mesenchymal stem cells for the formation of bone, as a first step to an intelligent 
therapeutic system for skeletal regeneration. 
The design and fabrication of a prototype of such a drug delivery device, 
which incorporates a porous structure as a drug reservoir and an integrated electro-
thermal actuation mechanism for the controlled release of the drug, are the aims of 
this thesis. The device packaging to prevent bio-fouling, and the interface circuitry 
for a pre-programmed or telemetry control to the active control mechanism, are not 
part of the work presented in this thesis. However, it is envisaged that the device 
can be feasibly packaged, as illustrated in Figure   1.2, within the metal plate or the 1.3 Summary of Main Achievements    7 
intramedullary rod that is commonly used to hold the fracture in place. The interface 
circuitry can be designed and assembled post-fabrication of the device. 
 
Figure   1.2: Conceptual illustration demonstrating the working principle of the envisaged 
integrated porous silicon membrane drug delivery device.  
1.3  Summary of Main Achievements 
A number of original contributions were achieved during this research, and these are 
outlined briefly as follows:  
Three alternative approaches to fabricate a porous polysilicon (PPSi) 
structure were investigated, which include the chemical stain etching method, a 
templating approach that uses a porous anodic alumina (PAA) and reactive ion 
etching (RIE), and another templating approach that uses nanosphere lithography 
(NSL) technique and the RIE process. The stain etching method produced PPSi 
structures with random order of pore arrays, while the two templating methods 
created quasi-ordered PPSi structures. Although the quasi-ordered PPSi exhibited a 
tapered profile, this is the first demonstration of the fabrication of PPSi with ordered 
pores and a pore sizes in the macropore range of ~ 370 nm. 1.4 Organisation of Thesis    8 
A novel fabrication technique, using a modified NSL technique and an 
improved, Bosch-based RIE process, to realise a quasi-ordered, vertical, cylindrical 
porous silicon (PSi) structure, with pore diameter in the region of 100 nm, was 
successfully demonstrated. The fabrication technique is versatile and pores with 
various sizes and periodicities can be feasibly tuned. It is a “materials general” 
nanofabrication technique and has been successfully demonstrated on both p-type 
and n-type silicon substrates. Ordered PSi with pores in 100 nm diameter range has 
been difficult to achieve using conventional electrochemical etching method. 
A drug delivery device, which incorporates a nanostructured, quasi-ordered 
PSi structure as a drug reservoir and an integrated heater and temperature sensor 
as an active control mechanism, was designed and successfully fabricated. 
Preliminary investigation, using a model protein, suggested that the nanostructured 
PSi improves the passive release of the protein. 
1.4  Organisation of Thesis 
A two-part literature review is presented next. The current state-of-the-art drug 
delivery system derived from microfabrication technologies is first examined. These 
include microdevices that are aimed for oral administration, transdermal drug 
delivery and BioMEMS-based implantable drug delivery devices. The next half of the 
chapter reviews the properties of PSi and the application of PSi in the field of drug 
delivery. The fabrication techniques to produce PSi are briefly discussed. 
In Chapter 3, the design and fabrication of a PPSi-based drug delivery 
prototype device is presented. The fabrication of PPSi structures using the stain 
etching method is described. The evaluation and optimisation of the stain etching 
conditions, followed by the characterisation of the porous structures, are discussed. 
As a result of the poor reproducibility of the stain etch method to produce 
PPSi structures, alternative, more reliable methods to form orderly porous 
structures with pore sizes in the low, macropore regime (~ 50 nm to 100 nm) were 
evaluated. In Chapter 4 and 5, the potential and feasibility of using two templating 1.4 Organisation of Thesis    9 
methods to fabricate ordered PPSi structures is described. In specific, Chapter 4 
describes the work carried out at the University of Manchester using self-organised 
PAA as a masking template for RIE methods to create ordered PPSi. The fabrication 
of the test structures is discussed. 
Chapter 5 presents another templating approach which combines the NSL 
technique and the RIE technology. The NSL technique relies on the self-assembly 
properties of polymer nanospheres; by using a RIE process to reduce the size of 
nanospheres, followed by evaporation of metal thin films and subsequent removal of 
nanospheres, a masking template with hexagonally arranged, non-close-packed 
nanoholes was created. Subsequent RIE process via this masking template 
transferred the nanoholes’ pattern into polysilicon to realise PPSi structures. The 
challenge and limitations of the fabrication method are also discussed. 
The design and fabrication of a PSi membrane-based drug delivery device are 
detailed in Chapter 6. The design and process development of the silicon membrane, 
the PSi drug reservoir, and an integrated heater and temperature sensor, is first 
described. A thermal analysis, using finite element modelling, to investigate the 
theoretical operating range of the integrated heater and temperature sensor, is 
presented. The fabrication and characterisation of the microdevice is then discussed. 
This includes the fabrication of the silicon membrane carried out at Chalmers 
University of Technology, the fabrication of the nanostructured PSi, as the drug 
reservoir, using the NSL technique described in Chapter 5, and the fabrication of the 
integrated heater and sensor using a lift-off method. The calibration and 
functionality characterisation of the integrated heater and temperature sensor 
conclude the chapter. 
Chapter 7 details “proof-of-concept” studies of the loading and release of a 
model protein from the PSi membrane drug delivery device. The investigation 
focuses on the passive release of the model protein into de-ionised water, in a 
constant temperature environment. 
Finally, Chapter 8 concludes the thesis by summarising the overall 
achievements of this research, followed by suggestions for future work. 10 
2  Microfabricated Drug Delivery Devices: A Literature Review 
Chapter  2 
Microfabricated Drug Delivery 
Devices: A Literature Review 
2.1  Introduction 
Drug delivery, in simplistic terms, refers to the method or process of introducing 
pharmaceuticals into the human body to achieve a therapeutic effect. Synergism 
between the pharmacology of drugs and its route of administration is key to 
efficacious and cost effective therapies [31]. Therapeutic agents often have an 
optimum spatial and temporal range within which maximum therapeutic benefit is 
obtained [32]. Below this optimum range, the therapeutic effect could not be 
achieved; while above this optimum range, adverse effects such as fatal toxicity may 
be encountered. The effective delivery of a drug, to realise its designed therapeutic 
effect, is of both scientific and economic importance. 
Conventional drug delivery systems, which are predominantly based on oral 
delivery or intravenous injection, only offer moderately efficient treatment. Drugs 
administered orally or intravenously, in general, produce a “burst effect” [33] release 
profile, as depicted in Figure    2.1, which is consistent with first-order kinetics, 
meaning that there is a high plasma level of drugs above optimum therapeutic 
range, immediately after the initial administration. This is followed by a rapid, often 
exponential fall below the optimum therapeutic range [34]. Hence, because the time 
at the optimum therapeutic window may be short, the therapy can be inefficacious. 2.1 Introduction    11 
In contrast, controlled release is used to provide a sustained plasma level of drugs 
over a period of time, such that the concentration of the therapeutic agent is 
maintained at the optimum range consistent with zero-order kinetics [34]. Moreover, 
controlled release devices can also be used for pulsatile delivery of a drug, if 
necessary, for certain treatments, such as in the delivery of insulin or growth factors, 







































Figure   2.1: Exemplary plasma drug concentration, as a function of time, for conventional “burst 
effect” release profile (red) and controlled release with sustained delivery (blue) or pulsatile 
delivery (green) (adapted from [32]).  
In addition, orally administered drugs often have a reduced bioavalability 
due to gastrointestinal (GI) degradation and hepatic first-pass metabolism [37, 38]. 
Routine hypodermic injection to diabetic patients, for instance, causes an 
unacceptable level of pain and, hence, the quality of treatment is poor. Many of the 
newly discovered drugs are increasingly based on recombinant proteins, monoclonal 
antibodies and nucleic acids [39]. These biopharmaceuticals require novel delivery 
routes straight to a specific or a targeted site. Along with a need for better patient 
compliances and cost effective therapeutic care, drug delivery technologies may need 
to be redesigned. Modern drug delivery systems, therefore, require combined 
consideration of several factors including the characteristic properties of drugs, route 
and nature of administration, mechanism and pharmacokinetic of release and the 2.1 Introduction    12 
ability of site specific targeting. To achieve these goals, novel drug delivery systems 
are required. 
Advances in microsystems technology (also known as microelectromechanical 
systems, MEMS) have enabled the fabrication of highly precise and reproducible 
miniaturised structures and devices [40-42] that can be on the same size scale as the 
biological entity. These microfabrication techniques use a broad range of established 
technologies developed by the microelectronics industry. This ability to fabricate 
microstructures for biological applications is especially compelling and perceived by 
many to be one of the approaches needed to rise above the challenges faced in the 
drug delivery industry, as evident by the increase in the new developments reported 
recently [33-36, 43-57]. These approaches could be broadly categorized into 
biomedical MEMS (BioMEMS) based drug delivery microdevices [33-36, 43-50], 
which combine microfluidic (especially micropump technology), electronics and 
micromachining and offer the possibility for the implant route; and nanoparticles 
based drug delivery vehicles [33, 50-57], which use liposomes, polymer or 
microfabricated particles as carriers for targeted drug delivery and is relatively new 
in development. 
In particular, microfabricated drug delivery devices used as implants are 
envisaged to be revolutionary to the field of therapeutic care [58, 59]. With the ease 
of integration of microelectronics and biosensing systems, implantable microdevices 
are capable of providing personalised and ultimately the responsive controlled 
release of therapeutic agents. This can be achieved either by a pre-programmed 
release profile, by using a telemetry system to provide wireless controlled release or 
by feedback from integrated biosensors to provide timely and precise dosage as 
required by the human body [59]. These enormous potentials rightly translate into 
greater challenges in the design consideration of the implantable microdevices. The 
materials used in fabricating microdevices need to be biocompatible, the delivery 
mechanisms need to be reliable and reproducible, and there is also a need for an 
effective fail safe mechanism to avoid dose-dumping upon device failure. 
Porous silicon (PSi) is considered as one of the emerging and promising 
materials in drug delivery technology. It is biocompatible and can be made bioinert, 
bioactive or biodegradable depending on its microstructural properties (such as 2.1 Introduction    13 
porosity and pore morphology), which can be tailored with microfabrication 
techniques [60, 61]. The porous structure is ideal for entrapping therapeutic 
agents, and biodegradable PSi can be safely dissolved into the human body [62] at 
the same time bringing along the therapeutic agents. PSi, in particulate forms, has 
been used as a drug delivery vehicle [54, 55] and the integration of PSi as a drug 
reservoir of an implantable microdevice could be advantageous. 
The following review first examines the contribution of microsystem 
technologies in three of the major drug delivery approaches – oral delivery, 
transdermal delivery and implantable devices. Current example microdevices are 
presented and the microfabrication techniques involved are briefly discussed. In view 
of the potential of PSi in drug delivery technology, the properties of PSi are next 
examined. Existing examples of the use of PSi for drug delivery applications and the 
fabrication techniques are then discussed. 
2.2  Microdevices for Drug Delivery 
Microfabrication technology is instrumental in developing novel approaches for drug 
delivery. The ability to miniaturise structure or devices to the same feature size of 
living cells prompted enormous interest and subsequently countless efforts both from 
the academia and industry [33-36, 43-55]. These contributions are summarised here 
into three major areas: micromachined microparticles for oral drug delivery, 
microneedles for transdermal drug delivery and implantable microchips for localised 
delivery. 
2.2.1  Micromachined Particles for Oral Drug Delivery 
Oral administration of drugs remains the preferred route of delivery due to its non-
invasive nature and ease of self-administration. However, oral drug delivery in 
general provides only moderately efficient treatment [37, 38]. Orally administered 
drugs are subjected to both an acidic and enzymatic environments in the stomach 
and a physical barrier in the intestine before being absorbed. Once absorbed, these 2.2 Microdevices for Drug Delivery    14 
drugs enter the hepatic portal system and experience metabolism by the liver before 
being circulated throughout the body. By this time, the concentration of the drugs 
has been greatly reduced; hence this leads to low oral bioavailability of the drug and 
consequently a degraded therapeutic effect. Due to this degradation in the GI tract 
and by hepatic first pass metabolism, oral administration is generally not a viable 
route for biopharmaceuticals such as proteins, peptides, DNA and vaccines [33, 63]. 
These biopharmaceuticals are naturally broken down into smaller molecules by the 
GI tract, and nearly all macromolecules would have been destroyed or marginally 
absorbed into the system.  
A number of approaches are currently being developed to address the 
problem of degraded bioavailability in orally administered drugs. These include 
using protective coatings such as lipids and polymers, bioadhesive agents, 
permeation enhancers and protease inhibitors [33]. Drug-eluting micro- and 
nanoparticles have been used for site-specific and targeted delivery of therapeutic 
agents either by oral administration or intravenous injection [33]. These 
microparticles are often made from natural or synthetic polymers and can be 
specially designed to be pH and temperature sensitive [64]. However, due to the 
manufacturing method used, these microparticles, in general, are spherical and 
polydisperse in size. This has a number of implications – the spherical geometry 
inherently limits contact to the cell surface and the drug is often released in all 
directions; the size polydispersity on the other hand, results in variance in drug 
loading [64]. 
Microfabrication technology, on the other hand, offers an alternative 
approach to addressing some of the challenges faced by oral drug (in particular, 
peptides and proteins) delivery systems. Micromachined particles encapsulating 
macromolecular drugs, for instance, have been investigated as a new drug delivery 
method [33, 36, 49, 50]. Unlike the conventional synthesised microparticles, 
micromachined particles can be manufactured with precise control over size, shape, 
aspect ratio and surface features [33, 50]. These microparticles can thus be designed 
to be flat, thin and disc-shaped, such as the one depicted in Figure   2.2, to optimise 
the flow of the microparticles within the GI tract and maximise the contact area with 
cells or intestinal walls [65]. The general concept of using micromachined particles 
for oral drug delivery [33] is as follows: 2.2 Microdevices for Drug Delivery    15 
i)  Microparticles are first filled into enterically coated capsules for 
protection during passage through the acidic environment of the 
stomach. 
ii)  Once in the upper intestines, the enteric capsule is designed to 
dissolve, hence releasing the microparticles. These microparticles 
are typically coated with bioadhesive agents (such as lectin) on one 
side to ease binding to the surface of the epithelial cells of the 
intestines. This intentionally orientates the microparticles towards 
the target intestinal lining, and hence limits the exposure of the 
coated peptide or protein to enzymatic degradation. 
iii)  The reservoir contents in the microparticles are hydrated and have 
a high local concentration of permeation enhancer (and, if needed, 
enzyme inhibitors) which allows the transport of macromolecules 
through intestinal barriers. 
iv)  The microparticles are then designed to effectively be cleared from 
the GI system; the macromolecules enter the bloodstream below 






Figure   2.2: Conceptual illustration showing (a) the contact area of conventional spherical drug 
delivery microparticles compared to that of micromachined particles (reprinted from [63]); and (b) a 
typical micromachined particles with some key features (reprinted from [33]). 2.2 Microdevices for Drug Delivery    16 
One of the groups actively involved in the development of micromachined 
particles for oral drug delivery is the group of Desai3. Microparticles of various 
materials, such as polymers [63, 66, 67] and silicon dioxide (SiO2) [65], have been 
fabricated using a combination of a micro-moulding technique and photolithography 
and etching processes. These square-shaped microparticles, as depicted in Figure 
  2.3, ranged between 50 μm and 150 μm and consist of a square recess of various sizes 
defining the reservoirs. Surface modifications were carried out to provide viable 
covalent bonding to biological molecules, specifically for conjugation of avidin-biotin-
lectin binding. These reservoirs were then filled with an aqueous polymeric drug 
solution, using a microinjection technique, before being detached from the substrate. 
Different polymers can be used to provide various drug release rate and time. 
Recently, the group incorporated hydrogel into the reservoir for a responsive drug 
delivery system [64]. The in vitro studies of permeation of drug (chemotherapeutic 
camptothecin) through a Caco-2 epithelial monolayer demonstrated a significantly 
improved permeation with drug filled in microparticles as compared to drug filled 
into hydrogel alone and free drug. 
 
100 m μ  
(a) 
150 m μ  
(b) 
Figure   2.3: Micromachined particles developed by Desai’s group. Plane-view SEM micrographs of 
(a) SiO2 microparticles of 100 μm x 100 μm with four-wells reservoirs of 35 μm x 35 μm each 
(reprinted from [65]); and (b) poly(methyl methacrylate) (PMMA) microparticles of 150 μm x 150 
μm with single-well reservoirs of 80 μm x 80 μm. One of the PMMA microparticles is shown 
released from the substrate (reprinted from [67]). 
                                                           
3 Tejal A. Desai, Professor in Physiology, University of California San Francisco, USA. 
http://physio.ucsf.edu/desai/ (last accessed Jul. 2009). 2.2 Microdevices for Drug Delivery    17 
Apart from SiO2 and polymers, porous silicon (PSi) has also been used as 
material for the fabrication of microparticles [68, 69]. PSi is biocompatible and 
biodegradable [60], and the size of the pores can range from nanometers to 
micrometers. Hence, PSi microparticles can be used as a drug delivery vehicle for 
various sizes of therapeutic agents, as demonstrated by Salonen et al. [70]. After 
loading or entrapping drugs into the pores, PSi microparticles can be delivered to the 
target site. The drugs can be released by diffusion to the surroundings, assisted by 
biodegradation of PSi. In fact, based on a similar principle, a multistage delivery 
system has been recently proposed and demonstrated [71]. The core of the system is 
the micrometer-sized PSi particles with mesoscale size pores (between 2 nm and 50 
nm) which act as the first stage delivery vehicle. With proper surface chemistries, 
one or more smaller particles (second stage nanoparticles), such as therapeutic 
nanovectors and imaging contrast nanoparticles, can then be loaded in the first stage 
mesoporous silicon particles. Consequently, the mesoporous silicon particles reduce 
the system uptake of the second stage nanoparticles, hence providing a better chance 
for the second stage nanoparticles to accomplish their intended tasks. Quantum-dots 
and single-walled carbon nanotubes have been used as second stage nanoparticles in 
this study [71], where intravenous injection is proposed as the administration route 
of the mesoporous silicon particles. 
2.2.2  Microneedles for Transdermal Drug Delivery 
Although oral administration of drugs is the preferred route, there are times when it 
is not feasible due to poor bioavailability of therapeutic agents as a result of 
degradation in the GI tract and hepatic first pass metabolism [37, 38]. The common 
alternative is to inject the drugs intravenously. In addition to the pain caused to the 
patients, intravenous injection requires trained medical personnel to avoid infection 
and injury, hence rendering self-administration difficult. 
An alternative and possibly more appealing approach is by transdermal drug 
delivery, which offers the possibility of painless controlled release over time. 
Transdermal drug delivery refers to the administration of a drug through the skin, 
(specifically the epidermis layer) into the bloodstream via diffusion to achieve a 
systemic delivery, although some transdermal approaches are meant for topical 
delivery [72-74]. Apart from reducing the aforementioned issues faced by oral and 2.2 Microdevices for Drug Delivery    18 
intravenous routes of administration, transdermal drug delivery with controlled 
release requires relatively smaller amounts or doses of drug to achieve the desired 
therapeutic effect, and is thus more cost effective. In addition, transdermal delivery 
can allow the administration of drug with short biological half-lives and in a narrow 
therapeutic window [74] due to its closer vicinity to the target site. Therefore, 
transdermal delivery of drugs could potentially lead to reduced side effects due to the 
reduced peak plasma level and lower fluctuations in plasma levels of these drugs 
[75]. 
A transdermal route of administration is, however, often limited to the 
transport of therapeutic agents with low molecular mass (typically < 500 Dalton), 
high lipophilicity and low potency [76]. One of the reasons for these limitations is the 
poor penetration of therapeutic agents through the stratum corneum – 10 μm to 20 
μm thick, “hard” outermost layer of the skin. There are a number of strategies 
currently explored to enhance the permeation of drugs through the stratum 
corneum. These approaches [75-79] endeavour to affect the physicochemical 
properties of stratum corneum either by means of chemical enhancer, physical 
enhancer (such as microneedles), electric (by iontophoresis or electroporation), 
ultrasound (by sonophoresis), thermal or laser radiation. 
Among the approaches developed to enhance transdermal drug delivery, 
physical enhancement using microfabricated arrays of micrometer dimensions 
needles (microneedles) has been one of the more actively researched methods [45, 80-
82]. Microneedles can be designed and precisely fabricated such that the 
microneedles are long, and robust enough to penetrate the stratum corneum, and 
thus create holes that are feasible for transport of drug molecules. At the same time, 
the length of the microneedles is short enough to avoid the nerves and blood vessels 
mostly found in the dermis layer, hence avoiding pain and bleeding. In addition, 
unlike other approaches, microneedles have been used to deliver larger and more 
hydrophilic molecules, including proteins, DNA and nanoparticles [83, 84]. 
Microneedle technology is also envisaged to provide efficacious vaccine delivery; the 
dendritic cells, which are responsible for the immune response, are located in the 
epidermis layer, and hence could be better targeted by using microneedles [85]. 2.2 Microdevices for Drug Delivery    19 
In general, microneedles could be categorised as either in-plane or out-of-
plane, based on whether the microneedles are either parallel or normal to the 
substrate, respectively. In addition, microneedles are also recognised by the shapes, 
notably either solid or hollow. The materials used to fabricate microneedle arrays 
include silicon, metal and more recently polymer. Most silicon microneedles are 
fabricated using a series of MEMS technology processes including deposition, 
photolithography, wet chemical etching and reactive ion etching (RIE); while 
polymer microneedles are typically micro-moulded. Currently, there are four 
strategies to deliver therapeutic agents into the skin [83]: i) by piercing the skin 
using the microneedles, followed by application of a drug patch; ii) by dry coating 
drug onto the microneedles and inserting into the skin for subsequent dissolution of 
the coated drug; iii) by delivering through a hollow channel of microneedles; and iv) 
by encapsulating drug within the biodegradable polymer forming the microneedles, 
followed by insertion into the skin and dissolution of the polymeric microneedles 
along with the drugs. 
2.2.2.1  In-plane Microneedles 
With the advancement in the planar integrated circuit microfabrication technology, 
in-plane microneedles were the earlier type of microneedles developed, as the length 
and shape of the microneedles can be easily defined by photolithography. In fact, in-
plane microneedles had been developed as early as the 1970s by Wise et al., but were 
initially used as neural microprobes for biopotential recording [86]. Microchannels 
were later incorporated into the improved version of the neural microprobes, 
allowing the delivery of a chemical into the central nervous system of guinea pigs for 
studies of spontaneous neural responses [87]. The trapezoidal microchannels, as 
depicted in Figure    2.4, were fabricated by anisotropic etching into the silicon 
substrate using ethylenediamine pyrocatechol (EDP) via an array of chevron-shaped, 
boron-doped silicon masks. The microchannels were then sealed by thermal 
oxidation and low pressure chemical vapour deposition (LPCVD) of multilayers of 
dielectrics materials. Polycrystalline silicon (polysilicon) interconnects and metal 
contact pads were integrated for recording of neural responses. The shank of the 
microneedles was defined by deep boron diffusion prior to sealing and a final etch in 
EDP to release the structure. Microneedles with one to four delivery channels have 
been fabricated in this way, with the lumen ranging from 10 μm to 32 μm wide and a 2.2 Microdevices for Drug Delivery    20 








Figure   2.4: In-plane microneedles for chemical delivery at the cellular level developed by Wise et al. 
(a) A conceptual drawing of a three delivery channel microneedle probe with recording and 
stimulating electrodes. (b) – (c): SEM micrographs of the (b) micromachined three delivery channel 
microneedle with recording sites; and (c) back of a two delivery channel microneedle (reprinted 
from [87]). 
Instead of etching into the bulk silicon to form the microchannels, Lin and 
Pisano used sacrificial layers (combined phosphosilicate glass (PSG) and low 
temperature silicon oxide (LTO)) by surface micromachining to define the 
microchannels [88]. By depositing a layer of silicon nitride (Si3N4) over the sacrificial 
layers and subsequent removal of these sacrificial layers, in-plane microhypodermic 
needles of 1 mm to 6 mm in length with lumens of 9 μm high and 30 μm or 50 μm 
wide have been realised. Polysilicon heater strips were integrated at the proximal 
ends of the microneedles to generate bubbles to pump fluid down the lumen. 
In an attempt to form a more complex, responsive drug delivery system, 
microneedles have been integrated with microsensors or microactuators. Zahn et al. 
demonstrated that by incorporating an on-chip MEMS micropump, sustainable 
continuous drug delivery could be achieved [89]. The proof-of-concept polysilicon 
microneedles, with a micropump fabricated by micromolding demonstrated a water 
flow rate of ~ 1.0 nL·s-1 with continuous pumping for more than 6 hours. 2.2 Microdevices for Drug Delivery    21 
2.2.2.2  Out-of-plane Microneedles 
In contrast to the in-plane microneedles, which are mostly hollow, the out-of-plane 
microneedles are mostly solid due to the ease of microfabrication. One of the first 
microneedles to demonstrate enhancement in transdermal drug delivery was 
reported by Prausnitz4 and his research group [90], who have since been at the 
forefront of developments in microneedles for transdermal drug delivery. The 
microneedle arrays reported were fabricated using RIE of silicon to form an array of 
out-of-plane, conical microneedles. Each microneedle is approximately 150 μm long 
with a base diameter of ~ 80 μm; 400 of these microneedles formed a 20 x 20 array in 
a 3 mm x 3 mm area, as depicted in Figure   2.5 (a). The single mask RIE process used 
was based on the “black silicon” method [91], with modified parameters such that 
deep vertical etching with controlled mask undercut could be achieved, hence 
forming sharp silicon spikes. Using these microneedles to create holes in human 
cadaver skin, the permeability of calcein through the skin has been reported to 
increase by up to 25 000-fold post insertion [90]. Further studies on the pain caused 
by these microneedles concluded that essentially no pain was experienced by the 12 








Figure   2.5: Solid, out-of-plane silicon microneedles array by Prausnitz’s group. (a) SEM micrograph 
showing a section of the 400 microneedles in an area of 3 mm x 3 mm (reprinted from [90]). (b) 
Digital image showing a 5 x 10 array of microneedles patch resting on a tip of a human thumb 
(reprinted from [93]). 
 
                                                           
4 Mark R. Prausnitz, Professor of Chemical and Biomedical, and the Emerson Lewis Faculty Fellow, Georgia 
Institute of Technology, USA, http://www.che.gatech.edu/drugdelivery (last accessed Jul. 2009). 2.2 Microdevices for Drug Delivery    22 
transdermal patch for delivery of naltrexone (NTX), which is a hydrophilic, skin-
impermeant, potent mu-opioid receptor antagonist used to treat opiate and alcohol 
dependence [93]. In a human proof-of-concept study, healthy volunteers who were 
pre-treated with the microneedles array demonstrated steady-state plasma 
concentrations within 2 hours of patch application and were maintained for at least 
48 hours. In comparison, volunteers who did not go through the pre-treatment of 
microneedles showed undetectable drug plasma levels post-patch application. 
By using a two-step RIE process, Stoeber and Liepmann demonstrated that 
arrays of hollow out-of-plane silicon microneedles, as depicted in Figure   2.6 (a), could 
be fabricated [94]. The first RIE (substrate etch through) was used to create the 
lumen of the microneedle by deep RIE of the silicon substrate using the Bosch 
process [95]. The substrate was turned over and an isotropic RIE was carried out to 
define the shape of the microneedles. A wet chemical etch was also carried out to 
smoothen the surface of the microneedles. In order to prevent tissue clogging on the 
tip of hollow microneedles, Griss and Stemme fabricated the fluidic opening at the 
sides of the microneedles instead, as depicted in Figure    2.6 (b) [96]. Hollow 
microneedles with a complex out-of-plane structure and flow profiles have also been 
developed by NanoPass Tech. Ltd.5 and the University of Twente [97]. The MicronJet 
needle, which is essentially a standard syringe mounted with arrays of 
MicroPyramids, similar to that depicted in Figure   2.6 (d), has been developed for 
intradermal administration of drugs, proteins and vaccines. Another company 
currently pursuing microneedles technology as transdermal drug delivery system is 
Zosano PharmaTM Inc.6. The Macroflux® technology, which uses stainless steel, out-
of-plane microprojection arrays has been developed since 2001 [98] and is currently 
in Phase II clinical trials for treating osteoporosis using a parathyroid hormone 
(hPTH 1-34). The Macroflux® technology has been previously demonstrated to 
provide bolus release of oligodeoxynucleotides [98] and ovalbumin [99, 100] in a 
hairless guinea pig. 
                                                           
5 NanoPass Technologies Ltd., Israel. http://www.nanopass.com/ (last accessed Jul. 2009). 
6 Zosano PharmaTM, Inc. (previously Macroflux Corp., spinoff from ALZA), Fremont, CA, USA. 









Figure   2.6: Micromachined hollow out-of-plane silicon microneedles. SEM micrographs of (a) an 
array of hollow microneedles by Stoeber and Liepmann (reprinted from [94]); (b) side-opened 
microneedles fabricated by Griss and Stemme (reprinted from [96]) and (c) – (d) hollow 
microneedles fabricated by Gardeniers et al. (reprinted from [97]). 
Biodegradable Microneedles 
More recently, due to the increased concern of broken microneedles causing possible 
undesirable infections, microneedles have been fabricated using biodegradable 
materials [83, 101-109]. Prausnitz and his team have been working on polymer-
based biodegradable microneedles [83, 101-105] and, recently, demonstrated that by 
micro-moulding biocompatible, water soluble polysaccharide (carboxymethyl 
cellulose (CMC) or amylopectin), solid, out-of-plane, conical or pyramidal (with a 
base of 300 μm in width over microneedle length of 600 μm to 800 μm) microneedle 
arrays could be fabricated [101]. The microneedle arrays encapsulated with model 
drugs, in this case, sulforhodamine B, bovine serum albumin (BSA) and lysozyme, 
have been shown to be strong enough for insertion into cadaver skin and 
spontaneously (within minutes) dissolved to release the model drugs either by bolus 
or sustained delivery, as demonstrated in Figure    2 . 7 .  I n  t h i s  w a y ,  n o  s h a r p  






Figure   2.7: Self-dissolving polymer based microneedles by Prausnitz’s group. The brightfield 
microscope images show the CMC pyramidal microneedles (a) prior to and (b) 1 minute after 
insertion into pig cadaver skin (reprinted from [101]). 
In contrast, Tay and his team anodised the tips of solid, out-of-plane silicon 
microneedles thus making them porous [107-109]. Porous silicon has been known to 
be biocompatible and biodegradable [60]; this approach is also advantageous as the 
porous silicon tips can, at the same time, be used to carry drugs. 
2.2.3  Implantable Microchips for Localised Delivery 
Similar to microneedles technology, implantable microdevices provide an alternative 
route of administration which addresses the issues faced by oral delivery and 
intravenous injection. Implantable microdevices (microchips) are preferred for 
therapies that require controlled release over the therapeutic period, which is 
typically achieved by daily or weekly intravenous injection [34]. These microchips 
can be strategically implanted into the human body or placed just under the skin 
(subcutaneously), hence eliminating the need for frequent injections and avoiding 
pain or risk of infection. In addition, when placed near the specific site where the 
drug is needed, these microchips offer the potential of site-specific localised delivery, 
an attractive therapeutic effect particularly for treatment using potent drugs, such 
as in chemotherapies of cancer patients [110]. The typically high concentration of the 
drugs required can be administered at the site, while keeping the systemic level low, 
hence reducing adverse side effects as compared to by systemically administered the 
drugs in high dose. It is also more cost effective, as the amount of drug used is less. 
Most implantable microchips are also designed for controlled release either by active 
control (potentially with sophisticated microelectronics systems) or passive release. 2.2 Microdevices for Drug Delivery    25 
Hence, the dose level and dose frequency could be personalised and precisely 
regulated for the therapeutic needs. 
Implantable microchips could be broadly categorised into microfluidic and 
non-microfluidic based devices. Microfluidic based drug delivery devices often 
incorporate active components such as micropumps and microvalves [111, 112]; 
while non-microfluidic based microchips may use either active or passive release 
mechanisms [32, 34, 43, 46, 47, 113]. Non-microfluidic based microchips do not 
typically consist of moving parts, hence reducing the adverse effect caused by 
malfunction of these components. 
2.2.3.1  Microfluidic based Microchips 
Drug delivery devices derived from the microfluidic technology [42, 114] often 
incorporate micropumps, microvalves and flow channels as the basic components. 
These components, combined with flow sensing, have been well-known to provide 
accurate, nano- to pico-litre volume liquid metering and dispensing [115]. Hence, in 
principle, microfluidic based microchips are able to provide a controlled release of 
accurate quantities of pharmaceuticals on demand, possibly by telemetry or feedback 
from biosensors that could be integrated into the device. While most non-microfluidic 
based, controlled release, microchips rely on the diffusion of drugs as a result of the 
concentration gradient, microfluidic based microchips (mostly actuated by a 
micropump) depend on the pressure gradient from the surroundings. This is 
advantageous as the diffusion rate of most molecules, in general, is relatively slower 
than the flow rate that is able to be generated from micropumps. The pressure 
gradient is typically created by either pressurising the drug reservoir, by osmotic 
action or by direct actuation of micropumps with various methods [111, 112]. As with 
other drug delivery technology, there are some concerns and challenges to be 
addressed especially on microchips intended for implantation. The specific design 
considerations relating to microfluidic based microchips include i) reduction of 
biofouling; ii) biocompatibility with the drugs and the surrounding tissue; iii) the 
need for external sources and high power consumption; and iv) the safety and 
reliability of moving parts within the microfluidic system [111, 112]. 2.2 Microdevices for Drug Delivery    26 
The group of Woias7 at the Institute of Microsystem Technology (IMTEK), 
Germany is one of the many academic research groups working in the development 
of micropumps. Recently, based on their experience in micropump technology, the 
group has been focusing on developing a fully integrated drug delivery system, so-
called “active microport” which strives to address some of the challenges faced by 
most implantable microchip technologies [116]. The microport is envisaged to offer a 
freely programmable release profile within a low flow drug delivery regime. The core 
of the system is a two-stage piezoelectrically actuated micropump specifically 
developed to deliver a pulsatile flow of liquid drug with high resolution volumetric 
dosing, at the same time being small, demand less power and be easy to fabricate 
[117, 118]. The resolution of the micropump is determined by the voltage controlled 
stroke volume, which currently can be preset between 10 nL and 200 nL [116]. The 
high resolution volumetric dosing has been facilitated by the low backpressure 





Figure   2.8: Active microport developed by the group of Woais.The conceptual drawing of (a) the 
two-stage piezoelectrically driven micropumps and (b) the microport (reprinted from [116]). 
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the susceptibility of the flow rate to an increase in the static pressure at the outlet of 
the micropump [118]. This feature ensures a constant flow rate, and coupled with an 
integrated pressure sensor to monitor the flow rate, the system potentially is able to 
address the problem of varying pressures caused by the changing blood or tissue 
pressure – an imperative consideration to ensure safety and reliability of an 
implantable microchip system. In comparison, one of the commercial micropumps 
developed by Debiotech S. A.8 can only provide a constant flow rate up to 20 kPa 
backpressure (within low flow regime up to 33 μL·min-1), with a constant stroke 
volume of 160 nL [119]. The disposable NanopumpTM utilises piezoelectric actuation 
with a reciprocating membrane, and achieves the backpressure independency by 
means of a “double limiter concept”. Its predecessor, MIP implantable micropump 
which was developed for implantable drug delivery system, is larger in size and more 
complex in design with similar accuracy and reliability [120]. Currently, the 
NanopumpTM is developed to provide continuous subcutaneous insulin infusion for a 
week. Other marketed insulin infusion devices include the leading MiniMed 
Paradigm® developed and marketed by Medtronic Inc.9. The insulin pump can be 
wirelessly linked to the REAL-Time System which measures the glucose level 
continuously, hence providing real-time monitoring and management of insulin 
uptake. Medtronic’s SynchroMed® II Drug Pump, on the other hand, is a fully 
implantable intrathecal drug delivery system for managing severe chronic pain or 
treating severe spasticity. 
Most of the micropump based microchips discussed thus far, require some 
forms of external power source for actuation. In contrast, micropumps that are based 
on osmotic pressure, such as one developed by Su and Lin [121], could release the 
drug without the need for mechanical or electrical sources. The two-part prototype 
device, as depicted conceptually in Figure    2.9, is composed of an osmotic 
microactuator at the bottom, bonded to polydimethylsiloxane (PDMS) microfluidic 
components consisting of reservoir, delivery channel and delivery port at the top. 
The PDMS microfluidic components were cast from an SU-8 mould, while the bottom 
osmotic microactuator was fabricated from cellulose acetate using the hot embossing 
technique [121].  
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Figure   2.9: Conceptual illustration of the osmosis actuated micropump for drug delivery developed 
by Su and Lin (reprinted from [121]).  
Due to a concentration gradient across the semipermeable membrane at the 
bottom of the osmotic microactuator, water from the surrounding aqueous 
environment is drawn through the membrane into the chamber filled with the salt, 
hence the actuating membrane is deflected and this forces the liquid drug, stored in 
the reservoir, to be dispensed though the delivery channel to the delivery port. The 
device is capable of inducing pressure up to 25 MPa, and this is believed to be 
sufficient to overcome the pressure from surrounding cells or tissue, during 
operation, and hence deliver a total drug volume of 2 μL at a constant rate of 0.2 
μL·h-1 for an operation period of 10 hours [121]. 
Other simpler osmotically driven micropump-based drug delivery devices 
include a biodegradable prototype [122] and a commercial implant, Viadur®. The 
biodegradable device developed by Ryu et al. was fabricated by micro-moulding and 
thermal assembly of 85/15 poly(L-lactide-co-glycolide) sheet [122]. The in vitro 
release of basic fibroblast growth factor (bFGF) was regulated at 40 nanogram per 
day, on average, over four weeks. The commercial device, Viadur® is developed by 
Durect Corp.10 via the DUROS® technology and was distributed by Bayer 
HealthCare Pharmaceutical11 before being phased out in April 2008 [123]. The 
implantable, 44 mm long, 3.8 mm diameter cylindrical device with titanium casing, 
delivers leuprolide acetate for 1 year to manage symptoms associated with advanced 
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prostate cancer. By attaching a micro-catheter, the DUROS® technology can be 
modified to allow site-specific local drug delivery [124]. 
2.2.3.2  Non-microfluidic based Microchips 
One of the earliest demonstrations of controlled drug delivery using an implantable 
microchip has been reported by Langer12 and co-workers [32, 125]. The 
microreservoirs-based microchip has been used for the controlled release of 
microgram quantities of either single or multiple substances in a pulsatile manner, 
potentially on demand. In these studies, model chemical substances, sodium 
fluorescein and radioactive calcium chloride (45CaCl2) were loaded into separate 
reservoirs capped with thin gold membranes. The release mechanism was based on 
the electrochemical dissolution of the gold membrane in the presence of chloride ions 
at the bias voltage, hence allowing the loaded chemical substances to diffuse into the 
surrounding medium. 
The proof-of-concept prototype microchips used in the studies, as depicted in 
Figure   2.10 (a), were 17 mm x 17 mm x 310 μm in size and contained 34 reservoirs 
[125]. The 480 μm square reservoirs, providing vol u m e  o f  ~  2 5  n L  e a c h ,  w e r e  
chemically etched from the back of the silicon wafer using potassium hydroxide, 
through a photolithographically patterned silicon nitride etch mask, forming the 
typical anisotropically etched square pyramidal voids with silicon nitride 
membranes. Gold electrodes of 300 nm thick, patterned using the lift-off method 
were deposited over the silicon nitride membranes. A passivation silicon dioxide 
layer of 600 nm thick was deposited, patterned and etched using electron cyclotron 
resonance (ECR) enhanced RIE. This serves as electrical isolation and protection to 
some portions of the electrodes. The silicon nitride membrane underneath the gold 
membrane was then removed using the ECR-enhanced RIE. An aqueous solution of 
liquid polyethylene glycol and model chemical substances were loaded using inkjet 
printing and a microsyringe pump capable of dispensing nanolitre solution or gel. 
The reservoirs were then covered with thin adhesive plastic and sealed with 
waterproof epoxy.  
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By applying an electrical potential of +1.04 V (with respect to the saturated 
colomel reference electrode) to the gold membranes, release of the chemical 
substances was detected within a few minutes, with a typical 70 % of the chemical 
released within 30 min [125]. The release studies also demonstrated the ability to 
activate each reservoir individually, hence creating the possibility for designing 
complex release profiles. Currently, the microreservoirs-based microchip technology 
is developed by MicroCHIPS Inc.13. The improved microchip, as depicted in Figure 
  2.10 (b) and (c), contains a better release mechanism using electro-thermal effect 
[126], an electronics control and telemetry circuitry, and a biocompatible packaging. 
The device is currently in preclinical trials for treating prostate cancer using model 
polypeptide leuprolide [127, 128] and treating osteoporosis using human parathyroid 









Figure   2.10: Implantable microchip for controlled release of drug by Langer’s group and 
MicroCHIP Inc. (a) The conceptual illustration of the first prototype device (reprinted from [125]) 
and (b) the improved device. (c) Photographic images of the device complete with electronics 
components and packaging ((b) and (c) reprinted from [128]). 
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In addition, by using a similar concept of “reservoir trapping” of drugs, 
Langer’s group developed a biodegradable, polymer-based, multi-dose delivery 
microreservoir microchip [130]. Instead of using active control, the polymeric 
microchip relies on a passive release mechanism without the need for external 
sources and triggers. The 1.2 cm diameter, 480 μm to 560 μm thick prototype used in 
the study was fabricated from poly(L-lactic acid) using compression moulding 
technology. The device was microinjected with ~ 150 μm thick, biodegradable 
poly(D,L-lactic-co-glycolic acid) membranes of different molecular masses covering 
the 36 reservoirs to control the release of various chemicals (radiolabelled dextran, 
human growth hormone or heparin) in vivo. The passive release relies on the pure 
diffusion of the drugs and can be tailored to a preset rate by careful design and 
selection of various parameters including the size and polymer composition, the 
number and volume of the reservoirs, and the thickness and composition of the 
membrane. 
By using surface and bulk silicon micromachining processes, Ferrari14 and co-
workers developed silicon nanoporous [131] and nanochannel [132] microchips for 
sustained drug delivery. These microchips are based on a single dose, passive release 
concept to the delivery of liquid drugs following a zero-order kinetic. The nanoporous 
microchip implant, NanoGATE consists mainly of a nanopore membrane, as depicted 
in Figure   2.11 (a) and (b), which was fabricated using a series of key process step to 
create sacrificial SiO2 layer sandwiched between silicon and polysilicon [131]. Upon 
removal of the sacrificial SiO2 layer, nanopores could be realised with a pore width 
essentially defined by the thickness of the sacrificial SiO2 layer. In vitro diffusion 
kinetics of model antitumor agent human recombinant interferon α−2b (rhIFN- α) 
and fluorescein isothiocyanate (FITC)-labelled BSA loaded into nanopore membranes 
with 20 nm and 13 nm pore width, respectively, demonstrated a non-Fickian15 
behaviour [131]. In vivo studies using the NanoGATE implant with 13 nm pore 
membrane loaded with radio-labelled BSA (125I-BSA) demonstrated sustained 
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Center; Professor of Bioengineering, Rice University; Professor of Biochemistry and Molecular Biology, 
University of Texas Medical Branch; and President of Alliance for NanoHealth, USA. 
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release over a period of 45 days post insertion [131]. More recently, the group 
developed and fabricated a proof-of-concept nanochannel drug system (nDS) using 
fusion bonding of two silicon wafers, encapsulating nanochannels which were formed 
by similar SiO2 sacrificial layer technique prior to the bonding [132]. rhIFN -α was 
released using these passive release microchips (nDS1, 100 nm channel size) and the 
in vitro result demonstrated the bioactivity of IFN-α on both host immune cells and a 
human melanoma cell line [133]. Future nDS microchips are envisaged to be 
integrated with on-board electronics to allow pre-programmed (electro-osmotically 







Figure   2.11: Implantable NanoGATE microchips developed by Ferrari’s group. (a) Cross-sectional 
view SEM micrograph of the membrane with 50 nm pores separated by silicon and polysilicon; (b) 
Plane-view SEM micrograph of the membrane showing 45 μm long pores separated by 10 μm long 
anchors; and (c) Implant device fitted with nanopore membrane. Top: Conceptual drawing of the 
device. Bottom: Photograph of the actual prototype in relation to a US 1 cent coin (all images 
reprinted from [131]). 
Implantable microchips drug delivery technology is still in an early 
development stage. The major challenges faced by these technologies are the safety 
and reliability, and biofouling and biocompatibility. There is also a need for an 2.2 Microdevices for Drug Delivery    33 
effective fail safe mechanism that can protect the patient when the device fails, 
which potentially could lead to fatality as the stored drugs could be dose-dumped 
into the body. The delivery mechanism needs to be reliable and reproducible in 
maintaining its drug delivery performance over the therapeutic period, or at least a 
reasonable period of time to justify the need for surgery to place or remove the 
implant. The implantable microchips need to be biologically, chemically and 
physically stable. Hence, the materials used to fabricate the implantable microchips 
need to have the same requirements and be compatible with the drugs and 
surrounding biological environment so that the microchips are non-inflammatory, 
non-antigenic and non-carcinogenic. Ideally, an implantable drug delivery microchip 
should also be easy to use by both the patient and the health professional, flexible 
and programmable in setting up the dosing requirement, implantable under local 
anaesthesia, small and light, efficient in consuming power and ultimately have some 
sort of feedback or monitoring mechanism for a responsive drug delivery system. 
Once these challenges have been satisfactorily addressed, the true potential of the 
implantable microchips will be realised. 
2.2.4  Summary 
Novel approaches in drug delivery, which benefitted from the advancement in 
microfabrication technology, were discussed with a focus on three major areas: 
micromachined particles for oral drug delivery, microneedles for transdermal drug 
delivery and implantable microchips for localised delivery. 
Micromachined particles, which are often designed to be flat and disc-shaped, 
as depicted in Figure   2.2, can be fabricated with precise control over size, shape, 
aspect ratio and surface features. This way, optimum flow within the GI tract and 
maximum contact area with the intestinal walls could be potentially achieved. 
Polymers [63, 64], SiO2 [65] and PSi [68-70] microparticles have been demonstrated 
to deliver therapeutic agents and model drugs, albeit mostly in  vitro. These 
micromachined particles, which mostly rely on passive release, are more appropriate 
for applications where sustainable, localised delivery is required. 
The use of microneedles is a promising drug delivery technology, firstly 
because it resembles the hypodermic needles used in intravenous injection. They also 2.2 Microdevices for Drug Delivery    34 
offer better permeability for a breadth of biopharmaceuticals, hence potentially 
providing greater bioavailability compared to other transdermal delivery approaches. 
Out-of-plane microneedles, including solid [90] (see Figure    2.5), hollow [94] (see 
Figure   2.6 (a)) and porous-tip [107] silicon microneedles, require relatively straight-
forward fabrication processes; while polymer-based biodegradable microneedles, 
mainly developed by Prausnitz and co-workers [83, 101-105], potentially reduce the 
risk of infection caused by broken silicon or stainless steel microneedles. Thus far, 
the drug delivery devices utilising microneedles, such as the MicronJet needle [97] or 
the Macroflux® transdermal patch [100], are already in clinical trials. In order to 
fully realise the potential of self-administration using microneedles for transdermal 
drug delivery, the safety and ease of use, of these microneedles-based devices, need 
to be improved. 
Microfabricated implantable microchip devices could eventually incorporate 
all the benefits of microsystem technology. With the integration of microelectronics 
and biosensing systems, implantable microdevices are capable of providing 
personalised and ultimately responsive controlled release of therapeutic agents. 
Release mechanisms, with both active control [116, 125] and passive release [121, 
122, 130-132], have been demonstrated using microfabricated microchips. However, 
at the same time, these microchips are the most challenging in terms of design and 
implementation. A microfluidic-based implantable microchip which uses a 
micropump, such as one depicted in Figure   2.8, for instance, requires an external 
source to drive the micropump. In addition to the needs for biocompatibility and 
reduction of biofouling, the micropump poses safety and reliability issues, as the 
moving parts could potentially fail and hence, unintended, adverse release of drugs 
(dose-dumping) could occur. In contrast, the microdevice developed by Langer’s 
group (see Figure   2.10) is more interesting and promising. It does not require any 
moving parts and the concept of reservoir trapping of drugs and electrical dissolution 
of the capping membrane, is an attractive approach. The sealable reservoir with the 
capping membrane used in the study [125], however, is potential for dose-dumping 
upon failure; accidental removal of the sealing or the capping membrane could 
adversely release the drug. Perhaps, using a porous media, such as porous silicon as 
the drug reservoir could better entrap the therapeutic agent without the need for an 
external valving mechanism. This proposition is, thus, explored extensively and 
served as the basis of this study. 2.3 PSi as an Emerging Material in Drug Delivery Technology  35 
2.3  Porous Silicon as an Emerging Material in 
Drug Delivery Technology 
Porous silicon (PSi) has been well-known for its unique luminescent properties since 
the demonstration of its visible photoluminescence at room temperature almost 
simultaneously by Canham16 [134] and by Lehman and Gösele [135]. Since then, 
there have been growing efforts in understanding the various aspects of PSi, 
including its fabrication methods, characterisations and applications, as shown by 
the increased amount of literature on PSi [136, 137]. In 1995, Canham also 
demonstrated the bioactivity and biocompatibility of PSi [60], and thus initiated 
various studies to develop PSi for biomedical applications [61, 136]. In the field of 
drug delivery, PSi has been mainly used as a vehicle or a carrier for the therapeutic 
agents [54, 55]. The following review first examines the properties of PSi, in 
particular its micro-structural, photoluminescence and biochemical properties. The 
applications of PSi in the field of drug delivery are then investigated. Lastly, the 
approaches used to fabricate PSi are briefly examined. 
2.3.1  Properties of Porous Silicon 
Porous silicon has various properties that make it uniquely attractive for many 
applications, in particular its large surface area to volume ratio for the application in 
biochemical sensing [138, 139]; its photoluminescence properties for optical [140-142] 
and optoelectronics applications [143, 144]; and its bioactivity and biocompatibility 
for implantable biomedical applications [61, 136]. Here, some of the interesting 
properties, along with some recent findings are summarised. 
2.3.1.1  Micro-structural Properties 
The unique physical and structural properties of PSi have been the subject of 
interest since the postulation of the quantum size confinement as the origin of visible 
light emission from PSi [145, 146]. The ability to determine and control these 
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physical properties, using established fabrication processes, has also attracted 
interest in the applications of biochemical sensing [138, 139] and biofiltration [61, 
147]. 
Fundamentally, the microstructure of PSi can be characterised by the pore 
sizes and their distribution, the pore types and shapes, the porosity and surface area, 
although other aspects such as the skeleton size, pore morphology, pore spacing, and 
many more parameters have also been extensively examined [137, 148]. Many of 
these parameters are not always easy to obtain, and thus far various techniques – 
electron microscopy [149-152], gas adsorption-desorption analysis [153-155], X-ray 
investigations [156-158] and many more [159-162], have been used to investigate 
certain aspects of the microstructure characteristics of PSi.  
In classifying the microstructure of PSi, guidelines by the International 
Union of Pure and Applied Chemistry (IUPAC) on the characterisation of porous 
solids have been generally adopted [163, 164]. The IUPAC defines a ‘pore’ as a 
cavity, channel or interstice with depth exceeding its width [163]. The pore size is 
hence generally accepted as the width or “the distance between two opposite walls” of 
the pore [163]. The ranges of pore size exhibiting characteristic adsorption properties 
defined by IUPAC [164] are summarised in Table    2.1 and this is widely used to 
classify PSi. Most of the PSi structures studied thus far are in the micro- to 
mesopore regime, although recently there has been an increased interest in the 
macroporous silicon structure. In practice, the mesopore sized PSi structures are 
readily obtained by typical electrochemical (anodisation) or chemical (stain) etching 
of silicon; while microporous silicon is mostly associated to anodisation using highly 
concentrated hydrofluoric acid (HF). Macroporous silicon, on the other hand, is 
conventionally fabricated by anodisation of silicon with predefined starting pits [165, 
166]. The macropores formed this way are ordered with a typically cylindrical shape, 
but the pore sizes are limited to the range of 0.2 μm to 20 μm due to limitations in 
the fabrication and formation mechanism [165, 167]. On the other hand, the term 
“nanoporous silicon” has also been used in the literature to loosely describe PSi with 
a pore width in the nanometer regime (<1 μm) [168, 169]. 
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Classification  Pore Width (nm) 
Micropore  ≤ 2 
Mesopore  2 – 50 
Macropore  ≥ 50 
Table   2.1: IUPAC classification of pore size. 
The pore size alone does not always provide a complete understanding of the 
morphology of a porous structure. To better understand the microstructure of the 
PSi, the geometrical shape and the size distribution of the pore should also be 
investigated [170]. However, it is not always possible to distinguish the types and 
shapes of pores as typical anodisation or stain etching of silicon tends to produce 
irregular and poorly-defined pores. This is especially the case for microporous silicon. 
In principle, however, there are several types and shapes of pore that can be formed. 
Most meso- and macroporous silicon structures (or layers) consist of pores that are 
closed at one end (blind) and interconnected or branched to some degree, as depicted 
in Figure   2.12. Through pores, which are open at both ends, are often associated to 
free-standing PSi membrane and are useful in biofilteration application. Closed or 
isolated pores are less typical but could be realised via a capping process which 
minimises the ageing of the PSi [171].  
(a) (b) (c) (d) (e)
(f)
 
Figure   2.12: Conceptual illustration of (a) a rough surface and the types of pores: (b) and (c) blind 
or dead-end, (d) interconnected or branched, (e) through pore and (f) closed or isolated pores 
(adapted from [170]).  
The most common pore shape observed in electrochemically formed PSi is 
cylindrical with varying degrees of branching. Mesoporous silicon also exhibits 
gradual decrease in pore size with depth, resulting in a funnel-like shape; while 
some macroporous silicon structures have been demonstrated to exhibit a thin 
surface porous film of smaller pore size [172], resulting in ink-bottle shape 
morphology. Crystallography of the wafers can also affect the pore shape – <100>-2.3 PSi as an Emerging Material in Drug Delivery Technology  38 
oriented silicon wafers have been demonstrated to produce square cross-sectional 
pores; whereas <111>-oriented wafers exhibit triangular shaped pores [173]. 
The pore size distribution (PSD) has also been used as one of the more 
quantitative parameters to characterise a PSi structure. The PSD of PSi with meso- 
to macropore size regimes can be determined by using high resolution transmission 
(TEM) and scanning electron microscopy (SEM). These techniques provide direct 
observation of pore morphology and microstructural characteristics [149-152]. 
However, as the observed area using these techniques is limited, only the pore sizes 
within the field of view can be determined, hence may not entirely represent the PSD 
of the PSi structure. A more common method, especially in determining the size 
distribution of mesopores, is by analysing the adsorption isotherms of gases at low 
temperature [153-155]. Combined with spectroscopic ellipsometry [161], a non-
destructive measurement of PSD could be obtained. 
The porosity of PSi has been reported to range from 4 %, observed in 
macroporous layers, to above 95 %, observed in mesoporous materials [170]. Porosity 
can be measured by gravimetric and optical techniques [174], and the potential 
applications associated with different porosity ranges are depicted in Table   2.2. The 
specific surface area or the area of solid surface per unit mass of PSi, on the other 
hand, is generally inversely proportional to the porosity of the PSi layer [175]. 
Void Content (%)  Porosity  Potential Applications 
0 – 30  Low  Microcapacitors, wafer bonding, tissue binding 
30 – 70  Medium  Micromachining, sensors, silicon-on-insulator 
70 – 100  High  Light emitting diode, anti-reflective coating, non-linear optics 
Table   2.2: Classification of porosity and its associated potential applications (reprinted from [170]). 
2.3.1.2  Luminescence Properties 
By far, the most studied property of PSi is its luminescent behaviour [137, 176, 177]. 
The great interest was primarily a result of poor luminescence of bulk silicon due to 
its indirect bandgap. PSi, on the other hand, emits visible light at room temperature, 
hence making it a potentially ideal material for integration into optoelectronics. 
Photoluminescence (PL) [134, 145, 158, 176, 178-189], cathodoluminescence (CL) 
[190, 191], electrolumiscence (EL) [192-197] and chemiluminescence [171, 198] of PSi 2.3 PSi as an Emerging Material in Drug Delivery Technology  39 
have been extensively studied and the existence of these luminescences in different 







PL CL EL 
UV ~  350  UV-band  Yes Yes No 
Blue – green  ~ 470  F-band  Yes Yes No 
Blue – red  400 – 600  S-band  Yes Yes Yes 
Near IR  1100 – 1500  IR-band  Yes No No 
Table   2.3: Porous silicon luminescence band (reprinted from [137]). 
Canham showed that the layers of freshly anodised silicon with high porosity 
exhibits a highly efficient PL in the visible range (the S-band) [134]. The first of such 
spectra published are depicted in Figure   2.13 (a), which shows a typical trend of PL 
in PSi, as a function of anodisation time. As the single layer PSi is continuously 
anodised from 1 hour to 6 hours, the porosity increases from 70 % to 80 % with a 
colour change of surface appearance, from dark golden brown through gold to yellow. 
The resultant yellow layer glows bright red at room temperature when illuminated 
by a 514.5 nm Ar laser. The corresponding PL is shifted from the near infrared (IR) 
to the visible region with a significant increase in the intensity. A similar blue shift 






Figure   2.13: Room temperature PL spectra observed by Canham (a) when freshly anodised silicon 
was probed with a 200 mW unfocused 514.5 nm Ar laser in air and amplified by the relative gains 
indicated. The p-type silicon was anodised in 40 % aqueous HF for the times indicated (reprinted 
from [134]); and (b) when a 11.6 μm thick PSi layer with 77 % porosity was excited at 325 nm, 
following extended air exposure for the indicated times (reprinted from [199]). 2.3 PSi as an Emerging Material in Drug Delivery Technology  40 
Many models have been proposed to explain the origin of PL in the PSi [137], 
as depicted in Figure   2.14, but the two models that have been broadly accepted are 
the quantum confinement effect in crystalline silicon and the highly localised defects 
states. Recently, Godefroo et al. proposed that both the quantum confinement effect 
and the localised defects states actually involved in certain aspect of PL [200]. By 
using high magnetic fields, they postulated that localised defects are the dominant 
source of light in nanocrystalline silicon. By passivation with hydrogen to remove 
these defects, the PL then originates from quantum-confinement states; subsequent 
UV illumination, however, reintroduced the defects making them the origin of the 
light again. 
   
Figure   2.14: The six groups of models proposed to explain the PL from PSi. Detailed discussion of 
these models can be found in [137]. 
Porous silicon that is optically uniform has been demonstrated to exhibit a 
Fabry-Pérot thin film interference effect when illuminated by visible light [201]. In a 
PSi film, the Fabry-Pérot interference fringes observed in a reflectivity spectrum 
correspond to the constructive and destructive interference from light reflected at the 
air / PSi layer and PSi / bulk silicon interfaces. By taking the Fourier transform of 
the reflectivity spectrum, the optical thickness (OT), which is the product of the 
effective refractive index and the thickness of the film [201] can be extracted. When 
the refractive index of the PSi changes, for instance due to introduction of a molecule 2.3 PSi as an Emerging Material in Drug Delivery Technology  41 
by absorption, a red spectral shift in these fringes occurs [55], as depicted in Figure 
  2.15. Conversely, a blue shift in the spectrum can be observed when the process is 
reversed. Both the refractive index and the thickness of the PSi film, and thus the 
effective OT, can be reliably controlled by electrochemical etching process, hence 
making this method useful for in-situ biosensing [141, 202, 203] and drug loading 
and release monitoring [55, 204]. 
 
Figure   2.15: Schematic illustration demonstrating the red shift of the Fabry-Pérot interference 
fringes in a reflectivity spectrum from a PSi layer upon introduction of a molecular species into the 
porous structure. The reverse process yields a blue shift in the spectrum instead (reprinted from 
[55]). 
2.3.1.3  Porous Silicon as a Biomaterial 
Biocompatibility, in simplistic terms, is the ability of a biomaterial to co-exist and 
interface with the human body without “eliciting any undesirable local or systemic 
effects in the recipient” [205]. The human body typically responds to contact with 
synthetic materials by depositing proteins at the surface of the materials [206]. This 
biofouling effect can cause infection and biological rejection of devices implanted in 
the human body. Some materials such as polycarbonate and stainless steel are 
tolerated by the human body and are described as bioinert. Bulk silicon is relatively 
bioinert but PSi could be made bioinert, bioactive or biodegradable depending on the 
porosity and pore morphology [60, 61, 207]. Mesoporous silicon with high porosity 
was observed to dissolve in all the simulated body fluids (SBF); while medium 
porosity meso- and microporous silicon was found to be bioactive and slowly 
biodegradable [61]. No calcification was observed on macroporous silicon or PSi with 
very low porosity, suggesting that these materials are quite bioinert. A recent study 2.3 PSi as an Emerging Material in Drug Delivery Technology  42 
confirms that macroporous silicon shows marginal bioactivity, but this can be 
improved by surface functionalisation techniques [208]. 
Porous silicon hydrolyses under physiological environment and degrades into 
the human body as silicic acid (specifically, orthosilicic acid (Si(OH)4)) [55], a natural 
form of silicon that is readily absorbed by the human body [209]. This makes PSi 
based implantable devices or drug vehicles attractive as these devices could be 
potentially dissolved and excreted by the body, hence no further surgery is required 
to recover the devices. Canham and co-workers investigated the dissolution of PSi 
under simulated physiological conditions [62] and electrical enhancement [210]. 
Mesoporous silicon were anodised to achieve different porosity levels: medium (60 
%), high (80 %) and very high (88 %) porosity. The content of aqueous silicon (Si) 
released due to dissolution of PSi was measured using inductively coupled plasma 
optical emission spectroscopy [62]. At pH 7, mesoporous silicon with high and very 
high porosity showed an exponential increase in the release of Si over time (implying 
high biodegradability); while the increase in dissolution of PSi was also observed at 
higher pH and higher temperature. In a separate study, a PSi sample of 40.2 % 
porosity was found to dissolve when placed near to the electrode biased at – 6 V in a 
electrolyte (pH 7.6) [210]. The enhanced dissolution was believed to be due to the 
modulation of pH near the electrode when an electrical current is flowing, hence 
increasing the pH when negatively biased, while decreasing the pH when positively 
biased [210]. 
2.3.2  PSi for Drug Delivery and Therapeutic 
Applications 
Since the demonstration of bioactivity and biocompatibility of PSi by Canham in 
1995 [60], PSi has been increasingly used as drug delivery vehicles [54, 55]. The 
surface of PSi can be suitably modified [211, 212] to favour adsorption of therapeutic 
agents [136] and micron-sized PSi particles, pieces or thin films have been used to 
carry nanosized payload including drugs, such as the anticancer agent doxorubicin 
[213], steroid dexamethasone [204], ibuprofen and other model drugs [70, 214], 
imaging contrast nanoparticles [71] and biomolecules such as proteins [215, 216], 
peptides [216] and enzymes [217]. 2.3 PSi as an Emerging Material in Drug Delivery Technology  43 
One of the earlier demonstrations of the use of PSi microparticles in drug 
delivery was reported by Foraker et al. [69]. In the study, FITC-labelled insulin was 
loaded into PSi particles (between (150 x 150 x 25) μm and (240 x 240 x 25) μm; pore 
size distribution of 20 nm to 100 nm) by capillary action and dried using vacuum 
drying or freeze-drying. The transport of both liquid and particle-encapsulated 
insulin across a differentiated human intestinal Caco-2 cell monolayer was 
investigated. In the presence of permeation enhancer (sodium laurate, C12), a nearly 
10-fold increase in the permeability of FITC-insulin was reported from PSi particles, 
as compared to insulin in liquid form. Maximum insulin transport of 20 % per hour 
was achieved by incorporation of 0.337 μg sodium laurate per PSi particle with 
loading coverage at 25 % across the Caco-2 cell monolayer. 
Moreover, PSi particles can be surface-treated by thermal carbonization or 
thermal oxidation and have been demonstrated to provide suitable surfaces for the 
loading of model drugs such as antipyrine, ibuprofen, griseofulvin, ranitidine and 
furosemide [70]. The modified surface has not only provided stability to the PSi 
particles, but also affected the affinity of the chemical substances towards the 
particles, as evidenced by the varied loading efficiencies. More importantly, based on 
the release experiments, the loading of these drugs into mesoporous silicon particles 
have been demonstrated to improve the overall dissolution of poorly dissolving drugs 
and reduce the pH dependency of the dissolution. 
Porous silicon has also been used as a carrier for controlled delivery of 
doxorubicin anticancer agent [213]. The fabricated PSi consists of a macroporous 
layer of several microns deep, capped with a layer of 200 nm thick microporous 
silicon, as depicted in Figure   2.16. This unique structure enables loading of water 
soluble doxorubicin via the capillary effect, while the dissolution of the top layer of 
microporous silicon in a simulated physiological environment demonstrated a 
continuous release of doxorubicin that reached a plateau in 5 hours. The cytotoxicity 
of the released doxorubicin has been evaluated towards human colon 
adenocarcinoma cell lines LoVo and HT29, and suggested an appreciable and time-
dependent anti-proliferation that is in-line with the doxorubicin release profile. The 
biocompatibility of the unloaded PSi structure was also investigated and showed no 
significant anti-proliferative effects in both LoVo and HT29 cell lines after 7 days 
exposure.  2.3 PSi as an Emerging Material in Drug Delivery Technology  44 
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Figure   2.16: Cross-sectional SEM  micrograph of the two-layer PSi structure produced by Vaccari 
et al. for controlled delivery of doxorubicin anticancer agent (reprinted from [213]). 
Prestidge  et al. demonstrated that a model protein, Papain (intermediate 
sized, ~ 23 000 Dalton hydrophilic protein) could be loaded into both anodised and 
stain etched PSi powders [215]. Freeze-drying has been used in the impregnation, 
solvent evaporation-based loading process, with pre-wetting of samples in methanol 
prior to loading process was carried out to improve the infiltration of Papain into the 
pores. They first observed a burst release of 22 % to 37 % and 35 % to 45 % of Papain 
from the electrochemically etched and the stain-etched PSi powder, respectively 
[215], indicating that a higher percentage of Papain was surface bound to stain 
etched PSi. The release of Papain over time was observed to be linear from 
electrochemically etched PSi; whilst stain etched PSi exhibited a more pseudo first 
order (exponential) release kinetic. These observed characteristics of loading and 
release behaviour are indicative of differences in porous structure and surface 
chemistry derived from the methods used to fabricate PSi. They have subsequently 
demonstrated that size and hydrophobicity of biomolecules, coupled with loading 
methodology, are some of the factors that influence the loading efficiency [216]. Both 
Gramicidin A (a small, ~ 1800 Dalton, hydrophobic peptide) and the larger Papain 
could penetrate the PSi layer to distances of > 60 μm, but Papain did not load as 
efficiently into the pores and has the higher tendency to bind to the surface. 
Since the observation of the Fabry-Pérot interference effect in luminescent 
PSi layers [201], Sailor17 and his research group have been exploiting this unique 
optical property of PSi for biosensing [141, 202, 203] and drug delivery applications 
[55, 204]. In one of the studies [204], Sailor’s group demonstrated that the optical 
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thickness (OT) (see also §  2.3.1 – Luminescent properties) changed over time, as 
depicted in Figure   2.17, when a Fabry-Pérot PSi film was undergoing a pore size 
expansion process in a volume ratio of 9:1 HF: dimethyl sulfoxide (DSMO) etching 
solution. In this process, the DMSO acts as the slow oxidant agent, while the HF 
helps to dissolve the newly formed oxide and hence enlarges the pore width. The 
release of the loaded steroid dexamethasone from the hydrosilylated, pore expanded 
PSi samples into phosphate-buffered saline solution was found to be ~ 20 times 
slower than the unmodified freshly etched samples, observed by simultaneous UV 
absorbance spectrophotometry and optical reflectance spectrometry. The OT was also 
observed to be linearly correlated to the concentration of the released 
dexamethasone. In a separate study, Sailor’s group has infused iron oxide magnetic 
nanoparticles of 30 nm diameter into PSi pieces [217]. Based on similar optical 
reflectance spectrometry, they were able to determine the amount (in nanogram 
quantities) of enzyme horseradish peroxidase that was loaded into the “magnetised” 
PSi pieces. Single PSi pieces could then be transported through air or a hydrocarbon 
liquid using an external magnetic field and have shown no loss in enzymatic activity 
after the transport. 
 
Figure   2.17: Change in optical thickness (OT) observed by Anglin et al. during the pore size 
expansion process of a PSi film. Point a represents the initial OT of the film in air (7570 nm). An 
increase in OT (to 8430 nm) at point b was observed upon the immersion of the PSi film into a HF: 
DMSO solution due to an increase in the effective refractive index of the film. As the HF gradually 
removed the formed oxide from the pores, a continuous decrease in OT was observed at point c. The 
porosity of the film was increased by ~ 10 % in this process (reprinted from [204]). 
Using a similar concept, Koh et  al. developed a free-standing distributed 
Bragg reflector PSi film (DBR PSi) for monitoring drug release within a smart patch 
intended for the application of transdermal drug delivery [218]. The as-prepared 
DBR PSi film exhibits a high reflectivity at 524 nm but when the film was covered by 
caffeine-impregnated PMMA layers a shift to 547 nm was observed, suggesting the 2.3 PSi as an Emerging Material in Drug Delivery Technology  46 
filling of the pores with the PMMA. Conversely, a blue shift was observed when the 
caffeine was released into a buffer solution. The DBR PSi / PMMA composite films 
are chemically stable and show no apparent degradation in their optical reflectivity 
after several days’ exposure to aqueous HF or 3 M potassium hydroxide. 
In other therapeutic applications, PSi has shown promising osteoconductivity 
for use as a cell interface for bone tissue engineering [219, 220]. In these studies, 
primary rat calvaria cells (osteoblasts) or the rat osteosarcoma cells (ROS 17/2.8 cell 
line) were seeded on the PSi substrates with various morphologies and sizes – 
straight macropores with pore width > 1 μm, branching mesopores with pore width ~ 
50 nm and spongy micropores with pore width < 15 nm [219, 220]. It was observed 
that cells adhered to all three types of PSi, but only spread out well on a 
macroporous and micro-PSi substrate. In addition, the macro-PSi substrate 









Figure   2.18: (a) – (b) Fluorescence microscope images showing the osteoblasts (stained by 
propidium iodide dye) on a macro-PSi surface (a) spread out after 18 hours of incubation; and (b) 
migrated, proliferated and clustered to form mineralizing nodules within 3 – 5 days of culture. (c) – 
(d) Plan view SEM micrographs showing the osteoblast and protein matrix on a macro-PSi 
substrate after one week of culture: (c) a mature osteoblast surrounded by fibrous mesh; and (d) 
fibrils with banding characteristics of type I collagen (reprinted from [219]). 2.3 PSi as an Emerging Material in Drug Delivery Technology  47 
increased after 5 and 7 days, as depicted in Figure    2.18. Moreover, macroporous 
silicon substrate demonstrated a higher level of transcription of three characteristic 
biomarkers of bone formation – alkaline phosphatase, osteocalcin and type I 
collagen. These results suggest that macroporous silicon is not toxic to osteoblasts 
and provides a favourable interface for osteoblasts growth and functionalisation. 
In cancer treatment, PSi has been used as a brachytherapy device by pSivida 
Corp.18., a leading company in the biomedical applications of PSi. The BrachysilTM 
(32P-BioSiliconTM), which comprises a combination of proprietary PSi particles and 
the isotope 32Phosphorus, a proven anti-cancer therapeutic, has been demonstrated 
to be safe and well tolerated with a significant degree of antitumor efficacy during 
their Phase II clinical trials for inoperable primary liver cancer [221]. 
2.3.3  Fabrication of Porous Silicon 
Porous silicon was first observed in the 1950s by the Uhlirs at Bell Laboratories, US 
during studies of electro-polishing of silicon and germanium in HF-based solutions 
[222]. They observed that silicon surfaces often developed a “matte black, brown or 
red deposit” during the process. Fuller and Ditzenberger then reported a similar 
“dark stain” surface appearance during chemical etching of silicon in a solution 
containing HF and nitric acid (HNO3), without applying external bias [223]. Later, 
the anodised films first received a more detailed study by Turner [224]; while Archer 
further described the chemical stain etching of silicon [225]. However, it was not 
until a decade later, that Watanabe and co-workers described the porous nature of 
these anodised silicon surfaces, and hence evoked the term “porous silicon” [137, 
226]. 
Since the demonstration of its visible PL at room temperature [134, 135], 
there have been significant efforts to improve the conventional anodisation and stain 
etching methods to produce PSi with various morphologies and physical 
characteristics [137, 148, 165, 227-229]; while at the same time, the development of 
novel fabrication approaches for specific applications have also emerged [230-238]. 
To date, however, anodisation or electrochemical etching of silicon remains the most 
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popular method used to produce PSi, simply because it has been well-studied and 
hence its reproducibility, even for processing of up to 200 mm wafers [168], has been 
greatly improved. In this process, silicon is etched by applying an external bias in a 
HF-based electrolyte, typically carried out in an etching cell made of highly acid-
resistant polymer such as Teflon®. Aqueous or ethanoic HF electrolyte has been 
conventionally used, but organic solvent such as acetonitrile or dimethyl formamide 
(DMF) has also been mixed with HF, especially for the formation of meso- and 
macropores [165]. In general, there are three configurations of the etching cell: 
lateral or immersion cell, single-tank or o-ring cell and double-tank cell [227, 228]. 
The cathode is a mesh or rod made of HF-resistant and conducting material, 
typically platinum; while the silicon acts as the anode. Sometimes, a third reference 
electrode is also used. Any silicon surface in contact with the electrolyte will be made 
porous. Hence, a patterned layer of HF-resistant material, such as silicon nitride 
could be used to protect the areas not intended for anodisation. 
The mechanism of pore formation during anodisation, including the pore 
initiation and pore propagation has long been scrutinised. Many factors have been 
proposed [239], but it has been generally accepted that quantum size effects are 
responsible for micropore formation [134, 135], while the formation of larger (meso- 
and macro-) pores is understood to be due to the electric field in the space charge 
region (known as the current burst model) [165, 229]. The dissolution chemistry 
itself has been generally agreed to follow the following reaction [227]: 
( )
− + + ⋅ − + ⋅ + → ⋅ + ⋅ + e n h n 2 H 2 SiF HF 2 Si 2    (   2.1) 
2 4 2 H SiF HF 2 SiF + → ⋅ +      (   2.2) 
6 2 4 SiF H HF 2 SiF → ⋅ +      (   2.3) 
where  h+ and e- are the exchanged hole and electron, respectively, and n is the 
number of charges exchanged during the elementary step. For n-type silicon, where 
holes are the minority carries, the hole injections are often assisted by illumination 
with white light to generate more electron / hole pairs [227]. The dissolution process 
itself is controlled by either monitoring the anodic current or potential. In general, 2.3 PSi as an Emerging Material in Drug Delivery Technology  49 
galvanostatic or constant current is preferred due to good reproducibility with a 
better control of both the porosity and thickness of PSi [227]. A typical current 
density – potential curve during the anodisation of silicon in aqueous HF electrolyte 
is depicted in Figure   2.19. Pores are typically formed during the initial rising current 
density where 0 < V < Vep with Vep denotes the potential at the smaller electro-
polishing peak. The current density at this peak, Jep is mostly dependent on the 
composition of the electrolyte [239]; beyond this, electro-polishing occurs and is 
characterised by the strong oxidation that forms an oxide layer on the surface. 
Electro-polishing is not observed when organic solvent is used in the electrolyte [165, 
239]. 
 
Figure   2.19: Typical current density – voltage curve during the anodisation of silicon (reprinted 
from [239]). 
It is also well-studied that the current density, the electrolyte including the 
chemical composition, the concentration of HF, temperature and mechanical stirring; 
the resistivity, type and crystallographic orientation of wafer – determines many of 
the properties of PSi, in particular the pore size and distribution, the pore 
morphology, porosity, and photoluminescence [137, 177, 228, 240]. For instance, the 
pore density for PSi layers of different size regimes is influenced by the silicon 
substrate doping density, as depicted in Figure   2.20. The detailed parameters and 
assumptions used in this plot are discussed in [229]. Figure   2.21 and Figure   2.22 
depict the examples of different pore morphologies as a function of anodisation 
current density, anodisation time and silicon doping density of n-type and p-type 
substrates, respectively. 
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Figure   2.20: Pore density as a function of silicon doping density for PSi layers of different size 




Figure   2.21: Cross-sectional view SEM micrographs showing the pore morphology at the interface 
between bulk and PSi for n-type <100> silicon substrate anodised galvanostatically in ethanoic HF 
electrolyte, as a function of current density, anodisation time and doping density (reprinted from 
[229]). 2.3 PSi as an Emerging Material in Drug Delivery Technology  51 
 
Figure   2.22: Cross-sectional view SEM micrographs showing the pore morphology at the interface 
between bulk and PSi for p-type <100> silicon substrate anodised galvanostatically in ethanoic HF 
electrolyte, as a function of current density, anodisation time and doping density (reprinted from 
[229]). 
The chemical stain etch method is a simpler alternative to the anodisation 
process for the porosification of silicon [241]. Stain etching is based purely on 
chemical reaction and does not require complex experimental equipment to provide 
an external bias. The generation of holes is essential in the stain etching process, as 
it is in the anodisation process, and this is achieved by introducing strong oxidising 
agents [242, 243]. HNO3 (sometimes with addition of sodium nitrate, NaNO2) is most 
commonly used as the oxidant, although potassium permanganate (KMnO4) and 
sodium chromate (Na2CrO4) [244] have been used as well. Non-uniform etching 
profiles are typical of stain etching due to bubble formation [180]. The possible 
thickness of PSi layer obtained by stain etching is often thinner than that produced 
by anodisation [245, 246]. These characteristics of stain etching may be the reasons 
behind a typically lower intensity in the photoluminescent emission observed in 
stain etched films [242, 244]. A more detailed review (see §3.2) and discussion on 
stain etching is presented in Chapter 3. 2.4 Conclusion    52 
Other methods to fabricate PSi include variations of stain etching processes, 
such as introducing intense illumination during stain etching to generate more 
electron / hole pairs (known as photochemical [230] or laser-assisted [231] etching); 
using heat to induce stain etching process (known as hydrothermal etching) [232]; or 
using the vapour generated by stain etching of a metal or silicon (known as reaction-
induced vapour-phase stain etching) [233]. Galvanic etching, which relies on internal 
current generated between silicon and a nearby noble metal immersed in HF-
hydrogen peroxide (H2O2) based electrolyte, has also been used to produce PSi [234-
237]. The internal current leads to a similar etching chemistry as in anodisation 
process, and thick (>10 μm) PSi layers could be formed this way. Relatively 
cylindrical macropores has also been produced when silver particles were used as the 
catalyst instead [238]. 
2.4  Conclusion 
The use of microsystems technology, to develop novel approaches and microdevices 
for drug delivery by oral administration, transdermal delivery and implantation, 
were discussed. These novel techniques, which include micromachined polymer [63, 
64] and silicon-based [65, 68-70] particles, biodegradable polymer-based [83, 101-
105] and solid [90] and hollow [94, 96, 97] silicon out-of-plane microneedles and 
implantable microfluidic [116, 119, 121] and non-microfluidic [125, 130-132] based 
microchips, offer an alternative to the conventional drug delivery technologies. The 
aims are to improve the bioavailability of therapeutic agents, to provide a controlled 
(either sustainable or pulsatile) drug release and, ultimately, to realise a responsive 
drug delivery system for improved therapeutic care with better patient compliance.  
Among the drug delivery microdevices studied, the implantable microchips 
offer the true potential of the benefit of microfabirication technologies. In particular, 
the non-fluidic based microchips [125, 130-132], which do not typically require 
moving parts (such as a micropump), offer a lower risk for dose-dumping upon device 
failure. The implantable microdevice depicted in Figure   2.10, developed by Langer 
and co-workers, is of particular interest. The concept, of trapping the drugs in 
individual reservoirs and later releasing the drugs in a controlled manner by 2.4 Conclusion    53 
electrical dissolution of the capping membrane, is an attractive approach. However, 
the issue of dose-dumping remains; accidental removal of the capping membrane 
could still release the drug adversely. 
A porous drug reservoir, with better entrapment and retention of the drugs, 
could offer a solution. Porous silicon (PSi) is an emerging material for drug delivery 
technology [54, 55], and is a good candidate to be used as the drug reservoir. PSi is 
biocompatible and can be made bioinert, bioactive or biodegradable depending on its 
microstructural properties (such as porosity and pore morphology) [60, 61, 207]. 
Various PSi structures, such as those depicted in Figure   2.21 and Figure   2.22, have 
been fabricated using electrochemical etching [137, 148, 165, 227-229] and other 
fabrication methods such as stain etching [241-243] and galvanic etching [234-237]. 
The porous structure is ideal for entrapping therapeutic agents and biodegradable 
PSi can be safely dissolved into the human body [62], thus introducing the 
therapeutic agents. The surface of PSi can also be suitably modified to favour 
adsorption of therapeutic agents [136, 239]. 
Thus far, micron-sized PSi particles, pieces or thin films have been used as 
drug delivery vehicles [54, 55] to carry nanosized payload including drugs, such as 
anticancer agent doxorubicin [213], steroid dexamethasone [204], ibuprofen and 
other model drugs [70, 214], imaging contrast nanoparticles [71] and biomolecules 
such as protein [215, 216], peptide [216] and enzyme [217]. However, there have 
been limited attempts to integrate PSi into a MEMS device for electrically-induced 
release of the drug. Therefore, a drug delivery microdevice incorporating a PSi drug 
reservoir is proposed and an attempt to fabricate the PSi structure using the stain 
etching method is discussed in Chapter 3. 54 
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Chapter  3 
The Fabrication of a Porous 
Polysilicon Device using Stain 
Etching 
3.1  Introduction 
Microfabricated drug delivery devices, in particular implantable microdevices with 
integrated electronics, have the potential to offer responsive and controlled delivery 
of therapeutic agents. So far, none of these systems has included both porous silicon 
(PSi) structures for drug storage and delivery, and electronics components for 
controlled drug delivery. PSi is biocompatible and its porous structure is ideal for 
entrapping the therapeutic agents into the pores by the capillary effect. Hence, a 
novel drug delivery system with an integrated PSi drug reservoir is proposed. 
Passive release by the dissolution of biodegradable PSi and the desorption or 
diffusion of drugs’ molecules could be used to provide a form of sustainable drug 
release. Here, as a prototype device, electro-thermal actuation is proposed as a 
mechanism for the active control in the release of the therapeutic agents [247]. By 
applying a current across a pair of electrodes and using the resistive porous silicon 
structure, it is envisaged that the entrapped drug could be released by local Joule 
heating. 
In this chapter, the design and fabrication of the prototype drug delivery 
device is described and discussed. A porous polysilicon (PPSi) structure is proposed 3.2 PPSi by Stain Etching: An Overview    55 
as the drug reservoir and its fabrication using the stain etching method is described. 
At present, limited information exists (in the literature) about the stain-etched PPSi 
structure, especially how the various conditions used for stain etching impact upon 
the different PPSi structures. In addition, stain-etched PPSi structures have not 
been evaluated for use as a drug reservoir. Hence, a series of investigations were 
performed to investigate the stain etching method’s suitability to fabricate a possible 
drug delivery structure. 
The study described here is focused towards applying established chemical 
stain etch conditions and the identification of the resultant morphology of the PPSi 
structure. The microstructural morphology and surface topography of the prepared 
samples have been characterised using scanning electron microscopy (SEM) and 
atomic force microscopy (AFM), respectively. 
3.2  Porous Polysilicon by Stain Etching: An 
Overview 
Stain etching is the primary alternative method to the conventional anodic 
porosification of silicon [241]. In contrast to the anodisation method, where an 
external bias to form porous silicon (PSi) is used, for stain etching an open-circuit 
chemical method is utilised with an oxidising agent, a fluoride source for oxide 
removal and a common diluent. Typical oxidising agents include nitric acid (HNO3) 
and sodium nitrate (NaNO2), while hydrofluoric acid (HF) is mainly used to dissolve 
the oxide formed. The common diluent is de-ionised (DI) water, although acetic acid 
(CH3COOH) is sometimes an alternative [242]. The advantages of using the stain 
etching method include (i) straight-forward implementation, (ii) relatively 
inexpensive experimental setup for wafer scale processing and (iii) compatibility 
with main-stream silicon microelectronics fabrication processes. However, most 
stain-etched porous structures suffer from relatively poor reproducibility and 
uniformity [180]. The possible maximum thickness of PSi layer obtained by the stain 
etching process is often thinner than that produced by anodisation due to a ‘self-
limiting’ effect [245, 246], which is a result of simultaneous etching of the top layer of 
porous film and the formation of the porous structure at the porous-crystalline 3.2 PPSi by Stain Etching: An Overview    56 
interface. These characteristics may be the reasons behind a typically lower intensity 
in the photoluminescent emission observed in stain-etched films [242, 244].  
3.2.1  Principle of Stain Etching 
Chemical etching of silicon is essentially an electrochemical process with localised 
cathode and anode sites [243], albeit in this case, the reaction is started chemically. 
The dissolution of silicon is believed to consumes holes (h+) [239, 242, 243] and in a 
typical electrochemical etching of silicon, the generation of holes is supplied by an 
external bias, which is sometimes assisted by a strong illumination [227]. For the 
stain etching method, on the other hand, the key contributor to the injection of holes 
is the reduction of an oxidising agent at the cathode sites [242, 243]. In a typical 
stain etching system consisting of HNO3 (as the oxidising agent) and HF (as the 
fluoride source), the overall chemical reaction can be written as follows [243]: 
( )( )
− + ⋅ − + ⋅ − + ⋅ + ⋅ + ⋅ → ⋅ + ⋅ + ⋅ e n h n 4 3 4 3 O H 8 NO 4 SiF H 3 HF 18 HNO 4 Si 3 2 6 2 3
(  3.1) 
where h+ and e– are the exchanged holes and electrons, respectively; and n is the 
average number of holes  required to dissociate one atom of silicon. In principle, this 
reaction can be analysed by the reactions occurring at both the cathode and anode 
sites separately. 
The localised cathode and anode sites are typically formed randomly during 
the etching process. The local cathode sites are formed by reaction or attack by the 
HNO3 at the surface of the crystalline silicon, especially at the defect sites, such as 
dislocation or grain boundaries [242]. The HNO3 reduces to nitric oxide (NO) at these 
cathode sites via a complex, multi-step reaction and, in the process, holes required 
for the anodic dissolution of silicon are generated [243]. The typical reaction at these 
cathode sites can be written as follows: 
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If the injected holes react with silicon, the silicon atoms will be dissolved and 
thereby switch the original local cathode site into an anode site [242]. Depending on 
the composition of the etching solution, hence the rate of etching and the current 
multiplication factor, the average number of holes (n) required to dissociate one atom 
of silicon can range from 2 to 4 [243]. In general, a dissolution valence of 4 is 
assumed for HNO3-rich solutions and hence no excess holes and electrons are 
produced [243], based on equation 3.1. However, for HF-rich solutions, silicon 
dissolution could be divalent [222, 225], hence producing excess electrons and holes. 
The dissolution of silicon is believed to be a two-step process. Firstly, silicon dioxide 
(SiO2) is formed as a result of hole injections (equation 3.3). The SiO2 then reacts 
with HF to form a water-soluble silicofluoride (H2SiF6) complex (equation 3.4). These 
reactions can be written as follows: 
( )
− + + ⋅ − + ⋅ + → ⋅ + ⋅ + e n h n 4 H 4 SiO O H 2 Si 2 2     (   3.3) 
O H 2 SiF H HF 6 SiO 2 6 2 2 ⋅ + → ⋅ +      (   3.4) 
The residual H+ at the anode site (equation 3.3) might participate in further reaction 
with HNO3 (equation 3.2) and hence repeat the reaction cycle. The constant 
switching of the reaction (from the cathodic to anodic reaction) thus results in 
polishing of the silicon by uniformly removing the surface of a silicon substrate [242]. 
In contrast, during the formation of PSi, the etching of silicon is non-uniform. 
In this case, the holes from the cathode reaction may not react with the silicon at the 
original site. Instead, the holes may recombine with the free electrons from the 
solution before they can react with silicon or may move to another site due to more 
favourable surroundings [242]. Therefore, the original site remains a cathode while a 
corresponding site, somewhere else, remains an anode (in order to keep the overall 
reaction neutral). Over time, this non-uniform, preferential etching produces a 
rough, porous surface [242]. The rate limiting factor in the stain etching process is 
believed to be the formation of HNO2 during the complex reduction of HNO3 [225, 
242]. The reaction cannot occur until a trace of HNO2 exists and this “wait” time is 
typically known as the incubation time, ti. 3.2 PPSi by Stain Etching: An Overview    58 
3.2.2  Stain Etching of Silicon 
Fuller and Ditzenberger first reported a “dark stain” surface appearance similar to 
that observed on anodised silicon, during a chemical etching of silicon in solution 
containing HF and HNO3, without applying external bias [223]. Archer [225] and 
Turner [243] later described chemical stain etching of silicon in greater detail. By 
using cross-sectional transmission electron microscopy (TEM), Beale and co-workers 
confirmed that these stain-etched films were indeed porous silicon [248]. They also 
demonstrated, for the first time, that oxidising agents such as NaNO2 and chromium 
trioxide (CrO3) could be used in place of HNO3.  
The earliest studies on the room-temperature photoluminescence (PL) of 
stain-etched PSi were reported by Fathauer et al. [180] and Sarathy et al. [181]. In 
their investigation, Fathauer and co-workers used silicon substrates with various 
levels of resistivity, doping and crystal orientation and stain etching solutions 
consisting of HF:HNO3:H2O with volume ratios of either 1:5:10 or 4:1:5 [180]. They 
observed that under white light, these stain-etched PSi films appeared to be coloured 
(from brown, blue to yellow) and these colours changed with increased etch time. 
Under ultraviolet irradiation, the samples emitted dull red to bright orange light. 
Although they have also used NaNO2 in HF and CrO 3 in HF as the stain etching 
solution, they only observed PL in films stain-etched with NaNO2 in HF. 
Concomitantly, Sarathy and co-workers also demonstrated that silicon stain-
etched for 5 minutes in a solution containing HF:HNO3:CH3COOH:H2O (with a 
volume ratio of 1:2:1:4) exhibited a PL spectrum when exposed to a 488 nm laser 
[181]. They also observed a degradation in the PL intensity as the exposure time was 
increased. In a separate study, when compared to an anodised PSi sample, they 
observed an order of magnitude smaller PL intensity with a slight blue shift from 
PSi stain-etched in 1:3:5 HF:HNO3:H2O for 120 s [242]. The stain-etched porous 
films were also limited in thickness due to the mechanism of chemical etching. The 
incubation time, ti, was found to be strongly dependent on the content of HNO3 in the 
etching solution. 
Steckl and his group later associated the ti of stain etching to the resistivity, 
ρ of the substrate [249]. They observed, for p-type boron-doped silicon substrates, 3.2 PPSi by Stain Etching: An Overview    59 
that the ti increased significantly with greater silicon substrate resistivity; while for 
phosphorus-doped n-type silicon substrates, increased resistivity resulted in a 
shorter ti. By exploiting this phenomenon, they selectively doped an n-type substrate 
with 30 kV Ga+ using a focused ion beam (FIB) to achieve, for the first time, a 
selectively patterned photoluminescence with submicron resolution [249, 250]. 
 
Figure   3.1: Plot of porous layer thickness, h against the etching time in 1:6:5 (1, ■) and 1:6:6 (2, U) 
volume ratio of HF:HNO3:H2O observed by Starostina et al.. The substrate used was <100>, 7.5 
Ωcm p-type silicon (reprinted from [246]). 
The primary recipe used for the stain etching process mostly consists of HF, 
HNO3 and DI water with various volume fractions and composition ratios. Starostina 
et  al. investigated the effect of changing these chemical compositions on the 
morphology of the resultant porous film [246]. In one scenario (type I), they used a 
higher proportion of HNO3 than HF and evaluated 10 different volume ratios. The 
use of DI water was found to be critical in this system as no pores were observed 
without the addition of DI water. They also found that the thickness of the porous 
layer varies in an oscillatory fashion, as depicted in Figure   3.1, and the absolute 
thickness is determined by various factors such as etching time and substrate 
resistivity. In the other scenario (type II), a higher proportion of HF to HNO3 is used, 
and they evaluated 5 different volume ratios. Contrary to the previous studies, they 
observed that without the addition of DI water, the porous layer formed and the 
thickness was in fact higher than that formed by type I system. They conclude that 3.2 PPSi by Stain Etching: An Overview    60 
for the type II system, there is a less critical transition between a porous etch and 
etch polishing and hence a more controllable stain etching is achieved. 
Vázsonyi et al. also observed a similar limited thickness in stain-etched PSi 
film [245]. By using gravimetry and spectroscopic ellipsometry, they concluded that 
the thickness was ‘self-limiting’ due to simultaneous etching of the top layer of 
porous film and the formation of the porous structure at the porous-crystalline 
interface. The stain etching solutions with volume ratios of between 50:1 and 500:1 
of HF:HNO3, were used.  
On the other hand, Kelly et al. used different stain etching compositions and 
reported a more reproducible PL (admittedly with a quantum yield ~ ¼ of that 
observed with anodised porous silicon) [244]. The stain etching systems investigated 
include those using solutions with various oxidising agents such as nitrosonium 
tetrafluoroborate (NOBF4), NaNO2, potassium permanganate (KMnO4) and sodium 
chromate (Na2CrO4), with sulphuric acid (H2SO4), perchloric acid (HClO4) and DI 
water as diluents. They proposed that, instead of HNO2 [243], nitrosodium ions 
(NO+) were the active oxidising agents in the reduction of HNO3 to NO, due to a 
more positive redox potential of NO+ which suggests that NO+ is a better source of 
injectable holes [244]. 
Nahidi and Kolasinski later proposed that a large positive redox potential is 
not the sole deterministic factor in the reliable fabrication of porous silicon [251]. 
They demonstrated that bubble formation is more deleterious to film homogeneity 
and can be avoided by using transition metal-containing oxidants such as ferric 
chloride (FeCl3) and sodium permanganate (NaMnO4). Less bubble formation and 
more intense PL were also observed when acidified ammonium hydrogen fluoride 
(NH4HF2) was used in place of HF. They also found that, by using an oxidant with a 
more positive redox potential, a blue shift of the PL occurred. 
More recently, González-Díaz and co-workers investigated the effect of 
temperature on stain etching and reported that, at low temperature (< 10 °C), 
samples etched for 2 minutes exhibited an anisotropic structure preferentially 
oriented to Si <100> direction [252]. However, the PL intensity of these samples was 
relatively low, possibly due to the larger size of porous structure produced. 3.2 PPSi by Stain Etching: An Overview    61 
3.2.3  Porous Polysilicon 
Polycrystalline silicon (polysilicon) is an important material both in microelectronics 
systems and MEMS and its properties have been extensively studied [253, 254]. 
Polysilicon is the polycrystalline form of silicon which is made up of small single-
crystal domains called grains [255]. It can be deposited with various crystallinities 
and grain sizes using the chemical vapour deposition technology [255]. The as-
deposited polysilicon has very high resistivity, but this can be altered by introducing 
dopants by diffusion or ion implant techniques [255, 256]. On the other hand, 
polysilicon has been demonstrated to be more chemically reactive than bulk single-
crystalline silicon and, like microporous silicon, is bioactive [257]. Hence, it is 
reasonable to expect that the porous form of polysilicon is also a bioactive material. 
In fact, porous polysilicon (PPSi) has long been considered as a potential material in 
MEMS [258]. PPSi has shown significant potential for integration into 
optoelectronics devices [144], field emission displays [259], as permeable layers for 
MEMS device packaging [260] and as gas sensors [261, 262]. 
Despite the vast depository of literature on porous silicon (including stain-
etched PSi) and anodised PPSi, the use of stain etching on polysilicon substrates is 
not widely reported. The earliest report on using stain etching to form a PPSi 
structure is probably by Jung and co-workers [263]. They demonstrated that 
epitaxially grown boron-doped amorphous silicon showed visible PL only after 
annealing at temperature ≥ 725 °C (hence, polycrystalline) and stain-etched in a 
solution with a ratio of 5:12:32 by volume of HF:HNO3:H2O. Steckl and his group 
later demonstrated similar results and showed that, by using a 1:3:5 volume ratio of 
HF:HNO3:H2O, phosphorus-doped and undoped polysilicon film on oxidised silicon or 
quartz could be made porous [182]. In this case, the polysilicon was deposited at 180 
mTorr using low pressure chemical vapour deposition (LPCVD) from silane (SiH4). 
By incorporating X-ray diffraction (XRD), scanning electron microscopy (SEM) and 
atomic force microscopy (AFM) studies [264], they observed that the pore sizes and 
surface morphologies of PPSi film, as depicted in Figure    3.2, varied with the 
crystallinity of the polysilicon films deposited at different temperatures. They 
further suggested that, to a certain degree, the presence of surface Si oxyhydrides 


































Figure   3.2: Plane-view SEM micrographs of the (a)-(c) as-deposited and (d)-(f) stain-etched 
polysilicon reported by Steckl et al.. The 1 μm thick polysilicon was deposited using LPCVD at 
various temperatures as indicated. The stain etching was carried out in 1:3:5 volume ratio of HF: 
HNO3: H2O for 2 minutes (reproduced from [264]). 
200 nm
 
Figure   3.3: Oblique, cross-sectional view SEM micrograph of a PPSi first primed in 1:5:5 HF: 
HNO3: H2O followed by stain etching in 1:3:5 HF: HNO3: H2O (reproduced from [188]). 
In a separate study, Huang and co-workers incorporated a pre-etching step, 
by a 1:5:5 volume ratio of HF:HNO3:H2O to reduce the incubation time [188]. The 
stain-etched film, as depicted in Figure   3.3, consists of large granules of size 800 nm 
to 1000 nm, with gaps or cracks between the granules. They ascribed the formation 
of these gaps to a faster etch rate due to higher defect densities at these regions. On 
the other hand, Higa and co-workers used 500:1 volume ratio of HF:HNO3 to produce 
PPSi films that exhibit PL peaks ranged between 610 nm and 680 nm, depending on 
the annealing temperature of the polysilicon [266]. 3.2 PPSi by Stain Etching: An Overview    63 
An alternative approach to form PPSi, using a self-aligned oxide mask, has 
been demonstrated by Han et al. [267]. A thicker oxide layer can naturally form, at 
the polycrystalline grain boundaries, during the thermal oxidation. When the oxide 
was etched using a short reactive ion etching (RIE), the thicker oxide at the grain 
boundaries remained and served as a mask. Subsequent RIE of the polysilicon 
formed the polysilicon islands. 
The deposition of polysilicon using LPCVD, within a narrow process window, 
can spontaneously form pores of 10 nm to 50 nm in diameter [268]. Dougherty et al. 
demonstrated that polysilicon films deposited using LPCVD at 550 mTorr and ~ 600 
°C are permeable, suggesting the formation of pores [268, 269]. Permeable 
polysilicon films were observed at a well-defined process window located at the 
transition between the tensile, low temperature film growth, and a compressive, high 
temperature growth regime. 
3.2.4  Summary 
The stain etching method to produce PSi and PPSi structures has the advantage of 
straight-forward implementation, relatively inexpensive experimental setups for 
wafer scale processing and compatibility with main-stream silicon microelectronics 
fabrication processes. However, it is generally accepted that most stain-etched 
porous structures suffer from relatively poor fabrication reproducibility and non-
uniformity, possibly due to the uncontrolled differences in incubation time and the 
random sites of pore initiation and pore growth [225, 242, 249]. The possible 
thickness of PSi layers, obtained by stain etching methods, is usually thinner than 
that produced by anodisation due to the self-limiting process [245, 246] and this 
could explain the typically lower intensity in the photoluminescent emission 
observed in stain-etched films compared to anodised porous film [242, 244]. 
A summary of various different stain etching conditions, including the 
chemical composition and etch time, in producing PSi and PPSi, and the 
microstructural and photoluminescent properties of the resultant PSi and PPSi 
structures, is presented in Table   3.1. As summarised therein, the combination of HF, 
HNO3 and DI water, with a typical volume ratio of 1:3:5, is the most widely used 












































Characterisations  First Author 
(Year, 
Reference) 




p-type and n-type with 
various resistivity in both 
<100> and <111>  Si 
1:5:10 or 4:1:5 HF:HNO3:H2O; 
NaNO2:HF; CrO3:HF; typical 30 s 
to 10 min 
(SEM, TEM, XPS) Non-planar, 
“web-like” surface; ~ 0.5 μm thick; 
amorphous near surface 




Si substrates (type and 
resistivity not reported) 
1:2:1:4 HF:HNO3:CH3COOH:H2O; 
5 min 
(AFM) 40 nm to 60 nm feature 
size; (0.8 – 1.0) μm  thick 




p-type ((0.02 – 24) Ωcm) and 
n-type ((0.1 – 10) Ωcm) Si 
1:3:5 HF:HNO3:H2O, 120 s 
(SEM) p-type: Rough and pitted 
(thousands of Å); n-type: irregular 
cracks; (100 – 1000) nm thick 




p-type annealed and un-
annealed amorphous Si on Si 
5:12:32 HF:HNO3:H2O 
(TEM, TED) Amorphous-like, no 
evidence of micro-crystallite 
Peaks centred at ~ 
640 nm to 680 nm 
Steckl 
(1993, [182]) 
n-type, 400 nm thick, 
polysilicon on oxidised Si, 
~20 Ω/sq 
1:3:5 HF:HNO3:H2O, 30 to 120 s 
(SEM) Grainy; doped: ~ (0.2 – 0.4) 
μm; undoped: ~ (0.1 – 0.2) μm; 
(AFM) surface roughness 18.0 nm, 
Peaks centred at 




polysilicon, 1 μm thick 
500:1 HF:HNO3, 1 min 
(FEGSEM, TEM) ~ 5 nm nano- 
crystallites; (500 – 700) nm thick, 
Peaks centred at 
610 nm to 680 nm 
Huang 
(1997, [188]) 
p-type, 1 μm thick polysilicon 
on Si; 1015 cm-3 doping 
1:3:5 HF:HNO3:H2O with pre-
etching in 1:5:5 volume ratio 
(SEM, TEM, XRD) Large granules 
(800 – 1000) nm with gaps in 
between; amorphous-like; faster 
etching at <111> 
Peaks at 720 nm 
Starostina 
(2002, [246]) 
p-type ((0.01, 7.5, 12 and 
1000) Ωcm), <100>  and high 
resistivity <111> doped to n+-
type (0.003 Ωcm) Si 
Type I (1:20:0, 1:15:0, 1:6:2, 1:6:3, 
1:6:5, 1:6:6, 1.2:6:15, 1.3:6:15, 
1.3:6:25, 1:7:20) and Type II 
(1500:1:0, 1200:1:0, 900:1:0, 
250:1:0 and 4:1:5) HF:HNO3:H2O 
(TEM, profilometer, SIMS) 
Oscillating thicknesses; Type 1: 20 
nm to 250 nm; Type 2: 150 nm to 
630 nm 
Not reported 
Table   3.1: Summary of selected stain-etching conditions used in the formation of porous silicon (PSi) and porous polysilicon (PPSi) discussed in §  3.2. The 
microstructural characteristic and photoluminescent (PL) property of the resultant PSi and PPSi are included for comparison. 3 3 Design of a PPSi Drug Delivery Device    65 
 
PPSi structure after stain etching in 1:3:5 volume ratio of HF:HNO3:H2O were 
reported to be either rough and pitted [242] or grainy [182] and granular-like with 
cracks [188], with typical PL peaks centred at 630 nm to 720 nm. This system is used 
as the starting point for the investigation here and the development of a stain 
etching process to form a PPSi structure within the prototype drug delivery device. 
3.3  Design of a Porous Polysilicon Drug 
Delivery Device 
The implantable drug delivery microdevices, reported so far, are equipped with one 
or more micromachined physical containers as drug reservoirs, which are usually 
capped with biocompatible membranes [125, 130]. A major concern of such a design 
is the potential for dose-dumping upon device failure, especially the accidental 
rupture of the membrane. To address this concern, it is proposed that a porous 
structure, such PSi, is instead used as the drug reservoir. PSi is biocompatible and 
can be made bioinert, bioactive or biodegradable by manipulating its microstructural 
properties, such as porosity and pore morphology [60, 61]. The porous structure is 
ideal for entrapping therapeutic agents by the capillary effect. The biodegradable PSi 
can be readily and safely dissolved into the human body [62], bringing along the 
therapeutic agents; while bioinert PSi can rely on the desorption or diffusion of drugs 
into the human body. These forms of passive release offer a uniform sustainable drug 
delivery. 
Here, a prototype drug delivery device based upon the concept of integrating 
a porous structure as a drug reservoir is proposed. The initial design of the prototype 
device, as depicted in Figure   3.4, and the fabrication process (discussed in §  3.3.2) 
have been conceptualised by C. Kaminski as an exchange student project [247]. In 
the design, electro-thermal actuation is envisaged as a mechanism for active control 
in the release of the therapeutic agents; a pair of electrodes is to be integrated into a 
porous drug reservoir. The nanopores are envisaged to be filled with liquid soluble 
therapeutic agents, which are introduced and incorporated by the capillary effect. By 
applying a current across the resistive porous drug reservoir, via the pair of 
electrodes, the entrapped drug could be released by Joule heating. With an 3 3 Design of a PPSi Drug Delivery Device    66 
 
integrated microelectronics system, a pulsatile release profile would be possible 
using a pre-programmed microcontroller or a telemetry circuitry, which is ideal for 
the therapeutic control of critical conditions. Alternatively, drugs could be released 
passively, either by desorption or diffusion, and this could be used where a more 




Figure   3.4: Oblique, cross-sectional view conceptual illustration of the envisaged prototype drug 
delivery device (not to scale; refer to Figure   3.5 for further fabrication details and colour scheme of 
materials used).  
3.3.1  Design Considerations and Challenges 
In order to realise a device, such as the one envisaged in Figure   3.4, a few design 
issues and requirements have to be considered. These design considerations are 
highlighted as follows: 
(I)  A good electrical isolation to the pair of electrodes is required to ensure 
that all the supplied current is used for heating the porous drug reservoir; 
(II)  A good thermal insulation is required so that the Joule heating generated 
is not unnecessarily dissipated to the external environment; 
(III)  A good contact between the pair of electrodes and the pores is essential to 
ensure efficient current conduction; 3 3 Design of a PPSi Drug Delivery Device    67 
 
(IV)  A porous structure with good electrical conductivity is essential to ensure 
current conduction between the pair of electrodes. A porous structure 
with suitable microstructural characteristics (pore size, porosity and 
thickness) is also desirable for ease of drug loading; 
These challenges, to some extent, are inter-related and hence a number of 
compromises are inevitable. It is, however, apparent that the silicon substrate will 
only be used as the handle wafer and a dedicated device area is certainly needed to 
ensure good electrical isolation and thermal insulation. Commonly, this is achieved 
by using a thick layer of dielectric material, such as silicon dioxide (SiO2) to separate 
the device layer from the bulk silicon. The silicon-on-insulator (SOI) technology is 
considered to be the most straight-forward to implement, as it essentially consists of 
two silicon layers sandwiching a dielectric (typically SiO2) layer. However, 
commercially fabricated SOI wafers are generally more costly; while ex-stock SOI 
wafers may not meet the required thickness and resistivity of the silicon device layer 
(of the SOI wafers). The device layer will mainly contain the porous drug reservoir 
and hence has to have a suitably low resistivity to address issue (IV), described 
earlier. Moreover, as the electrodes need to be in good contact with the porous 
structure (issue (III)), a porous thickness feasible for the fabrication of the electrodes 
has to be considered. 
Therefore, polysilicon is used as the material for the device layer for a 
number of reasons. Firstly, it can be practically deposited on almost any substrate to 
a reasonable thickness (up to 10 μm [270]). Its resistivity can be modified using ion 
implantation or diffusion to a desirable level, hence it is an attractive proposition to 
address issue (IV). Polysilicon has also been demonstrated to be bioactive [257], 
hence the drug reservoir made of PPSi is expected to be at least, biocompatible. By 
depositing a layer of polysilicon on a thick SiO2 layer (buried SiO2), an electrical and 
thermal isolation analogous to the SOI technology can be realised. 
Next, a device area has to be considered to define the porous drug reservoir. 
This, however, is related to how the PPSi is to be made. In this case, the anodisation 
method for the formation of PPSi is less appealing as the fabrication process would 
be complicated with the need for extra electrical contacts. In fact, the contacts would 
have to be fabricated on either the polysilicon device layer or connected to the bulk 3 3 Design of a PPSi Drug Delivery Device    68 
 
silicon (for back contact) outside the device area. Hence, the alternative stain etching 
process is preferred here due to its simple and cost effective fabrication setup, which 
is vital when fabricating a prototype device. In addition, since polysilicon can be 
deposited with various crystallinities and grain sizes, preferential etching at the 
grain boundaries, observed in the stain etching [242, 271], could be used to 
advantage. The resistivity of the polysilicon could also be modified to favour the stain 
etching process. A photolithographically patterned masking material, such as silicon 
nitride (Si3N4), which is resistant to the stain etching solutions, can then be used to 
define a region as the porous drug reservoir. 
For the electrodes, aluminium is proposed as the best material. Compared to 
other conductive materials, such as gold and copper, aluminium is relatively 
inexpensive, it is easier to deposit a sufficient thickness using the evaporation 
method and normally it does not require a metallic interlayer (such as chromium or 
titanium) to promote adhesion to the sample surface. However, to fully meet the 
requirement (III), further development may be necessary to ensure that the 
evaporated aluminium is able to impregnate the formed PPSi structure. 
Since the formation of the porous drug reservoir must be done before the 
fabrication of the electrodes, a compatible fabrication process has to be developed. 
The lift-off method is hence proposed. Lift-off is a process where a target (usually 
metal, and in this case aluminium) thin film is patterned by removal of a sacrificial 
material (typically photoresist) underneath, hence lifting away the target film at the 
unwanted areas [272]. In contrast, a conventional wet etch process requires a 
selective chemical etchant to etch the metal film and this could leave undesirable 
inorganic residues within the fabricated PPSi structure. 
The electrodes must also be electrically isolated from the device layer (issue 
(I)). This could be achieved by using standard dielectric materials, such as the Si3N4 
and SiO2. In fact, both materials are proposed to be used to also provide a masking 
material, as discussed previously, to define a device area for the porous drug 
reservoir. 
The conceptualised device has a total size of 12 mm x 12 mm, with a 6 mm 
diameter circular region which defines the PPSi drug reservoir. The buried SiO2 is 3 3 Design of a PPSi Drug Delivery Device    69 
 
proposed to be 600 nm thick, which should be sufficient to isolate, electrically and 
thermally, the device layer from the bulk silicon substrate. The proposed polysilicon 
device layer is 1 μm thick, with four different resistivity levels to facilitate the 
investigation of suitable stain etching conditions. Although a thicker polysilicon 
layer (hence yielding a thicker PPSi structure) may be advantageous for drug 
loading, because of the “self-limiting” effect of the stain etching process, a porous 
thickness formed in this way has been typically limited to less than 1 μm thick [228]. 
In addition, the deposition of aluminium of > 1 μm thick is technically challenging 
using the proposed evaporation method. Hence, a polysilicon layer of 1 μm thick is 
deemed a good compromise. The Si3N4 and the SiO2 layer are proposed to be 160 nm 
and 300 nm thick, respectively, and to be patterned by photolithography and RIE. 
The aluminium is proposed to be 1 μm (similar to the thickness of polysilicon device 
layer), but the achievement of a good step coverage, at the boundary of the PPSi drug 
reservoir, has to be verified to ensure good conductivity. A fabrication process to 
realise the proposed prototype device is discussed next. 
3.3.2  Proposed Fabrication Process 
The design of the fabrication process has taken into consideration the four 
requirements (I to IV) discussed in §  3.3.1. A number of electrode designs have also 
been considered [247] and translated into mask layouts (mask KB35M, see Appendix 
B.1.1 and B.1.2). The proposed fabrication process has been divided into 3 main 
stages and its major steps are schematically depicted in Figure    3.5. The 3 main 
stages of the fabrication are:  
Stage 1:  Fabrication of the device area with a multilayer structure (steps (a) to 
(h) in Figure   3.5). 
Stage 2:  Formation of a PPSi layer using the stain etching method (step (i) in 
Figure   3.5). 
Stage 3:  Fabrication of electrodes using the lift-off method (steps (j) to (k) in 
Figure   3.5). 3 3 Design of a PPSi Drug Delivery Device    70 
 
g) Etch Si N  and SiO  by RIE 34 2
a) Grow SiO  by wet oxidation 2
b) Deposit polysilicon by LPCVD
c) Dope polysilicon by ion implantation
d) Deposit SiO  by LTO, then high temperature drive-in 2
e) Deposit Si N  by LPCVD 34
f) Spin and pattern photoresist by photolithography ( ) KB35M-AA
h) Strip photoresist by plasma ashing and FNA
Stage 1: Fabrication of Device Area
 
 
Figure   3.5: Schematic illustration of the fabrication process of the porous polysilicon drug delivery 





j) Spin and pattern bi-layer photoresist by photolithography ( ) KB35M-M1
k) Deposit aluminium by evaporation
l) Lift-off aluminium by stripping photoresist
 Silicon Substrate
 Undoped Polysilicon
 Silicon Dioxide, SiO2
 Doped Polysilicon





Stage 2: Formation of PPSi Layer
Stage 3: Fabrication of Electrodes
 
 
Figure   3.5: Schematic illustration of the fabrication process of the porous polysilicon drug delivery 
device (not to scale). 3 3 Design of a PPSi Drug Delivery Device    72 
 
Stage 1: Fabrication of the Device Area 
The first fabrication stage is to define a device area with the necessary electrical 
isolation and the masking layers for subsequent processes. The resistivity of the 
polysilicon device layer is also processed using ion implantation to achieve the 
desired resistivity levels. The resultant structure is expected to have a 6 mm 
diameter circular region with an exposed polysilicon layer, while being isolated from 
the bulk silicon substrate by the buried SiO2, as conceptually depicted in Figure   3.6. 
The starting material consists of both p- and n-type 100 mm diameter silicon wafers. 
As illustrated in Figure   3.5, the major fabrication steps for Stage 1 are: 
Step (a) The wafers are first cleaned using a standard two-stage RCA19 silicon 
cleaning process [273]. A wet thermal oxidation is then carried out at 1100 °C to 
grow a layer of 600 nm thick SiO2. Apart from electrically and thermally isolating 
the device layers from the bulk silicon substrate, it also minimises the dopant 
diffusion from the polysilicon device layer to the silicon substrate during, and post, 
ion implantation [274]; hence improving the doping profile of the polysilicon. 
Step (b) A layer of 1 μm thick polysilicon is deposited by thermal decomposition of 
silane (SiH4) at 610 °C using the LPCVD method.  
1 m  Polysilicon μ




Figure   3.6: Oblique, cross-sectional view, schematic illustration of the prototype device after the 
first stage of fabrication (not to scale). 
                                                           
19 The RCA clean was first developed by Werner Kern at the Radio Corporation of America (RCA), hence the 
name. It consists of first stage clean with a 1:1:5 volume ratio of NH4OH: H2O2: H2O followed by a second stage 
clean in a 1:1:6 volume ratio of HCl: H2O2: H2O. In both stages, the cleaning is carried out at a temperature of 
between 75 °C and 85 °C, for 10 min to 20 min. 3 3 Design of a PPSi Drug Delivery Device    73 
 
Step (c) The polysilicon layer is doped with either boron (for p-type) or phosphorus 
(for n-type) using ion implantation with four different implantation parameters (dose 
and energy), as summarised in Table   3.2, to achieve different resistivity levels. The 
effect of these ion implantations on the resistivity of the polysilicon layer is further 
discussed in §  3.4.1. 






(Ω/sq) [247]  Dose (ion/cm-2) Energy  (keV) 





40  Boron, 5 x 1015 80 




1  Boron, 1 x 1016 80 




100  Boron, 5 x 1014 50 






1.8 x 1012 
100 
Table   3.2: Summary of the dose and energy used in the ion implantation process. Wx denotes the 
wafer number and wafers #c13p, #c14p, #c15p and #c4n are the four check wafers used for the 
measurement of sheet resistance. The Rs_exp are calculated based on a process simulation detailed 
in [247]. 
Step (d) A layer of SiO2 with a nominal thickness of 300 nm is then deposited on the 
wafers by low temperature oxidation (LTO) at 400 °C using SiH4 and O2 gases. This 
SiO2 layer firstly protects the polysilicon during the subsequent high temperature 
drive-in process; and secondly serves as an adhesion and a stress relief layer for the 
subsequent Si3N4 deposition. Next, the drive-in, or annealing, process is carried out 
at 1150 °C under a nitrogen atmosphere for 200 minutes. This process activates and 
distributes the ion implanted boron or phosphorus dopants so that the polysilicon 
lattice could be re-crystallined after the anticipated damage from the implantation 
process and thus produces a homogenous doping profile [275]. 
Step (e) A layer of 160 nm thick Si3N4 is deposited by LPCVD at 740 °C using 
dichlorosilane (SiCl2H2) and ammonia (NH3) gases. The as-deposited Si3N4 layer 
exhibits a tensile stress which is compensated by the underlying SiO2 layer.  
Step (f) A layer of Shipley SPRT-510 photoresist (positive) is spin-coated on the 
wafer at 6000 rpm to achieve a nominal thickness of 1.1 μm. The photoresist is then 
exposed with the first mask (mask KB35M-AA, see Appendix B.1.1) and developed. 3 3 Design of a PPSi Drug Delivery Device    74 
 
Subsequently, the photoresist is hard baked for 1 hour at 140 °C in an oven to 
improve its robustness to sustain the RIE process. 
Step (g) A mixture of argon (Ar) and trichloromethane (CHF3) is used for the RIE 
process. For etching the Si3N4 layer, the flow rate of the Ar / CHF3 gas mixture is set 
at 6 sccm / 3 sccm; while to etch the SiO2 layer, the flow rate of both Ar and CHF3 
gases is set to 25 sccm each. A pressure of 25 mTorr and a radio frequency (RF) 
power of 160 W are used for the RIE of the Si3N4 layer; while the pressure and RF 
power used for RIE of SiO2 layer are 40 mTorr and 200 W, respectively.  
Step (h) The photoresist is stripped using O2 plasma ashing and cleaned in fuming 
nitric acid (FNA). 
Stage 2: Formation of a PPSi Layer 
The wafers are then stain-etched to form the PPSi layer within the exposed 
polysilicon region, as masked by the patterned SiO2-Si3N4 layers. Based on previous 
work [247, 276] and from literature recipes (see §  3.2, [182, 188, 242]), a volume ratio 
of 1:3:5 of HF:HNO3:H2O, with an etching time ranging from 10 s to 60 s, was 
proposed for the initial investigation of the stain etching process. The lower 
percentage of HF in the stain etching solution is preferred over other systems [246, 
266], in order to minimise the undercut caused by HF to the SiO2 masking layer. The 
etching conditions are fine-tuned in order to take into account the different 
resistivity of the wafers and the incubation time. The major step in Stage 2 
fabrication, as illustrated in Figure   3.5, includes: 
Step (i) PPSi layer is formed using the stain etching. 
Stage 3: Fabrication of electrodes 
Lastly, the electrodes are fabricated onto the wafers using the lift-off method with a 
bi-layer photoresist (MicroChem’s polymethylglutarimide (PMGI) and Shipley S1813 
photoresist) [272]. The S1813 photoresist (positive) is used as the patterning 
photoresist which would be photolithographically defined. The PMGI photoresist 
(positive) is used to provide extra undercut so that the bi-layer photoresist could be 3.4 Fabrication of Device Area (Stage 1)    75 
 
feasibly stripped during the last lift-off step. As illustrated in Figure   3.5, the major 
steps for Stage 3 fabrication are: 
Step (j) The PMGI is first spin-coated at 4000 rpm for 30 s to achieve a nominal 
thickness of 1 μm. The PMGI is then soft baked before being flood-exposed with deep 
ultraviolet (UV) light. The S1813 photoresist is then spin-coated at 5500 rpm for 30 s 
and exposed using the second mask (mask KB35M-M1, see Appendix B.1.2). The bi-
layer photoresist is then developed and hard baked at 95 °C for 30 minutes.  
Step (k) A quick dip into 20:1 BHF is carried out to remove the native oxide and a 
blanket of 1 μm thick aluminium is then evaporated onto the wafers.  
Step (l) The bi-layer photoresist is removed in N-methylpyrrolidone (NMP) to realise 
the electrode patterns. 
3.4  Fabrication of the Device Area (Stage 1) 
The proposed fabrication has been carried out using the batch number K2714s 
(process listing detailed in Appendix A.1) as detailed in [247, 276]. The Stage 1 
fabrication to realise the device area was carried out at the cleanroom facility at the 
then Southampton University Microelectronics Centre (SUMC) (later known as 
Innos Ltd. (Innos)). All of the processes in Stage 1 fabrication were processed at the 
wafer level, mostly performed by the technical staff of SUMC / Innos. Some results 
and issues faced during the fabrication are discussed here in two parts. 
3.4.1  Results and Discussions: Part 1 (Steps (a) to (e)) 
Steps (a) to (e) (Figure   3.5) of the Stage 1 fabrication were carried out to create a 
suitably doped device layer with a multilayer structure which aims to provide an 
adequate electrical isolation and a masking region for the stain etching process. The 
parameters used in the fabrication are detailed in [247, 276]. The thickness of each 
of the layers was measured post fabrication using a tabletop small spot spectroscopic 





Step (a) Wet Oxidation  SiO2  600 ± 20  595.5 ± 1.1 
Step (b) LPCVD Polysilicon  Polysilicon 1000  ±  25  1049.2 ± 1.0 
Step (d) LTO  SiO2  300 ± 30  289.6 ± 21.8 
Step (e) LPCVD Si3N4 Si3N4  160 ± 20  159.6 ± 1.9 
Table   3.3: Summary of the layer thickness measured after each process steps (a) to (e) (refer to 
Figure   3.5 for the complete fabrication flow). 
As summarised in Table    3.3, apart from the thickness of the LPCVD 
polysilicon, the measured thicknesses of the buried SiO2 (Step (a)), LTO SiO2 (Step 
(d)) and the LPCVD Si3N4 (Step (e)) are within the specified range. This is acceptable 
as it is expected that the thickness of the polysilicon device layer will be reduced in 
the subsequent fabrication processes. In particular, there is a tendency to over-etch 
the SiO2 layer above the polysilicon layer during the RIE process (Step (g)) to ensure 
full removal of the SiO2.  
The as-deposited polysilicon typically has a very high resistivity and this 
could be altered by a process known as doping, whereby suitable impurities are 
introduced into the substrate thus changing its physical properties [275]. This is 
typically done using the ion implantation process, in which the ions of the desired 
dopant are produced and accelerated to a high energy to finally impinge onto the 
target substrate. The implantation dose (or concentration of ions) and the 
implantation energy, among other parameters, influence the amount, depth and 
profile of the dopant introduced into the substrate. 
Four different sets of implantation parameters within the operational range 
of the ion implanter, as summarised in Table    3.2, were proposed to modify the 
resistivity of the polysilicon device layer. In order to evaluate the altered resistivity 
caused by the ion implantation (Step (c)), the SiO2 layer on the four check wafers 
(#c13p, #c14p, #c15p and #c4n, which were processed concurrently with the device 
wafers from the start of the fabrication), were stripped in 7:1 buffered HF (BHF) 
after the drive-in process (Step (d)). The sheet resistance, Rs, of the annealed, doped 
polysilicon was then measured [247] using an automated four-point probe station 
(QuadPro Resistivity System) and results are tabulated in Table   3.4. The four sets of 
ion implantation parameters from Table    3.2 and the expected sheet resistances, 3.4 Fabrication of Device Area (Stage 1)    77 
 
Rs_exp, (calculated based on a process simulation in [247]) are repeated in Table   3.4 
for easier reference. The Rs of the n-type check wafers, #c4n, was beyond the 
measurable range of the probe station, and was assumed to be 10000 Ω/sq. The 
actual resistivity of the device wafers was then inferred from these measurements.  
The percentage difference (% difference) was calculated with respect to the 
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where  Rs_sim is the simulated sheet resistance. When the Rs_mea values were 
compared to the simulated values of Rs_exp, as depicted in Table   3.4, a significant 
deviation between Rs_mea and Rs_exp , in fact more than 70 %, was observed for all but 
check wafer #c13p. These deviations were ascribed to either a simulation error (as in 
check wafer #c4n) or fabrication-related issues (as in check wafer #c15p) [247]. As 
briefly discussed in §  3.2.2, the resistivity of the substrate is one of the factors that 
influences the characteristic of the porous structure obtained by the stain etching 
process. Hence, to validate the experimental results, a revised process simulation 
was carried out. 





















5 x 1015 cm-2, 
80 keV 
32.54 ± 0.19  40  22.93  23.60  27.47 
#c14p 
Boron, 
1 x 1016 cm-2, 
80 keV 
28.67 ± 0.59  1  96.51  12.04  58.00 
#c15p 
Boron, 
5 x 1014 cm-2, 
50 keV 
338.94 ± 4.95  100  70.50  175.29  48.28 
#c4n 
Phosphorus, 
1.8 x 1012 cm-2, 
80 keV 
>> 1000*  85  99.15  2911.6  70.88 
Table   3.4: Comparison of simulated and measured sheet resistance with respect to four different 
ion implantation parameters (* assumed to be 10000 Ω/sq for the calculation of % difference). 3.4 Fabrication of Device Area (Stage 1)    78 
 
3.4.1.1  Process Simulation 
A revised process simulation was performed using the same two-dimensional, 
physically-based, numerical process simulation tool, Athena (Silvaco Data Systems 
Inc.20), used in [247]. The ion implantation was simulated using the Secondary Ion 
Mass Spectrometry (SIMS)-Verified Dual Pearson (SVDP) models, instead of the 
Gaussian distribution used in [247]. The SVDP models are based on the empirical 
data extracted from implantation experiments conducted by the University of Texas 
at Austin [277]. In addition, the Rs_sim was extracted directly from the simulated 
device structure by using the built-in extraction tool, which estimates Rs_sim based on 
the following integral [278]: 
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     (   3.6) 
where x_right and x_left are determined by the semiconductor material boundaries 
(here, the thickness of polysilicon layer), q is the magnitude of electron charge, μn 
and  μp are the mobility of electron and hole, respectively, and n and p are the 
concentration of electrons and holes, respectively. A number of assumptions were 
made during the simulation. Importantly, the deposited polysilicon was assumed to 
be 1 μm thick, the tilt or angle of ion implantation was assumed to be zero (since the 
polysilicon was modelled as amorphous) while the damage induced by the ion 
implantation process was not modelled. In addition, parameters used in the 
processes from steps (a) to (e), depicted in Figure    3.5, were considered in the 
simulation. An example simulation input file is included in Appendix C. 
Compared to the symmetric parabolic shape of an ideal Gaussian 
distribution, the doping profile after the ion implantation process (marked by U), 
simulated using the SVDP models, has a slight skew and an exponential tail, as 
depicted in Figure   3.7. The dopants, after the drive-in process, are observed to be 
well-distributed within the polysilicon layer, as depicted by a flat doping profile 
(marked by °) in Figure   3.7.  
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Figure   3.7: Plot of the simulated boron concentration (in log. scale) along the depth of the device 
structure, before (U) and after (°) the drive-in process (Step (d)). Here, the boron implantation 
was modelled with a dose of 5 x 1015 cm-2 and an energy of 80 keV.  
The difference between the Rs_sim values extracted from this work (denoted as 
Rs_rev for clarity) and the Rs_mea values was found to be less than 70 %, as tabulated in 
Table   3.4. Overall, the Rs_rev for each of the check wafers was observed to be lower 
than the Rs_mea. Hence, it can be said that the simulation over-estimated the impact 
of ion implantation on the shift in resistivity of the polysilicon layer. The two 
simulations showing the greatest difference between Rs_rev and Rs_mea, are for check 
wafers #c14p (58.00 %) and #c4n (70.88 %) and these can be justified by the 
limitation of the SVDP model, which has an experimentally verified dose range of 1 x 
1013 cm-2 to 8 x 1015 cm-2 [277]. Beyond this range, extrapolation was used by the 
simulator and that could explain the result. 
Essentially, compared to the Rs_exp, the revised simulation (of Rs_rev) provides 
a better estimation of the sheet resistance. It is also clear that the selection of ion 
implantation dose and energy did not yield the variation in resistivity as initially 
intended. By both measurement and simulation, as summarised in Table   3.4, the Rs 
of the high (#c14p) and medium (#c13p) dose boron-doped polysilicon device layers 
were found to be very similar. Hence, effectively, only two ranges of resistivity of p-
type have been created. This does not affect the fabrication of the final prototype 3.4 Fabrication of Device Area (Stage 1)    80 
 
device, but it does have an implication on the possible stain etching processes 
available for development and initial investigation. 
3.4.2  Results and Discussions: Part 2 (Steps (f) to (h)) 
The fabricated multilayer structure was then patterned by photolithography (Step 
(f)) and RIE (Step (g)) to define the region for the drug reservoir. However, the 
photolithography was not optimised. In particular, some defects such as pinholes and 
cracking of photoresist due to particulate contaminations were introduced during the 
photoresist patterning using the first mask (KB35M-AA). The photolithography used 
here provides a mask to define the circular region (6 mm diameter) where drugs for 
delivery are to be contained. The masked area would eventually provide the surface 
for the contact pads for the electrodes.  
Unfortunately, these lithography defects were overlooked and, as a result, 
the defects were transferred over to the SiO2-Si3N4 layers by the RIE process (Step 
(g)) [276]. These defects affect the integrity of the SiO2-Si3N4 layers at the periphery 
of the drug delivery reservoir where the contact pads are contacting the electrodes. 
All the exposed polysilicon areas would also be made porous during the subsequent 
stain etching process. This fabrication error meant that significant levels of wafer 
inspection were needed prior to the fabrication stages required for the electrodes. 
3.4.2.1  Photolithography and RIE Rework 
Therefore, in order to mitigate the problem, the SiO2-Si3N4 layers were removed and 
re-fabricated. The Si3N4 layer was first stripped in phosphoric acid, set at 70 °C for 
over an hour; the SiO2 layer was then etched using 7:1 BHF. The SiO2-Si3N4 layers 
were re-deposited using the methods discussed previously (LTO and LPCVD, 
respectively). The photolithography rework was then carried out with two attempts 
before achieving a more satisfactory outcome. The first attempt of rework used a 
similar photolithography protocol but, instead of the typical hard contact, a soft 
contact mode was used when aligning the substrate to the mask. The soft contact 
mode applies minimal pressure to bring the substrate in contact with the mask, 
hence minimising the damage to the photoresist due to contamination from the mask 3.4 Fabrication of Device Area (Stage 1)    81 
 
and vice versa. This attempt yielded an improved photolithography quality, but small 
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Figure   3.8: Optical microscope images of photoresist defects showing (a) broken and (b) cracked 
photoresist due to particulate contamination. 
The contamination was probably caused by one or all of the three possible 
sources: the wafer, the photoresist and the mask. Hence in the second attempt of the 
photolithography rework, the mask and the wafers were thoroughly cleaned using 
standard cleaning processes (FNA for wafers followed by solvent using acetone and 
isopropanol (IPA) for both the wafers and the mask). A fresh and thicker Shipley 
SPRT-518 photoresist, which provides a nominal thickness of 2.2 μm, was used. The 
thicker photoresist is more robust and hence is less susceptible to breakage or 
cracking. The final photolithography rework was considerably better with 
significantly fewer defects observable across the batch. 
The RIE was then carried out to etch the SiO2-Si3N4 layers using the same 
parameters as previously discussed (Step (g)). The patterned SiO2-Si3N4 layers 
exhibit a “double-tone” pattern, as depicted in Figure   3.9, due to the patterns left by 
the initial RIE process. This is understandable as the initial RIE process to etch the 
SiO2 layer was longer than necessary to ensure that all the SiO2 has been completely 
removed. Hence, a thin layer of polysilicon would also have been etched during the 
process. This marginal thickness variation may have some effects on the stain 
etching process, as depicted in Figure    3.9 (b), but the likely influence was not 
comprehensively investigated. 





















Figure   3.9: Optical microscope images showing the overlapped patterns due to the 
photolithography and RIE rework after (a) the RIE of Si3N4-SiO2 layers and (b) a stain etching 
process. 
The photoresist on the wafers was only removed (Step (h)) prior to the stain 
etching process (Stage 2 Fabrication). A typical structure of the device, after the 
Stage 1 fabrication, is depicted in Figure    3.10. The FEGSEM shows the exposed 
polysilicon after the patterning and RIE of SiO2-Si3N4 layers. The surface of the 
polysilicon appears to be rather rough, as expected, due to its polycrystalline grain 
boundary. This consequently results in an uneven, wavy-like surface of the 
subsequently deposited SiO2 and Si3N4 layers. 







Figure   3.10: Cross-sectional view FEGSEM micrograph showing a typical multilayer structure 
after the completion of Stage 1 fabrication (up to Step (h) of Figure   3.5). 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  83 
 
3.5  Formation of the PPSi Layer by the Stain 
Etching Method (Stage 2) 
Prior to the batch process of the wafers to form the PPSi structure (Stage 2 
fabrication), a series of investigations was carried out to evaluate and develop a stain 
etching process suitable to yield a PPSi structure as a porous drug reservoir. The 
first phases of the investigation of the stain etching process, which are detailed in 
[247, 276] and briefly discussed here, were conducted at the SUMC / Innos. However, 
subsequent work on stain etching was carried out at the cleanroom facility at the 
University of Manchester after the loss of the facility at SUMC / Innos in the fire 
(Oct. 2005). The development work on the stain etching process was mostly carried 
out at the chip level. 
3.5.1  Early Investigation of Stain Etching Process  
In the early phase of the investigation of the stain etching process, both silicon and 
polysilicon substrates were used to evaluate the feasibility of the stain etching 
process [247, 276]. The use of a silicon substrate provides a straightforward way to 
evaluate the stain etching process with minimal prior fabrication. The silicon 
substrates used were from p-type and n-type wafers with a resistivity of 85 Ωcm and 
39  Ωcm, respectively. A mixture of either 4:1:5 or 1:4:5 volume ratio of 
HF:HNO3:H2O, with an etching time between 5 minutes and 45 minutes, was used 
during the experiment. It has been observed that etching times of at least 20 
minutes are required to produce a porous structure with the desired porosity and 
pore density. Based on these findings, further investigations of the stain etching 
process on polysilicon substrates (sawn from check wafers #c14p, #c15p and #c4n 
with Rs_mea as detailed in Table   3.4) were carried out with modified volume ratios 
(1:4:5, 2:5:5 and 1:4:2) of HF:HNO3:H2O to adjust for the difference in resistivity 
between the silicon and polysilicon substrates. The volume ratio of 2:5:5 of 
HF:HNO3:H2O was suggested to be more suitable for the fabrication of the PPSi 
structure [247]. 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  84 
 
However, subsequent investigation suggested that the stain etching time of 
20 minutes was excessive for polysilicon. In fact, when wafer 6 (W6, Rs ≈ (28.67 ± 
0.59) Ω/sq) was stain-etched in 1:4:4 volume ratio of HF:HNO3:H2O for 17 minutes, 
the polysilicon film, the buried SiO2 and some of the bulk silicon substrate (~ 30 μm) 
were removed [276]. This, consequently, prompted a re-examination into the etching 
time and the composition of etching solutions. 
3.5.2  The Stain Etching Process: Setup and Procedures 
The re-examination of the stain etching process was firstly carried at the SUMC / 
Innos with help from a MSc student, S. Mohmad [276], and subsequently continued 
at the cleanroom facility at the University of Manchester. Individual chips (samples) 
of polysilicon substrates with the sheet resistance, Rs  ≈ (28.67 ± 0.59) Ω/sq from 
wafers 5 (W5) and 7 (W7) of the batch K2714s, were used in this experiment. W5 was 
diced using an automated wafer dicing machine; while W7 was scribed and cleaved 
manually. These samples were still coated with the post-RIE photolithographically 
patterned photoresist of Step (g) (in Figure   3.5). To remove this photoresist (Step 
(h)), some of the samples were then ashed using the TePla System 300 Ash Barrel 
(30 minutes of standard recipe); while others were treated using a RIE system 
(Plasma Tech RIE80), with an O2 flow rate of 50 sccm, at a pressure of 5 mTorr and 
an RF power of 150 W, for 10 minutes. Subsequently, a wet chemical etching using 
FNA was carried out to completely remove the photoresist. Typical etching times for 
FNA are up to 30 minutes and the samples were then rinsed with copious amount of 
DI water. 
The typical chemical composition used for the stain etch is a mixture of 48 % 
to 49% concentrated HF, 68 % to 70% concentrated HNO3 and DI water. The acids 
used were either of electronics (MOS) or AnalaR grade. A volume ratio of 1:3:5 of 
HF:HNO3:H2O was used as the starting point for the process optimisation, based 
upon the earlier studies [276] and literature studies (refer to §  3.2). For most 
experiments, the etching solution was freshly prepared by mixing, for instance, 15 
mL of HNO3 followed by 5 mL of HF into 25 mL of DI water, in a HF-resistant 
beaker. The mixture was left “to settle” for at least one hour prior to the stain 
etching process. The etching solution was re-used during the session, but discarded 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  85 
 
at the end. No more than 6 samples were evaluated in a single experimental run. 
Typically, a sample was immersed into the etching solution and the timer was 
started simultaneously. After a preset time (typically, less than 1 minute) the sample 
was taken out and immediately rinsed with copious amount of DI water. For some 
experiments, other stain etching volume ratios, including using an additional pre-
etch step (with 1:5:5 volume ratio of HF:HNO3:H2O to reduce the incubation time 
[188]), have also been evaluated. Most of the experiments were carried out at room 
temperature under ambient light conditions. Table    3.5 summarises some of the 
samples discussed here and their respective stain etching conditions. The samples 
were identified by a simple notation WxSxx, where Wx denotes the wafer number 





W5S01  Photoresist stripped in TePla Ash Barrel. 
1:5:5 (15 s) then 
1:3:5 (15 s) of 
HF:HNO3:H2O 
W5S05 
Photoresist stripped in TePla Ash Barrel. 
Cleaned with acetone (5 min) in ultrasonic bath, rinsed with 
IPA then in DI water (5 min). Dip in 48 % HF for 5 s and 
rinsed with copious amount of DI water. 
1:5:5 (10 s) then 
1:3:5 (10 s) of 
HF:HNO3:H2O 
W5S14 
Photoresist stripped in TePla Ash Barrel. 
Cleaned with acetone (5 min) in ultrasonic bath, rinsed with 
IPA then in DI water (5 min). 
1:5:5 (10 s) then 





Photoresist stripped in TePla Ash Barrel. 
Cleaned with FNA (10 min) and rinsed in DI water in rinse 
tank (5 min) and super-Q tank (3 min). 
1:3:5 (25 s) of 
HF:HNO3:H2O  
W7S15 
Photoresist stripped in RIE80. 
Cleaned with FNA (5 min) then rinsed in DI water (5 min). 




Photoresist stripped and cleaned in FNA (5 min) then rinsed 
in DI water (10 min). 
1:3:5 (35 s) of 
HF:HNO3:H2O 
W7S28 
Photoresist stripped in RIE80. 
Cleaned with FNA (20 min) then rinsed in DI water (10 min). 
1:5:5 (15 s) then 
1:3:5 (15 s) of 
HF:HNO3:H2O 
W7S35 
Photoresist stripped in RIE80. 
Cleaned with FNA (5 min) then rinsed in DI water (5 min). 
1:5:5 (15 s) then 
1:3:5 (15 s) of 
HF:HNO3:H2O 
W7S38 
Photoresist stripped and cleaned in FNA (5 min) then rinsed 
in DI water (10 min). 
500:1 (30 s) of 
HF:HNO3 
Table   3.5: Summary of the pre-processing steps and the stain etching parameters used in the 
experiment to investigate the etching time and composition of the etching solution. All the samples 
used here have an Rs ≈ (28.67 ± 0.59) Ω/sq as measured by using check wafer #c14p. 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  86 
 
3.5.2.1  Investigation of the Effect of Substrate Resistivity 
The porous structure and the incubation time during the porosification of silicon 
either by anodisation or chemical dissolution is believed to be influenced by many 
factors, including the type of silicon substrate and its resistivity [249]. However, 
limited literature data exists on how the resistivity of polysilicon substrates would 
influence the stain etching and yield different porous structures.  Hence, a separate 
experiment was later carried out at the Optoelectronics Research Centre (ORC) 
temporary cleanroom (the Dairybox), at the University of Southampton, to 
investigate the effect of substrate resistivity on the stain etching process. 
Eight polysilicon samples (W8S11, W8S12, W3S11, W3S12, W9S11, W9S12, 
W15S04 and W15S05), which have been doped with 4 different ion implantation 
parameters (resulting in different resistivity levels), were used for this experiment. 
The substrate type and the sheet resistance (as measured using the check wafers) 
are tabulated in Table   3.6. These samples were first ashed, to strip the photoresist, 
using an O2 RIE system (Oxford Instruments Plasmalab® 80 Plus) with an O2 flow 
rate of 10 sccm, a pressure of 50 mTorr and an RF power of 100 W for 10 minutes. A 






W8S11  ti + 40 
W8S12 
28.67 ± 0.59 
W3S11 
W3S12 




338.94 ± 4.95 
W15S04 
W15S05 
n-type >>  1000 
ti + 30 
Table   3.6: The substrate type and the sheet resistance (as measured using the check wafers) of 
samples used to investigate the effect of substrate resistivity on the stain etching. All the samples 
were processed and stain-etched in 1:3:5 volume ratio of HF:HNO3:H2O, as detailed in the text. The 
ti is the incubation time observed in the experiment. 
The stain etch solution with a volume ratio of 1:3:5 of HF:HNO3:H2O was 
prepared one day in advance. For each sample, about 10 mL of etching solution was 
used and disposed of after each use. The incubation time, ti was measured from the 
time the sample was immersed into the etching solution, to the time when the first 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  87 
 
sign of etching could be physically observed. The indicator for etching taking place 
was either the formation of bubbles or a change of colour on the sample surface. All 
samples were stain-etched for 30 s after the onset of etching, except for sample 
W8S11 which was etched for 40 s. The entire experiment was carried out at room 
temperature under ambient light conditions. 
3.5.3  Results and Discussions 
A range of samples were stain-etched with a variety of different etching conditions. 
The stain-etched samples were evaluated by visual inspection and by using the 
optical microscope. Some of the samples were characterised using the SEM and 
AFM. 
During the stain etching process, there is a period, known as the incubation 
time, ti, between immersion of the sample into the stain etching solution and the 
onset of the stain etching. Bubble formation was normally observed after the 
incubation time, and this was conveniently used as an indication of “productive” 
stain etching. Bubbles that formed and were trapped onto the surface of the samples 
were believed to be one of the sources of non-uniformity of the stain etching across 
the surface [180]. In addition, a change in the appearance on the surface of the 
samples could also be observed, as a function of time due to the thin-film 
interference effect [279]. Not all the stain-etched samples yielded bubbles during the 
etching process, but most of the samples exhibited a change of colour or appearance 
on the surface after the stain etching. 
In general, the surface of the stain-etched samples varied in colour, with 
some samples appearing pink to dark brown (under room light) to the naked eye, 
while the others appeared light green to pale blue in colour. Examples of these 
surface colour variations are depicted by the bright field optical microscopy images 
in Figure   3.11, which were acquired using a 2-mega pixels colour digital camera 
(Nikon Digital Sight, DS-2Mv) fitted to an upright microscope (Nikon Eclipse LV100 
with a 12 V, 50 W halogen lamp). It is also common to observe spots or stains on the 
surface of most of the samples, which is very likely due to the trapping of bubbles 
which may enhance localised etching. The variation in surface appearance, which 






(a) W5S01; stain-etched in a 1:5:5 (15 s) then a 
1:3:5 (15 s) volume ratio of HF:HNO3:H2O 
500 m μ
 
(d) W7S15; stain-etched in a 1.3:6:15 (5 min) 
volume ratio of HF:HNO3:H2O 
500 m μ
 
(b) W5S14; stain-etched in a 1:5:5 (10 s) then a 
1:3:5 (15 s) volume ratio of HF:HNO3:H2O 
200 m μ
 
(e) W7S28; stain-etched in a 1:5:5 (15 s) then a 
1:3:5 (15 s) volume ratio of HF:HNO3:H2O 
200 m μ
 
(c) W5S28; stain-etched in a 1:3:5 (25 s) volume 




(f) W5S38; stain-etched in a 1:3:5 (25 s) volume 
ratio of HF:HNO3:H2O 
Figure   3.11: Plan-view, bright field optical microscopy images showing the surface appearance of 
selected stain-etched samples (Rs ≈ (28.67 ± 0.59) Ω/sq). The stain etching conditions and pre-
processing treatments are detailed in Table   3.5. 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  89 
 
outcome of the different etching parameters used on the samples. On a closer 
observation, however, the variation also occurs in two situations: (i) on samples with 
“identical” etching parameters, as depicted in samples W5S28 and W5S38 (Figure 
  3.11 (c) and (f), respectively, both with Rs  ≈ (28.67 ± 0.59) Ω/sq); and (ii) on the 
individual sample itself, as depicted in samples such as W7S15 (Figure   3.11 (d)) and 
W7S28 ( Figure    3.11 (e)). Variation of these surface appearances, to some extent 
substantiates the irreproducibility and non-uniformity associated to stain etching 
prepared samples often reported in the literature [180, 225, 242, 249]. The 
subsequent sections thus discuss the use of SEM and AFM to better understand the 
microstructure of the prepared PPSi samples. 
3.5.3.1  Scanning Electron Microscopy 
Scanning electron microscopy (SEM) can be used to investigate the structural 
morphology and material properties of a sample. By using the secondary electron 
(SE) imaging, the SEM is capable of producing high resolution images with three-
dimensional appearances which are useful for the understanding of the surface 
structure of a sample. When coupled with backscattering electrons (BSE) and X-ray 
emission, an image contrast due to the variation in atomic mass number provides an 
indication of the elemental composition of the sample [280]. 
In principle, the SEM produces images by detecting the signals from the 
interaction of the sample’s surface with a high energy beam of electrons focused onto 
the surface of the sample. Typically, a tungsten filament or a lanthanum hexaboride 
(LaB6) cathode is used as an electron source where the electrons are thermionically 
emitted and then accelerated. Alternatively, electrons can also be emitted via a field 
emission gun (FEG). The FEGSEM micrographs discussed here are obtained from 
FEI/Philips XL30 or FEI/Philips Sirion FEGSEM at the School of Material, 
University of Manchester; while the SEM micrographs are obtained from the LEO 
(now Carl Zeiss) 1455VP SEM at the NanoMaterial Rapid Prototyping Facility, 
University of Southampton. 
Figure    3.12 depicts the cross-sectional FEGSEM micrograph of a typical 
porous polysilicon sample stain-etched in a system consisting of a 1:3:5 volume ratio 
of HF:HNO3:H2O. The sample used for this SEM, W7S35 (Rs ≈ (28.67 ± 0.59) Ω/sq) 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  90 
 
was first stain-etched in a 1:5:5 volume ratio of HF:HNO3:H2O solution for 15 s, 
followed by another stain etch in a typical 1:3:5 volume ratio solution for an 
additional 15 s (see Table    3.5 for details). In both stages, the sample was raised 
about one third off the surface of the stain etch solution, hence it maintained a 
region of un-etched surface. This way, the effect of stain etching could be 
unambiguously examined by comparing the two regions. The cross-sectional 
FEGSEM micrographs were obtained 9 days after the stain etching process. 
Compared to the un-etched region (depicted in Figure   3.10), the stain-etched area of 
sample  W7S35 is distinctly different. The SiO2 and Si3N4 layers could still be 
observed, but the majority of the polysilicon has been etched away. The undercut at 
the SiO2 and Si3N4 masking layers is measured to be ~ 390 nm, with an etch depth of 
around 605 nm. In this case, the stain etching is believed to have consumed more 
than half the polysilicon due to chemical dissolution and the etching is observed to be 
isotropic with a ratio of about 2:1 etch depth versus lateral etch. Some of the SiO2 
has also been etched, as is visible from the slight undercut under the Si3N4 layer, but 
the stain etching solution is clearly selective. 
 









Figure   3.12: Cross-sectional view FEGSEM micrograph showing the undercut caused by the stain 
etching process on sample W7S35 (Rs ≈ (28.67 ± 0.59) Ω/sq). The stain etching parameters are 
detailed in Table   3.5. 
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The surface of the stain-etched polysilicon of sample W7S35 is rather rough 
and granular-like, with irregularly shaped, random etch pits, as depicted in Figure 
  3.13. The rough surface appearance is in agreement with some of the AFM images 
(discussed in §  3.5.3.4, see Figure    3.23 and related text) on similar stain-etched 
polysilicon samples of the same sheet resistance. The top layer, which is believed to 
be the PPSi layer, is measured to be ~ 100 nm thick. When examined with a higher 
magnification, as depicted in the inset of Figure   3.13, the porous structure could be 
loosely categorised as interconnected, with some isolated pores. The size of the pores 
is estimated to be around 70 nm thick and 20 nm to 30 nm in width. 
200 nm
 
Figure   3.13:Cross-sectional view FEGSEM micrograph showing the top layer of sample W7S35 
after the stain etching. The inset shows a different area of the sample imaged with higher 
magnification. 
Figure   3.14 depicts a FEGSEM micrograph of the cross-section of sample 
W7S27 (Rs ≈ (28.67 ± 0.59) Ω/sq), imaged one week after it was stain-etched in a 
1:3:5 volume ratio of HF:HNO3:H2O solution for 35 s. In order to slow down the 
natural oxidation and aging process, the sample was stored in a high vacuum 
chamber and kept at ~ 8.7 x 10-7 mbar until the SEM session. The secondary electron 
image shows a rough surface with some shallow pits, similar to that observed on 
sample W7S35 (as depicted in Figure   3.13), albeit with a thicker polysilicon layer 










Figure   3.14: Cross-sectional view secondary electron FEGSEM micrograph of sample W7S27 (Rs ≈ 
(28.67 ± 0.59) Ω/sq) stain-etched in a 1:3:5 volume ratio of HF:HNO3:H2O for 35 s. The inset shows 












Figure   3.15: Cross-sectional view FEGSEM micrograph of sample W7S27, at the same area as in 
Figure   3.14, imaged by detecting the BSE, clearly showing a good contrast between the PPSi and 
polysilicon layers. The inset shows the EDX map of the sample with elements of silicon (red) and 
oxygen (green) highlighted. 
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uniform in thickness but the pore structure is not clearly visible even when imaged 
at high magnification (100,000 x). 
However, when the sample W7S27 was subsequently imaged using the BSE 
detector, a layer of dark contrast of thickness ~ 360 nm on top of the polysilicon 
layer, as depicted in Figure   3.15, could be observed. The layer, which is believed to 
be the PPSi structure, is clearly of a different elementary composition than the bulk 
polysilicon. When examined with the SEM-equipped energy-dispersive X-ray (EDX) 
map, a more concentrated oxygen component could be observed in the top layer of 
the polysilicon, as depicted in the inset of Figure   3.15. Since the sample was stored 
in high vacuum almost immediately after the stain etching, the thick layer of SiO2 
could not be ascribed to the formation of native oxide on the polysilicon layer. In fact, 
it is well-established that fresh PSi structure naturally oxidises when exposed to air 
[281]. In addition, stain-etched PSi and PSi that has been cleaned in DI water have 
been demonstrated to produce higher initial oxidation levels [282]. Hence, it is likely 
that the SiO2 layer observed was formed as a result of natural oxidation of the PPSi 
structure. This provides a good evidence of the existence of the PPSi structure albeit 
not readily visible in the physical form (by SE imaging). An EDX spectrum would 
have provided both qualitative and quantitative elemental analysis with 
characteristic peaks and corresponding intensities (count) to better confirm the 
existence of the PPSi structure. 
3.5.3.2  Stain Etching using Different Volume Ratios 
PPSi structures have also been observed when a different chemical composition was 
used for the stain etching process. For instance, when the sample W7S15 (see Figure 
  3.11 (d) for optical microscope image and Table   3.5 for full etching conditions) was 
stain-etched in a 1.3:6:15 volume ratio solution of HF:HNO3:H2O, a PPSi structure 
readily visible under SEM, as depicted in Figure   3.16, was produced. The sample 
was stain-etched for 5 minutes, but the formation of bubbles was only observed 4 
minutes after the immersion of the sample into the etching solution. The PPSi is 
measured to be around 250 nm thick, with a remaining un-etched polysilicon layer of 
565 nm thickness. The pores appear to be branched and roughly aligned to the 
source of the holes injection point. Due to the limitation of the SEM machine (with 












Figure   3.16: Oblique view SEM micrograph showing the PPSi structure formed by stain etching of 
sample W7S15(Rs ≈ (28.67 ± 0.59) Ω/sq), using a 1.3:6:15 volume ratio of HF:HNO3:H2O for 5 










Figure   3.17: Cross-sectional view BSE, FEGSEM micrograph showing the etching of buried SiO2 of 
sample W7S38 (Rs ≈ (28.67 ± 0.59) Ω/sq) stain-etched in a 500:1 volume ratio of HF:HNO3 for 30 s. 
The inset shows the magnified view of the hole etched in the buried SiO2 imaged by SE. 
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between 30 nm and 50 nm. A layer of capping material, thought to be SiO2, can also 
be observed and is believed to be formed as a result of long oxidation in an ambient 
environment, as the SEM was taken almost 1 ½ years after the stain etching 
process. 
In a slightly different system, where a significantly higher proportion of HF 
is used [246, 266], a PPSi structure, as depicted in Figure   3.17, could be observed. 
The sample W7S38 (Rs ≈ (28.67 ± 0.59) Ω/sq) was stain-etched in a 500:1 volume 
ratio of HF:HNO3 for 30 s (see Table   3.5 for full etching conditions). A significant 
etching of the masking SiO2 layer, which created an undercut of ~ 2 μm at the Si3N4 
layer, could be observed. Interestingly, the polysilicon thickness remained at ~ 1 μm 
and yet, some of the buried SiO2 layer has been attacked by the stain etching 
solution, as clearly depicted in the inset of Figure   3.17. This finding is unique and is 
likely to have been caused by the stain etching solution permeating the polysilicon 
layer. Hence, the polysilicon is very likely to be porous, at least in the region where 
the hole has been created. The PPSi structure formed here is believed to be in 
micropore regime, as deduced by the AFM analysis (discussed in §  3.5.3.4, see Figure 
  3.22 and related text). 
3.5.3.3  Investigation of the Effect of Substrate Resistivity 
In the experiment to investigate the effect of different polysilicon resistivity (product 
of Rs and film thickness) levels on the stain etching process, the incubation time, ti of 
each sample during the process was monitored (as described in §  3.5.2.1) as one of the 
parameters for analysis. The ti was believed to be the period required for the 
accumulation of sufficient HNO2 and the initiation of preferential etching [242]. It 
has been demonstrated to be a function of the type and resistivity of the substrate. In 
fact, it was reported that, when silicon substrates were stain-etched in a 1:3:5 
volume ratio of HF:HNO3:H2O, an increased resistivity of the p-type silicon 
substrates resulted in an extended incubation time; while for the n-type silicon 
substrates, a reduced incubation time was observed with an increased resistivity 
[249].  
In this experiment, the ti, as tabulated in Table   3.7, was observed to be more 
than 75 s for all the 8 samples evaluated. In fact, a ti of > 100 s was observed for 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  96 
 
samples with Rs  ≈ (28.67 ± 0.59) Ω/sq. This is inconsistent with previous 
observations, where “productive” etching was observed within a total etching time 
(inclusive of ti) of less than 60 s on samples (with Rs ≈ (28.67 ± 0.59) Ω/sq)) stain-
etched in a 1:3:5 volume ratio of HF:HNO3:H2O (see Table   3.5 for example samples 
and [276]). It is believed that the fresh etching solution used in this experiment could 
have extended the ti; in previous experiment, the stain etching solution was re-used, 





time, ti (s) 
Averaged 
ti (s) 
W8S11  105 
W8S12 
28.67 ± 0.59 
109 
107 ± 2.8 
W3S11  105 
W3S12 
32.54 ± 0.19 
89 
97 ± 11.3 
W9S11  189 
W9S12 
p-type 
338.94 ± 4.95 
142 
165.5 ± 33.2 
W15S04  85 
W15S05 
n-type >>  1000 
75 
80 ± 7.1 
Table   3.7: Measured incubation time during stain etching of samples with various levels of sheet 
resistance (refer to Table   3.6). These samples have been stain-etched in a 1:3:5 volume ratio of 
HF:HNO3:H2O. The detailed sample preparations are described in the §  3.5.2.1. 
In general, the ti was found to be dependent on the type and the resistivity of 
the substrate. For the 8 samples evaluated, it was observed that the phosphorus-
doped n-type samples, despite having the highest Rs (>> 1000 Ω/sq), required the 
shortest  ti, of 80 s ± 7.1 s, to initiate a “productive” stain etching process. The 
conjecture that a reduced ti correlates to an increased resistivity in n-type substrates 
(as proposed by [249]), however, could not be verified since only one resistivity of the 
n-type substrate was available for evaluation. 
For the four p-type samples (W8S11, W8S12, W3S11 and W3S12) with the 
lowest two Rs ((28.67 ± 0.59) Ω/sq and (32.54 ± 0.19) Ω/sq), the ti was very similar 
(between 105 s and 109 s), except for one sample (W3S12) which has a shorter ti of 89 
s. Samples W9S11 and W9S12 with higher Rs (32.54 ± 0.19) Ω/sq exhibited a longer 
incubation time; this dependency of ti on Rs is similar to the findings by [249]. 
However, with the distribution of only 6 data points (from the 6 p-type samples 
evaluated), it is insufficient to produce a statistical correlation to establish if the ti is 
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Four of the 8 polysilicon samples (W8S11, W3S11, W9S11 and W15S04) were 
then examined using the SEM to establish the effect of different substrate resistivity 
on the morphology of the porous structure. The p-type sample with low boron doping 
(W9S11, Rs ≈ (338.94 ± 4.95) Ω/sq) and the n-type sample (W15S04, Rs >> 1000 Ω/sq) 
both exhibit similar irregular hillocks with cracking, as depicted in Figure   3.18 and 
Figure    3.19, respectively. These PPSi structures appear to be similar to those 
previously reported [188, 283], and has been ascribed to lateral strain induced 
during the porosification process [283]. The lateral strain is believed to result from 
the disturbed lattice forces in the silicon crystal as the silicon near the surface region 
is removed. This causes the formed columnar porous structures to collapse in order 
to compensate the differential strain, hence forming the hillocks. The effect is 
believed to be more severe in polysilicon due to preferential etching at the grain 
boundaries, resulting in cracking in the PPSi and this propagating to the underlying 
polysilicon layer. In fact, since a similar observation was observed in both p- and n-
type samples, as depicted in Figure   3.18 and Figure   3.19, respectively, this cracking 
phenomenon appears to be independent of the type of the substrate. 
Characteristically rough surfaces with shallow pits, as discussed previously 
on samples W7S35 and W7S27 (both with Rs ≈ (28.67 ± 0.59) Ω/sq) have also been 
observed on the highly-doped p-type samples (W8S11 and W3S11, with Rs ≈ (28.67 ± 
0.59) Ω/sq and (32.54 ± 0.19) Ω/sq, respectively). However, when the top surface of 
sample W8S11 was examined by SEM, some tiny circular pits, in the range of 40 nm 
to 50 nm in diameter, resembling pores could be observed at certain areas of the 
sample; while a crack-like structure, as depicted in the inset of Figure   3.20, could be 
observed in other areas. This distinctive variation in morphology, observed on 
sample W8S11, is a further evidence of the non-uniform etching of the stain etching 
process. The tiny pits appear mostly near the grain boundaries of the polysilicon, 
suggesting that the preferential etching has just started and the porosification rate 
could be very slow. However, at other areas of the sample, the favourable local 
environment, perhaps as a result of trapped bubbles, increased the porosification 
process, hence resulting in the cracking phenomenon, discussed previously.  
In addition, in this experiment, the stain-etching process did not appear to 
etch the stain-etched PPSi layer; the final thickness of the PPSi layer (~ 700 nm to 1 










Figure   3.18: Oblique cross-sectional view SEM micrograph showing the crack-like porous structure 
on the low boron doping p-type sample W9S11 (Rs ≈ (338.94 ± 4.95) Ω/sq; stain-etched in a 1:3:5 
volume ratio of HF:HNO3:H2O for (189 + 30) s). The inset shows the plane-view SEM micrograph of 







Figure   3.19: Oblique cross-sectional view SEM micrograph showing the crack-like porous structure 
on the n-type sample W15S04 (Rs >> 1000 Ω/sq; stain-etched in a 1:3:5 volume ratio of 
HF:HNO3:H2O for (85 + 30) s). The inset shows the plane-view SEM micrograph of the sample 
imaged at a different area. 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  99 
 




Figure   3.20: Oblique cross-sectional view SEM micrograph showing the porous structure on the 
highly-doped p-type sample W8S11 (Rs ≈ (28.67 ± 0.59) Ω/sq; stain-etched in a 1:3:5 volume ratio of 
HF:HNO3:H2O for (105 + 40) s). The inset shows the plane-view SEM micrograph of the sample at 
two different areas with distinctly different morphology. 
four samples (W8S11, W3S11, W9S11 and W15S04) observed. This is different from 
the behaviour of the stain etching process discussed previously (in the experiment to 
re-examine the stain etching process), whereby the remaining (PPSi and polysilicon) 
structure is significantly less than 1 μm (such as that of samples W7S35 and W7S27, 
as depicted in Figure   3.12 and Figure   3.15, respectively). It is proposed that the stain 
etching process used in this experiment was more effective, as preferential etching to 
create random pores was faster than the etch polishing that removes the polysilicon 
uniformly. The factor that contributes to this phenomenon is postulated to be the 
fresh solution used during each etching, which inevitably also results in a more 
extended incubation time.  
3.5.3.4  Atomic Force Microscopy 
In order to better understand the surface topography and the 3-dimensional 
structure of the PPSi sample, the AFM is used. The AFM is one of the scanning 
probe microscopy (SPM) methods, first developed in 1986 by Binnig and co-workers 
[284]. Instead of using an electron or light source, like in a SEM or optical 
microscopy, SPM uses a probe or a tip to investigate the sample by sensing the 
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the probe (as in AFM) or the evanescent wave of the scattered light (as in Near-field 
Scanning Optical Microscope (NSOM)) [285].  
A typical AFM system primarily consists of a cantilever with a sharp tip, a 
laser system and a position-sensitive photodetector (PSPD) [285]. The sharp tip, 
often less than 10 nm in diameter at the apex, is located at the free end of the 
cantilever. The tip can either make soft physical contact with the sample (as in the 
contact mode), be vibrating near (tens to hundreds of Å) the surface of a sample (as 
in the non-contact mode) or be vibrating while intermittently in soft contact with the 
sample (as in the tapping mode). When a sample is scanned under the tip, forces 
between the tip and the surface of the sample cause the cantilever to either bend or 
deflect. The movement of the cantilever is measured by the laser and the PSPD and 
the data is corrected to provide a map of the surface topography.  
The contact AFM could operate in one of two modes – constant height or 
constant force mode [285]. In the constant height mode, the height of the scanner is 
fixed during the scan; hence the deflection of the cantilever can be used directly to 
evaluate the surface topography. This mode is more often used for taking atomic 
resolution images of samples with atomically flat surfaces. In contrast, with the 
constant force mode, the deflection of the cantilever is fixed. The feedback circuit 
then moves the scanner up and down during scanning, hence generating the 
topographic data. This is the preferred mode as the force exerted onto the sample is 
kept constant and can be well controlled.  
The AFM images presented in the following discussion have been obtained 
using the Omicron NanoTechnology Scanning Probe Microscope at Prof. B. 
Hamilton’s group at the University of Manchester. The Omicron SPM, which is 
normally maintained at pressures around 10-10 mbar, is an ultra high vacuum (UHV) 
multi-mode SPM capable of carrying out contact and non-contact AFM, and also 
scanning tunnelling microscopy and spectroscopy. The acquired raw AFM data was 
typically processed using a SPM image processing software (SPIPTM, Image 
Metrology) to correct for plane distortions. To improve the colour contrast, a typical 
cut-off of 1.5 standard deviation (or 5 % to 91 % of the full colour map) was used so 
that only the features of interest are clearly revealed. All of the samples analysed 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  101 
 
using the AFM were from the experiment to re-examine the stain etching 
parameters and the details of the samples are summarised in Table   3.5. 
Figure   3.21 depicts 3-dimensional representations of the AFM topography of 
the polysilicon surface of sample W7S38 prior to and after the stain etching process. 
The AFM was carried out in air using a diamond-coated, doped Si conductive tip 
(radius of curvature ~ 175 nm) operating in the constant force contact mode. The 
sample was cleaned in acetone for 5 minutes prior to the AFM measurement. The 
surface of the polysilicon prior to the stain etching process (Figure    3.21 (a)) was 
observed to be granular and similar to the rough surface observed using SEM (as 
depicted in Figure   3.10) and that reported in the literature [264]. The root mean 
square (RMS) roughness (of the AFM image in Figure   3.21 (a)) was measured to be 
19.4 nm. The granules or hillocks, which average between 300 nm and 500 nm in 
width, are believed to be the grains of the polysilicon. 
After a stain etch in a 500:1 volume ratio solution of HF:HNO3 for 30 s, the 
sample W7S38 (see Figure   3.17 for SEM micrograph and Table   3.5 for processing 
details of this sample) shows a similar rough structure (with RMS roughness of 19.1 
nm). However, some smaller granule-like features in between the larger hillocks, as 
depicted in the 3-dimensional AFM representation in Figure    3.21 (b), can be 
observed. When a reduced area of 2 μm by 2 μm was scanned, as depicted in Figure 
  3.22, the higher resolution AFM revealed that these smaller features are indeed on 
the surface of the hillocks or the polysilicon grains. These fine features could be a 
collection of a wide range of pore sizes at the surface, which have been imaged as a 
continuous curve due to tip convolution; the tip could have completely missed or 
underestimated the depth of very narrow features [286]. This potentially justifies the 
postulation of the existence of microporous structure in PPSi which could not be 
readily examined using SEM (in Figure   3.17). 
A typical AFM image of a PPSi structure stain-etched with the standard 
etching system of HF:HNO3:H2O is depicted in Figure   3.23. The sample W5S05 (see 
Table   3.5 for detailed pre- stain etch treatment) was first pre-etched in a 1:5:5 
volume ratio of HF:HNO3:H2O for 10 s, followed by a stain etch in a 1:3:5 volume 











































































(b) after stain etching 
 
Figure   3.21: 3D AFM image (4 μm x 4 μm) of sample W7S38 (Rs ≈ (28.67 ± 0.59) Ω/sq) (a) prior to 





















Figure   3.22: 2D AFM topography image (2 μm x 2 μm) of sample W7S38 (Rs ≈ (28.67 ± 0.59) Ω/sq) 







































Figure   3.23: 2D AFM image with an area of (a) 2.5 μm x 2.5 μm and (b) 0.5 μm x 0.5 μm of sample 
W5S05 (Rs ≈ (28.67 ± 0.59) Ω/sq) after a pre-etch in a 1:5:5 volume ratio of HF:HNO3:H2O for 10 s, 
followed by a stain etch in a 1:3:5 volume ratio of HF:HNO3:H2O for 10 s. The arrows indicate the 
present of streaking artefacts. 
into the vacuum at the load-lock of the Omicron SPM to minimise the build-up of 
native oxide. The AFM was carried out in UHV using a platinum-iridium (Pt-Ir) 
coated Si tip (radius of curvature ~ 25 nm) operating in the constant force contact 
mode. As depicted in Figure   3.23, the PPSi structure of stain-etched sample W5S05 
exhibits similar granular features (such as those depicted in Figure   3.22), but with 
greater height variation (~ 98 nm as compared to ~ 55 nm depicted in Figure   3.22) 
across the scanned area. The granules or hillocks are also observed to be smaller in 
size (between 100 nm and 200 nm). Some random etch pits with irregular shape, 
which may indicate the present of pores, could be observed. However, a subsequent 
AFM scan with a reduced area of 500 nm by 500 nm (about the centre of the area 
depicted in Figure   3.23 (a)) reveals additional granular-like features on the etch pit, 3.5 Formation of the PPSi Layer by Stain Etching (Stage 2)  104 
 
suggesting no existence of apparent pores (within the resolution limit of the AFM 
system). During the AFM measurements of sample W5S05, streaking in the acquired 
AFM images could be observed even after a few scans of the same area. This could be 
due to the present of loose debris on the sample surface which interacts strongly 
with the tip. 
3.5.4  Summary 
The implication of stain etching parameters (etching time and chemical composition) 
on the formation of PPSi has been investigated. Variations in the surface appearance 
of the stain-etched samples, as depicted in Figure   3.11, which implies a divergence of 
porous structure and thickness, could be observed by the naked eye and with an 
optical microscope. These variations appeared locally on a sample (for instance, 
sample W7S28; stain-etched in a 1:5:5 (15 s) followed by a 1:3:5 (15 s) volume ratio of 
HF:HNO3:H2O) and across samples processed in identical etching times and 
chemical composition (for instance, samples W5S28 and W5S38, both with Rs  ≈ 
(28.67 ± 0.59) Ω/sq and stain-etched in a 1:3:5 volume ratio of HF:HNO3:H2O for 25 
s). These observations, to some extent substantiate the irreproducibility and non-
uniformity associated with porous structure formed by using stain etching, often 
reported in the literature [180, 225, 242, 249]. 
In general, most samples prepared by the stain etching method do not 
produce a PPSi film with a distinct pore morphology or clear microstructural 
characteristics observable using the SEM and the AFM. In fact, most of the PPSi 
structures observed under SEM and AFM often show a rough surface with shallow 
pits or a cracked structure, as summarised in Table   3.8. The rough surface exhibited 
by most samples (such as W7S35 and W5S05, see Table   3.8 for details) may be an 
indication of a chemical polishing instead of a “productive” porosification of 
polysilicon; the random, preferential etching of the polysilicon may have been 
suppressed by the uniform chemical etching. In contrast, the cracked-like PPSi 
structure (as observed on samples W9S11 and W15S04, see Table   3.8 for details) is 
believed to result from the intense preferential etching, especially at the grain 































































W7S35  Boron, p-type  28.67 ± 0.59 
1:5:5 (15 s) then 1:3:5 
(15 s) volume ratio of 
HF:HNO3:H2O 
FEGSEM 
(Figure   3.12 and 
Figure   3.13) 
Rough surface with 20 nm to 30 nm 
interconnected pores; thin (~ 70 nm) PPSi 
layer; huge undercut suggesting vigorous 
etching 
W7S27  Boron, p-type  28.67 ± 0.59 
1:3:5 (35 s) volume 
ratio of HF:HNO3:H2O 
FEGSEM (Figure 
  3.13); BSE and EDX 
map (Figure   3.15) 
Similar to W7S35; BSE and EDX map 
suggest existence of PPSi of ~ 360 nm thick 
W7S15  Boron, p-type  28.67 ± 0.59 
1.3:6:15 (5 min) 
volume ratio of 
HF:HNO3:H2O 
SEM (Figure   3.16) 
Best PPSi observed, 30 nm to 50 nm 
branched pores, ~ 250 nm thick PPSi layer 
W7S38  Boron, p-type  28.67 ± 0.59 
500:1 (30 s) volume 
ratio of HF:HNO3 
FEGSEM and BSE 
(Figure   3.17); AFM 
(Figure   3.21 and 
Figure   3.22) 
Rough surface; PPSi possibly exists shown 
by etched buried SiO2 
W9S11  Boron, p-type  338.94 ± 4.9 
1:3:5 (189 s + 30 s) 
volume ratio of 
HF:HNO3:H2O 
SEM (Figure   3.18) 
Crack-like PPSi structure similar to that 
reported [188, 283], ~ 800 nm to 1 μm thick 
W15S04  Phosphorus, n-
type 
>> 1000 
1:3:5 (85 s + 30 s) 
volume ratio of 
HF:HNO3:H2O 
SEM (Figure   3.19)  Similar to W9S11, ~ 700 nm to 1 μm thick 
W8S11  Boron, p-type  28.67 ± 0.59 
1:3:5 (105 s + 40 s) 
volume ratio of 
HF:HNO3:H2O 
SEM (Figure   3.20) 
Rough surface with tiny circular pits (40 
nm to 50 nm in width) at some areas; 
crack-like PPSi structure in other areas 
W5S05  Boron, p-type  28.67 ± 0.59 
1:5:5 (15 s) then 1:3:5 
(15 s) volume ratio of 
HF:HNO3:H2O  
AFM (Figure   3.23) 
Granular-like topography with hillocks 
between 100 nm and 200 nm in width 
Table   3.8: Summary of selected samples discussed in this section, with their corresponding sheet resistance, stain etching conditions and characterisation 
methods. The order of the samples in the table follows the order as they first appeared in the text. 3.6 The Fabrication of Electrodes (Stage 3)    106 
 
Nevertheless, there are indications of pore formation, such as the finding of 
EDX analysis (sample W7S27, see Figure    3.15) and the observation of etching of 
buried SiO2 (sample W7S38, see Figure   3.17). It is proposed that the PPSi structures 
formed in these two samples (W7S27 and W7S38) are in the micropore size regime (< 
2 nm), where the imaging of this kind of porous structure using SEM is more 
challenging due to the resolution limit of most of the SEM.  
Based on the samples evaluated thus far (summarised in Table   3.8), the stain 
etching using a volume ratio of 1.3:6:15 of HF:HNO3:H2O appears to produce the best 
PPSi structure which could be suitably used as drug reservoir. The sample (W7S15 
with  Rs  ≈ (28.67 ± 0.59) Ω/sq) etched for 5 minutes (presumably inclusive of 4 
minutes incubation time) using this volume ratio produced pores visible under SEM, 
as depicted in Figure    3.16, with a size in the range of 30 nm to 50 nm and a 
thickness of ~ 250 nm.  
In the experiment to investigate the effect of substrate resistivity on the stain 
etching process, the incubation time, ti, was found to increase with higher substrate 
resistivity in p-type samples. The substrate resistivity, however, did not seem to 
influence the resultant PPSi structure, as generally, similar PPSi structures (with 
cracking) can be observed in both p-type (such as W9S11, Rs ≈ (338.94 ± 4.95) Ω/sq, 
as depicted in Figure   3.18) and n-type (such as sample W15S04, Rs >> 1000 Ω/sq, as 
depicted in Figure    3.19) samples after a stain etch in a 1:3:5 volume ratio of 
HF:HNO3:H2O for 30 s past the ti. 
3.6  The Fabrication of Electrodes (Stage 3) 
The development work, to fabricate the electrodes required for the drug delivery 
device (Stage 3 fabrication), was carried out in the cleanroom facility at the 
University of Manchester, concurrent to the work on the stain etching process 
described in §  3.5. The aim is to establish a feasible revised lift-off process; this was 
due to the change of cleanroom facility which necessitated a modification to the 
proposed bi-layer photoresist (of PMGI and S1813 in Step (j)) in the lift-off process.  3.6 The Fabrication of Electrodes (Stage 3)    107 
 
In this work, a single layer lift-off process was used instead. In order to 
ensure a good lift-off with a single layer process, the photoresist should be at least 
twice the thickness of the deposited metal film to be lifted-off. Since the aluminium 
electrodes are proposed to be 1 μm thick, the positive Shipley S1828 photoresist, 
which has a nominal thickness of 2.8 μm, was used. In addition, in order to improve 
the success of lift-off, an undercut can be formed by surface modification of the S1828 
such that the top surface of the photoresist is hardened and hence dissolved in the 
photoresist developer at a slower rate than the bulk of the photoresist. Typically, this 
is achieved by soaking the photoresist coated wafer in toluene or chlorobenzene 
either before or after the UV exposure step [287].  
3.6.1  Revised Lift-off Process: Setup and Procedures 
Due to the restriction of wafer size (device wafers are 4 inch in diameter but most 
machines at the University of Manchester only capable of handling 3 inch wafers), 
individual chips or samples were used for the development work. A new 3” emulsion 
mask (see Appendix B.1.3 for mask layout) with the pattern of electrodes was 
designed and fabricated to comply with the mask aligner (Karl Suss MJB-3). The p-
type polysilicon samples used for this work were manually scribed and cleaved from 
wafers 7 (W7, Rs ≈ (28.67 ± 0.59) Ω/sq) and wafer 10 (W10, Rs ≈ (338.94 ± 4.95) Ω/sq) 
of the batch K2714s. 
The samples were first pre-treated to remove the photoresist (as detailed in 
§  3.5.2) and stain-etched in a 1:3:5 volume ratio of HF:HNO3:H2O to form the PPSi 
structure; Table   3.9 summarises the detailed process parameters. Immediately after 
the stain etching process, the samples were dehydrated in an oven at 110 °C for at 
least 30 minutes. The S1828 photoresist was then spin-coated on the stain-etched 
sample at 4000 rpm for 40 s to 60 s. Next, the samples were pre-baked in an oven for 
25 minutes at 90 °C. The samples were then cooled to room temperature before being 
immersed in chlorobenzene for 4 minutes to 6 minutes. Once gently blown dry using 
a nitrogen gun, the samples were exposed using the mask aligner with either a 
simple stripe pattern (2 mm wide stripe from an existing mask) or a four-square (1 
mm by 1 mm) electrode pattern (from the 3 inch emulsion mask), as depicted in 
Figure   3.24. The exposure wavelength was 365 nm and exposure time ranged from 3.6 The Fabrication of Electrodes (Stage 3)    108 
 
90 s to 100 s with a power density of 18 mW·cm-2. Finally, the sample was developed 
in a diluted 1:1 volume ratio of Shipley MICROPOSIT® developer: DI water, for 1 
minute to 2 minutes. The samples were then immediately rinsed with copious 








W7S14  28.67 ± 0.59 
Photoresist stripped in RIE80. 
Cleaned with FNA (5 min) then rinsed in 
DI water (10 min). 
1:3:5 (30 s) 
volume ratio of 
HF:HNO3:H2O 
W7S25  28.67 ± 0.59 
Photoresist stripped in FNA (5 min) then 
rinsed in DI water (10 min). 
1:3:5 (30 s) 
volume ratio of 
HF:HNO3:H2O 
W7S26  28.67 ± 0.59 
Photoresist stripped in FNA (5 min) then 
rinsed in DI water (10 min). 
1:3:5 (40 s) 
volume ratio of 
HF:HNO3:H2O 
W10S40  338.94 ± 4.95 
Photoresist stripped in RIE80. 
Cleaned with FNA (5 min) then rinsed in 
DI water (10 min). 
1:3:5 (60 s) 
volume ratio of 
HF:HNO3:H2O 
Table   3.9: Summary of the pre-processing and stain etching parameters used by the samples 




W7S14 W7S25  W7S26  W10S40 
i)  Dehydration bake  110 °C in oven, 30 minutes 
ii)  Spin coat S1828 
photoresist at 4000 rpm 
60 s  60 s  60 s  40 s 
iii)  Pre-bake  90 °C in oven, 25 minutes 
iv)  Chlorobenzene soak  5 minutes  5 minutes  5 minutes  4 minutes 
v)  UV expose with mask  100 s  90 s  90 s  100 s 
vi)  Develop in 1:1 Microposit 
developer: DI water 
120 s  60 s  60 s  120 s 
vii)  Attach to carrier using 
S1813 photoresist 
110 °C in oven, 30 minutes  - 
viii)  Aluminium evaporation  ~ 1.2 μm ~  1.4  μm ~  1.4  μm  - 
ix)  Lift-off of aluminium in 
acetone 
Short (~ 30 s) 
ultrasonication 




Table   3.10: Summary of the steps involved in the revised lift-off process and the relevant 
parameters used for selected samples. All samples have been pre-treated and stain-etched as 
detailed in Table   3.9. 3.6 The Fabrication of Electrodes (Stage 3)    109 
 
The photoresist patterned samples were then attached to a carrier (a 
microscope glass slide or a cut wafer piece) using the Shipley S1813 positive 
photoresist. The carrier and the attached samples were then post-baked in an oven 
at 110 °C for 30 minutes, prior to the deposition of aluminium. Instead of using an e-
beam evaporation, the aluminium was deposited using a modified thermal 
evaporator with aluminium pellets (99.999 % purity, Goodfellow Cambridge Ltd., 
UK) that are manually delivered using a custom-made feeding system [288] (see 
Chapter 4, §4.3.1 for more details). Here, aluminium of thickness between 1.2 μm 
and 1.4 μm was deposited. Finally, to realise the aluminium electrodes, the samples 
were immersed in acetone (sometimes with ultrasonication) to dissolve the 
photoresist and, hence, achieve lift-off and removal of the aluminium at the 
unwanted areas. The exact process parameters of selected samples, used during the 
lift-off process, are summarised in Table   3.10. 
3.6.2  Fabrication Results and Issues 
Figure    3.24 depicts the digital photographs (captured using Canon IXUS 55, 5 
megapixels) of samples W10S40 and W7S26 (see Table   3.9 and Table   3.10 for details 
of samples and processing conditions) after the photolithography patterning of the 
S1828 photoresist. The thickness of the S1828 was measured using a stylus 
profilometer (Talystep 1, Rank Taylor Hobson) and was found to range from 2.8 μm 
to 2.9 μm. Some photoresist defects, such as pinholes and particulate contamination, 
could be observed but this was not critical. In most cases, the chip-level alignment 
marks (120 μm by 120 μm, at the four corners of the chip) were not properly 
developed due to an edge bead effect, which is particularly severe in 
photolithography with small samples. The problem is not critical, as this is the last 
photolithography step of the fabrication process. The edge bead problem is typically 
overcome by using commercially available edge bead remover solvent (such as 
Microposit EBR-10A) or by additional exposures of the edge (prior to pattern 
exposure) using a suitable mask. 
After the aluminium deposition, the samples were immersed in acetone to 
remove the photoresist for the lift-off of the aluminium film. Samples with a simple 














Figure   3.24: Digital photographs of samples (a) W10S40 and (b) W7S25 patterned with photoresist 
S1828, ready for aluminium evaporation to realise (a) a simple two contact pads as electrodes and 
(b) a four-square (1 mm by 1 mm) electrode pattern. Both the samples have been processed up to 
















Figure   3.25: Digital photographs of aluminium patterned samples after lift-off process: (a) W7S14 




















Figure   3.26: Optical microscope images showing samples (a) W7S25; and (b) W7S26 after the lift-
off process. Aluminium electrode was partially damaged in (a) with some “left-over” aluminium due 
to unsuccessful lift-off. In (b), residual photoresist can be observed even after ultrasonication and 
mechanical scrubbing. 3.6 The Fabrication of Electrodes (Stage 3)    111 
 
were found to easily achieve a successful lift-off. The S1828 dissolved in acetone after 
a quick (~30 s) ultrasonication. The aluminium electrode at one edge of the pads was 
found to have peeled off from the surface during the process, as depicted in Figure 
  3.25 (a), possibly due to poor adhesion to the Si3N4 surface of the aluminium film. 
In contrast, samples with the actual electrode pattern (such as sample 
W7S26, as depicted in Figure   3.25 (b)) showed a less successful lift-off process even 
after mechanically scrubbing (using a cotton bud) the surface of the samples during 
the ultrasonication in acetone. This is believed to be mainly due to the S1828 
photoresist becoming hardened as a result of overheating during the aluminium 
evaporation. The “burnt” S1828 showed severe cracking and was very difficult to 
remove as it adheres well to the surface of the samples (see example depicted in 
Figure   3.26 (b)). Due to excessive scrubbing, scratch marks were observed on many 
regions of these samples (such as samples W7S25 and W7S26) and some regions of 
the electrodes were found to be damaged (see example depicted in Figure   3.26 (a)). In 
both samples (W7S25 and W7S26), the aluminium electrode was observed to exhibit 
black-rusty-like (possibly oxidised) patches, at some arbitrary regions, likely to be 
due to high temperature treatment during the evaporation process.  
The development of the lift-off process described here provides a number of 
useful observations. Firstly, the conditions necessary for the aluminium evaporation 
are critical, most importantly over-heating must be avoided. Photoresist which has 
been exposed to high temperature is difficult to remove in the subsequent lift-off 
process (Step (j)) and hence damaged electrodes can result. Secondly, the thickness of 
the photoresist and accessibility to the sacrificial photoresist layer via an undercut 
both influence the success of the single-layer lift-off process. A thicker photoresist 
and a greater undercut improve the success of the lift-off. Finally, the aluminium 
layer adheres mostly on the sample without the need for a quick dip in BHF to 
remove the native oxide.  
There are several issues that have not been extensively assessed in this 
development work. Firstly, the level of residual photoresist, which may have been 
trapped in the porous structure after a successful lift-off step, has not been fully 
investigated. The PPSi structure should retain its porosity and be free of photoresist 
at the end of the lift-off step, to allow for the loading of the therapeutic agents. 3.7 Conclusion    112 
 
Secondly, the level of impregnation of aluminium into the pores has not been 
extensively studied. It is desirable that the evaporated aluminium infiltrates well 
into the porous structure to make a good electrical contact (to fulfil design 
requirement (III)). These issues, however, can be better examined when a suitable 
PPSi structure has been fabricated.  
3.7  Conclusion 
This chapter describes the design and the fabrication of a porous polysilicon (PPSi) 
based drug delivery device, with an emphasis on the development of a stain etching 
process to form a suitable PPSi structure for incorporation as a drug reservoir.  
During the Stage 1 fabrication of the device, the ion implantation process 
(Step (c)) effectively yielded only two different resistivity levels of boron-doped p-type 
polysilicon layers. The sheet resistance of the high boron doping (dose of 1 x 1016 cm-2 
at 80 keV) and medium boron doping (dose of 5 x 1015 cm-2 at 80 keV) p-type 
polysilicon layers were found to be very similar (measured to be (28.67 ± 0.59) Ω/sq 
and (32.54 ± 0.19) Ω/sq, respectively) and were confirmed by a process simulation 
detailed in §  3.4.1.1. 
The investigation of the stain etching process to form the PPSi structure 
(Stage 2) resulted in mixed conclusions. Based on the evidence obtained by SEM and 
AFM, the stain etching on sample W7S15 (with Rs ≈ (28.67 ± 0.59) Ω/sq) using a 
1.3:6:15 volume ratio of HF:HNO3:H2O appears to produce the best PPSi structure, 
which may be suitable as a drug reservoir. By stain etching in the mentioned system 
for 5 minutes, branched pores in the range of 30 nm to 50 nm in width, and a 
thickness of ~ 250 nm have been produced (see Figure   3.16). 
However, in general, most samples prepared by the stain etching process, do 
not produce a PPSi film with a distinct pore morphology or microstructural 
characteristics observable using SEM and AFM. Most of the PPSi structures 
observed under SEM have hillocks, cracked or rough surfaces, as summarised in 
Table    3.8. There are indications of pore formation, such as the findings of EDX 3.7 Conclusion    113 
 
analysis (sample W7S27, see Figure   3.15) and the observation of etching of buried 
SiO2 (sample W7S38, see Figure    3.17), but these observations alone could not 
quantitatively characterise the physical properties (in particular, the pore width, 
inter-pore spacing and porous thickness) of the formed PPSi structure. 
The development work on a revised lift-off process to fabricate the electrodes 
(Stage 3) is preliminary and is greatly dependent on the outcome of the formation of 
PPSi in Stage 2 fabrication. Some potential fabrication issues and challenges were 
identified. The evaporation of the 1 μm thick aluminium must be carefully carried 
out to avoid over-heating of the photoresist and substrate. Photoresist that was 
exposed to a high temperature was found to be difficult to remove in the subsequent 
lift-off step, which can result in damaged electrodes (as depicted in Figure   3.26). The 
revised lift-off process used a single layer of S1828 positive photoresist, with a 
chlorobenzene soak of 5 minutes to surface modify the S1828 to achieve an undercut 
for successful lift-off. An exposure time of 90 s (with a power density of 18.3 mW/cm2) 
and a development time of 60 s were found to be sufficient to pattern the S1828. 
Further work is still needed to investigate the level of residual photoresist after the 
lift-off process. The impregnation of aluminium into the porous structure needs to be 
investigated to ensure a good electrical contact. 
The lack of success in obtaining well-characterised PPSi structures formed by 
the stain etching processes tested, increases the reliability issues in the entire 
fabrication of the drug delivery device. This also casts doubt as to whether a PPSi 
structure formed in this way would be suitable as the reservoir of the drug delivery 
device. The size of the pores created thus far was estimated to be in the micro- to 
mesopore size regimes. Typical sizes of proteins and peptides are often in the size 
regime of 5 nm to 20 nm [61, 228]. Hence, a microporous structure (< 2 nm in width) 
may be too small to entrap proteins and peptides; while protein loading into the 
mesoporous structure (2 nm to 50 nm in width) may be very challenging. The 
random pore structure and the self-limiting thickness of PPSi structure formed by 
stain etching further increased the need to investigate alternative, novel methods, 
such as those discussed in Chapter 4 and Chapter 5, to fabricate a more orderly and 
reproducible porous structure, in the size range of 50 nm to 100 nm.   
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Chapter  4 
The Fabrication of Porous 
Polysilicon using a Porous Anodic 
Alumina Template 
4.1  Introduction 
Conventionally, ordered porous silicon (PSi) structures have been fabricated by the 
electrochemical etching of a silicon substrate that is pre-patterned with ordered 
starting pits. These predefined pits are created firstly by the fabrication of a 
patterned masking layer, and then the creation of pits by anisotropic etching into 
silicon using an alkaline-based etchant such as potassium hydroxide [165, 166, 289, 
290]. The diameter of the pores and the interpore distance is usually restricted in 
size (typically > 1 μm with contact optical lithography). This size restriction is due to 
the limitation of the optical lithography process, which is typically used to define a 
masking layer for the creation of the initial pits. The achievable pore structure, such 
as the pore diameter, pore depth, type and size distribution, is also restricted by the 
electrochemical etching process. The type of silicon (either p-type or n-type), its 
resistivity and orientation and anodisation conditions, such as current density, 
electrolyte compositions, etching time and temperature, all play a significant role in 
the pore geometry obtained by anodisation. Thus far, the smallest straight 
cylindrical ordered PSi structure realised is of the order of 0.2 μm in diameter [165, 
167]. 4.2 Porous Anodic Alumina: An Overview    115 
 
Alternatively, next-generation lithography technologies [42], such as extreme 
ultraviolet, electron beam (e-beam), X-ray and scanning probe lithography 
techniques, can be used to produce patterns with nanoscale features. However, these 
techniques, in general, are costly and relatively slow for creating large pattern areas. 
On the other hand, lithography methods, which are dependent on self-organisation, 
such as anodic alumina [291-293] or self-assembly of nanospheres [294, 295], have 
been used as a cost effective alternative to nanoscale patterning. In particular, 
porous anodic alumina (PAA), which is formed during the electrochemical etching 
(anodisation) of aluminium, has recently been demonstrated to provide a high aspect 
ratio, ordered, porous structure [296]. Primarily, PAA film has been used as 
templates in the fabrication of metal nanowires [291, 297-299] and carbon nanotubes 
[291, 300]. 
In this chapter, an attempt to fabricate a porous polysilicon (PPSi) structure 
with pore sizes in the 50 nm range, using a PAA film as a masking template, is 
described. Thick aluminium film (> 7 μm) was deposited on a polysilicon substrate, 
which was initially designed for the fabrication of a PPSi structure using the stain 
etching method (see Chapter 3). Therefore, a number of modifications were made to 
allow for the fabrication of the PAA template. A reactive ion etching (RIE) process 
was subsequently used to transfer the pattern of the PAA template onto the 
polysilicon layer. 
4.2  Porous Anodic Alumina (PAA): An Overview 
Depending on the pH of the electrolyte, two types of aluminium oxide (Al2O3) can be 
formed during the anodisation process of aluminium. A thin, uniform, nonporous 
oxide layer (commonly known as the barrier-type alumina) is typically formed when 
a near neutral electrolyte (pH 5 to 7) is used [293]. In contrast, when an acidic 
electrolyte (such as sulphuric, oxalic and phosphoric acid) is used, a thick porous 
oxide layer (or porous anodic alumina, PA A )  i s  f o r m e d  a s  a  r e s u l t  o f  p a r t i a l  
dissolution of the oxide layer in the strong acidic environments [293]. Under 
optimum anodisation conditions, the porous-type alumina self-organises into a 
hexagonally ordered structure, and the pores fabricated in this way are typically 4.2 Porous Anodic Alumina: An Overview    116 
 
straight and cylindrical in shape. These pores have diameters ranging from 20 nm to 
200 nm and depths of up to a few microns. The spacing between adjacent pores (or 
the interpore distant) is well-established to be linearly related to the applied anodic 
voltage with a proportionality constant, ζint, of ~ 2.5 nm·V-1 [301]. The pore diameter 
is determined by the applied voltage and the concentration and temperature of the 
electrolyte. In addition, the pore diameter can be adjusted by a post-anodisation 
process. It is the consensus that an ideal, naturally occurring pore has a diameter 
primarily affected by the applied voltage with a proportionality constant, ζp, of ~ 1.29 
nm·V-1 [302, 303]. The pore depth of the PAA is directly proportional to the anodising 
time. The ability to effectively control these geometrical structures of PAA thus 
provides an attractive proposition to using the PAA as a template for the fabrication 
of nanostructures and nanomaterials [291-293]. 
4.2.1  Fabrication Approaches 
A typical fabrication of PAA film includes pre-treatment of the aluminium surface, 
the anodisation and a post-anodisation treatment step. The pre-treatment process, 
which includes annealing, degreasing and polishing of the aluminium surface, is 
essential to provide a highly smooth surface that is required for a self-organised 
anodisation process [304]. Annealing of the aluminium film or substrate is typically 
performed between 400 °C and 500 °C, in an Ar or N2 atmosphere, for half an hour to 
6 hours. The annealing process re-crystallises the aluminium grains of deposited 
aluminium [305], and reduces stresses and increases the grain size of the bulk 
aluminium substrate [304]. The degreasing step is typically carried out using 
solvents such as acetone and ethanol. The essential step of the pre-treatment process 
is the polishing step, which can be achieved by means of mechanical [306] or 
electrochemical polishing. The electrochemical polishing, using either a mixture of 
phosphoric acid (H3PO4), and sulphuric acid (H2SO4) [304, 307] or a mixture of 
perchloric acid (HClO4) and ethanol [308-310], with a typical voltage of < 30 V, is 
more commonly used. 
The anodisation of aluminium to form a self-organised PAA with long-range 
ordered structure, is known to occur within a relatively narrow range of fabrication 
conditions [293, 308]. The most critical parameter is the applied voltage, which is 4.2 Porous Anodic Alumina: An Overview    117 
 
specific to the type of electrolyte used for the anodisation. The three most 
investigated and commonly used conditions include using:  
i)  sulphuric acid (H2SO4) at 25 V [311-315]; 
ii)  oxalic acid (H2C2O4) at 40 V [296, 300, 302, 304, 307, 310, 316]; 










Figure   4.1: (a) – (c) Plane-view and (d) cross-sectional view SEM micrographs of various PAA 
structures fabricated by anodisation in (a) 0.5 M H2SO4 at 25 V for 750 minutes at 10 °C (reprinted 
from [315]); (b) 10 wt% H3PO4 at 195 V for 240 minutes (reprinted from [317]); (c) and (d) 0.3 M 
H2C2O4 at 40 V for several hours at 10 °C using a 2-step anodisation process (reprinted from[310]). 
Example PAA structures fabricated using these three conditions are depicted 
in Figure   4.1. The voltages used in these cases typically result in low current density 
and hence a slow growth rate of PAA (2 μm·h-1 to 6 μm·h-1) [320]; this is commonly 
known as the mild anodisation. Recently an anodisation technique, using voltages 
higher than the conventional ones, which results in high current density with a 2 
500- to 3 500-fold increase in oxide growth rate, has been successfully developed 
[320-322]; this is known as the hard (or high-field) anodisation. The PAA structure 
fabricated using the hard anodisation process exhibits a non-conventional self-4.2 Porous Anodic Alumina: An Overview    118 
 
ordering regime with a lower ζint of ~ 2.0 nm·V-1 (ζint for mild anodisation is ~ 2.5 
nm·V-1) [320]. 
In order to improve the process, a two-step anodisation process was first 
demonstrated by Masuda and Satoh in 1996 [316]. The process significantly reduces 
the total anodisation time that is required to achieve a long-range ordering of the 
self-organised PAA; a typical one-step anodisation process needs a long period (of a 
few days) to achieve similar ordering [296]. In the two-step anodisation process, 
following an initial anodisation process (at the pre-selected electrolyte-voltage 
condition), the formed quasi-ordered PAA is removed using a mixture of H3PO4 and 
chromic acid (H2CrO4) at a temperature between 60 °C and 80 °C. The removal of the 
PAA forms a textured pattern of shallow concave features on the surface of the 
aluminium, which now becomes a template for pore initiation sites during the 
subsequent anodisation. The second anodisation is typically carried out using the 
same parameters as in the first anodisation, but with a much shorter anodisation 
time. The anodising and removing of PAA can be repeated for a three-step [309] or 
multistep [300, 308] anodisation process; generally, the uniformity of pore size 
increases with an increasing number of anodisation-removal cycles. The idea of pre-
texturing the polished aluminium surface to form an ideally ordered PAA in a large 
area, has also been extended by direct indentation using scanning probe microscopy 
[323], focused-ion beam methods [324] and nanoimprint lithography [325-328]. 
A post-anodisation treatment step is primarily used to obtain a PAA template 
suitable for the subsequent fabrication of nanostructures and nanomaterials. The 
post-anodisation process includes removal of the aluminium base, pore widening and 
barrier layer removal. The removal of the un-oxidised aluminium base is mainly 
applicable to the PAA formed using an aluminium substrate (such as a foil, sheet, 
plate or disc) and is typically performed using wet chemical etching of aluminium in 
a saturated mercuric chloride (HgCl2) solution [296, 304, 316]. The barrier layer of 
the PAA formed by the anodisation process can be removed by chemical etching of 
the oxide, typically using a solution of H3PO4; this opens the base of the pores and as 
a result, through-pores are created. The barrier layer removal process, when 
performed over a longer time, can simultaneously enlarge the pore diameter [316, 
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4.2.2  Anodisation of Aluminium-on-Silicon 
Much of the effort in the fabrication and characterisation of PAA has been focused on 
using high purity aluminium substrates. Recently, greater attention has been 
focused on the fabrication of PAA films using aluminium deposited on top of different 
substrates, such as silicon [302, 305, 330-332] and glass [333-335]. This approach of 
forming a PAA template has numerous advantages – the substrates can be patterned 
into nanoholes or nanodots [331, 332] by subsequent post-anodisation processes. In 
addition, nanomaterials can be grown or deposited [291, 298, 310] with ease using 
various established methods previously developed for silicon substrates. In 
particular, PSi structures have been fabricated by RIE [302, 328] and 
electrochemical etching [330] using PAA templates as masks. 
A typical anodisation process of aluminium-on-silicon has the current-time 
characteristic as depicted in Figure   4.2. Briefly, the current density rises sharply 
during the first few ms due to a spontaneous localised anodisation of the aluminium 
thus starting the formation of a thin oxide (Al2O3) barrier layer. After reaching its 
maximum, the current density drops sharply as the oxide barrier layer grows in 
thickness and spreads onto the entire surface of the aluminium that is exposed to the 
electrolyte. The current density then rises slightly due to a field-enhanced partial 
dissolution of the formed oxide barrier layer, at the interface between the barrier 
layer and the electrolyte [336]; a pore nucleation process is believed to have taken 
place [337]. A competing oxidation (of aluminium) and dissolution (of Al2O3) occurs 
as a result of anodisation across the entire exposed surface. As the growth and 
dissolution of Al2O3 reaches equilibrium, the current density remains more or less 
constant. During this constant-current stage, the formation and self-organisation of 
PAA take place (up until point A in Figure    4.2); this is a common behaviour in 
anodisation of both high purity aluminium substrate [309, 336, 337] and aluminium 
deposited on a silicon substrate [331, 332, 338]. 
A rapid decrease in current density (point B in Figure   4.2) is then observed, 
as the aluminium film is consumed gradually and converted into a transparent PAA 
film, which could be verified by a visible change in colour of the Al2O3 / Al / Si 
structure [331]. When the aluminium film is completely exhausted, the current 
density reaches a minimum value (point C in Figure    4.2) and it is believed that 4.2 Porous Anodic Alumina: An Overview    120 
 
silicon dioxide is formed at the interface of the barrier layer and the silicon substrate 
[339, 340]. The barrier layer, at this stage, is typically found to be inverted and 
arched, as depicted in Figure   4.3, and voids are formed at the interface between the 
barrier layer and the silicon substrate [302, 305, 333]. Further anodisation results in 
a sharp increase in the current density (point D in Figure    4.2), suggesting the 
localised anodisation of the underlying silicon. A partial detachment of the barrier 
layer of the PAA film from the silicon substrate accompanied by gas evolution may 
occur at this stage [331]. The subsequent broad peak (point E in Figure   4.2) indicates 
that the anodisation of the silicon substrate has been extended to the entire area of 
the sample and the PAA film will eventually detach from the substrate by extensive 




































Figure   4.2: A representative current-time curve during anodisation of an aluminium film sputtered 
on top of a silicon substrate. The anodisation was carried out in 0.3 M oxalic acid at 20 °C at a 
constant voltage of 40 V (adapted from [332]). 
200 nm
 
Figure   4.3: Cross-sectional view SEM micrograph of the inverted, arched barrier layers (outlined 
with dotted lines) typically formed when the aluminium is almost exhausted, during the 
anodisation of aluminium-on-silicon (reprinted from [302]). 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  121 
 
4.3  Fabrication of a PAA Template on a 
Polysilicon Substrate 
The use of a PAA template for the fabrication of a PPSi structure was proposed and 
subsequently investigated using a check wafer (#c13p, p-type, sheet resistance of 
(32.54 ± 0.19) Ω/sq) from batch K2714s (which was previously developed for the 
investigation of stain etching method to produce a PPSi structure (see Chapter 3)). 
The check wafer was used for the measurement of the sheet resistance (as discussed 
in Chapter 3, §3.4.1), and was processed in the same way as the device wafers, up to 
Step (d) of Figure 3.6. The use of a check wafer simplifies the modifications required 
for the fabrication of the PAA template. These modifications include: 
i)  depositing a thick layer of aluminium on top of the polysilicon layer (Step 
(a) of Figure   4.4); 
ii)  dicing the wafer into chips of 10 mm x 10 mm (Step (b) of Figure   4.4); 
iii)  making an electrical connection, between the bulk silicon substrate and 
the polysilicon layer (Step (b) and (c) of Figure   4.4); 
The fabrication of the PAA template was primarily carried out at Prof. B. 
Hamilton’s group, at the University of Manchester, using a fabrication method 
developed by Mazhar E. Nasir [288], which includes a low temperature 
electrochemical polishing step (Step (d) of Figure   4.4) and a multistep anodisation 
process (Step (e) of Figure   4.4) using oxalic acid-based electrolyte. The pattern on the 
PAA template can then be transferred to the polysilicon layer, for instance, by using 
a RIE process (Step (f) of Figure   4.4), to realise a PPSi structure. 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  122 
 
 
Check wafer #  after stripping the SiO  by 7:1 buffered HF
for the measurement of sheet resistance (see Chapter 3, section 3.4.1)
c13p 2
a) Deposit thick (> 4  m) layer of aluminium by evaporation via a shadow 
mask and then anneal at 450  C
μ
°
b) Deposit Au by evaporation and then dice into chips
Front-side
Back-side
c) Deposit Au by evaporation to bridge contact to front-side
e) Multistep anodisation and barrier removal
d) Low temperature electro-polishing of aluminium
 
 
Figure   4.4: Schematic illustration of the proposed fabrication of the PPSi structure using a PAA 
template (not to scale; see next page for continued process steps and colour scheme of materials 
used). 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  123 
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Figure   4.4: Schematic illustration of the proposed fabrication of the PPSi structure using a PAA 
template (not to scale). 
4.3.1  Aluminium Deposition and Electrical Contact 
The check wafer #c13p was first cleaned using plasma, solvent and chemical 
approaches. A RIE (Plasma Technology RIE80) using O2 gas, with a flow rate of 50 
sccm, was first performed at a pressure of 60 mTorr and a radio frequency (RF) 
power of 150 W. The RIE was performed for 10 minutes. Next, a solvent clean using 
trichloroethylene (TCE), followed by acetone, methanol and de-ionised (DI) water, for 
10 minutes each in an ultrasonic bath, was carried out. The wafer was then sawn 
into a square piece of 75 mm x 75 mm and then thoroughly degreased with a similar 
solvent cleaning process. A Piranha clean with 2:1 volume ratio of 95 % concentrated 
H2SO4: 30 % weight in volume (w/v) hydrogen peroxide, was performed to remove 
any organic residues off the substrate. The wafer was finally cleaned with 10:1 
volume ratio of DI water: 48 % hydrofluoric acid (HF) to remove the native oxide 
prior to the evaporation process. 
A thermal evaporation of aluminium (Step (a) of Figure   4.4) was carried out 
using a modified resistive thermal evaporator (BOC Edwards) [288]. High purity 
aluminium pellets (99.999 % purity, Goodfellow Cambridge Ltd. UK) were used as 
the source and were delivered using a custom-made, movable, solenoid-controlled 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  124 
 
feeding system, as depicted in Figure   4.5. This allows multiple evaporations without 
the need to break the vacuum system to provide the aluminium source; hence a thick 
layer of aluminium (potentially up to 10 μm) can be deposited. A shadow mask, made 
of stainless steel, with a 7 x 7 array of 8 mm diameter circular holes, was used to 
pattern the wafer. Each cycle of evaporation was performed at a base pressure of < 4 
x 10-6 mbar; only one aluminium pellet was used per cycle. A total of 27 aluminium 
pellets were used in the evaporation process, resulting in an aluminium thickness of 
~ 7.04 μm, as recorded by a quartz crystal film thickness monitor interfaced to a 























Figure   4.5: Digital photographs of the custom-made feeding system in the modified thermal 
evaporator, with the feeding system (a) in the standby position, after an aluminium pellet was 
dropped on a ceramic evaporation boat; and (b) in the feeding position, ready for dropping the 
aluminium pellets. 
The surface of the as-deposited aluminium varied in appearance, from dull, 
milky white colour to metallic silver colour, as conceptually depicted in Figure   4.6, 
which suggests non-uniformity in the aluminium thickness. This is possibly a result 
of a secondary evaporation masked by a mechanical, substrate shutter, which was 
used to protect the wafer from excessive heat radiation, at the beginning and near 
the end of each evaporation cycle. This non-uniformity in thickness proved to be 
problematic to subsequent processes, as discussed in the following sections. The lack 
of a mirror-like surface finish also suggests a grainy surface roughness. 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  125 
 















Figure   4.6: Illustration of the colour variation across the wafer indicating the non-uniformity in 
thickness of the evaporated aluminium. The colour scheme used is not truely representative of the 
colour observed and is simply for illustration purposes only. 
The wafer was subsequently annealed at 450 °C for 45 minutes, in a nitrogen 
atmosphere, to re-crystallise the aluminium grains [305]. However, as a typical 
result of the annealing, hillocks were observed when the wafer was inspected with a 
microscope, and this was confirmed by SEM micrographs, as depicted in Figure   4.7. 
The size (longest length) of the hillocks varies from as large as a few microns, to as 
small as ~ 0.5 μm. The average size of the hillocks was estimated to be ~ 1.4 μm, 
based on the SEM micrograph inset in Figure   4.7. 
The annealed wafer was then spin-coated with a layer of Shipley S1813 
photoresist on the front-side and hard-baked at 110 °C for at least 1 hour. The wafer 
was then cleaned with 10:1 DI water: HF prior to a gold evaporation to make the 
back electrical contact. Gold of ~ 100 nm thick was evaporated at the back-side of the 
wafer (Step (b) of Figure    4.4) using the same thermal evaporator, with a base 
pressure of 5 x 10-6 mbar. The back-side of the wafer was then spin-coated with 
another layer of the S1813 photoresist to protect the wafer from silicon particulates 
during the dicing process. The wafer was diced into 10 mm x 10 mm smaller pieces 
with the 8 mm diameter aluminium roughly centred on each samples. The samples 
were labelled as per their grid position (as depicted in Figure    4.6) for easier 
identification. Side contacts (Step (c) of Figure   4.4) were then made individually on 
the samples, such that a bridge could be created that extended from the front-side, to 
the edge-side and to the back-side contact of the sample, as conceptually depicted in 
Figure   4.8. Electrical connection was then made, at the back-side of each sample, 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  126 
 
using a two-part conductive silver epoxy, and cured at 120 °C for at least 30 minutes. 
The resistance from the wire to the surface of aluminium was measured and found to 




Figure   4.7: Plane-view SEM micrograph showing the surface of the annealed aluminium on sample 
D5. The annealing was performed at 450 °C in a N2 atmosphere for 45 minutes. The inset shows 
the magnified view at a different area of the sample. 









Figure   4.8: Schematic illustration of a sample deposited with aluminium and ready for the 
fabrication of the PAA template. 
4.3.2  Electro-polishing of Aluminium 
Individual samples were then electrochemically polished (Step (d) of Figure   4.4) in a 
custom-made, polytetrafluoroethylene (PTFE) electrochemical etching cell [288], as 
depicted in Figure   4.9. The electrolyte used in the electro-polishing process consists 
of 1:2:4 volume ratio of 2-butoxyethanol (> 99 %): 35 percent volume per volume (% 
v/v) HClO4: ethanol (all reagents are of ACS grade from Sigma-Aldrich Ltd., UK). 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  127 
 
Due to the highly flammable and explosive nature of HClO4, the mixture was 
prepared in an ice bath. The electro-polishing was performed under a controlled low 
temperature (of below 5 °C), which was achieved by feeding liquid nitrogen to the 
back-side of the sample, and circulating the liquid nitrogen within the etching cell, 
as depicted in Figure    4.9. The electrolyte was stirred (~ 40 rpm), using a PTFE 
stirrer connected to an electric motor (330-799, RS Components Ltd., UK), during the 
electro-polishing process. 
An aluminium counter electrode was used as the cathode, with the sample as 
the anode, and connected to a constant voltage power supply (Delta Electronika 
E0300-0.1). The voltage drop across the sample and the counter electrode was 
measured using a digital multimeter (TTi 1604, Thurlby Thandar Instruments Ltd. 
UK). The current passing through the sample and the counter electrode was 
measured using a programmable multimeter (TTi 1705, Thurlby Thandar 
Instruments Ltd. UK), which also measures the temperature in the etching cell via a 
thermocouple. The two multimeters were connected to a computer via an RS-232 



















Figure   4.9: Digital photograph of the electrochemical etching cell used in an electro-polishing 
configuration, which allows for the cooling by liquid nitrogen. 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  128 
 
The electro-polishing voltage ranged from 20 V to 30 V and the etching time 
was between 35 s and 70 s. At 20 V, the maximum electro-polishing time before some 
of the aluminium was exhausted was found to be between 50 s and 60 s, while 
samples electro-polished with 25 V and 30 V appeared to be over-polished after 55 s 
and 45 s, respectively. The rate of electro-polishing was not only influenced by the 
etching time and the applied voltage, but also dependent on other factors, such as 
the initial surface roughness of the aluminium, the thickness of the aluminium, the 
etching temperature, and the stirring of the electrolyte [288]. The electro-polishing 
process also appears to have a narrow window of optimum conditions. 
The surface finish of the electro-polished aluminium depends on the rate of 
electro-polishing. Some samples exhibited a mirror-like finish when electro-polished 
at the optimum conditions. These samples, including sample E5, which is depicted in 
Figure    4.10, when observed under the SEM, showed a smooth surface with a 
significant reduction in aluminium grain sizes. Other samples, although they 
appeared to have a mirror-like finish, exhibited macroscopic defects, such as etch 










Figure   4.10: Oblique, cross-sectional view SEM micrograph of sample E5, which was electro-
polished for 45 s at a voltage of 20 V. 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  129 
 
4.3.3  Anodisation of Aluminium 
Anodisation (Step (e) of Figure   4.4) of the samples was then carried out using the 
same electrochemical etching setup, at room temperature (varies from 18 °C to 24 
°C). A platinum counter electrode was used instead of the aluminium electrode (used 
in the electro-polishing process). The electrolyte consists of 0.3 M oxalic acid, which 
was prepared by dissolving 5.4 g anhydrous H2C2O4 (> 99.0 %, puriss. p.a. grade) 
into 200 mL DI water. The typical voltage used for the anodisation process was at 40 
V, although anodisation steps using 50 V and 60 V have also been tested on selected 
samples. The anodisation process ranged from a single step to 5 steps. Between each 
step, of the multistep anodisation process, the formed PAA was removed in a mixture 
of 1:1 volume ratio of 45 g·L-1 H2CrO4 (prepared from chromium (III) oxide, > 98 %): 
3.5 % v/v H3PO4 (> 85 % in weight, ACS grade) that was heated to 70 °C, typically for 
30 minutes (all reagents are from Sigma-Aldrich Ltd., UK). Multiple steps of 
anodisation were carried out so that a thinner PAA film, with ordered, cylindrical 
straight pores, could be fabricated. Some of the anodised samples were then 
immersed in a mixture of DI water and 10 % v/v H3PO4 with equal volume, for 1 
hour, to remove the barrier layer and enlarge the pore size. Table   4.1 summarises 
the parameters used in the electro-polishing and anodisation processes, of selected 
samples discussed in this chapter. 
Sample Electro-polishing  Anodisation  Post-anodisation 
E5  20 V, 45 s  -  - 
F5  20 V, 55 s  Single step: 40 V, 3600 s  - 
F4  20 V, 45 s 
1st step: 40 V, 1200 s 
2nd step: 40 V, 1200 s 
3rd step: 40 V, 3800 s 
- 
E4  20 V, 45 s 
1st step: 40 V, 600 s 
2nd step: 40 V, 900 s 
3rd step: 40 V, 900 s 
4th step: 40 V, 600s 
Pore widening and 
barrier removal, 1 
hour 
G6  20 V, 35 s 
1st step: 40 V, 200 s 
2nd step: 40 V, 600 s 
3rd step: 40 V, 1800 s 
4th step: 40 V, 1200s 
5th step: 40 V, 480 s 
Pore widening and 
barrier removal, 1 
hour; RIE of 
polysilicon 
Table   4.1: Summary of the parameters used during the electro-polishing and anodisation process, 
of some of the samples, sorted in the order as they first appeared in the text. 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  130 
 
4.3.3.1  Single Step Anodisation 
Based on the understanding of the anodisation current curve (see §  4.2.2), the 
anodisation should be stopped just before the point where the current density 
reaches a minimum value (between point B and C of Figure   4.2), thus when the 
barrier layer has been removed, the PAA film will selectively expose the polysilicon 
layer. In this way, a subsequent RIE of the polysilicon can be carried out to transfer 
the pattern on the PAA template to the polysilicon layer. In order to predict the 
stoppage point, a single step anodisation was performed, where current density 
measurements were taken whilst the entire thickness of the deposited aluminium 
was consumed and anodised. 
To examine the typical anodisation behaviour, sample F5 was anodised for 1 
hour and the current density transient at constant voltage was recorded, and plotted 
in Figure   4.11. After the initial formation of barrier layer and the initiation of pores, 
the anodisation process reached equilibrium between oxidisation and dissolution of 
the formed alumina. However, instead of a constant-current behaviour typically 
observed in the anodisation of aluminium, the sample F5 exhibits a gradual decrease 
in current density. The characteristic sudden drop (point B in Figure   4.2), followed 
by a rapid increase (point D in Figure   4.2) in the current density, could not be readily 
observed; this made the estimation of the stoppage point during the anodisation 
process difficult. It is suspected that these non-typical behaviours are partly due to a 
non-uniform thickness of the deposited aluminium (as discussed in §  4.3.1) and the 
resultant etch pits from the electro-polishing process, and partly due to a poor 
contact between the aluminium film and the polysilicon layer. Thus, a non-uniform 
etch rate across the surface of a sample is believed to have occurred during the 
anodisation process and results in different regions of the sample experiencing 
different stages of the anodisation process. Consequently, the current measurement 
is less indicative of the different phases of the anodisation process.  
The current density during the anodisation of sample F5, as depicted in 
Figure   4.11, eventually reaches a minimum point; it is believed that the aluminium 
has been completely exhausted at this stage. The SEM micrographs of sample F5, as 
depicted in Figure    4.12, obtained after the anodisation process, confirm that the 
aluminium has been completely consumed, forming a ~ 7.5 μm thick PAA film. Some 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  131 
 
voids within the formed PAA film, as depicted in Figure   4.12 (a), could be observed; 
these voids are large in size (microns range) and not to be confused with the typical 
voids resulting from the arching of the barrier layer at the base of the pores (see 
§  4.2.2). The voids were believed to be formed prior to the electro-polishing process 
and most likely as a result of the annealing process [341, 342], which forms hillocks 
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Figure   4.11: Current-time anodisation curve of sample F5, which was anodised for 1 hour in 0.3 M 
oxalic acid with a constant voltage of 40 V, at room temperature (22 °C to 24 °C). 
The pores of the formed PAA film were observed to be in a quasi-order, 
hexagonal arrangement, as depicted in Figure    4.12 (e). The pore diameter is 
estimated to be 38 nm ± 7 nm, while the interpore distance is ~ 73 nm; both were 
measured using an edge detection tool of the NI Vision AssistantTM image processing 
software. These are consistently lower (~ 27 %) than the theoretical values of 100 nm 
(based on ζint of 2.5 nm·V-1 [301]) and 52 nm (based on ζp of 1.29 nm·V-1 [302, 303]) 
for interpore distance and pore diameter, respectively. It is believed that the 
discrepancy is primarily due to the poor resolution obtained by the SEM, which 
underestimates the actual pore diameter and interpore distance. In addition, it is 
observed that the pores are not entirely vertical, as depicted in Figure   4.12 (c), and 
this could be problematic for the subsequent RIE process. The PAA film is believed to 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  132 
 
start to detach from the polysilicon surface, as depicted in Figure   4.12 (d), this is 
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Figure   4.12: SEM micrographs showing (a) an oblique, cross-section view; (b) – (d) magnified view 
of the corresponding boxed areas in (a); and (e) plane-view of sample F5. The single step 
anodisation was carried out in 0.3 M oxalic acid, at room temperature (22 °C to 24 °C), with a 
constant voltage of 40 V, for 1 hour. 
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4.3.3.2  Multistep Anodisation 
Multistep anodisation was performed in an attempt to fabricate a highly ordered, 
thin (< 1 μm) PAA film. Figure   4.13 depicts the cross-sectional view SEM micrograph 
of sample F4, which was anodised at 40 V with a 3-step process (detailed parameters 
are summarised in Table   4.1). The pore diameter was measured to be 53 nm ± 9 nm, 
and the interpore distance is ~ 103 nm; both values are close to the theoretical 
estimation. The depth of the resultant PAA film was ~ 3.7 μm, which is thicker than 
the desired thickness and hence may not be suitable as a masking template for the 
RIE of polysilicon. It is observed that a slightly porous layer of ~ 370 nm thick exists 
in between the polysilicon layer and the PAA template. It is suspected that the layer 
is a form of aluminosilicate, which is porous in nature. The PAA film is also observed 









Figure   4.13: Cross-sectional view SEM micrograph of sample F4 after a 3-step anodisation process, 
using the process parameters as detailed in Table   4.1. The last step anodisation was performed 
using 0.3 M oxalic acid, at room temperature (20 °C to 21 °C), with a constant of 40 V, for 3800 s. 
The inset shows the plane-view SEM micrograph of the same sample. 
The problem of non-uniform aluminium thickness is more evident in sample 
E4, which was anodised at 40 V with four, shorter steps of anodisation (anodisation 
time detailed in Table   4.1). At a region of the sample, the aluminium was completely 
consumed, as depicted in Figure    4.14 (a), however, relatively thick (~ 920 nm) 
aluminium was still present at certain parts of the sample, such as the one depicted 
in  Figure    4.14 (b). The current-time anodisation curve of the fourth step process 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  134 
 
exhibited typical constant-current behaviour and did not show signs of aluminium 











Figure   4.14: Oblique, cross-sectional view SEM micrographs of sample E4 after the pore widening 
and barrier removal process. The 4-step anodisation was performed based on the parameters 
summarised in Table   4.1. In (a), the aluminium was completely consumed by the anodisation 
process but in (b), ~ 920 nm thick of aluminium layer still remains. 
In an attempt to produce a much thinner PAA film, a 5-step anodisation was 
performed.  Figure    4.15 depicts the current-time curve of sample G6 which was 
anodised in 5 steps of varying anodisation time, as summarised in Table   4.1. The 
fourth step anodisation of sample G6, which was performed for 20 minutes, exhibited 
a current density transient consistent with the characteristic behaviour of a typical 
anodisation process. However, during the last step anodisation, a higher average 
current density, accompanied with uncharacteristic anodisation behaviour, as 
depicted in Figure   4.15, was observed. The higher current density suggests that the 
aluminium film was significantly thinner while the uncharacteristically oscillating 
current-time behaviour could be explained by the vigorous and aggressive 
anodisation process due to a non-uniform thickness of the aluminium film; it is 
believed that the aluminium film at some regions of the sample could have already 
been completely consumed. The anodisation process could not be predicted and hence 
was stopped after 8 minutes of anodisation. 
Figure   4.16 depicts the cross-sectional SEM micrograph of the anodised 
sample G6 after the pore widening process. Instead of film with a uniform thickness, 
the formed PAA film exhibits a hemispherical structure, with the maximum 
thickness of ~ 1.1 μm at the centre of the hillock. The pores are observed to be 
formed at an angle such that each pore is perpendicularly aligned to the curved top 









































Figure   4.15: Current-time curve during the fourth and fifth step anodisation of sample G6. The 
anodisation was carried out using 0.3 M oxalic acid with a constant voltage of 40 V, at room 
temperature (18.5 °C to 20.5 °C for the fourth step; 15 °C to 25 °C for the fifth step) for anodisation 








Figure   4.16: Cross-sectional view SEM micrograph of sample G6 after the pore widening and 
barrier removal process. The 5-step anodisation was performed based on the parameters 
summarised in Table   4.1. The inset depicts the plane-view SEM micrograph of the sample at a 
different area. 
and pre-annealed aluminium film on silicon [305]. At some regions of the formed 
PAA film, the barrier layer and a thin interface between the polysilicon and the PAA 
film are still present. The plane-view SEM micrograph, as depicted in the inset of 
Figure   4.16, further demonstrates the non-uniformity of the PAA films. Some PAA 
films were removed thus exposing the underlying material, possibly the polysilicon. 4.3 Fabrication of a PAA Template on a Polysilicon Substrate  136 
 
This could be associated to the non-uniform, aggressive etching during the last step 
anodisation. 
4.3.4  RIE of Polysilicon 
The RIE of the polysilicon layer (Step (f) of Figure   4.4), using the PAA template as a 
mask, was performed using a Plasmalab 80 Plus (Oxford Instruments Ltd. UK) RIE 
system. A gas flow rate of 10 sccm of sulphur hexafluoride (SF6), at a pressure of 50 
mTorr and an RF power of 100 W, was used in the 2-minute RIE process. The RIE 
using SF6 gas alone typically results in isotropic etching of silicon [42]. This is 
evident on sample G6, as depicted in Figure   4.17, which has a thin PAA template 
formed by a 5-step anodisation process. Some of the PAA structures are believed to 
have collapsed and removed during the RIE process, resulting in a non-preferential 
etching of the underlying material (possibly a mixture of polysilicon and barrier 
oxide layer). The angled pore structure of the PAA film is also believed to inhibit the 
exposure of SF6 gas to the polysilicon layer, thus producing a less effective 
directional etching. The PAA film used in this preliminary investigation was found 
to be less suitable as a masking template, due to its uneven film thickness, as 
discussed in previous section. In addition, the RIE process is clearly not optimised 
for anisotropic etching of the polysilicon; an improved RIE process (with more 







Figure   4.17: Cross-sectional view SEM micrograph of sample G6 after RIE of the polysilicon layer 
using a PAA template (depicted in Figure   4.16) as a mask. The RIE process was performed using 
10 sccm flow rate of SF6, at a pressure of 50 mTorr and an RF power of 100 W, for 2 minutes. 4.4 Conclusion    137 
 
4.4  Conclusion 
A PAA film was fabricated on top of a polysilicon surface by using electro-polishing 
and multistep anodisation processes. The electro-polishing process was used to 
remove the surface roughness of the annealed aluminium layer that is grainy with 
hillocks of microns in size. Some etch pits were observed after the electro-polishing 
process, suggesting a non-uniform etching possibly due to a non-uniform thickness in 
the evaporated aluminium. It is suspected that the substrate shutter of the 
evaporator may have masked part of the evaporated aluminium source, during the 
evaporation process, hence resulting in a varied thickness across the wafer. 
The anodisation of the aluminium was performed using the one step and 
multistep process with various etching times. Ideally, the anodisation should be 
stopped after the entire thickness of aluminium has been consumed, but just before 
the formed PAA film starting to detach from the substrate surface. This is 
characteristically manifested in the current density transient curve by a sudden 
drop, followed by a rapid increase in the current density (see Figure   4.2). However, 
during the anodisation process, this characteristic behaviour could not be readily 
observed. Hence, the point when the anodisation needs to be stopped is difficult to 
predict during the anodisation process. As a result, most of the fabricated PAA films 
were either already detached from the polysilicon surface (due to over-anodisation) 
or not fully anodised. It is suspected that these non-typical behaviours are partly due 
to a non-uniform thickness of the deposited aluminium. 
The non-vertical pore structure, observed for some of the fabricated PAA 
films, is unsuitable as a mask for RIE of the polysilicon layer. An additional problem 
is the fact that some samples also had detached or non-uniform PAA layers which 
are not ideal as masking templates for the RIE of the polysilicon layer. Therefore, in 
Chapter 5, an alternative templating method was developed.  
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Chapter  5 
The Fabrication of Porous 
Polysilicon using the Nanosphere 
Lithography Technique 
5.1  Introduction 
In this chapter a novel approach for the fabrication of porous polysilicon (PPSi) is 
presented. This approach makes use of the nanosphere lithography (NSL) technique, 
to fabricate a masking layer suitable for the reactive ion etching (RIE) of the 
polysilicon. The NSL technique, which utilises the self-assembly of polymer 
nanospheres, is well-known as an inexpensive and scalable method of producing 
periodically-ordered patterns. A metal mask consisting of arrays of nanoholes 
patterns was produced by careful deposition of a monolayer of hexagonally close-
packed nanospheres and subsequently reducing the size of the nanospheres. This 
metal mask was then used in an RIE process to form a quasi-ordered PPSi structure 
with macropore sizes. Nanospheres with mean diameters of 500 nm and 200 nm 
were used to demonstrate the feasibility of the proposed technique. 5.2 The NSL Technique: An Overview    139 
 
5.2  The NSL Technique: An Overview 
The NSL technique was initially demonstrated by Deckman and Dunsmuir [344] 
and, has recently been extensively studied and improved by the group of Van 
Duyne 21 [345-351]. The NSL technique exploits the self-assembly of polymer 
nanospheres (typically polystyrene) and subsequent etching or deposition processes, 
as depicted in Figure   5.1, to realise various hexagonally ordered nanostructures. The 
most straight-forward implementation of the NSL technique is to directly use the 
self-assembled nanospheres as a masking layer (route A of Figure   5.1), and deposit a 
thin layer of metal film to realise arrays of triangular-shaped nanodots [345, 347, 
349, 350, 352]. The size of the nanodots can be reduced by increasing the initial 
diameter of the nanospheres (route B of Figure   5.1), either by microwave annealing 
[353] or by thermal annealing near the glass transition temperature of the polymer 
[354]. The shape of the nanodots can be modified into nano-scale rings and rods [353] 
by tilting the deposition angle of the metal film. Alternatively, by reducing the initial 





















Figure   5.1: Schematic illustration of possible routes (A, B or C) of fabrication, using the NSL 
technique, to produce various hexagonally ordered nanostructures. 
                                                           
21 Richard P. Van Duyne, Charles E. and Emma H. Morrison Professor of Chemistry, Northwestern University, 
Illinois, USA, http://chemgroups.northwestern.edu/vanduyne/ (last accessed Jul. 2009). 5.2 The NSL Technique: An Overview    140 
 
nanopillars [355-357] or nanoholes [358] can be fabricated from the size-reduced 
nanosphere template or its inverse pattern created from the deposition of a thin 
metal film, followed by removal of the nanosphere template. The diameter of the 
size-reduced nanospheres thus defines the diameter of the nanoholes or the 
nanopillars. 
The NSL technique is an inexpensive, simple to implement and “materials 
general” nanofabrication technique. It has been demonstrated to provide masking 
against ion implantation [359] and electrochemical etching [360] for the fabrication 
of porous silicon, and to serve as the template for the fabrication of nanoholes [358], 
nanopillars [355-357], nanowires [361, 362] and carbon nanotubes [352, 363]. In the 
case of macroporous polysilicon, a nanosphere template can be used to define a metal 
mask to be used during the etching of polysilicon. 
5.2.1  Methods of Nanospheres’ Self-Assembly 
Monodispersed nanospheres can be self-assembled into a monolayer of hexagonally 
close-packed arrays by a number of approaches. Figure   5.2 illustrates some typical 

















(d) Self-assembly at air-liquid interface 
Figure   5.2: Schematic illustration of the typical fabrication methods to produce a self-assembled 
nanosphere template. 5.2 The NSL Technique: An Overview    141 
 
The most straight-forward method to form a self-assembled nanosphere array 
is to drop-coat the nanosphere suspension onto the surface of a flat substrate; this 
method has been largely explored by Nagayawa and co-workers [364-368]. Under 
controlled environmental conditions (temperature and humidity are the key 
elements), the dispersant solvent (typically water) slowly evaporates and 
spontaneously starts the self-ordering process when the thickness of the liquid layer 
of the suspension becomes smaller than the diameter of the nanospheres [364, 365]. 
A nucleus – an ordered domain of a number of nanospheres – is formed, which 
subsequently attracts and organises more nanospheres around the nucleus due to 
attractive capillary forces (see Figure   5.2 (a)). A flat and clean surface is necessary to 
form a highly ordered array with large domain sizes. The substrate can be tilted to 
control the solvent evaporation process, hence improving the ordering of the 
nanospheres [358, 369, 370]. 
The solvent evaporation rate can also be controlled by using the dip-coating 
or the vertical deposition method (see Figure    5.2 (b)). In this case, the wettable 
substrate is placed vertically into a vial containing the nanosphere suspension. The 
evaporation of the dispersant solvent is achieved at the triple point of the 
suspension-substrate-air interface, by lateral capillary forces, under a controlled 
temperature [371, 372] and pressure [373] environment. A stepper motor can be used 
to provide a controlled evaporation process by slowly (between 0.1 μm·s-1 and 30 
μm·s-1) lifting up the wettable substrate from the vial [366].  
By contrast, the spin-coating method [345, 346, 355, 374] (see Figure   5.2 (c)) 
accelerates the solvent evaporation process by centrifugal spreading. The substrate 
surface must be wettable and exhibit an electrostatic repulsion against the 
nanospheres [294, 295]. The group of Van Duyne improved the wettability of the 
nanosphere dispersion to the substrate by incorporating the surfactant Triton X-100 
into the nanosphere suspension prior to the spin-coating process [345, 346]. The spin 
speed and the nanosphere concentration are two critical parameters that determine 
the thickness and the quality of the self-assembled layer [294, 295]. Low spin speeds 
coupled with high solid concentrations result in multilayer structures with a higher 
apparent level of defects [294]. The spin-coating method is capable of wafer-scale 
mass production, as demonstrated by Jiang and McFarland using silica particles 
dispersed in a photocurable polymer matrix [375]. Well-ordered non-close-packed 3-5.3 Fabrication of PPSi by the NSL Technique  142 
 
dimensional colloidal crystals were formed within minutes, and the thickness was 
controlled uniformly over a 4-inch wafer. 
The drop-coating, dip-coating and spin-coating approaches discussed thus far 
mainly rely on the capillary force-induced convective solvent evaporation, self-
ordering phenomenon. Another way to form an ordered monolayer of nanospheres is 
by self-assembly at an interface, such as a water-air interface [352, 353, 376-378], an 
octane-water interface [376] or a hexane-water interface [379]; subsequently, the 
ordered array can be transferred onto the surface of a substrate by lifting up the 
monolayer film (see Figure   5.2 (d)) [377, 379] or by controlled evaporation of the 
underlying liquid [353, 378]. The nanospheres are typically negatively charged as a 
result of the polymerisation process used in the manufacturing. A mismatch in the 
dielectric constants can arise if the nanospheres are trapped between a non-polar 
(such as air or oil) interface, which results in long-range dipolar repulsion [380]. The 
electrostatic stresses caused by the dipolar field also distort the interface and hence 
induce capillary forces which attract neighbouring nanospheres to each other [380]. 
This strong, long-range attractive interaction leads to the formation of an ordered 
monolayer at the interface [378, 380, 381]. The quality and packing of the array can 
be controlled by optimising the size, concentration and surface charge density of the 
nanospheres, and the electrolytic properties of the underlying liquid [294, 295]. 
Compared to other methods discussed thus far, the interface assembly method is the 
most suitable to form a uniform monolayer with large area ordering. 
5.3  Fabrication of Porous Polysilicon by the 
NSL Technique 
Macroporous (pore width > 50 nm) structures are fabricated in polysilicon substrates 
using the NSL technique. The schematic flow of the fabrication process is illustrated 
in  Figure   5.3, and described in detail in the following sections. Briefly, the NSL 
technique is used to create a metal mask (here, chromium (Cr) and gold (Au)) with 
arrays of holes arranged in a hexagonal pattern. The pattern of holes is then 
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Pre-processed polysilicon substrate (after Step (h) in Figure 3.5)
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Figure   5.3: Schematic illustration of the fabrication process of the macro-PPSi structure using the 
NSL technique (not to scale). 5.3 Fabrication of PPSi by the NSL Technique  144 
 
transferred to the polysilicon device layer using a fluorine-based RIE process (Step 
(e) in Figure    5.3), followed by the removal of the metal mask by appropriate 
etchants, to realise the macro-PPSi (Step (f) in Figure   5.3). To create the patterned 
metal mask using the NSL technique, nanospheres are first assembled on the 
polysilicon surface (Step (a) in Figure   5.3) and a subsequent RIE is used to reduce 
the diameter of the polystyrene nanospheres (Step (b) in Figure   5.3). The metal mask 
is created by evaporation of thin layers of metal films (here, Cr then Au), over the 
ordered, size-reduced nanospheres (Step (c) in Figure   5.3). Lift-off of the nanospheres 
(Step (d) in Figure   5.3) thus provides the metal mask suitable for fabrication of the 
macro-PPSi. 
5.3.1  Substrate Preparation and Treatment 
The polysilicon substrates from the wafers of batch K2714s, which was partially used 
in the investigation of the stain etching method (as discussed in Chapter 3, §3.5), 
were used here. The wafers (W10 and W11, both with sheet resistance of ~ (338.94 ± 
4.95)  Ω/sq) were first cut by manual scribing and cleaving. Due to the lack of 
availability of ashing or RIE systems during the initial development work, the 
photoresist on the polysilicon substrate samples, mainly from W10, was stripped by 
successively sonicating the samples in acetone, methanol and deionised (DI) water, 
for 10 minutes to 30 minutes each. In order to maintain the cleanliness and improve 
the hydrophilicity of the surface, the samples were kept, until used, in specimen 
bottles containing DI water. These samples were primarily used for the evaluation of 
NSL using 500 nm spheres. 
Samples from W11 were used for the work using the smaller 200 nm spheres. 
The photoresist on the samples was “ashed” by using an RIE system (Plasmalab® 80 
Plus, Oxford Instruments, UK) with an oxygen (O2) gas flow rate of 10 sccm, a 
pressure of 50 mTorr and a radio frequency (RF) power of 100 W, for 10 minutes. 
After the ashing process, the samples were degreased by sonication in acetone, 
followed by methanol and DI water, for 10 minutes each. Next, the samples were 
cleaned using a Piranha solution, which typically consists of a 3:1 volume ratio of 95 
% concentrated sulphuric acid (electronic (MOS) grade, Fisher Scientific, UK): 30 % 
weight in volume (w/v) hydrogen peroxide (general laboratory work (SLR) grade, 5.3 Fabrication of PPSi by the NSL Technique  145 
 
Fisher Scientific, UK), to remove any organic and anionic contaminants. This also 
leaves a more hydrophilic surface on the samples. An O2 plasma clean, using the 
same parameters as described above, was then performed to further improve the 
hydrophilicity of the surface of the samples. Finally, the samples were kept 
individually, until used, in specimen bottles containing DI water. 
5.3.2  Nanosphere Template with 500 nm Spheres 
Monodispersed carboxyl polystyrene nanospheres (Polysciences Europe, Germany) 
with a nominal diameter of 500 nm (coefficient of variance of 3 %, 2.65 weight 
percent (wt%) aqueous suspension) were used to form the nanosphere template (Step 
(a) in Figure   5.3). These nanospheres were further diluted with DI water (ELGA® 
PURELAB Ultra, typical resistivity of 18.2 MΩ·cm, pH of 7.0), into a 1 wt% 
suspension before use.  
A method described by Abdelsalam et  al. [382] was used to produce the 
nanosphere template. This method is similar to the dip-coating method (see Figure 
  5.2 (b)); a physical confinement by two parallel plates, termed “thin layer cell” by 
Abdelsalam, was used to ensure the formation of monolayer ordered nanosphere 
arrays, during the vertical deposition process. First, the “thin layer cell” was 
prepared by sandwiching a thin layer (~ 100 μm thick) of spacer, cut from a single 
sheet of Parafilm® M (Fisher Scientific, Loughborough, UK), between a pre-treated 
sample and a glass cover slip ((20 x 20) mm x (0.16 to 0.19) mm thick, MNJ-400-
020L, Fisher Scientific UK Ltd., Loughborough, UK). The Parafilm® spacer was cut 
to form either a trapezoidal or a hexagonal void, as depicted in Figure   5.4 (a). The 
void was aligned to the 6 mm diameter circular region of the polysilicon device layer. 
The “thin layer cell” was heated, at 40 °C for about 30 s to enhance the adhesion of 
the Parafilm® spacer to both the sample and the cover slip, and thus ensuring a 
proper sealing. 
Next, a micropipette was used to dispense the diluted nanosphere suspension 
at the opening of the patterned void into the “thin layer cell”. Extra care was taken 
during the filling process to avoid the trapping of air bubbles into the cell. Trapped 
air bubbles were typically removed by gently tapping the sample. The filled sample, 
such as the one depicted in Figure    5.4 (b), was then held vertically in a sealed 5.3 Fabrication of PPSi by the NSL Technique  146 
 
container to control the evaporation of the aqueous solution. The samples typically 
took 12 to 24 hours to completely dry. Once dried, the “thin layer cell” was heated up 
to 40 °C to soften the Parafilm®; the glass cover slip and the Parafilm® template were 












Figure   5.4: Digital photographs of (a) two samples with a trapezoidal void (left) or a hexagonal void 
(right) cut from a thin layer of Parafilm®; and (b) the sample with trapezoidal void (in (a)) filled 
with the diluted nanosphere suspension.  
5.3.3  Nanosphere Template with 200 nm Spheres 
The 200 nm initial-sized nanosphere template was prepared using monodispersed, 
carboxylate-modified polystyrene (CMPS) nanospheres (Duke Scientifics, 
(Brookhaven, UK)) with a coefficient of variance of < 5 % and a surface group 
parking area of 45 Å2 per carboxyl group. The nanospheres, which were initially 
suspended into a 4 wt% aqueous solution when purchased, were further diluted with 
ethanol prior to use. 
Prior to a typical deposition process of the nanospheres, a pre-treated and 
cleaned sample was first coarsely patterned with a layer of thin Parafilm®, as 
depicted in the inset of Figure   5.5. A square pattern of approximately 6 mm x 6 mm 
was cut in the Parafilm® layer, so that only the polysilicon device region was exposed 
and would be deposited with nanospheres. The sample was heated to 40 °C to 
promote the adhesion of the Parafilm®. For the self-assembly of 200 nm diameter 
nanospheres, the method described by Weekes et al. [378], which relies on the self-5.3 Fabrication of PPSi by the NSL Technique  147 
 
assembly of nanospheres at the water-air interface (see Figure   5.2 (d)), was used. A 
trough, with an internal dimension of 190 mm x 45 mm and a depth of 10 mm, and 
two detachable sliders were made using Teflon® for this purpose. The bottom of the 
trough was covered with black adhesive tape to improve visibility of the monolayer 
during the deposition process. The trough was first slightly overfilled with DI water. 
Due to the strong hydrophobicity of Teflon®, it is possible to overfill and retain the DI 
water within the trough, and hence forming a convex meniscus. Any visible particles 
or contaminant on the water surface were removed using the sliders. A glass slide of 
about 100 mm x 40 mm, pre-treated in 1 % w/v of sodium dodecyl sulphate (SDS) 
was placed at an angle of about 30° at one end of the trough. The patterned sample 
was then placed onto a sample holder such that the sample surface would be just 
beneath the water meniscus. Figure   5.5 depicts a sample in the trough ready for the 











Figure   5.5: Digital photograph of a sample placed in the Teflon® trough, ready for the deposition of 
nanospheres. The inset shows a digital photograph of the sample patterned with a layer of 
Parafilm®. 
The diluted nanosphere suspension (1:1 mixture of ethanol: 4 wt% CMPS) 
was slowly dispensed onto the pre-treated glass slide using a micropipette. The 
nanospheres were allowed to gently float and self-assemble on the water surface. 
Four 20 μL aliquots of the nanosphere suspension were dispensed, to a total volume 
of 80 μL, to provide a partially ordered monolayer of nanospheres on the meniscus 5.3 Fabrication of PPSi by the NSL Technique  148 
 
surface of the water. The ordering of the self-assembled monolayer (SAM) of 
nanospheres was further improved by compressing the surface using the two sliders. 
Figure   5.6 depicts an area of a SAM of nanospheres at the surface of the water. Some 
water in the trough was then carefully withdrawn therefore transferring the SAM of 
the nanospheres to the upper surface of the polysilicon substrate in the trough. The 
sample was then covered and left to dry in the trough with the remaining water, 
usually overnight. Once dried, the sample was removed from the trough, and the 






Figure   5.6: Digital photograph of a sample with the self-assembled monolayer (SAM) of 
nanospheres “floating”, at the water-air interface, just above the sample. The dotted white line 
highlights the boundary of the SAM, for clarity. 
5.3.4  Nanosphere Size Reduction 
In order to create a template suitable for the formation of macro-PPSi, the 
nanospheres have to be non-closely packed while still maintaining a hexagonal 
lattice, as illustrated by the plane-view in Step (b) of Figure   5.3. This is achieved by 
reducing the diameter of the nanospheres using an RIE process. This way, the initial 
diameter of the nanospheres defines the spacing of the eventual macro-pores, while 
the reduced diameter determines the eventual diameter of the pores. 
The RIE process was performed in an RIE system (Plasmalab® 80 Plus, 
Oxford Instruments, UK) using a quartz cover plate. Pure O2 or a gas mixture of Ar 
and O2 was used, with a typical gas flow rate of 5 sccm each, at a pressure between 5 5.3 Fabrication of PPSi by the NSL Technique  149 
 
mTorr and 10 mTorr and an RF power of 100 W. It was necessary to first strike the 
plasma at a slightly higher pressure (typically at 50 mTorr) and later ramp down to 
the desired RIE pressure. The etching was performed for times between 2 minutes 
and 5 minutes for nanospheres of 500 nm in diameter, and for times between 60 s 
and 120 s for 200 nm diameter nanospheres. 
5.3.5  Metal Mask 
The etched polystyrene nanospheres were covered with a thin layer of chromium (Cr) 
and gold (Au) to produce a metal mask (Step (c) in Figure   5.3). Evaporation was 
performed using a BOC Edwards E306A thermal evaporator. The typical mass 
thickness of the evaporated Cr was 20 nm and the Au was between 100 nm and 120 
nm thick for the initial-sized 500 nm diameter nanosphere template, although a 
mask of only 20 nm Cr was used for the subsequent lift-off process (see §  5.4.3). For 
the nanosphere template with initial diameters of 200 nm, the typical mass 
thickness of Cr was 5 nm and that of Au was 15 nm, deposited using an electron-
beam evaporator (BOC Edwards E500A). The evaporation base pressure was 
between 1 x 10-6 mbar and 5 x 10-6 mbar for both cases.  
After deposition of the metal layer, lift-off of the nanospheres (Step (d) in 
Figure   5.3) was achieved by sonicating the substrate in toluene, for approximately 30 
minutes to 1 hour, to yield the patterned metal mask. 
5.3.6  RIE of Polysilicon 
The fabrication of the macro-PPSi by RIE (Step (e) in Figure   5.3) was performed 
using a Plasmalab® 80 Plus (Oxford Instruments, UK), with a gas mixture of 
SF6/CHF3/O2. This method is commonly known as the “black silicon” method [383]. 
The typical etching pressure was at 5 mTorr, with an RF power of 100 W, and the 
etching time ranged from 5 minutes to 10 minutes. After the RIE, the Cr / Au metal 
mask was removed by sequential exposure of the substrate to gold and chromium 
etchants (OM Group Ultra Pure Chemicals Ltd., UK) (Step (f) in Figure    5.3), to 
realise the macro-PPSi structure. 5.4 Results and Discussions    150 
 
5.4  Results and Discussions 
All of the scanning electron microscopy (SEM) micrographs were obtained using the 
LEO (now Carl Zeiss) 1455VP. Some of the SEM micrographs were image-processed 
using the National InstrumentsTM Vision Assistant image processing package to 
enhance the contrast of the image. Mean diameters of the nanospheres or the pores 
were measured using an edge detection tool in the Vision Assistant software. Fast 
Fourier Transforms (FFT) (512 x 512 pixels) of the SEM micrographs were produced 
using Gwyddion22 with a 2D FFT tool using Hann windowing.  
5.4.1  Nanosphere Template 
For the creation of nanosphere templates, polystyrene nanospheres of 500 nm and 
200 nm were used. In the case of templates made from 500 nm diameter 
nanospheres, the majority of the surface of the polysilicon substrates is covered with 
a monolayer of self assembled polystyrene nanospheres in a hexagonally close-
packed structure; other areas consist of either double layers of nanospheres or 
sparsely-packed nanospheres. In particular, the regions near to the edge of the 
Parafilm® spacer exhibited multiple growth bands or stripes, as depicted in Figure 
  5.7, similar to that observed during the growth of colloidal crystals using the vertical 
deposition method [372]. It is likely that the non-uniform solvent evaporation 
process, coupled with competing surface tensions from the suspension, resulted in 
stick-slip motion [372], which alternates the deposition of ordered arrays of 
nanospheres (the “stick” phase) with no nanosphere deposition (the “slip” phase). 
Figure    5.8 depicts the SEM micrograph of the hexagonally close-packed 
monolayer region of a template formed using the 500 nm diameter polystyrene 
nanospheres. The nanosphere template typically exhibits polycrystalline domains 
and natural microscopic defects which are inherent to the NSL technique. These 
point and line defects, such as those depicted in Figure    5.8, and polycrystalline 
boundaries are typically due to disordered packing attributed to the polydispersity of 
                                                           
22 Gwyddion is a scanning probe microscopy (SPM) data visualisation and analysis tool. http://gwyddion.net 
(last accessed Jul. 2009). 5.4 Results and Discussions    151 
 
the nanospheres, multiple nucleation sites, and uncontrolled solvent evaporation 
process [350, 384]. The inset of Figure    5.8, which is the digital FFT of the SEM 
micrograph, demonstrates the effect of defects on the diffraction pattern of the 
nanosphere arrays. Six first-order Bragg peaks can be observed in the FFT image, 
which reveals the contributions from the ordering of the hexagonal structure. 
However, the peaks are not sharp and almost form complete ring patterns at higher 









Figure   5.7: Optical microscope image of sample W10S7 showing the alternating growth bands of 
nanosphere arrays and empty regions. The inset shows the magnified view of the circled region. 




Figure   5.8: Plane-view SEM micrograph of a self-assembled nanosphere template formed by 500 
nm diameter polystyrene nanospheres on the polysilicon substrate (sample W10S1). The inset 
shows the digital FFT of the SEM micrograph. 5.4 Results and Discussions    152 
 
Whilst the assembly method of Abdelsalam et al. [382] worked well for the 
500 nm sized nanospheres, this method was less successful for the assembly of 200 
nm sized nanospheres and thus the method of using a Teflon trough (see §  5.3.3) was 
used. The assembly of the 200 nm nanospheres using the Teflon trough method 
yielded a higher coverage of the polysilicon substrate in a monolayer (> 98 %) of 
hexagonally close-packed nanospheres and with fewer overall defects, as depicted in 
Figure   5.9. The FFT of the SEM micrograph shows distinct, well-defined equidistant 
first-order peaks, which indicates that the image is constituted from larger single 
crystalline, hexagonal grains; a negligible amount of defects and polycrystalline 
domains are present. 
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Figure   5.9: Plane-view SEM micrograph of a self-assembled nanosphere template, formed by 200 
nm diameter polystyrene nanospheres on a polysilicon substrate (sample W11S20). The inset 
shows the digital FFT of the SEM micrograph. 
5.4.2  Nanosphere Size-Reduction 
The self-assembled, hexagonally close-packed nanosphere template was etched using 
an RIE process (Step (b) in Figure   5.3). Theoretically, the diameter of the etched 
nanospheres determines the eventual diameter of the macropores. In order to better 
control the size-reduction of the nanospheres, the RIE process must be carefully 
controlled. Therefore, the size of the resulting nanospheres after the Ar/O2 RIE was 
measured as a function of the etch time, and this is plotted in Figure   5.10. Typically, 
a 2-minute etch at a pressure of 10 mTorr and an RF power of 100 W resulted in a 5.4 Results and Discussions    153 
 
reduction in the mean diameter, of the 500 nm diameter nanospheres, to 403 nm ± 
16 nm (SEM micrograph depicted in Figure   5.11 (a)). A 4-minute RIE reduced the 
diameter to 284 nm ± 29 nm. As for the 200 nm diameter nanosphere templates, a 60 
s and 90 s RIE at a pressure of 5 mTorr, reduced the mean diameter of the 
nanospheres to 143 nm ± 9 nm (SEM micrograph depicted in Figure   5.11 (b)) and 139 
nm ± 14 nm, respectively. As depicted in Figure   5.10, the RIE etching time is found 
to correlate linearly with the nanosphere diameter, as previously observed by 
Cheung et al. [355]. Based on the linear regression, the etch rates are estimated to be 
0.86 nm·s-1 and 0.72 nm·s-1 for nanospheres with initial sizes of 500 nm and 200 nm, 
respectively. 
After RIE the nanospheres were observed to have a high surface roughness, 
which has also been reported by other groups [355, 358]. For short etch times, 
“oblate spheroidal-shaped” nanospheres are formed because the etching occurs 
preferentially along the top surface of the nanospheres as opposed to the sidewalls. 
However, for the longer etching times, the polystyrene nanospheres have rather 
d = - 0.8579 t + 501.25
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Figure   5.10: Plot of the mean diameter of the nanospheres against the RIE etch time, for 
nanosphere templates with initial diameter of 500 nm () and 200 nm (), fitted with linear 
regression represented by a solid line and a dashed line, respectively. The error bars represent the 
standard deviations of the detected and measured diameters on the respective SEM micrographs. 
All the nanosphere templates were processed using Ar/O2 gas flow of 5 sccm each, with an RF 
power of 100 W, and at a pressure of 10 mTorr for the 500 nm nanosphere templates and 5 mTorr 









(b) Sample W11S30 
Figure   5.11: Plane-view SEM micrographs of the size-reduced nanosphere template, after an Ar/O2 
RIE of (a) 2 minutes, at a pressure of 10 mTorr, to achieve a reduction in diameter from 500 nm to 
403 nm ± 16 nm; and (b) 1 minute, at a pressure of 5 mTorr, to achieve a reduction in diameter 
from 200 nm to 143 nm ± 9 nm. The insets in (a) and (b) show the micrographs of the magnified 
view of the respective sample at a different area. 
distorted geometries. This was most obvious for the 500 nm diameter nanospheres, 
which were etched for times of 3 minutes or longer. For instance, nanospheres etched 
for 5 minutes (at a pressure of 5 mTorr) are presented in the SEM micrographs 
depicted in Figure    5.12; it is proposed that the outer shell of the polystyrene 
nanospheres has swollen and become distorted after exposure to the etching gases 
for the longer time scales. Therefore, in most cases, the size of the nanospheres was 






Figure   5.12: Plane-view SEM micrograph of the 500 nm initial-sized nanospheres (sample W10S26) 
after 5 minutes RIE using Ar/O2 gases, at a pressure of 5 mTorr and an RF power of 100 W. The 
inset shows the magnified view of the boxed area of the micrograph, showing the swollen outer 
shell of the polystyrene nanospheres. 
5.4.3  Metal Mask 
The size-reduced, non-close-packed, hexagonally-ordered nanosphere template was 
used as a mask for the subsequent metal evaporation and lift-off processes. The size-
reduced nanospheres exhibited an oblate spheroidal shape, therefore an evaluation 
of the optimal thickness of the evaporated metal was required in order to provide a 
mask that is thin enough to allow successful lift-off of the etched nanospheres, but 
thick enough to provide sufficient masking for the subsequent RIE of polysilicon. For 
the 500 nm diameter initial-sized nanosphere template, a thickness of between 100 
nm and 120 nm of Au was used, with a 20 nm thick Cr as the adhesion layer. 
However, during the lift-off process, most of the nanospheres were found to be 
embedded by the Cr / Au films; some of the nanospheres were eventually removed 
after the Au film was etched in a gold etchant (1% - 10 % iodine: < 25 % potassium 
iodide, OM Group Ultra Pure Chemicals Ltd., UK). Therefore, the total thickness of 
t h e  m e t a l  m a s k  w a s  r e d u c e d  t o  2 0  n m  ( 5  n m  o f  C r  a n d  1 5  n m  o f  A u )  f o r  t h e  
nanosphere templates prepared using the 200 nm diameter nanospheres. An 
improved lift-off process was observed with this thinner metal masking layer. 











(b) Sample W10S27 
 
Figure   5.13: Plane-view SEM micrographs of the metal mask after removal of the size-reduced 
nanosphere template. (a) the 500 nm diameter nanosphere template (sample W10S18) was RIE for 
3 minutes using Ar/O2 gases, at a pressure of 10 mTorr, and then coated with 20 nm thick Cr; (b) 
the 200 nm diameter nanosphere template (sample W10S27) was RIE for 60 s using Ar/O2 gases, at 
a pressure of 5 mTorr, and coated with 6.8 nm thick Cr and 14.1 nm thick Au. The insets show the 
digital FFT diffraction pattern (left) and a magnified view (right) of the SEM micrograph. 5.4 Results and Discussions    157 
 
Figure   5.13 (a) depicts a high resolution SEM micrograph of an area of 117 
μm by 88 μm of sample W10S18 with the patterned Cr metal mask. The sample was 
prepared using the self-assembled 500 nm diameter nanospheres, which were then 
reduced to 336 nm ± 19 nm in diameter by a 3- minute RIE process. The digital FFT 
of the SEM micrograph, as depicted in the inset of Figure   5.13 (a), demonstrates the 
preservation of the six-fold hexagonal lattice; the first-order peaks are not sharp, 
which indicates the presence of defects in the lattice. The mean diameter of the 
nanoholes in the metal mask was measured to be 337 nm ± 16 nm. Thus, the size of 
the size-reduced nanospheres was transferred to the metal mask with good accuracy. 
The metal mask produced by using the 200 nm initial-sized nanospheres, 
which were then reduced to 143 nm ± 9 nm in diameter, shows intense, well-defined 
first-order peaks of the hexagonal diffraction pattern, as depicted by the FFT image 
of the inset in Figure   5.13 (b). The presence of higher-order peaks demonstrates the 
high degree, long-range ordering of the hexagonal hole array. The sample W10S27 
was coated with ~ 7 nm thick Cr and 14 nm thick Au. Here, the mean diameter of 
the nanoholes of the metal mask was measured to be 135 nm ± 10 nm. Thus, the size 
of the nanoholes, of the metal mask, is ~ 5.6 % smaller than the reduced diameter of 
the nanospheres, very likely due to a different evaporation condition of the e-beam 
evaporator used in this case; a thermal evaporator was used for the preparation of 
the metal mask for the 500 nm initial-sized nanosphere template. 
5.4.4  RIE of Polysilicon 
The RIE using the “black silicon” method (with appropriate etch conditions as 
reported by Elwenspoek et al. [383]) was used to transfer the pattern of the metal 
mask to the polysilicon substrate, to form an ordered macro-PPSi structure. 
Typically, the RIE resulted in a positively tapered etch profile. A number of etch 
conditions were tested to establish the most effective conditions for transfer of the 
pattern of holes into the polysilicon substrate with a minimum degree of tapering in 
the porous structures. 
The example, presented in Figure   5.14 was fabricated from self-assembled 
500 nm diameter nanospheres. The holes in the metal mask had a diameter of 257 














Figure   5.14: SEM micrographs of the macro-PPSi structure (sample W10S26) after 10 minutes RIE 
of polysilicon, using 15/5/10 sccm of SF6/O2/CHF3, at a pressure of 5 mTorr and an RF power of 100 
W. (a) the plane-view SEM micrograph shows that some regions of the metal mask were etched by 
the RIE, thus revealing the macro-PPSi structure (the inset shows magnified view of the boxed 
area); and (b) the oblique, cross-sectional view SEM micrograph shows the metal mask detached 
from the porous structure (the inset is a magnified view of pores not within the hexagonal ordered 
arrays, showing full taper). 
 
SF6/O2/CHF3, at a pressure of 5 mTorr and an RF power of 100 W, the polysilicon 
layer was etched to a depth of 795 nm. The pore diameter of the fabricated macro-
PPSi was measured to be 382 nm ± 39 nm after the removal of the metal mask. An 
undercut of approximately 130 nm, as depicted by the inset of Figure   5.14 (b), is 5.4 Results and Discussions    159 
 
observed for pores created from spheres in a sparsely-packed arrangement. Due to 
the undercutting and the tapered etch that results from the etch conditions used, it 
is clear that there is a limitation to the etch depth before lateral etching at the top 
surface of the pores would lead to interconnection. This was observed for the area of 
the sample where the pores in the mask are in the ordered hexagonal array. Figure 
  5.14 (b) shows a cleaved wafer where the upper surface of the etched polysilicon has 
pointed ‘crown-like’ structures, with the point apex at a location where the metal 
mask width between adjacent pores is greatest. As depicted in Figure   5.14 (a), the 
regions where the metal mask has been unintentionally removed by the RIE process 
show that the porous structure is intact. The polysilicon surface and structure show 
various etch rate under the conditions used, possibly due to the polycrystalline 
nature of the polysilicon, slight non-uniformities of the original polysilicon surfaces, 




Figure   5.15: Cross-sectional view SEM micrograph of cleaved sample W11S29 showing the macro-
PPSi structure after a 10 minutes RIE of polysilicon using 15/5/10 sccm flow rate of SF6/O2/CHF3 at 
a pressure of 5 mTorr and an RF power of 50 W. 
By an ‘over-etching’ of the samples or the use of non-optimised etch 
conditions, hexagonally ordered, microneedle-like, spiked triangular pyramids were 
formed rather than pores. This is a result of the tapered etch profile, which 
ultimately causes a lateral ‘through-etching’ between the pores at the upper surface. 
An example of the spiked structure is depicted in Figure   5.15, where the sample 
W11S29 was fabricated from the self-assembled 200 nm diameter nanospheres. A 
metal mask with holes of 134 nm ± 9 nm in diameter was used. The RIE of the 5.5 Conclusion    160 
 
polysilicon layer was carried out with a reduced power of 50 W. In this sample, the 
structures were measured to be ~ 500 nm high; ordered spikes are clearly seen below 
the metal mask. 
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Figure   5.16: Oblique, cross-sectional view SEM micrograph of the macro-PPSi structure of sample 
W10S13, after 5 minutes RIE of polysilicon using 30/10/12 sccm flow rate of SF6/O2/CHF3, at a 
pressure of 5 mTorr and an RF power of 100 W. The inset SEM micrographs show the plane-view 
(left) and the magnified view (right) of the cleaved edge. 
A macro-PPSi structure after the chemical removal of the metal mask is 
illustrated in Figure   5.16. The sample W10S13 was fabricated using a metal mask 
with holes of 279 nm ± 15 nm in diameter. The RIE of polysilicon was performed 
using a gas flow rate of 30/10/12 sccm of SF6/O2/CHF3 and an etch time of 5 minutes. 
The etch depth of the positively tapered pores was limited to ~ 417 nm and the pore 
diameter was measured to be 370 nm ± 30 nm. The reduced etch depth ensures that 
the sample has a smooth upper surface with uniformly sized pores in hexagonally 
ordered arrays. 
5.5  Conclusion 
A practical approach for fabricating a PPSi structure using the NSL technique has 
been described. Nanospheres with mean diameters of 500 nm and 200 nm were used 
to form metal masks with hexagonally arranged hole-patterns. Macro-PPSi with 5.5 Conclusion    161 
 
tapered pores was fabricated from these metal masks. For example, a macro-PPSi 
with pore width of 370 nm ± 30 nm and a pore depth of ~ 417 nm (see Figure   5.16) 
was achieved using the “black silicon” RIE process and a metal mask formed using 
the 500 nm initial-sized nanospheres. Although the quasi-ordered PPSi exhibited a 
tapered profile, this is the first demonstration of the fabrication of PPSi with ordered 
pores of sizes in the macropore range (of ~ 370 nm). PPSi structures fabricated using 
a metal mask formed using the 200 nm initial-sized nanospheres typically exhibit a 
microneedle-like, spiked trian g u l a r  p y r a m i d a l  s h a p e .  T h i s  i s  a  r e s u l t  o f  l a t e r a l  
through-etching between the pores at the upper surface (see Figure   5.15). 
In principle, the NSL technique provides an inexpensive and practical 
approach for pattern generation of hexagonally-arranged holes, with tuneable 
diameter and spacing (or pitch size) of the holes. The initial size of the nanospheres 
used in the NSL technique provides the pitch size; while careful control of the RIE 
process reduces the size of the nanospheres (quasi-linearly, as depicted in Figure 
  5.10), and hence defines the eventual diameter of the holes. In practise, however, 
there is a limit to the minimum size that can be achieved. The smaller the size-
reduced nanospheres are, the thinner the metal mask has to be to enable the later 
removal of nanospheres. Additionally, a thin metal mask limits the etch depth of the 
polysilicon using the RIE process. Therefore, in most cases, the size of the 
nanospheres was not reduced (by RIE) by more than half the original size. A metal 
mask with total thickness of 20 nm was found to produce successful lift-off and was 
also sufficiently robust during the RIE of the polysilicon layer. 
Due to the under-cutting and the formation of a tapered etch profile, as a 
result of using the etch tool, it was necessary to limit the depth by which the samples 
were etched. Lateral etching between adjacent pores resulted in interconnecting 
porous structures at the upper surface, or even hexagonally-ordered, spiked 
triangular pyramid surfaces. It is clear that the fabrication approach could be used 
for creating macroporous regions in other substrates. With different etching tools, 
the geometry of the pores could be improved so that the sidewalls would be straight. 
Hexagonally ordered, uniform, cylindrical macro-PPSi structures could thus be 
obtained by careful control of the etch conditions.  
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Chapter  6 
The Design and Fabrication of a 
Porous Silicon Membrane Drug 
Delivery Device 
6.1  Introduction 
Novel fabrication techniques, by applying a porous anodic alumina (PAA) template 
or the nanosphere lithography (NSL) approach, to form a porous polysilicon (PPSi) 
structure, have been demonstrated and discussed in Chapter 4 and Chapter 5, 
respectively. Both successful and less successful outcomes were achieved, primarily 
affected by the physical properties of the polysilicon device layer. However, it is clear 
that, with the proper tools and optimised processes, there is very good potential for 
these techniques.  
In this chapter, the design and fabrication of a drug delivery device with a 
silicon substrate, rather than a polysilicon layer, is described. A silicon membrane, 
with a quasi-ordered porous silicon (PSi) structure as the drug reservoir, was 
integrated and fabricated using an improved NSL technique. An integrated heater 
and temperature sensor, instead of a pair of electrodes (as discussed in Chapter 3), 
was proposed for the electro-thermal actuation of the drug delivery device. The 
application of a finite element analysis (FEA) modelling approach to investigate the 
operational range of the heater is also presented. 6.2 Device Design    163 
 
6.2  Device Design 
The PPSi-based drug delivery prototype device, discussed thus far, was found to be 
non-ideal. Firstly, the polysilicon device layer, used as a material for the fabrication 
of PPSi, created a number of fabrication issues. Two novel approaches to fabricate 
the PPSi structure have been described and these include using a PAA template (as 
discussed in Chapter 4) and the NSL technique (as discussed in Chapter 5). In the 
case of the PAA template, the non-uniform thickness in the evaporated aluminium 
caused uncharacteristic anodising behaviours, which resulted in the PAA films to 
detach from the substrate due to over-etching (see Chapter 4, §4.3.3 for details). 
This, in addition to the poor contact between the deposited aluminium and the rough 
polysilicon surface, led to the formation of pores with sloped side walls. As such, 
these PAA structures are not ideal to be used as a masking template for the 
subsequent reactive ion etching (RIE) of the polysilicon layer. In the case of the NSL 
technique, the “black silicon” method used in the RIE of the polysilicon layer formed 
an undercut beneath the NSL-formed metal mask and thus resulted in a positively 
tapered, “crown-like” PPSi structure (see Chapter 5, §5.4.4 for details). The depth of 
the fabricated pores is therefore limited. Secondly, the fabrication of the aluminium 
electrode, as described in Chapter 3, §3.6, was not feasible. For a good electrical 
contact, the evaporated aluminium needs to fill the pores in the PPSi structure, 
which is technically challenging.  
Therefore, an improved prototype drug delivery device, using a silicon 
membrane substrate with an alternative electro-thermal actuation method, is 
proposed. In this design, as depicted in Figure   6.1, the silicon membrane substrate 
consists of a nanostructured, quasi-ordered PSi layer, fabricated at the back-side of 
the membrane, which is used as the drug reservoir. An integrated heater and 
temperature sensor is incorporated at the front-side of the silicon membrane. By 
using a resistive heating, it is envisaged that the heating element will provide a 
rapid increase in temperature, for a short period of time, to the PSi structure, 
therefore promoting the release of the loaded therapeutic agents from the pores. The 
temperature sensor can be used to provide feedback of the temperature distribution 
of the device. When coupled with a closed-loop control circuitry, this enables precise 











Figure   6.1: Oblique, cross-sectional view, conceptual illustration of the envisaged prototype drug 
delivery device (not to scale; see Figure   6.8 for further fabrication details and colour scheme of 
materials used).  
6.2.1  Design of the Silicon Membrane 
For this revised, second generation prototype drug delivery device, single-crystal 
silicon is used instead of polysilicon as the substrate. Single-crystal silicon is a 
popular and well-established substrate for the fabrication of microelectromechanical 
systems (MEMS) devices. A polished silicon wafer is nearly atomically flat and hence 
provides a smoother surface than the polysilicon layer. The RIE of silicon has also 
been more comprehensively investigated than the RIE of polysilicon. Fabrication of a 
porous structure in single-crystal silicon has been extensively studied (see Chapter 2, 
§2.3 for a literature review of PSi), and various fabrication approaches, including 
using PAA templating and the NSL technique have been investigated by both 
academia and industry.  
A thin silicon membrane is preferred over the bulk silicon substrate, for the 
device area, to ensure a good thermal conductivity and heat transfer from the 
heating element to the PSi layer. The membrane is proposed to be 50 μm thick, 
which is a compromise between ease of fabrication, mechanical robustness (for 
handling) and optimum heat transfer. Three membrane sizes were proposed – 3 mm 6.2 Device Design    165 
 
x 3 mm, 4 mm x 4 mm and 5 mm x 5 mm and the conceptualised prototype device 
has an overall dimension of 10 mm x 10 mm. 
A wet chemical anisotropic etch is the most straight-forward method to 
fabricate the proposed membrane structure [42]. Potassium hydroxide (KOH), 
tetramethyl ammonium hydroxide (TMAH) and ethylenediamine pyrocatechol (EDP) 
are three common etchants that are capable of anisotropic etching of silicon. These 
etchants produce characteristic 54.74° inward sloping walls, as depicted in Figure 
  6.2, on silicon wafers with <100> orientation. To realise the three membrane sizes on 
a silicon wafer with thickness of 525 μm, the masking materials (typically silicon 
dioxide (SiO2) and silicon nitride (Si3N4)) would need an opening of either 3.67 mm x 
3.67 mm, 4.67 mm x 4.67 mm or 5.67 mm x 5.67 mm. To achieve a membrane 
thickness of 50 μm, the etch depth is measured intermittently during the etching 
process. An etch rate can then be estimated, hence providing a total etch time 
needed to achieve the 50 μm thickness for the silicon membrane. Alternatively, in-
situ optical monitoring [385, 386] can be used to control the etching; a boron-doped 
layer can be used as an etch stop; or a silicon-on-insulator (SOI) technology can be 
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Figure   6.2: Cross-sectional view of the conceptualised, 50 μm thick, silicon membrane. 
6.2.2  Nanostructuring of Porous Silicon 
The PSi region is designed to have a pore diameter in the range of 50 nm to 100 nm, 
with an aspect ratio of 10:1 (due to the limitation of dry etching), resulting in a pore 
depth in the range of 500 nm to 1 μm. The fabrication of the PSi structure was 
originally proposed to be carried out using RIE with both masking approaches: i) a 
PAA template (for a smaller pore diameter in the range of 50 nm), as discussed in 
Chapter 4; and ii) a metal mask formed by NSL technique (for a pore diameter in the 6.2 Device Design    166 
 
range of 100 nm), as discussed in Chapter 5. However, the approach using the PAA 
template was later suspended, primarily due to the limited access to the modified 
thermal evaporator used to deposit a thick layer of aluminium that is necessary for 
the formation of the PAA template. 
The PSi structure could be formed either on the front-side or the back-side of 
the silicon membrane. However, at the back-side of the silicon membrane, optical 
lithography is not easy to achieve inside the etched cavity as the sloping wall of the 
silicon membrane imposes a potential problem in getting a uniform thickness of 
photoresist. Since a lithographic step is required for the fabrication of the heater and 
the temperature sensor, it is sensible to fabricate the PSi structure (which does not 
involve a process using photoresist) in the base of the etched cavity. 
6.2.3  Design of the Integrated Heater and Temperature 
Sensor 
Instead of using a pair of electrodes impregnated into the porous structure, as 
described in Chapter 3, a heating element was proposed for the electro-thermal 
actuation. The principle is to rapidly heat the PSi structure for a short time to 
accelerate the dissolution of the PSi and assist desorption of the therapeutic agents 
into the environment (human body). The generated heat needs to be localised; it 
should not critically increase the temperature of the surroundings (to prevent 
thermal shock to the human body), and should not affect the biological activity of the 
therapeutic agents (such as protein and peptide-based biopharmaceuticals, 
specifically, bone morphogenetic protein-2 (BMP-2), see Chapter 1, §1.1.1). Hence, 
two primary design specifications and assumptions for the heater were prescribed: 
i)  The critical temperature of the surrounding environment to avoid thermal 
shock was assumed to be 43.5 °C ± 1.5 °C [387]. The heater should not be 
heated beyond the critical temperature for a long time (not more than 1 s) 
when it is turned on, and should cool down relatively quickly to below the 
critical temperature after being turned off; 
ii)  The temperature limit deemed safe before a significant reduction in biological 
activity of the therapeutic agents was assumed to be 60 °C ± 10 °C (since 6.2 Device Design    167 
 
recombinant human BMP-2 showed little reduction in biological activity, 
after being heat-treated for 8 hours at 70 °C [30]). Therefore, the heating 
element should be made of material with a high thermal conductivity (hence, 
a short thermal response time), so that the heat can be generated and 
transferred before the temperature of the surrounding environment exceeded 
the critical temperature, as discussed above. 
The temperature sensor is essentially a resistance temperature detector, 
which exploits the predictable change in electrical resistance with changing 
temperature. Hence the temperature sensor should have a linear, stable and 
reproducible thermoelectric characteristic. Importantly, the temperature coefficient 
of resistance (TCR) of the material used to fabricate the thin film temperature sensor 
should be low, so that the resistance of the material does not change over a long 
operational time.  
The most widely used material for the temperature sensor is platinum and, 
due to an integrated fabrication process, the heater is commonly made of the same 
material as the temperature sensor. Platinum has a low TCR value of 0.00373 K-1 
[388], but the thermal conductivity is only 71.6 W·m-1·K-1 [389]. In addition, gold 
wires (for connection to the external world) do not bond well to a platinum surface; 
additional fabrication process steps are required to create the bond pads. In contrast, 
gold has a similar TCR value (0.00372 K-1 [388]), but a higher thermal conductivity 
(317 W·m-1·K-1  [389]), and hence a potentially shorter thermal response time. 
Consequently, gold is preferred over platinum for both the integrated heater and the 
temperature sensor. 
Three designs of the heater and the temperature sensor were proposed: 
meander, spiral and coil, as depicted in Figure    6.3. The meander design is an 
implementation of a simple resistor design and serves as the basis for comparison. 
The spiral design optimises the heater length with area, while the coil design 
minimises the hot spot typically created by sharp, abrupt corners. The thickness of 
the gold (Au) heater and temperature sensor was proposed to be 300 nm, with a 10 
nm thick layer of titanium (Ti) as the adhesion layer. Table    6.1 summarises the 
dimensions and expected resistance of the designed heaters and temperature 
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Figure   6.3: Schematic illustration of the heater and the temperature sensor designs: (a) meander; 
(b) spiral; and (c) coil. 



















3 x 3  150  16.2  13.8 
4 x 4  200  21.6  18.4  Meander 




3 x 3  150  12.0  13.8 
4 x 4  200  16.0  18.4  Spiral 




3 x 3  150  10.1  4.971  19.4  9.532 
4 x 4  200  14.7  5.418  19.4  7.161  Coil 
5 x 5  250  19.4  5.739  19.8  5.858 
Table   6.1: The dimensions of the three designed heaters and temperature sensors. The thickness of 
both the heater and the temperature sensor is 300 nm. 
6.2.3.1  Thermal Analysis of the Heater 
In order to investigate the temperature distribution resulting from the three heater 
designs, and thus to estimate the performance and operational range, an electro-
thermal analysis using an FEA simulation tool, COMSOL23, was performed. In 
addition to the heater material (as discussed previously), other parameters that 
affect the heat generation by Joule heating are the voltage applied to the heater 
(actuation voltage) and the time the heater is turned on (heater on-time). Hence, 
actuation voltages of 1 V to 5 V, with a heater on-time of 0.5 s, were investigated in 
                                                           
23 COMSOL Ltd., http://www.comsol.com/ (last accessed Jul. 2009). 6.2 Device Design    169 
 
the simulation; heater on-times of 0.1 s and 1.0 s were also used in some simulations. 
Both steady-state and time-dependent analyses were performed. 
The 3D simulation was performed by coupling the electrical heat generation 
by the Joule heating and the heat transferred to the device due to this heat 
generation. This multiphysics simulation uses the AC / DC Module in combination 
with the Heat Transfer Module of COMSOL. In the AC / DC Module, the Shell, 
Conductive Media DC application mode (see Appendix D.1.2 for details) was used to 
take into account the thickness effect of the heater, without the need to 
geometrically model the actual dimensions of the heater. The geometrical 
dimensions of the heater span 4 orders of magnitude (the heater thickness is 300 nm, 
while the length is in the millimetre range). This makes the simulation practically 
unfeasible with common desktop computers. The Shell, Conductive Media DC 
application mode eliminates this geometrical constraint by providing a reasonably 
accurate approximation to the actual solution of the FEA. 
The heat generated by the Joule heating is then coupled into the General 
Heat Transfer application mode (see Appendix D.2.1 for details) of the Heat Transfer 
Module. The Highly Conductive Layer feature was enabled, to model the thin 
conducting layer of the heater, which specifies the generated heat as an inward heat 
flux at the top surface of the silicon membrane. 
The following assumptions were also made in the COMSOL simulation: 
i)  The heat transfer is assumed to be mainly by conduction, from the heater to 
the PSi structure (at the back-side of the silicon membrane), and a natural 
convective heat transfer occurs from the device to the surrounding 
environment, which is modelled as a fluid with a constant temperature of 37 
°C. All the surfaces of the device are thus subjected to a natural convective 
heat transfer coefficient, hc, which is assumed to be 200 W·m-2·K-1. The value 
of hc was assumed based on the typical value of hc of liquid (between 50 W·m-
2·K-1 and 1000 W·m-2·K-1 [390]) and a proposed equivalent heat transfer 
coefficient (of between 100 W·m-2·K-1 and 300 W·m-2·K-1), between a biological 
tissue and blood, based on a porous media model [391]; 6.2 Device Design    170 
 
ii)  The temperature sensor was not included in the model. The heat transferred 
to the temperature sensor, by convection and radiation from the heater, is 
hence assumed to be negligible in accordance to assumption (i) above; 
iii)  The Ti adhesion layer (of 10 nm thick) was not considered in the model, since 
its resistance (in kΩ range) is much larger than the resistance of the heater 
and, thus, the effective resistance is dominated by the resistance of the 
heater; 
iv)  The insulating Si3N4 (160 nm) and SiO2 (40 nm) layers were not considered in 
the model. A 2D simulation (see Appendix D.3 for results) demonstrated that 
the effect of the insulating layers were negligible to the overall heat transfer; 
v)  The PSi structure was assumed to have the same thermal and electrical 
properties as the bulk silicon (which is not true since PSi is typically more 
resistive, both electrically [392] and thermally [393]) due to the thickness 
factor (as the PSi layer is between 500 nm and 1 μm); 
vi)  In the model, the silicon substrate has a size of 10 mm x 10 mm x 525 μm. 
Only the membrane with a size of 4 mm x 4 mm was simulated, with an 
assumed thickness of 50 μm. The length and width of the heater tracks were 
simulated using the dimensions of the 4 mm x 4 mm membrane, as described 
in Table   6.1, with a track thickness of 300 nm. 
The Joule heating was simulated as a result of an input voltage, Vin to the 
heater. In the steady-state simulation, Vin equates to the actuation voltage, Vdd. In 
the time-dependent simulation Vin is defined using a Heaviside function as follows: 
( ) [ ] HS ON dd in S t t hs flc V V , 1 1 − − =      (   6.1) 
where tON is the heater on-time and SHS is the slope of the Heaviside function, flc1hs, 
to model the transient switching off of the heater. Only the heater was involved in 
this part of the simulation, with the electrical conductivity as the only governing 
material property. The electrical conductivity of the heater, σHeater was modelled 
using a temperature-dependent equation: 6.2 Device Design    171 
 






σ      (   6.2) 
where ρ0 is the resistivity at a reference temperature, T0, and α is the TCR value of 
the material. For this, the electrical properties of gold, as summarised in Table   6.2, 
were used. 
Parameter Value  Unit  Reference 
Reference Resistivity, ρ0   2.2 x 10-8  Ω·m  [389] 
Reference Temperature, T0  293.15 K  [389] 
Temperature Coefficient of Resistance, α  0.00372  K-1 [388] 
Table   6.2: The electrical properties of gold used in the settings of the Shell, Conductive Media DC 
application mode. 
 
Properties Gold  Silicon 
Specific heat capacity, C (J·kg-1·K-1)   129 703 
Thermal conductivity, k (W·m-1·K-1)  317 163 
Density, ρ (kg·m-3)  19300 2330 
Table   6.3: The thermal properties of gold and silicon used in the settings of the General Heat 
Transfer application mode. All the properties were obtained from the Materials Libraries of 
COMSOL. 
In the heat transfer analysis, both the silicon membrane and the gold heater 
were included in the simulation. The thermal properties of both silicon and gold, as 
presented in Table   6.3, were used in the simulation. The time-dependent simulation 
was performed with an initial temperature of 37 °C, as described in assumption (i) 
(page 169). 
As predicted, the steady-state temperature of the device (at the centre of the 
membrane), as summarised in Table    6.4 and depicted in Figure    6.4, increases 
proportionally with an increase in the actuation voltage. In fact, the behaviour of 
steady-state temperature with respect to the actuation voltage can be best described 
by a 4th order polynomial, as depicted in Figure   6.4. Among the three heater designs, 
the coil heater (design (c) in Figure   6.3), having the shortest heater track length 
(hence, the least resistive), produces the greatest temperature rise per length. 6.2 Device Design    172 
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Figure   6.4: Simulated steady-state temperature, at the centre of the membrane, with respect to the 
actuation voltages of 1 V to 5 V for the meander (), spiral () and coil (c) heaters. The solid lines 































3 V, 1.0 s
3 V, 0.1 s
 
Figure   6.5: Simulated transient plot of temperature over time, at the centre of the membrane of the 
meander heater, after applying actuation voltages of 1 V to 5 V, for 0.5 s. The bold and dashed lines 
are the temperature curves with heater on-times of 0.1 s and 1.0 s, respectively, actuated with a 
voltage of 3 V. 6.2 Device Design    173 
 
Figure   6.5 depicts a time-dependent simulation in which a meander heater 
was investigated. Voltages from 1 V to 5 V and a heater on-time of 0.5 s were 
considered. The peak temperature at the centre of the membrane is shown to be 
directly proportional to the actuation voltage, as was expected. In addition, the peak 
temperature is also found to be directly proportional to the heater on-time, as 
depicted by the bold and dashed lines in Figure   6.5, for heater on-times of 0.1 s and 
1.0 s, respectively, with an actuation voltage of 3 V. These findings suggest that an 
optimum operational range of the heater can be found by careful selection of the 
actuation voltage and the heater on-time. 
The time-dependent simulations of different heater designs yield similar 
findings by the steady-state simulation: the coil heater produces the largest 
temperature rise. In fact, as depicted in Figure    6.6, apart from the high peak 
temperature (66.0 °C at a time of 0.45 s), the coil heater also cools down more rapidly 
(to 44.2 °C at time 0.55 s, or ~ 21.8 °C in 0.1 s, compared to 19.4 °C and 13.0 °C in 0.1 
































Figure   6.6: Simulated transient plot of temperature over time, at the centre of the membrane, after 
applying 3 V of actuation voltage, for 0.5 s, for the meander (), spiral () and coil (c) heaters. The 
insets show the temperature distribution, for graphical comparison, of the coil heater and the 
meander heater, at time = 0.45 s. 6.2 Device Design    174 
 
Table    6.4 summarises both the findings of the steady-state and the time-
dependent simulations for the three heater designs, with actuation voltages of 1 V to 
5 V and a heater on-time of 0.5 s. For the meander heater, an actuation voltage of 3 
V is sufficient to provide the heat to increase the temperature from 37 °C to ~ 55 °C, 
in 0.5 s; this is within the design requirement of the heater’s temperature limit of 60 
°C ± 10 °C and a heater on-time limit of 1 s. Moreover, the temperature reduced to ~ 
40 °C, 1 s after the meander heater was turned off; this is below the critical 
temperature of 43.5 °C. Hence, an actuation voltage of 3 V with a heater on-time of 
0.5 s will be used for the meander heater (highlighted in pink in Table   6.4) for the 
initial testing of the heater’s performance (discussed in §  6.4.3). The actuation voltage 
of 3 V can also be used for the spiral and the coil heaters, but the heater on-time 
needs to be reduced to 0.1 s (highlighted in yellow in Table   6.4). 
 
Temperature (°C) 
Time-Dependent  Design 
Actuation 
voltage 
(V)  Steady-state 
Peak  After 1.5 s 
1 40.73  39.07  37.31 
2 51.46  45.18  38.22 
3  68.07  55.02  39.69 
4 89.24  68.18  41.66 
Meander 
5 113.81  84.17  44.04 
1 42.25  40.04  37.42 
2 57.15  48.92  38.62 
3 79.69  63.09  40.56 
3 V, 0.1 s  -  57.58  37.54 
4 107.76  81.68  43.08 
Spiral 
5 139.69  103.88  46.09 
1 42.78  40.41  37.45 
2 59.08  50.30  38.74 
3 83.55  65.99  40.81 
3 V, 0.1 s  -  60.13  37.58 
4 113.79  86.41  43.48 
Coil 
5 147.96  110.61  46.65 
Table   6.4: The simulated steady-state and time-dependent temperature of the meander, spiral and 
coil heater, with actuation voltages of 1 V to 5 V. The time-dependent simulation was performed 
with a heater on-time of 0.5 s, except for the rows highlighted in yellow, which were simulated with 
an actuation voltage of 3 V and a heater on-time of 0.1 s. The bold parameters represent the 
proposed operational parameters for the respective heater designs. 6.3 Device Fabrication    175 
 
6.3  Device Fabrication 
The integration of the fabrication process has taken into consideration the design 
constraints and requirements discussed in §  6.2. The fabrication process is thus 
divided into 3 main stages, and the major steps are schematically depicted in Figure 
  6.8. The 3 main stages of the fabrication are:  
Stage 1:  Fabrication of the silicon membrane (steps (a) to (j) in Figure   6.8). 
Stage  2:  Formation of PSi structure using the NSL technique (step (k) in 
Figure   6.8). 
Stage 3:  Fabrication of the integrated heater and temperature sensor using the 
lift-off method (steps (l) to (n) in Figure   6.8). 
6.3.1  Fabrication of the Silicon Membrane (Stage 1) 
The fabrication of the silicon membrane was performed by the technical staff of the 
Nanofabrication Laboratory, Chalmers University of Technology, Sweden. The main 
aim of this fabrication was to realise a 50 μm thick silicon membrane, as depicted in 
Figure   6.7, with the proposed square membrane sizes of 9 mm2, 16 mm2 and 25 mm2. 
All of the processes in Stage 1 fabrication were processed at the wafer level. The 
detailed listing of the fabrication process is in Appendix A.2.  
160 nm Si N4 3
40 nm SiO2
 
Figure   6.7: Oblique, cross-sectional view, schematic illustration of the silicon membrane after the 
Stage 1 fabrication (not to scale; refer to Figure   6.8 for colour scheme of materials). 6.3 Device Fabrication    176 
 
a) Grow 40 nm thick SiO  by dry oxidation 2
Stage 1: Fabrication of Silicon Membrane
b) Deposit 160 nm thick Si N  by LPCVD 34
c) Spin and pattern photoresist by photolithography (mask  ) UoS-TM-CFC-M1
d) Etch Si N  and SiO  by RIE 34 2
e) Strip photoresist by plasma ashing
f) TMAH anisotropic silicon etch
50 m μ
~ 3 mm, 4 mm or 5 mm
g) Spin and pattern photoresist by photolithography (mask  ) UoS-TM-CFC-M2







Figure   6.8: Schematic illustration of the fabrication process of the PSi membrane drug delivery 
device (not to scale; see next page for continued process steps and colour scheme of materials used). 6.3 Device Fabrication    177 
 
i) Strip photoresist by plasma ashing
k) Formation of PSi by NSL technique (see section 6.3.2 for detailed steps)
 Silicon Substrate
 Silicon Dioxide, SiO2
 Gold, Au  Silicon Nitride, Si N 34




Stage 2: Nanostructuring of PSi Structure
l) Spin and pattern photoresist by photolithography (mask  ) UoS-TM-CFC-M4
Stage 3: Fabrication of Heater and Temperature Sensor
m) Deposit Ti/Au (10 nm / 300 nm) by evaporation
n) Lift-off Ti/Au by stripping photoresist
PSi Structure
j) Spin coat photoresist for protection and then dice into chips
 
Figure   6.8: Schematic illustration of the fabrication process of the PSi membrane drug delivery 
device (not to scale). 6.3 Device Fabrication    178 
 
The starting material consisted of twelve 150 mm diameter, 525 μm ± 25 μm 
thick, double-side polished, silicon wafers with <100> crystal orientation. Six of the 
twelve wafers were of boron-doped p-type (1 – 10 Ω·cm, labelled P01 to P06); while 
the other six were of phosphorus-doped n-type (1 – 10 Ω·cm, labelled N07 to N12) 
wafers. The major steps involved in the fabrication of the silicon membrane, as 
illustrated in Figure   6.8, include: 
Step (a) The wafers are first cleaned using a standard two-stage RCA silicon 
cleaning process [273]. A dry oxidation is then carried out at 950 °C to grow a layer 
of 40 nm ± 5 nm thick silicon dioxide (SiO2); this serves as a stress relief and an 
adhesion layer for the subsequently deposited silicon nitride (Si3N4) layer. 
Step (b) A layer of 160 nm ± 20 nm thick Si3N4 is deposited by LPCVD at 770 °C, at a 
pressure of 200 mTorr, using dichlorosilane (SiCl2H2) and ammonia (NH3) gases. The 
SiO2-Si3N4 bi-layer serves as a masking layer for the subsequent tetramethyl-
ammonium hydroxide (TMAH) deep anisotropic etch of silicon (Step (f)) to create the 
membrane. Furthermore, the front-side SiO2-Si3N4 bi-layer provides electrical 
isolation between the heater and temperature sensor. 
Step (c) The back-side of the wafers is then spin-coated with a layer of Clariant 
AZ1512HS positive photoresist, at 4000 rpm to achieve a nominal thickness of 1.2 
μm. The photoresist is then exposed with the first mask (mask UoS-TM-CFC-M1, see 
Appendix B.2.1) and developed. Subsequently, the photoresist is hard baked for 30 
minutes at 120 °C in an oven to improve its robustness to sustain the subsequent 
RIE processes. 
Step (d) A mixture of tetrafluoromethane (CF4) and oxygen (O2) gases is used for the 
RIE process of the SiO2-Si3N4 bi-layer. In both processes, the flow rate of the CF4/ O2 
gas mixture is set at 30 sccm / 3 sccm, while the RIE pressure and the radio 
frequency (RF) power are set at 100 mTorr and 100 W, respectively. 
Step (e) Following the RIE process in Step (d), the photoresist is stripped, within the 
same chamber, using a 40 sccm flow of O2 gas with an RF power of 250 W. 6.3 Device Fabrication    179 
 
Step (f) The exposed silicon is then deep-etched anisotropically using a 25 wt% 
TMAH solution maintained at 80 °C in a circulating bath. 
Step (g) A layer of AZ1512HS photoresist is then spin-coated at 4000 rpm onto the 
front-side of the wafers. The photoresist is then exposed with the second mask (mask 
UoS-TM-CFC-M2, see Appendix B.2.2), and developed and hard baked for 30 
minutes at 120 °C in an oven. The patterned photoresist defines the chip level 
alignment marks (used in Stage 3 fabrication) and the dicing tracks (for Step (i)). 
Step (h) RIE using CF4 and O2 gases, with process parameters similar to that of Step 
(d), is then carried out to etch the front-side SiO2-Si3N4 bi-layer. 
Step (i) The photoresist is then stripped, with the same process parameters detailed 
in Step (e). 
Step (j) A layer of AZ1512HS photoresist is then spin-coated on the front-side of the 
wafers, to protect the wafers from the contamination of the silicon dust typically 
produced during the wafer dicing process. The wafers are subsequently diced into 
chips for the following, Stage 2 and Stage 3 fabrication processes, which were carried 
out in-house (the Optoelectronics Research Centre (ORC) temporary cleanroom and 
the NanoMaterial Rapid Prototyping Facility) at the University of Southampton. 
6.3.1.1  Fabrication Results and Issues 
During the fabrication of the silicon membrane, all but one wafer (wafer P03) were 
damaged due to an accidental handling error. Wafer P03 was processed as a 
development wafer, ahead of the other wafers, and hence avoided the incident. A 
second batch of wafers was later processed and, for clarity, these wafers are 
identified with a prefix “b2”. 
The membrane thickness was measured using a stylus surface profiler (KLA-
Tencor P-16), to be about 70 μm for wafer P03, after etching in TMAH solution for 19 
hours 26 minutes. The overall etch rate, based on an estimated etch depth of 478 μm, 
was calculated to be 0.41 μm·min-1. Based on these measurements, the TMAH 
etching during the second batch fabrication was carried out with a longer etch time 6.3 Device Fabrication    180 
 
of 23 hours 42 minutes; this produced membranes with a thickness of 46.6 μm ± 0.5 
μm (measured on sample b2P02S38) and an etch rate of ~ 0.35 μm·min-1. The 
selectivity of <111> over <100> crystal orientation of silicon, was estimated to be 
between 1:10 and 1:35. Hence, the lateral etch (or mask undercut) was estimated to 
be between 14 μm and 49 μm for an etch depth of ~ 490 μm. This undercut, in certain 
cases, was severe enough to destroy some of the features on the wafer, such as the 
chip level alignment marks, as depicted in Figure    6.9 (b). Undercutting, due to 
failure of the Si3N4-SiO2 masking layers, was also observed and this produced 
undesirable features, as depicted in Figure   6.9 (c). 
 








500 m μ  
(d) 
Figure   6.9: Bright field, microscope images showing (a) the bottom trench or surface of the 
membrane; (b-c) undercut and lateral etch at the (b) chip level (the dashed line outlines the 
intended features) and (c) wafer level alignment marks; and (d) pinholes on the front-side of the 
membrane after the TMAH etch. 6.3 Device Fabrication    181 
 
During the initial fabrication process, the vacuum chuck often failed to hold 
the TMAH-etched wafers during the spin-coating of photoresist (Step (g) of Figure 
  6.8). The loss of vacuum was suspected to be due to cracked membranes and 
pinholes, such as those depicted in Figure   6.9 (d), produced by the TMAH etching. 
Hence, during the second batch fabrication, the wafers were mechanically clamped to 
the chuck during the spin-coating process. In addition, Step (i) in Figure   6.8 was 
omitted so that the photoresist could be re-used to protect the wafer during the 
dicing process (Step (j)). Photoresist drops were applied manually to protect the 
areas where the wafers were exposed (after the RIE process (Step (h) in Figure   6.8)), 
hence eliminating the need to deposit the photoresist by the spin-coating process. 
6.3.2  Fabrication of the PSi Structure using the NSL 
Technique (Stage 2) 
In the second stage of the fabrication process individual silicon membrane chips 
(samples) from the diced wafers are processed to form the PSi structure (Step (k) in 
Figure   6.8). The nanosphere lithography (NSL) technique, as detailed in Chapter 5, 
is used to fabricate a template made of a thin layer of metal film (here, chromium 
(Cr)) with holes arranged in a quasi-ordered, hexagonal lattice. By using an RIE, the 
pattern of holes is transferred into the silicon membrane, hence producing a quasi-
ordered PSi structure. Figure    6.10 illustrates the detailed steps of the NSL 
technique used in the fabrication of the PSi structure. 
Selected samples from the diced wafers P03,  b2P01,  b2P02,  b2P06 and 
b2N07, were primarily used for the fabrication of the PSi structures. These samples 
were coated with a layer of photoresist to protect the wafer in the dicing step (Step (j) 
in Figure   6.8). The samples were cleaned in acetone and then rinsed in isopropanol 
(IPA) to remove the photoresist. The samples were further treated in a Piranha 
solution, which typically consisted of a 3:1 volume ratio of 95 % concentrated 
sulphuric acid (electronic (MOS) grade, Fisher Scientific, UK): 30 % weight in 
volume (w/v) hydrogen peroxide (general laboratory work (SLR) grade, Fisher 
Scientific, UK). The Piranha solution removes organic and anionic contaminants and 
leaves a more hydrophilic surface, which is essential for the nanosphere deposition. 
The samples were typically cleaned in the Piranha solution for 30 minutes, rinsed 6.3 Device Fabrication    182 
 
with copious amount of DI water and individually kept, until used, in specimen 
bottles containing DI water. 
The NSL technique, as illustrated in Figure   6.10, was used to form the PSi 
structure at the back-side of the silicon membrane samples. Monodisperse, 
carboxylate-modified polystyrene nanospheres (Duke Scientifics (Brookhaven, UK)) 
with a nominal diameter of 200 nm, a coefficient of variance < 5 % and a surface 
group parking area of 45 Å2 per carboxyl group, were used. The nanospheres 
(suspended into a 4 weight percent (wt%) aqueous solution, as purchased) were 
further diluted, into a 1 wt% suspension (2:1:1 volume ratio of ethanol: DI water: 4 
wt% nanosphere suspension) prior to use. The nanosphere suspension was deposited 
(Step (k-1) in Figure   6.10) onto the samples, using the method described in Chapter 
5, §5.3.3, to provide self-assembled monolayer of hexagonally close-packed 
nanospheres. 
(k-1) Deposit nanospheres on the back
( ) Reduce size of nanospheres by RIE k-2
()  Evaporate Cr (10 nm thick) k-3
( ) Remove nanospheres in toluene k-4
( ) RIE of silicon k-5
50  m thick Si membrane μ
( ) Remove Cr k-6
   of the Si membrane
Nanospheres
 
Figure   6.10: Schematic illustration of the fabrication process of the PSi structure using the NSL 
technique (not to scale; see Figure   6.15 for colour scheme of materials used). 6.3 Device Fabrication    183 
 
In general, the nanospheres deposited on the silicon membrane substrates 
exhibited better ordering with less significant defects compared to on the polysilicon 
substrates, as depicted by the SEM micrograph (obtained from LEO 1455VP) in 
Figure   6.11. The inset fast Fourier transform (FFT) of the digital diffraction pattern 
of the SEM micrograph demonstrates the well-defined maxima and confirms the 
good hexagonally close-packed ordering. Minor defects, such as line dislocations, 
point vacancies and stacking of second-layer nanospheres, which are intrinsic to the 






Figure   6.11: Plane-view SEM micrograph showing a self-assembled monolayer, hexagonally close-
packed nanospheres (on sample b2N07S33), with defects such as line dislocations, stacking of 
nanospheres and vacancies. The inset depicts the FFT diffraction pattern of the SEM micrograph. 
The size of the nanospheres was reduced (Step (k-2) in Figure   6.10) by an 
RIE process using an Oxford Instruments Plasmalab® 80 Plus plasma etcher. This 
produces a non-close-packed nanosphere template, with the reduced diameter of the 
nanospheres defines the diameter of the pores of the eventual PSi structure. Instead 
of using the Ar/O2 gas mixture, as detailed in Chapter 5, §5.3.4, an O2 gas with a gas 
flow rate of 5 sccm, with a higher pressure of 10 mTorr and an RF power of 100 W, 
was used. This change of RIE parameters was necessary due to a significantly 
reduced DC bias (near zero), sometimes with flickering plasma, observed during the 
RIE process when the Ar/O2 gas mixture with the previous parameters was used. It 
is suspected that the reduced DC bias may have been caused by the prior deposition 
of polymer (from processes that use tri-fluoromethane (CHF3)) onto the electrode. 6.3 Device Fabrication    184 
 
The influence of the RIE etch time on the reduction of the diameter of the 
nanospheres, for the revised RIE parameters, was evaluated for etch times of 40 s to 
70 s, and the results are depicted in Figure   6.12. The mean diameter of the size-
reduced nanospheres was measured using the National InstrumentsTM (NI) Vision 
Assistant image processing package. Plane-view SEM micrographs of selected 
samples after the RIE process, with the same magnification (of 30 000 times), were 
first digitally enhanced. The boundaries of the nanospheres were detected and the 
bounded areas were measured, to deduce the diameter of the nanospheres. Assuming 
a linear regression, the etch rate was estimated to be ~ 1.9 nm·s-1, which yields a 
theoretical reduced diameter of 88 nm for a typical etch time of 60 s.  In principle, by 
the careful control of the RIE etch time, the diameter of the nanospheres can be 
arbitrarily reduced to achieve a required size. However, the reduction in the 
diameter of the nanospheres affects the success of the subsequent lift-off of the 
nanospheres and the metal over them (Step (k-4) in Figure   6.10). Hence, in practice, 
there is a limit of a reasonable size that can be reduced. For this reason, the RIE 
etch time of most of the samples was set to 60 s, which yielded an average reduced 
diameter of 86 nm ± 3 nm. 
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Figure   6.12: Plot of the mean diameter of the nanospheres after the RIE process, against the RIE 
time. The solid line represents the least squares experimental fit as described by the expression. 
The error bars represent the standard deviations of the total detectable diameters on a SEM 
micrograph. 6.3 Device Fabrication    185 
 
A layer of Cr with a nominal thickness of 10 nm was then deposited (Step (k-
3) in Figure    6.10) using an e-beam evaporator (BOC Edwards Auto E500). The 
typical evaporation base pressure was between 1 x 10-6 mbar and 5 x 10-6 mbar. The 
nanospheres were removed (Step (k-4) in Figure   6.10) by ultrasonication in toluene 
for 30 s to 60 s. The space left by the nanospheres thus formed holes, arranged in a 
non-close-packed hexagonal lattice, in the Cr layer, as depicted in Figure   6.13, which 
now serves as the template for the subsequent RIE of silicon to form the eventual 
PSi structure. 
The removal of nanospheres is a critical process, as the nanospheres that 
remained on the sample, as depicted in Figure   6.13, would act as a mask to prevent 
the formation of the pore in the silicon by the subsequent RIE of the silicon. 
However, a prolonged exposure to ultrasonication (of more than 120 s, for instance) 
to remove the nanospheres, has been demonstrated to crack the silicon membrane. 
Use of other solvents, such as tetrahydrofuran (THF), dichloromethane (DCM) and 
dimethylformamide (DMF), did not show any significant improvement. Hence, to 
achieve the best possible result, the compromises made include limiting i) the RIE 
etch time (to reduce the size of the nanospheres) to 60 s; ii) the thickness of Cr to 10 






Figure   6.13: Plane-view SEM micrograph showing the Cr template (sample b2N07S53), with holes 
of 80 nm ± 5 nm in diameter, after most of the nanospheres were removed. The insets show (right) 
the FFT diffraction pattern of the SEM micrograph and (left) the magnified view of the same 
sample at a different area. 6.3 Device Fabrication    186 
 
The RIE of silicon using the “black silicon” method, as described in Chapter 5, 
§5.3.6, was used to transfer the patterns on the Cr layer into the silicon membrane. 
A typical RIE process to etch the silicon uses a gas mixture of sulphur hexafluoride 
(SF6), CHF3 and O2 gases, with a gas flow rate of 15 sccm, 10 sccm and 5 sccm, 
respectively. The pressure was typically set at 5 mTorr with an RF power of 50 W. 
After etching for 10 minutes, a tapered profile, such as the one depicted in Figure 
  6.14, was observed. Here, the pointed, “crown-like” PSi structure was believed to be 
formed as a result of the severe undercut of the Cr layer. In fact, at an etch depth of 
~ 290 nm, as depicted in Figure   6.14, the width of the pore opening was more than 
200 nm; this suggests that an over-etching, which resulted in a lateral through-etch, 
has occurred. The Cr layer has been, very likely, completely etched. The pore (or 
more precisely, spiked triangular pyramid) diameter was measured to be 150 nm ± 6 
nm (based on the plane-view SEM micrograph in the inset of Figure    6.14), 
considerably enlarged from the initial, 134 nm ± 4 nm in diameter of the nanoholes 
in the Cr layer. 
 






Figure   6.14: Oblique, cross-sectional view SEM micrograph showing the cleaved edge of the sample 
P03S50 after an RIE in SF6/O2/CHF3 gases for 10 minutes (gas flow rate of 15/5/10 sccm, 
respectively, and a pressure of 5 mTorr with an RF power of 50 W). The inset shows the plane-view 
SEM micrograph of the sample at a different area. 6.3 Device Fabrication    187 
 
6.3.2.1  Improved Silicon RIE using STS LPX Pegasus 
The RIE conditions of the “black silicon” method result in undercutting, both on the 
silicon membrane and polysilicon samples. Initially, it had been thought that the 
substrate could be the root of the problem. In fact, after these studies it was decided 
that the “black silicon” method is unsuitable for the fabrication of the desired PSi 
structure. The use of conventional fluorine-based RIE processes to produce silicon 
structures with a high aspect ratio and a good profile control (vertical, smooth 
sidewall and critical dimensions in the sub-micrometer scale) is a technical challenge 
[394-396]. Instead, modern dry etching technologies, such as deep-RIE (DRIE) using 
the “Bosch process” [95], inductively coupled plasma (ICP) etching [397], chlorine-
based ICP [398] and cryogenic RIE [399], have been more widely used to fabricate 
high aspect ratio silicon structures. Among these technologies, the Bosch-based 
DRIE process, which is a sequential, cyclic ICP-RIE process consisting of alternating 
steps of etching (using SF6 gas) and passivation (using octafluorocyclobutane (C4F8) 
gas) processes [400], has been an increasingly important tool in MEMS fabrication. 
This is primarily due to its anisotropic silicon etch with high etch rate, which is 
capable of realising silicon structures with an aspect ratio of up to thirty [401, 402]. 
Here, the process was performed in a Surface Technology Systems24 (STS) 
LPX Pegasus system, which uses the Advanced Silicon Etch (ASE®) technology based 
on the Bosch process. The NSL technique was modified to incorporate a SiO2 hard 
mask to serve as the masking layer, for the transfer of the hole pattern into the 
silicon. This is necessary due to a compatibility issue; the NSL-patterned Cr layer 
previously used in the RIE of silicon could not be used in the STS LPX Pegasus 
system. The SiO2 hard mask was patterned using the Cr layer, which was fabricated 
in the same way as discussed previously. The modified NSL technique is detailed in 
Figure   6.15. 
In brief, after cleaning the samples in the Piranha solution (as described 
previously), a layer of SiO2 was deposited onto the back of the silicon membrane 
 
                                                           
24 Surface Technology Systems Plc., Newport, UK. http://www.stsystems.com/ (last accessed Jul. 2009). 6.3 Device Fabrication    188 
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Figure   6.15: Schematic illustration of the fabrication process of the PSi structure using a modified 
NSL technique with improved RIE of silicon (not to scale). 6.3 Device Fabrication    189 
 
(Step (k-1) in Figure   6.15), by either sputtering (Kurt J. Lesker Sputter system) or e-
beam evaporation (BOC Edwards Auto E500), to achieve nominal thicknesses 
between 150 nm and 200 nm. The SiO2 coated samples were then cleaned in the 
Piranha solution and individually kept, until used, in specimen bottles containing DI 
water. 
The typical NSL process steps were then performed, as described previously. 
These include the deposition of nanospheres onto the back of samples (Step (k-2) in 
Figure   6.15), size reduction of the nanosphere template using the RIE process (Step 
(k-3) in Figure   6.15), Cr deposition by the e-beam evaporation (Step (k-4) in Figure 
  6.15), and nanospheres’ removal in toluene with ultrasonication (Step (k-5) in Figure 
  6.15). The pattern on the Cr layer was then transferred onto the SiO2 hard mask by 
an RIE process (Step (k-6) in Figure   6.15), which utilised a gas mixture of CHF3 and 
Ar (with a flow rate of 25 sccm each) at a pressure of 40 mTorr and an RF power of 
200 W. The typical RIE etching of SiO2 was 10 minutes. The Cr layer was then 
removed in a Cr etchant (OM Group Ultra Pure Chemicals Ltd., UK) (Step (k-7) in 
Figure   6.15), which consists of acetic acid and ceric ammonium nitrate. 
The samples with a metal-free, SiO2 hard mask were then etched in the STS 
LPX Pegasus system (Step (k-8) in Figure   6.15). Most Bosch-based DRIE processes 
only produce good results for structures with critical dimensions in the micrometers 
scale. However, high aspect ratio structures in deeply sub-micrometer range (< 100 
nm), with a smooth (no scalloping) sidewall profile often requires considerable 
modifications to the conventional Bosch process [394, 395]. Hence, to realise the PSi 
structure with the desired pore diameter (in the range of 100 nm) with a good critical 
dimension control and a smooth sidewall profile, the low frequency (LF) process was 
exploited. Instead of operating at the widely used 13.56 MHz high frequency, the LF 
process utilises a power supply operating at 380 kHz to drive the platen. The LF 
process has been specifically developed to prevent the notching effect, which has 
been observed to frequently occur in etching of SOI wafers [403]. Here, the LF 
process has been applied to provide a controlled etch of tight critical dimensions with 
a virtually smooth sidewall profile by scarifying the high etch rate of a typical Bosch 
process. To slightly improve the etch rate, the parameter ramping feature of the 
ASE® technology [404] was used. The base recipe for the RIE process was modified 
from [394], and is detailed in Table   6.5. Typically, to maintain the macro-loading, 6.3 Device Fabrication    190 
 
two samples were attached to a 6 inch carrier wafer during each run. The micro-
loading, however, varied due to the nature of defects inherent in the NSL technique. 
The total process time was limited to 10 minutes, which amounts to 120 cycles of 
etching and passivation process steps.  
Parameters Etch  Cycle  Passivation  Cycle 
Cycle time  2 s  3 s 
Gas flow rate 
SF6 – 50 sccm 
O2 – 5 sccm 
C4F8 – 80 sccm 
Pressure  13 mTorr, ramped to 18 mTorr  18 mTorr, ramped to 23 mTorr 
LF Platen Power  11 W, ramped to 16 W  0 W 
Coil Power  350 W  350 W 
Table   6.5: The parameters developed for etching of silicon with feature sizes in 100 nm range, to 
realise the PSi structure using a STS LPX Pegasus system. 
The development of optimised process parameters was not performed due to 
inconsistent micro-loading and varied aspect ratios as a result of the intrinsic defects 
introduced by the nanosphere deposition method. The varied micro-loading and 
aspect ratios effectively result in a differential etch rate (also known as RIE-lag 
effect) by which isolated pores etch faster than pores in a dense array, while pores 
with smaller diameter tend to etch more slowly than relatively larger pores. SEM 
micrographs in Figure   6.16 depict such an effect, as clearly shown by the different 
etch depths. In fact, the sample b2N07S53 revealed two nanostructures – 
nanopillars and nanopores. It is believed that the nanopillars resulted from a double-
layer stacking of nanospheres during the deposition process. After the size-reduction 
process, the bottom layer of nanospheres retained its initial size, as the spheres were 
masked by the nanospheres on the top layer. Hence, instead of hole patterns, three-
pronged patterns (from the interstitial spaces between the nanospheres) were formed 
after the deposition of the Cr that was followed by the subsequent removal of 
nanospheres. The larger exposed area of the three-pronged nanopillar array (as 
opposed to the array of nanopores), as depicted by the plane-view SEM of the inset of 
Figure   6.16, hence resulted in faster etch rate. A more typical PSi structure, with the 
SiO2 hard mask, after the RIE of silicon using the STS LPX Pegasus, is depicted in 
Figure   6.17. The PSi structure of sample b2P06S62 exhibited a mean pore diameter 
of 105 nm ± 5 nm, while the pore depth was estimated to be 335 nm ± 28 nm. The 
SiO2 hard mask was observed to be intact, suggesting a good selectivity of SiO2 to 
silicon, although the precise figure was not investigated. Overall, pore diameters of 6.3 Device Fabrication    191 
 
between ~ 75 nm and ~ 120 nm have been observed on various samples, while the 
etch depth, for a process time of 10 minutes, was observed to range from ~ 330 nm to 







Figure   6.16: Oblique, cross-sectional view SEM micrograph showing the cleaved edge of the sample 
b2N07S53, highlighting the RIE-lag effect. The insets show the plane-view (right) and a magnified 





Figure   6.17: Oblique, cross-sectional view SEM micrograph showing the cleaved edge of sample 
b2P06S62 after the RIE of silicon using STS LPX Pegasus. The mean diameter of the pores was 
calculated to be 105 nm ± 5 nm, with a pore depth estimated to be 335 nm ± 28 nm. The inset 
shows the plane-view SEM micrograph of the sample at a different area. 6.3 Device Fabrication    192 
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Figure   6.18: Oblique, cross-sectional view SEM micrograph showing the cleaved edge of the PSi 
structure, of sample b2N07S72, after the removal of the SiO2 hard mask. The pore diameter was 
estimated to be 118 nm ± 7 nm; while the pore depth was estimated to be 334 nm ± 21 nm. The 
insets show the magnified, cross-sectional view (right) and the plane-view (left) of the same sample 
at a different area. 
Finally, the SiO2 hard mask was removed using a buffered oxide etchant 
(Lodyne SiO2 Etchant 7:1, OM Group Ultra Pure Chemicals Ltd., UK) to realise the 
PSi structure (Step (k-9) in Figure    6.15).  Figure    6.18 depicts an example PSi 
structure, with quasi-ordered, cylindrical pores, after the removal of the SiO2 hard 
mask. The pores (of sample b2N07S72) exhibited a relatively smooth and vertical 
sidewall. The mean pore diameter was calculated to be 118 nm ± 7 nm, with a pore 
size distribution (PSD) as depicted in Figure   6.19. The pore depth was estimated to 
be 334 nm ± 21 nm. The theoretical porosity, Ptheory for pores in a hexagonal 













      (   6.3) 
where dp is the mean pore diameter and dint is the interpore distance or the pitch 
size. The porosity derived from the plane-view SEM micrograph, used in the 
measurement of mean pore diameter and PSD, was found to be 27.4 %, which is in 
good agreement with the theoretical value. 
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Figure   6.19: The pore diameter distribution plot of sample b2N07S72, as estimated from a plane-
view SEM micrograph (partly shown as inset (left) of Figure   6.18; 30, 000 times magnification). 
The solid line represents a statistical fit with Weibull distribution25; while the dashed red lines 
represent the upper and lower bound of the 95 % confidence of the fit. 
6.3.3  Fabrication of the Integrated Heater and 
Temperature Sensor (Stage 3) 
The Stage 3 fabrication aims to create a patterned heater and a temperature sensor 
on the front-side of the silicon membrane devices, using the lift-off method described 
in Chapter 3, §3.6. Briefly, as illustrated in Figure   6.8, a typical process of the Stage 
3 fabrication includes the following steps: 
Step (l) The positive tone, Shipley MICROPOSIT® S1828 photoresist is first spin-
coated and exposed using a mask (mask UoS-TM-CFC-M4, see Appendix B.2.4). The 
S1828 photoresist is then surface modified by immersing the samples into toluene 
before being developed. Toluene was preferred over the previously used 
chlorobenzene, due to its reduced environmental hazard. 
Step (m) An adhesion layer of Ti with a nominal thickness of 10 nm is deposited by e-
beam evaporation, followed by a layer of Au with a nominal thickness of 300 nm. 
                                                           
25 Fitted using a non-linear regression tool of a graphing software, SigmaPlot (Systat Software Inc., 
http://www.sigmaplot.com (last accessed Jul. 2009)). 6.3 Device Fabrication    194 
 
Step (n) Finally, the S1828 photoresist is removed in a photoresist removal to realise 
the patterns of the heater and the temperature sensor. 
The silicon membrane devices with a PSi structure fabricated on the back-
side were primarily used in the fabrication of the heater and the temperature sensor. 
Some non-processed silicon membrane samples (“dummy samples”), mainly from 
wafers  P03,  b2P02 and b2N07, were also used to determine the exposure and 
development time. The samples were first cleaned using solvents (acetone and IPA), 
followed by a short, 1 minute RIE using O2 gas (with a gas flow rate of 10 sccm, at a 
pressure of 50 mTorr and an RF power of 100 W). Some of the samples (mainly from 
wafer  b2N07), which had the SiO2 hard mask removed, were further cleaned in 
fuming nitric acid (FNA) for 30 minutes before being sputter-deposited (Kurt J. 
Lesker Sputter system) with a nominal 200 nm thick SiO2 on the front-side of the 
samples, to serve as electrical insulation for the heater and temperature sensor. The 
samples were cleaned in a Piranha solution after the sputtering process.  
All the samples were then dehydrated in an oven (ED 23 Benchtop Oven, 
Binder UK) at 120 °C for at least 30 minutes. The samples were then attached to 
glass cover slips (22 mm x 22 mm, 0.13 mm to 0.16 mm thick, Menzel-Gläser) using 
the Shipley MICROPOSIT® S1813 photoresist. This is to assist the spin-coating 
process, as the samples could not be held firmly by the vacuum due to a cavity 
forming the membrane at the back of the samples. The Shipley MICROPOSIT® 
S1828 photoresist (Rohm and Haas Ltd., UK) was then spin-coated onto the samples 
using a programmable photoresist spincoater (SCS G3P-8 Spincoat, Specialty 
Coating Systems (SCS) Coating Centre, UK). A typical program includes the 
following steps: i) spin at 500 rpm for 5 s to spread the photoresist; ii) ramp to 3000 
rpm for 50 s for a uniform coating; iii) ramp to 5000 rpm for 10 s to expel the extra 
photoresist from the edges and for evaporation of residual solvent from the 
photoresist; and iv) reduce to 500 rpm for 5 s to settle the photoresist. The 
thicknesses of the S1828 photoresist, achieved using the described spin cycles, were 
between 3.7 μm and 4.2 μm, as measured using the KLA-Tencor P-16 stylus surface 
profiler. 
Next, the samples were pre-baked in an oven for 30 minutes to 45 minutes at 
90 °C. Once cooled to room temperature, a sample was placed on a Pyrex® (Corning 6.3 Device Fabrication    195 
 
7740, 100 mm diameter, 500 μm thick) handler wafer, which was overlaid on an one-
to-one scale mask layout. This way, the sample could be approximately aligned to the 
desired heater and temperature sensor pattern; while the precise alignment was 
performed using the mask aligner (MA-6, Suss MicroTec Ltd. UK). Using the mask 
UoS-TM-CFC-M4 (see Appendix B.2.4), the typical exposure time was 20 s, with an 
exposure wavelength of 365 nm and a power density of 18 mW·cm-2. 
The exposed samples were then immersed into toluene for 1 minute. Once 
gently blown dry using a nitrogen gun, the samples were dried on a hotplate (EMS 
1000-1, Electronic Micro System Ltd. UK), at 90 °C, for 15 s. Finally, the sample was 
developed in a metal-ion-free developer, Shipley MICROPOSIT® MF®-319 (Rohm and 
Haas Ltd., UK), for between 90 s and 120 s. The samples were then immediately 
rinsed with a copious amount of DI water to stop the developer from further etching 







Figure   6.20: Oblique, cross-sectional view SEM micrograph showing the cleaved edge of the 
photoresist S1828 with a shallow undercut (dummy sample b2N02sxA). 
A typical developed S1828 photoresist exhibits a positive taper profile, as 
depicted in Figure   6.20, with a sidewall slope between 40° and 60°. A sidewall profile 
less than 90° (resulting in an overcut) is characteristic of positive tone photoresists 
[42]. However, in this case, the slope of the taper was exacerbated, probably due to 
the un-optimised exposure time and exposure depth used in the process. In 
particular, it is suspected that the depth of focus of the UV lamp was thought to be 6.3 Device Fabrication    196 
 
near to the surface of the photoresist, very likely due to a wider than expected gap 
between the mask and the sample. This is possible since some dummy samples were 
placed around the Pyrex® handler wafer to accommodate the wedge error 
compensation feature of the MA-6 mask aligner; this could have, inadvertently, 
increased the mask-to-sample gap. 
The undercut achieved using the described method is shallow, as depicted in 
Figure   6.20, but is sufficient to provide a successful lift-off, as demonstrated later. 
The mask-to-sample misalignment, in general, is acceptable and estimated to be 
between 10 μm and 20 μm (in both x- and y-direction). Figure    6.21 depicts an 
example of a typical misalignment and the edge bead effect which renders the 
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Figure   6.21: Optical microscope images of (a) sample b2P06S32, showing the extent of the mask 
misalignment; and (b) sample b2P06S33, highlighting the edge bead effect.  
The samples with patterned photoresist were then blanket deposited, using 
the e-beam evaporation (BOC Edwards Auto E500), with a nominal 300 nm thick Au 
(99.99 % pure, G4-5005-M, Testbourne Ltd., UK) and a Ti (99.995 % pure, T8-5003-
M, Testbourne Ltd., UK) of 10 nm thick as the adhesion layer. The evaporation was 
carried out without rotating the sample holder to prevent the evaporated metal from 
coating the sidewall of the photoresist. Finally, the photoresist was removed, at 120 
°C, using the Shipley SVC-175 (Chestech Ltd., UK) photoresist removal, for 30 
minutes to 60 minutes. 
Despite the shallow undercut created on the S1828 photoresist, the unwanted 
sections of the metal films were successfully lifted-off on almost all of the samples. 6.3 Device Fabrication    197 
 
Figure   6.22 depicts the three designs of the heater and the temperature sensor, after 
undergoing the lift-off step. On closer examination using the optical microscope, 
however, the edges of the lifted-off heater and the temperature sensor were observed 
to peel off in places, as depicted in Figure   6.23 (b). SEM micrographs, such as the one 
depicted in Figure   6.24, later revealed that the edges were actually curved, following 
the positive taper profile of the photoresist. It is thought that the curved edges 
should have a negligible effect in terms of performance and functionality of the 
heater and the temperature sensor, but the full extents of the consequences were not 
investigated. An optimised photolithography process, to yield an undercut profile of 
the photoresist, should eradicate the problem. Some contamination and photoresist 
residue, as depicted in Figure   6.25, was also observed and believed to be related to 
the edge bead effect, as briefly discussed in Chapter 3, §3.6.2. 
 
Figure   6.22: Digital photograph of three samples with different heater and temperature sensor 
designs fabricated using the lift-off method. From left to right: meander, spiral and coil 
configurations of 3 mm x 3 mm size. 
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Figure   6.23: Optical microscope images of (a) low (5 x) and (b) high (100 x) magnifications of 
samples b2P02S51 (total Ti and Au thickness of 443.4 nm ± 5.2 nm) with the heater and the 
temperature sensor (TS) fabricated using the lift-off method. In (b), the edge of one of the heater 
tracks is shown to have peeled off. 6.3 Device Fabrication    198 
 
The total thickness of the evaporated Ti and Au, on average, is between 1.25 
and 1.5 times thicker than the desired total thickness (10 nm of Ti and 300 nm of 
Au). The thicker metal layers inadvertently result in reduced resistance of the heater 
and the temperature sensor. Due to the directional evaporation, the thickness of the 
deposited metal was not uniform. The thickness uniformity26 ranges between 2.5 % 






Figure   6.24: Oblique, cross-sectional view SEM micrograph showing the curved edge of the Ti / Au 
metal track (of sample b2P02S43 with total Ti and Au thickness of 414.9 nm ± 5.6 nm). 












Figure   6.25: Optical microscope images, of the same regions depicted in Figure   6.21, after the lift-
off step. (a) Sample b2P06S32 (total Ti and Au thickness of 460.6 nm ± 4.8 nm), showing regions of 
unsuccessful lift-off. (b) Sample b2P06S33 (total Ti and Au thickness of 409.9 nm ± 9.6 nm), 
showing the photoresist residue due to under-development caused by edge bead effect. 
                                                           
26 Based on: 100 % x (maximum thickness – minimum thickness) / average thickness. 6.4 Test of Integrated Heater and Temperature Sensor  199 
 
6.4  Tests of Integrated Heater and Temperature 
Sensor 
The fabricated heater and the temperature sensor need to be characterised and 
calibrated for proper operation. Fundamentally, the temperature sensor is a 
resistance temperature detector whose electrical resistance changes as a result of a 
varying temperature, as briefly discussed in §  6.2.3. It is thus imperative that this 
relative change of the resistance (or the temperature coefficient of resistance (TCR)) 
is characterised for the fabricated devices, to ensure proper functionality of the 
temperature sensor. In addition, the measurement of the TCR of the heating element 
will also provide useful information for the operation of the heater. Therefore, the 
resistance of both the heater and the temperature sensor were measured as a 
function of increasing temperature, and the TCR values were extracted from the 
measured resistance-temperature curves. 
For the proof-of-concept experiments, a simple open-loop driver circuit, which 
is based on a preset voltage and current value to actuate the heating element, is 
preferred over the more complex, closed-loop feedback-controlled circuit. Based on 
the measurement of the TCR, an actuation voltage and current value can be selected 
to achieve a temperature rise, to the first approximation, in the PSi structure. Thus, 
a test was performed to calibrate this driver circuit and examine the operational 
behaviour of the heater, in comparison with the results obtained in the simulation 
(as discussed in §  6.2.3.1). 
6.4.1  Experimental Apparatus and Procedures 
To determine the TCR values of the heater and the temperature sensor, two PSi 
membrane devices (P03S72 and b2P02S51) with an integrated heater and 
temperature sensor in the meander configuration (see Figure   6.3 for the designs of 
the heater and the temperature sensor) were used. The sample b2P02S51 was 
subsequently used to determine the functionality of the heater. The sample P03S72 
has a 3 mm x 3 mm nominal membrane size, while the sample b2P02S51 has a 
membrane size of 4 mm x 4 mm. Both samples were bonded to contact connectors 6.4 Test of Integrated Heater and Temperature Sensor  200 
 
using a two part silver-filled conductive epoxy (Aremco-BondTM 556), cured at room 
temperature for over 24 hours. A tiny amount of cyanoacrylate Superglue (159-3963, 
RS Components Ltd., UK) was also applied to the back of each connector to provide 
structural bonding. The connectors were then attached to connecting wires using 
soldering, as depicted in Figure   6.26. Finally, the heater, temperature sensor and the 
connectors were then coated with nail vanish (Boots, UK) to provide electrical 
isolation. 
PSi membrane
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Water bath Sensing circuitry  
(b) 
Figure   6.27: Digital photograph of (a) sample b2P02S51 immersed in a glass specimen bottle filled 
with ~ 5 mL of DI water; and (b) the experimental setup. 6.4 Test of Integrated Heater and Temperature Sensor  201 
 
6.4.1.1  Measurement of Temperature-Dependent Resistance 
In order to obtain the most relevant information, the measurement was carried out 
in a similar way to that devised for the protein release experiment (see Chapter 7). 
Here, the device under test was immersed into a glass specimen bottle containing DI 
water (typically 5 mL), as depicted in Figure   6.27 (a). To increase the temperature, 
the bottle was placed in a water bath (JB1, Grant Instruments Ltd., UK), which can 
be controlled up to 100 °C. A type K thermocouple (SC-TT-K-30-36, Omega 
Engineering Ltd., UK) was placed near the sample, to monitor the temperature of 
the DI water, in the specimen bottle. The thermocouple was connected to a handheld 
temperature / humidity meter (Omegaette® HH314, Omega Engineering Ltd., UK) 
and the measurement was recorded in the internal memory of the meter. 
To measure the temperature-dependent resistance of the temperature sensor, 
a small excitation current is needed to drive the temperature sensor, while the 
resulting voltage needs to be monitored to obtain the resistance (by Ohm’s Law). 
Hence, a sensing circuit, as schematically depicted in Figure   6.28, was constructed. 
The sensing circuit consists of a simple constant current source (CCS) and a voltage 
amplifier [405]. The CCS was tuned to output a constant current of (1.0 ± 0.05) mA, 
which is believed to be small enough to prevent self-heating of the temperature 
sensor. The change in the voltage across the temperature sensor was then amplified 
by an operational amplifier configured in the non-inverting mode. A positive and a 
negative voltage regulator (LM7815 and LM7915, respectively) were used to regulate 
the voltage supply to the sensing circuit. The sensing circuitry was monitored by a 
NI LabVIEWTM program via a NI Data Acquisition (DAQ) Card (NI PCI-6014) using 
the 68-pin terminal block (NI CB-68LP). The NI-DAQTMmx module, which greatly 
simplifies the programming of the software, was used in developing the LabVIEWTM-
based monitoring system. 
The change in resistance of the heating element was measured concurrently 
using a digital multimeter (DM100, Digimess). Figure   6.27 (b) depicts the overall 
experimental setup for the measurement of temperature-dependent resistance. The 
measurements were performed for a range of temperatures from room temperature 
(~ 20 °C) to ~ 100 °C, with an interval of around 5 °C. For each measurement, a 6.4 Test of Integrated Heater and Temperature Sensor  202 
 
period of 5 minutes wait time was used to ensure the temperature in the specimen 
bottle reached thermal equilibrium. 
 
Figure   6.28: Schematic diagram of the sensing circuit. The regulated +15V and -15V supplies were 
connected (not shown in the schematic) to LM7815 and LM7915, respectively. 
6.4.1.2  Heater Functionality Test 
To test the functionality of the heater, a simple voltage controlled current source 
[115], as depicted in Figure   6.29, was constructed to drive the heater. A separate 
DAQ card (NI USB-6009) was used to provide a signal to enable and disable the 
driver circuit, hence turning on and off the heater. A separate power supply 
(HY3003-2, Digimess) was used to power the driver circuit, which is used to turn the 
heater on at different actuation voltages of about 3 V to 5 V. These correspond to 
current values of between ~ 0.35 A and ~ 0.56 A, which pass through the heater and 
result in Joule heating. The temperature rise was then detected using the 
temperature sensor and measured using the sensing circuit, as described previously. 
Similarly, the driver circuit was controlled and monitored by the NI LabVIEWTM 
program, based on the NI-DAQTMmx module. 
During the experiment, sample b2P02S51 was immersed into a glass 
specimen bottle containing DI water (typically 5 mL), as described previously. The 6.4 Test of Integrated Heater and Temperature Sensor  203 
 
bottle was then placed into the water bath, which was maintained at 37 °C. Both the 
sensing and the driver circuits were started with the driver circuit programmed to 
actuate the heater at predetermined periods between 0.1 s and 1 s. When the 
temperature in the bottle reached a thermal equilibrium (at 37 °C), the heater was 
turned on with actuation voltages between 3 V and 5 V. The temperature rise of the 
sample was monitored and recorded by the temperature sensor, and the temperature 
change of the DI water was recorded using the SC-TT-K-30-36 thermocouple 
attached to the Omegaette® HH314 handheld temperature / humidity meter. 
 
Figure   6.29: Schematic diagram of the heater driver circuit. 
 
6.4.2  Resistance-Temperature Curves and TCR Values 
The measured resistance of the temperature sensor and the heater were plotted 
against the temperature, as depicted in Figure    6.30 and Figure    6.31 for sample 
P03S72 and b2P02S51, respectively. From the plots the measured data could be 
fitted with a linear approximation. The TCR, α, could then be approximated by the 
equation: 
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where R0 is the initial resistance at temperature T0. The y-intercept of the linear fit 
can be approximated to be R0 (by assuming T0 of 0 °C), and α can be obtained by 
dividing the slope of the linear fit by the y-intercept. Table    6.6 summarises the 
calculated α for both samples, P03S72 and b2P02S51. Overall, the TCR values were 
calculated to be ~ 16 % to ~ 25 % smaller than the theoretical TCR of bulk gold (3.72 
x 10-3 K-1 [388]). This is expected as the TCR of a metallic thin film, firmly attached 
to a substrate, is typically lower than its bulk TCR value, primarily due to a thermal 
mismatch between the film and its substrate [406]. The stray resistance from the 
contact connectors, the conducting epoxy and the connecting wires, could have also 
contributed to the discrepancies. 
Ideally, the TCR values of the temperature sensor and the heater should be 
similar, as both should have the same thicknesses of materials (Ti / Au). In addition, 
the TCR should be independent of the geometry factor (apart from the thickness 
effect); hence, the sample P03S72 should have similar TCR values to the sample 
b2P02S51. However, from Table   6.6, it is found that the TCR values for the heater 
(2.776 x 10-3 K -1 and 3.003 x 10-3 K -1) are smaller than the TCR values for the 
temperature sensor (3.097 x 10-3 K-1 and 3.117 x 10-3 K-1), for both the samples. It is 
also observed that the temperature sensor of both samples exhibited more consistent 
TCR values as compared to the heaters. Hence, it is believed that these errors could 
be attributed to the technique used to measure the resistance. The resistance of the 
heater was measured using a direct, two-probe connection to a DMM; this introduces 
an error to the resistance measurement due to the voltage drop across the probe 
resistance which adds to the measured voltage. In contrast, the resistance of the 
temperature sensor was measured using a four-probe technique (one pair for current 
excitation and one pair for voltage sensing), hence minimising the error contributed 
by the probes. 
Temperature Coefficient of Resistance, α (x 10-3 K-1) 
Sample 
Temperature sensor (% error)  Heater (% error) 
P03S72  3.097 (16.7 %)  2.776 (25.4 %) 
b2P02S51  3.117 (16.2 %)  3.003 (19.3 %) 
Table   6.6: The calculated temperature coefficient of resistance of the temperature sensor and 
heater of samples P03S72 and b2P02S51, based on the measured data plotted in Figure   6.30 and 
Figure   6.31, respectively. The % error was calculated based on a theoretical value of 3.72 x 10-3 K-1, 
used in the simulation. 6.4 Test of Integrated Heater and Temperature Sensor  205 
 
R = 0.0224 T + 8.0508
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Figure   6.30: Plot of resistance against temperature for sample P03S72. The solid lines represent 
the experimental fits based on linear approximations (shown as equations on the plot). 
R = 0.0214 T + 7.1251





























Figure   6.31: Plot of resistance against temperature for sample b2P02S51. The solid lines represent 
the experimental fits based on linear approximations (shown as equations on the plot). 6.4 Test of Integrated Heater and Temperature Sensor  206 
 
6.4.3  Heater Performance 
The functionality and performance of the heater were evaluated for actuation 
voltages of 3 V, 4 V and 5 V, with heater on-times of 0.1 s, 0.5 s and 1.0 s. The results 
are summarised in Table   6.7. Overall, the peak temperature during the on-time of 
the heater for sample b2P02S51 was measured to exceed the simulated peak 
temperature of the meander heater (see Figure   6.5 and Table   6.4). It is believed that 
the higher deposited thickness (hence, reduced resistance) of the metal layers (as 
discussed in §  6.3.3) and the smaller than expected TCR value (as discussed in §  6.4.2) 
are the two major factors that contributed to the discrepancy.  
Peak Temperature (°C)  Actuation 
Voltage (V)  0.1 s  0.5 s  1.0 s 
Average Power 
Consumption (W) 
3 62.65  64.86  69.34  1.03 
4 71.21  78.98  85.27  1.80 
5 - -  97.22 2.82 
Table   6.7: The measured peak temperature for actuation voltages of 3 V to 5 V, with heater on-time 
of 0.1 s, 0.5 s and 1.0 s. The average power consumed, P during the heater on-time was calculated 
based on the measured voltage, V, and current, I, across the heater (P = V x I). 
Figure   6.32 depicts a plot of temperature, as measured by the temperature 
sensor and the thermocouple, over time, for an actuation voltage of 3 V, with a 
heater on-time of 0.5 s. The temperature of the device, as measured by the 
temperature sensor, reached a steady state almost instantaneously after the heater 
was turned on. The mean temperature, averaged over the heater on-time, was found 
to be 62.7 °C ± 1.2 °C. The temperature of the DI water, as measured by the 
thermocouple, barely changed over the duration of the experiment (60 s). Although 
both the measured peak temperature and the mean temperature were beyond the 
simulated value, these are still within the limit of the critical temperature (of 60 °C ± 
10 °C) assumed in the design specification (as described in §  6.2.3). Hence, a rapid 
local heating, with minimal heat dissipation to the surrounding (DI water), was 
achieved.  
A revised simulation (for a heater on-time of 0.5 s), which uses a heater 
thickness of 443 nm, a TCR value of 3.00 x 10-3 K -1 and a natural convective heat 
transfer coefficient, hc of 200, shows a good agreement with the measured peak 
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Figure   6.32: Plot of the actuation voltage (_ _ _) and the temperature, of the temperature sensor (___) 
and the thermocouple (), over time, of sample b2P02S51. The sample was actuated using 3 V 
input voltage for 0.5 s. The inset shows the temperature variation of the thermocouple over the 
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Figure   6.33: Plot of the temperature over time for an actuation voltage of 3 V, for heater on-time of 
0.1 s, 0.5 s and 1.0 s. The dashed blue line represents a revised simulation using COMSOL, with an 
actuation voltage of 3 V and a heater on-time of 0.5 s, using a heater thickness of 443 nm, a TCR 
value of 3.00 x 10-3 K-1 and a natural convective heat transfer coefficient, hc of 200. 6.5 Conclusion    208 
 
an adaptive smoothing method27. The mean temperature was observed to increase, 
as summarised in Table   6.7. The simulated temperature reached ~ 40 °C after the 
heater was turned off; this is well above the ~ 37 °C measured. It is suspected that 
the value of hc used in the simulation may not be accurate. In fact, different values of 
hc used in the simulation resulted in different heat transfer rates to the 
surroundings, and hence affected the maximum transient temperature (see 
Appendix D.4 for detailed results). Therefore, it may be necessary to empirically 
determine the value of hc in order to validate the simulation. 
6.5  Conclusion 
The successful design and fabrication of an improved drug delivery prototype device, 
based on a silicon membrane substrate, was described. The silicon membrane, 
fabricated using an anisotropic wet chemical etching process, exhibited an average 
thickness of 46.6 μm ± 0.5 μm. A modified NSL technique, with an improved RIE of 
silicon using a STS LPX Pegasus system (see Figure   6.15 for detailed process steps) 
was used to realise a quasi-ordered, cylindrical PSi structure, at the back-side of the 
silicon membrane, to be used as the drug reservoir. Nanospheres with a mean 
diameter of 200 nm were used, thus resulting in the interpore distance of ~ 200 nm 
of the eventual PSi structure. An optimised O2 RIE etch time of 60 s was primarily 
used to reduce the size of the nanospheres. With a typical O2 gas flow rate of 5 sccm, 
a pressure of 10 mTorr and an RF power of 100 W, the nanospheres were reduced to 
a diameter of 86 nm ± 3 nm on average, which is in good agreement with the 
theoretical value of 88 nm (based on an etch rate of 1.9 nm·s-1). To improve the 
success of the removal of nanospheres, a 10 nm thick Cr layer and an ultrasonication 
time of < 60 s, were used. 
By exploiting the LF process and the parameter ramping feature of the STS 
LPX Pegasus system, the fabricated PSi structures exhibited mean pore diameters 
between ~ 75 nm and ~ 120 nm, with pore depths in the range of ~ 330 nm to 500 
nm. The theoretical porosity was thus calculated to be between 12.8 % and 32.6 %. 
                                                           
27 Implemented using a Microsoft® Office Excel© macro ELSauto of MacroBundle, developed by R. de Levie. 
http://www.bowdoin.edu/~rdelevie/excellaneous (last accessed Jul. 2009). 6.5 Conclusion    209 
 
The aspect ratio was found to be 5:1, at best; however, the parameters used in the 
STS LPX Pegasus system, as detailed in Table   6.5, could be optimised to achieve 
higher aspect ratios. This novel nanofabrication technique is versatile and various 
other nanostructures, such as nanopillars (see Appendix E, §E.6) and nanowires (see 
Appendix E, §E.7), have been successfully fabricated. It is a “materials general” 
technique and has been successfully demonstrated on both p-type and n-type silicon 
substrates (both substrates with resistivity of 1 – 10 Ω·cm); ordered PSi with 
cylindrical pores in 100 nm diameter range has been difficult to achieve using 
conventional electrochemical etching method. One limitation of this technique would 
be the possible non-uniformity in the pore diameter and the pore depth due to 
inconsistent micro-loading and varied aspect ratios as a result of the intrinsic defects 
introduced by the nanosphere deposition method. 
An integrated heater and temperature sensor, fabricated at the front-side of 
the silicon membrane, is envisaged to provide the electro-thermal actuation by 
rapidly heating the PSi structure, for a short time, to assist the desorption of the 
therapeutic agents into the environment (human body). Three configurations of the 
heater and temperature sensor were designed, as depicted in Figure   6.3, each with 
different sizes to accommodate the three sizes of the membrane. The heater and the 
temperature sensor were fabricated using the lift-off method described by Steps (l) to 
(n) in Figure   6.8. The total thickness of the evaporated Ti and Au was found to be on 
average 1.25 to 1.5 times thicker than the desired total thickness (10 nm of Ti and 
300 nm of Au). The uniformity of the thickness varied between 2.5 % and 6.5 % due 
to the directional evaporation. This resulted in a reduced resistance of the heater 
and the temperature sensor, and a ~ 16 % to 25 % (detailed in Table   6.6) reduction in 
TCR values (as compared to the bulk TCR value). Consequently, by using an 
actuation voltage of 3 V and a heater on-time of 0.5 s, the meander heater exhibited 
a peak temperature of 64.86 °C, which is well beyond the simulated value of 55.02 °C 
(see §  6.2.3.1 for details). A revised simulation using the measured thickness of 443 
nm and a calculated TCR value of 3.00 x 10-3 K -1 (of sample b2P02S51), however, 
demonstrated a good agreement with the experimental result. Hence it is verified, 
both by experiment and simulation, that the actuation voltage of 3 V and a heater 
on-time of 0.5 s is sufficient to provide a rapid local heating (up to 60 °C ± 10 °C) 
with minimal heat dissipation to the surrounding environment.  
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Chapter  7 
Protein Loading and Passive 
Release using a Porous Silicon 
Membrane Drug Delivery Device 
7.1  Introduction 
To date, the release of a drug using a porous silicon (PSi) structure has been 
demonstrated from PSi particles [54, 55], PSi powder [215] or PSi pieces [216] (see 
Chapter 2, §2.3.2 for a literature review); however, there are limited reported studies 
on using a PSi structure that is integrated on a microdevice, for the delivery of 
drugs. In this chapter, a “proof-of-concept” investigation of drug loading and release, 
using the drug delivery device fabricated as described in Chapter 6, is presented. The 
microdevice incorporates a nanostructured PSi on a thin membrane (as the drug 
reservoir) and an integrated heater and temperature sensor (for a controlled, active 
release using electro-thermal actuation). 
In this study, an attempt to achieve the loading and the passive release 
(without using the electro-thermal actuation) of a model protein, using the fabricated 
PSi membrane prototype device, is demonstrated. Fluorescently labelled model 
protein, Papain (see §  7.2.1 for more details) which has a similar molecular weight to 
the protein of interest (bone morphogenetic protein 2) was loaded into the PSi 
membrane device. Fluorescence microscopy and scanning electron microscopy (SEM) 7.1 Introduction    211 
 
were used to investigate the efficacy of the loading strategy. The protein was then 
released from the PSi membrane, in vitro, at different temperature conditions. The 
concentrations of the fluorescently-labelled Papain released were evaluated at single 
time points and interpolated from a plot of fluorescence emission as a function of a 
series of standards. 
7.1.1  Methods of Drug Loading into Porous Silicon 
The loading of model proteins or drugs into PSi structures can be performed using 
one of the three commonly used approaches: i) by covalent attachment [55], ii) by 
physical trapping [55] and iii) by spontaneous adsorption [54, 55]. Covalent 
attachment of drug molecules, to the inner pore walls of the PSi structure, is the 
most robust approach for attaching the drug payload to the porous matrix; the 
release of the drug payload can only be achieved by breaking the covalent bonds or 
by the degradation of the porous matrix [55]. However, this approach adds a level of 
complication for the fabricated PSi membrane device due to a need to chemically 
functionalise inside the pores without trapping secondary reaction products. The 
physical trapping approach requires the drug molecules to be trapped into the pores 
first. The oxidation process, used in the physical trapping approach, merely shrinks 
the pores and thus “locks” the drug molecules in place [55].  
A more straight-forward and hence commonly used method is the 
spontaneous adsorption of the drug molecules into a porous matrix [54, 55]. This can 
be achieved by a simple immersion of the porous matrix (typically in powder or 
particulate form) into a dissolved drug solution. Loading of model drugs, including 
ibuprofen and gentamicin, and human serum albumin, have been demonstrated in 
mesoporous silica, such as SBA-15 powder [407, 408] and MCM-41 particles [409, 
410], and PSi layers [411] and PSi particles [70, 71]. This method may require a 
controlled, but thorough, washing step to remove the fractions of drugs from the 
surface. Alternatively, a precise amount of the drug solution can be introduced into 
the porous structure by impregnation [54]. The drug solution is then allowed to 
infuse, via capillary action, into the pores; this is also known as the incipient wetness 
method [54]. PSi layers [216, 412] have been loaded with model protein or 
fluorescent dye this way. Both the immersion and impregnation techniques can be 
typically performed at room temperature and at favourable chemical (such as pH 7.2 Protein Labelling    212 
 
level) environments. The surface of the PSi structure can be also be chemically 
modified [211, 212] to enhance the adsorption of the drug molecules [54]. A suitable 
drying method is also important and methods, such as freeze drying [215], vacuum 
drying [69, 216, 408] or thermal drying [70, 409], have been used. 
7.2  Protein Labelling 
For selective optical detection and quantitative analysis, proteins are typically 
fluorescently labelled. The conjugation of the fluorescent probes to proteins is 
achieved by the formation of a covalent bond with the amine residues on the side 
chains of the proteins [413].  
In practice, the labelling reaction is also determined by a number of factors, 
including the pH value of the buffer solution, the concentration of the protein, the 
temperature of the reaction mixture and the time of reaction [413, 414]. Most protein 
labelling protocols are thus designed to provide reproducibility with an optimum 
molar reaction ratio, MR (or simply, the number of moles of labelling reagent to be 
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where MW, C and V represent the molecular weight (in Dalton), concentration (in 
mg·mL-1) and volume (in mL), respectively, of the fluorophore and protein, as 
denoted by the subscript of F and P, respectively. A favourable MR can better control 
the extent of conjugation and hence ensure optimum labelling yield. Over-labelling of 
protein may result in loss of protein activity and specificity, aggregation and 
precipitation and quenching of fluorophores [413]; while, in contrast, too few labels 
results in weak fluorescent signals, and thus the protein is difficult to detect.  7.2 Protein Labelling    213 
 
7.2.1  Model Protein: Papain 
The integrated drug delivery device is intended for the use of a sustained and 
controlled release of osteoinductive growth factors, specifically, bone morphogenetic 
protein 2 (BMP-2), to promote bone regeneration and repair (see Chapter 1, §1.1.1 
for more details). For the PSi membrane prototype device, as a proof of concept, a 
model protein was used which has similar molecular weight to BMP-2. BMP-2 has a 
molecular weight of about 26 000 Dalton [27], with dimensions of 7 nm x 3.5 nm x 3 
nm [28]. 
A few model proteins were considered, but Papain, which is a cysteine 
protease typically used in the enzymatic synthesis of amino acids and peptides, 
appeared to be the best candidate. Papain is a single chain polypeptide with 212 
residues [415] folded into two distinct parts which are separated by a cleft [416]. It 
has a molecular weight of 23 406 Dalton [415] and an approximate dimensions of 4.8 
nm x 3.6 nm x 3.6 nm [416]; both the molecular weight and dimension are similar to 
the BMP-2. In its native form (without activator), Papain exhibits low activity and is 
remarkably stable at high temperatures [416], hence making it suitable for this 
study. Papain is also readily soluble in water, which makes it more straight-forward 
to work with. In addition, it is inexpensive, compared to BMP-2, and hence is 
available in a larger quantity for experimental trials. Drug loading and release from 
PSi powders [215] or PSi pieces [216] have been demonstrated using Papain as a 
model drug. Table   7.1 highlights some of the properties of Papain. 
 
Property Typical  Value  Reference 
Molecular Weight, MW  23 406 Dalton  [415] 
Percent Absorption Coefficient (1 % or 
10 mg·mL-1 solution), ε1% at 278 nm  
25 L·g-1·cm-1 
[417] 
Molar Absorption Coefficient, ε  58515 L·mol-1·cm-1 calculated 
Optimal pH for activity  6.0 to 7.0  [418] 
Optimal temperature for activity  65 °C  [419] 
Table   7.1: Some physical properties and kinetics of Papain. The molar absorption coefficient was 
calculated as 0.1 x ε1% x MW. 7.2 Protein Labelling    214 
 
7.2.2  Methods and Procedure 
A typical protocol of protein labelling involves the preparation of the protein and the 
fluorescent dye, the incubation and conjugation of the fluorescent dye with the 
protein and, finally, the separation of non-reacted fluorescent dye from the mixture. 
For the labelling of Papain, the 5(6)-Carboxyfluorescein N-
hydroxysuccinimide (NHS) ester (FLUOS) was preferred as the fluorescent dye. 
FLUOS is one of the derivatives of fluorescein isothiocyanate (FITC), which is more 
widely used due to its higher quantum efficiency [420]. However, FLUOS has an 
advantage over FITC because the NHS esters react with the primary amino groups 
in proteins to form more stable carboxamide bonds as opposed to the thiol-urea bond 
formed by FITC [421]. These carboxamide bonds are relatively more resistant to 
hydrolysis [420]. Some of the properties of FLUOS are summarised in Table   7.2. 
Property Typical  Value 
Molecular Weight, MW  473.4 Dalton 
Molar Absorption Coefficient, ε  70 000 L·mol-1·cm-1 
Excitation Wavelength, λEX  494 nm 
Emission Wavelength, λEM  518 nm 
Optimum pH for labelling  7.0 to 9.0; 8.5 for 50 mM borate buffer 
Table   7.2: Some physical properties of FLUOS (adapted from [422]). 
The lyophilised Papain powder (P4762, Sigma-Aldrich Company Ltd., UK) 
and the lyophilised FLUOS powder from a Roche Protein Labelling kit (1386093, 
Roche Applied Science) were used as received. All the solvents were of reagent grade 
and were used without further purification, except for dimethylsulfoxide (DMSO), 
which was filtered using a 0.2 μm membrane filter. The de-ionised (DI) water was 
from ELGA® PURELAB Ultra system with a typical resistivity of 18.2 MΩ·cm and a 
pH value of 7.0. 
Papain was prepared by first dissolving 2.7 mg of the lyophilised Papain into 
270 μL of DI water (as the buffer solution). Then, 100 μL of the solution was diluted 
with 900 μL of DI water to make up 1 mL of Papain stock solution of a concentration 
of 1 mg·mL-1. Next, 1 mg of the lyophilised FLUOS powder was reconstituted with 50 
μL of filtered, analytical grade DMSO to produce a FLUOS solution with a 7.2 Protein Labelling    215 
 
concentration of 20 mg·mL-1 [421]. Papain has 10 side chains of lysine within its 
amino acid chains [415], which could be available for conjugation to FLUOS. Hence, 
a fluorophore to protein molar ratio of 10:1 was selected for the conjugation reaction. 
10.11  μL of the reconstituted FLUOS solution (concentration of 20 mg·mL-1), as 
calculated using equation 7.1, was used to react with 1 mL of the Papain stock 
solution (concentration of 1 mg·mL-1). The mixed solution was then incubated for 2 
hours, in the dark, at room temperature, with gentle stirring. 
Next, the free, unconjugated fluorophores were removed from the conjugation 
mixture. Instead of using the column separation technique, as suggested by the 
product information sheet [421], dialysis was preferred. Dialysis is the diffusion of 
molecules through a semi-permeable membrane, from the higher concentration side 
to a lower concentration side of the membrane, in an attempt to achieve equilibrium 
in concentration. A Slide-A-Lyzer® dialysis cassette (66382, Thermo Science Pierce) 
with a molecular weight cut-off (MWCO) of 10,000 Dalton and capacity of 0.5 mL to 3 
mL, was used. The conjugated FLUOS-Papain mixture was dialysed over 4 changes, 
against 1 L of DI water. The purified FLUOS-labelled Papain was stored in the 
freezer until use. 
7.2.3  Protein Concentration and Labelling Efficiency 
In the quantitative determination of protein concentration, ultraviolet / visible (UV / 
Vis) absorption spectrophotometry is widely used in conjunction with colorimetric 
protein assays, such as the Lowry assay, the Bradford assay, the Biuret assay or the 
bicinchoninic acid assay [423-425]. The most straight-forward method of quantifying 
proteins, however, is to measure the UV absorbance of the protein solution, typically 
at the wavelength of 280 nm or 205 nm [425, 426]. Most proteins have intrinsic 
absorbance at ~ 280 nm due to the aromatic amino acids, such as the tryptophan, 
tyrosine, phenylalanine and histidine [424]. Sometimes, the fraction of tryptophan or 
tyrosine residues of a protein can be too low for a measurable absorbance at 280 nm. 
In this case, measuring the absorbance at 205 nm is generally used, since this 
indicates the absorbance due to the peptide bonds of a protein [426]. 
In order to determine the efficiency of the labelling of Papain with FLUOS 
and to establish the concentration of Papain in the recovered mixture after the 7.2 Protein Labelling    216 
 
dialysis, a UV / Vis spectrophotometer (Varian Cary® 50) was used. For the 
measurement, 200 μL of the recovered, dialysed FLUOS-labelled Papain solution, 
was first diluted with 800 μL of DI water (5-fold dilution). About 120 μL of the 
diluted sample was dispensed, by using a pipette, into a cleaned cuvette (105.253 QS, 
Hellma Ltd., UK). The absorbance of the diluted FLUOS-labelled Papain solution 
was measured, between the wavelength of 200 nm and 800 nm, with a scan speed of 
4800 nm·s-1, and recorded using the software Cary WinUV. Two sets of 
measurements, using two different diluted samples (same dilution factor), were 
performed, with each run repeated 5 times. A typical baseline-corrected absorption 
spectrum of the 5-fold diluted FLUOS-labelled Papain solution is depicted in Figure 
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Figure   7.1: A typical corrected absorption spectrum of the 5-fold diluted FLUOS-labelled Papain (a. 
u. denotes arbitrary unit). 
The concentration of the FLUOS-labelled Papain, recovered from the dialysis 
process, was determined; the absorbance value at 280 nm, A280, was obtained from 
the UV / Vis spectrophotometry of the 5-fold diluted solution. Due to the presence of 
the fluorophore (FLUOS), a correction factor, CF of 0.255, deduced from [421], was 
introduced into the typical Beer-Lambert’s equation. The concentration of Papain (in 













495 280    (   7.2) 
where εPapain and MWPapain are the molar absorption coefficient and the molecular 
weight of Papain, respectively; l is the path length of the cuvette, A495 is the 
absorbance value at 495 nm (of FLUOS) and DF is the dilution factor. The εPapain 
value of 58 515 L·mol-1·cm-1 (see Table   7.1) was used in the calculation by assuming 
that the absorbance of Papain was not altered by the conjugation. The average 
concentration of Papain, based on the baseline-corrected spectra, was calculated to 
be (0.218 ± 0.003) mg·mL-1. 
The molar fluorophore to protein (F/P) ratio of the dialysed FLUOS-labelled 
P a p a i n  w a s  t h e n  d e t e r m i n e d  b y  t a k i n g  the ratio of the molar concentration of 
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where  εFLUOS is the molar absorption coefficient of the free FLUOS. The average 
molar F/P ratio, based on the baseline-corrected spectra, was calculated to be 0.875 ± 
0.011; this implies a labelling efficiency of less than 8.8 % since the initial molar 
reaction used was 10:1. Some of the Papain molecules may not be labelled and this 
may result in a low estimate to the actual concentration of Papain when analysed 
using spectrofluorimetry. 
7.3  Protein Loading 
7.3.1  Methods and Procedure 
The purified FLUOS-labelled Papain was loaded into selected PSi membrane devices 
using the impregnation technique with the vacuum drying method (see §  7.1.1), this 
is similar to the approach described by Prestidge et al. [216]. The devices were first 
pre-wetted in methanol (at least overnight), in order to enhance the hydrophilicity of 7.3 Protein Loading    218 
 
the porous surface. Prior to the loading process, the methanol was replaced with DI 
water, in a series of steps of reducing methanol concentration, to preserve the 
hydrophilicity of the devices and to avoid building up of air bubbles which could be 
problematic during the loading process. The devices pre-wetted in methanol were 
first immersed into a 1:3 DI water:methanol solution for 2 hours, with gentle 
stirring. Then the devices were immersed into a 1:1 DI water:methanol solution, 
followed by a 3:1 DI water: methanol solution, each for 2 hours while being gently 
stirred. Lastly, the devices were individually placed into separate glass specimen 
bottles filled with ~ 5 mL DI water. The devices were kept in the bottles for at least 1 
hour prior to the protein loading process.  
During the loading process, the devices were placed, one at a time, in a 
vacuum chamber of a mini sputter-coater (Polaron SC7620, Quorum Technologies 
Ltd., UK) while retaining the wetness. Typically, either 2.5 μL or 5.0 μL of FLUOS-
labelled Papain solution was carefully dispensed, using a pipette, onto the centre of 
the membrane cavity. The chamber was then closed and the vacuum pump was 
started. The aqueous solution would be slowly evaporated due to the vacuum, which 
typically takes about 5 minutes of vacuum pumping. The process was completed 
when the pressure finally reached 3 x 10-2 mbar. The devices were then examined by 
fluorescence microscopy and SEM to investigate the extent of the loading process. 
7.3.2  Analysis of Papain Loading 
Some of the membranes were observed to crack or break into pieces, during the 
initial stages of the vacuum drying process. The PSi membrane device was attached 
to the sample holder, which was merely a SEM stub, with carbon adhesive tape, 
hence creating a gap due to the finite thickness of the tape. Any water droplets 
trapped between the gap of the device and the sample holder, could have introduced 
additional stress to the weak-point (such as at the pinholes, see Chapter 6, §6.3.1.1) 
of the membrane, hence causing the cracks on the membrane. 
Quantifying the extent of drug loading into a porous matrix is not always 
straight-forward; it is difficult to distinguish between the fraction of drug on the 
surface of the porous structure and the fraction impregnated into the pores. In an 
attempt to investigate the efficiency of the loading process, the PSi membrane 7.3 Protein Loading    219 
 
devices loaded with FLUOS-labelled Papain, were examined using an inverted 
fluorescence microscope (Axio Observer.Z1, Carl Zeiss) and a SEM (LEO 1455VP). 
The fluorescence microscope is fitted with a monochromatic charge coupled camera 
(1388 x 1040 pixels, AxioCam HR3, Carl Zeiss) for image acquisition and equipped 
with a 100 W mercury arc lamp (HBO 100, Carl Zeiss). The Zeiss 09 filter set 
(488009-9901-00, Carl Zeiss), with a band pass between 450 nm and 490 nm for the 
excitation, a dichroic beam splitter at 510 nm and a long pass filter with a cut-off at 
515 nm for the emission spectrum, was used. The accompanied software, AxioVision 
4.6.3, was used for image acquisition and image processing. 
In general, a broad-ring pattern, as depicted in the SEM micrograph of 
Figure   7.2, could be observed on most of the devices after the loading process. The 
formation of such a ring pattern is a common phenomenon during drying from the 
receeding meniscus of aqueous solutions, including biological polyelectrolyte 
solutions [427]. A SEM micrograph, as depicted in Figure   7.3, confirms the formation 






Figure   7.2: Plane-view SEM micrograph of device b2P06S43, imaged in low magnification, showing 
almost the entire area of the PSi membrane surface. The fluorescence microscope images (with 
false colour) were acquired at the respective boxed areas of the device, highlighting the present of 






Figure   7.3: Plane-view SEM micrographs of device b2P06S63 after the protein loading process, 
clearly demonstrate the present of FLUOS-labelled Papain on the surface of the PSi membrane. 











Figure   7.4: (a) Fluorescence microscope image (with false colour); and (b) its corresponding plane-
view SEM micrograph at the boxed area, of device P03S32, after several washes in DI water. The 
inset (c) depicts a magnified view of the boxed area in (b). 7.4 Passive Release of Protein    221 
 
In an attempt to remove the weakly surface bound Papain, device P03S32 
(see Appendix E, §E.1 for additional SEM micrograph) which was loaded with 2.5 μL 
of FLUOS-labelled Papain solution, was washed several times under a stream of 
running DI water. The combined SEM-fluorescence microscopy, as depicted in Figure 
  7.4, of the device indicates a significant reduction in the extent of unspecific binding 
of FLUOS-labelled Papain on the surface of the PSi membrane. Some of the protein 
was observed over the pores, as shown by the arrows in Figure   7.4. However, it was 
not easy to establish if any of the protein was trapped within the pores.  
Fluorescence microscopy provides a good indication of the distribution of 
FLUOS across the sample; areas where the fluorescent signals are high indicate a 
relatively high concentration of FLUOS-labelled Papain. However, the fluorescence 
microscope does not quantify the amount of the detected Papain, nor is it possible to 
determine if the FLUOS-labelled Papain was indeed inside the ~ 100 nm diameter 
pores or just attached to the surface. By using the SEM, the FLUOS-labelled Papain 
could be easily detected on the surface. 
7.4  Passive Release of Protein 
7.4.1  Methods and Procedure 
To investigate the release of the loaded FLUOS-labelled Papain at different 
temperature conditions, three PSi membrane devices, with the characteristic of the 
PSi structure as summarised in Table   7.3, were used. The sample b2P06S51 cracked 
and broke into two during the protein loading process, hence only half of the chip 
was used. The sample b2N07S51 does not have the PSi structure and was used as a 
control. The passive release at two temperature conditions was performed: one at 37 
°C, to simulate the conditions of body temperature and the other at 60 °C, to 
replicate an elevated temperature caused by the actuation of the integrated heater. 
Firstly, in an attempt to remove the FLUOS-labelled Papain attached to the 
surface, the PSi membrane devices were leached at 37 °C for 24 hours. Here, ~ 5 mL 
of DI water was filled into a glass specimen bottle. A PSi membrane device, with pre-7.4 Passive Release of Protein    222 
 
loaded FLUOS-labelled Papain, was then immersed into the DI water, with the side 
containing the PSi structure (the back-side) facing up. The specimen bottle was 
capped and wrapped with aluminium foil to prevent photobleaching of the 
fluorophores. The bottle was then put in a water bath (JB1, Grant Instruments Ltd., 
UK) and subjected to a constant temperature of 37 °C. After 24 hours, the specimen 
bottle was removed from the water bath and the device was rinsed and dried. 
PSi characteristic 
Device 





b2P06S51  111 nm ± 7 nm 
545 nm ± 32 nm 
(inclusive of 
SiO2 hard mask) 
5.0 
~ Half chip (~ 2 mm by 4 
mm membrane size); SiO2 
hard mask still intact 
b2N07S62  112 nm ± 10 nm  340 nm ± 36 nm  2.5 
Full chip (4 mm by 4 mm 
membrane size); SiO2 hard 
mask removed 
b2N07S51  Without PSi structure  5.0 
Full chip (4 mm by 4 mm 
membrane size) with SiO2 
layer; used as control 
Table   7.3: The characteristics of the devices used in the protein release experiments (see Appendix 
E, §E.2 and §E.3 for SEM micrographs of b2P06S51 and b2N07S62, respectively). 
The same procedure was used for the passive release at 37 °C. The leached 
PSi membrane devices were individually immersed into glass specimen bottles filled 
with ~ 5 mL of DI water. The bottles were placed into the water bath (set at 37 °C) 
and the passive release was carried out for 24 hours. After that, the specimen bottle 
was removed from the water bath. The device was rinsed with 1 mL of DI water with 
the fraction collected into the glass specimen bottle. After drying with a nitrogen 
gun, the PSi membrane device was inspected under a fluorescence microscope. 1 mL 
of the solution in the specimen bottle was collected for later analysis using the 
spectrofluorimetry. The devices were then placed in new, DI water-filled (~ 5 mL), 
glass specimen bottles and the release process was repeated for another 24 hours, 
but with the water bath set at 60 °C. Similarly, after 24 hours, the devices were 
rinsed with 1 mL of DI water, dried and inspected, while 1 mL of the solution in the 
specimen bottle was collected for further analysis. 
7.4.1.1  Quantification of Released Protein 
The concentration of FLUOS-labelled Papain, released in the passive release 
experiments, was expected to be very low; hence a more sensitive technique than the 7.4 Passive Release of Protein    223 
 
UV / Vis spectrophotometry was required to determine the concentration. Hence, the 
spectrofluorimetry or fluorescence spectroscopy technique, based on the fluorescence 
emission of the conjugated FLUOS, was used.  
A standard curve of fluorescence emission intensity, as a function of 
concentration, was first obtained. Here, the remainder of the 5-fold diluted FLUOS-
labelled Papain solution, previously used in the UV / Vis spectrophotometry 
measurement (see §  7.2.3), was used as the stock solution for a series of dilutions (up 
to 50 000-fold dilution). To measure the fluorescence intensity of the emission 
spectra, a luminescence spectrometer (PerkinElmer® LS-50B), was used. Typically, ~ 
55  μL of the diluted FLUOS-labelled Papain solution was dispensed, by using a 
pipette, into a cleaned, 3-window, fluorescence quartz cuvette (105.254 QS, Hellma 
Ltd., UK). An excitation wavelength of 495 nm was used; while the emission 
wavelength was scanned from 505 nm to 605 nm, to obtain the fluorescence emission 
spectrum. The width of the excitation and emission slits was fixed at 5.0 nm and 5.5 
nm, respectively. The spectrum was typically recorded at 20 °C, using the software 
FL WinLabTM, at a scan speed of 50 nm·min-1. 
The fractions of FLUOS-labelled Papain solution, collected from the passive 
release experiments, were first freeze-dried and then reconstituted with 100 μL of DI 
water. The fluorescence emission spectrum of the concentrated FLUOS-labelled 
Papain was then obtained, using the same procedure and parameters as described 
above. The concentration of the FLUOS-labelled Papain was then deduced from the 
standard curve. 
7.4.1.2  Spectrofluorimetry Standard Curve 
For spectrofluorimetric determination of protein concentration, the area under the 
fluorescent emission spectrum was computed to provide the total emission intensity, 
using the widely-used Simpson’s rule of numerical integration method [428]. The 
composite Simpson’s rule is given as: 
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where I(λ) is the intensity curve within an interval [λa, λb] which is split up to n sub-
intervals, with n an even number; and λi = λa + ih for i = 0, 1, …, n–1, n with h = (λb 
– λa) / n. The area under the curve was computed for wavelengths between 510 nm 
and 600 nm, with 180 sub-intervals (λ0 = λa = 510 nm, λn = λb = 600 nm, n = 180, h = 
0.5). 
The concentration of the diluted FLUOS-labelled Papain was deduced from a 
stock concentration of 0.218 mg·mL-1 (based on the baseline-corrected calculation, as 
discussed in §  7.2.3). Based on the uncorrected emission spectra, a standard curve, as 
depicted in Figure   7.5, was produced. The standard curve could be best fitted with a 
linear fit, with a slope of 2.12 and a y-intercept of 14.81, and this was used to 
approximate the concentration of the FLUOS-labelled Papain released. 
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Figure   7.5: The standard curve of the fluorescence emission intensity of FLUOS-labelled Papain, of 
various concentrations, excited at 495 nm. 
7.4.2  Passive Release of Papain 
The in vitro passive release of the FLUOS-labelled Papain, of the three devices, was 
performed at 37 °C and 60 °C, over 24 hours. The fluorescence microscopy technique 
was used to provide a rapid, qualitative comparison and estimation of the extent of 
the Papain released in the experiments. Figure   7.6 depicts a series of fluorescence 7.4 Passive Release of Protein    225 
 
microscope images of device b2N07S62 acquired after the protein loading process, 
the leaching process, and the passive release at 37 °C and at 60 °C. By using the 
AxioVision software, the mean intensity was computed from the gray scale 
histogram of the acquired 14-bit raw image (16384 gray levels, 0 being lowest 
intensity, 16383 being the highest intensity). Figure   7.6 (a) shows a low mean 
intensity (241.1) due to a much shorter exposure time (of 7.2 ms compared to ~ 38 ms 
for others) used during the image acquisition. After the leaching process, a 
significant reduction in fluorescence signal was observed visually, as depicted in 
Figure   7.6 (b). It is therefore postulated that most of the weakly surface bound 
FLUOS-labelled Papain was removed by the leaching process. After the passive 
release at 37 °C and at 60 °C, the fluorescence microscope images, as depicted in 
Figure   7.6 (c) and (d) respectively, demonstrated a decrease in the mean intensity as 
100 m μ
 
(a) After loading; exposure time = 7.2 ms; mean 
intensity = 241.1 
100 m μ
 
(b) After leaching, exposure time = 36.8 ms; 
mean intensity = 393.2 
100 m μ
 
(c) After release in 37 °C; exposure time = 38.8 
ms; mean intensity = 245.7 
100 m μ
 
(d) After release in 60 °C; exposure time = 38.8 
ms; mean intensity = 207.6 
Figure   7.6: Fluorescence microscope images (with false colour) of device b2N07S62 after (a) the 
loading process; (b) the leaching process; (c) the passive release in 37 °C and (d) the passive release 
in 60 °C. The images were acquired at approximately the same area of the sample, with exposure 
times of (a) 7.2 ms; (b) 36.8 ms and (c) and (d) 38.8 ms. 7.4 Passive Release of Protein    226 
 
compared to Figure   7.6 (b) (after leaching), although they appeared similar visually. 
The small decrease in the mean intensity suggests that a marginal amount of Papain 
was released during both the passive release at 37 °C and at 60 °C. 
The aqueous fraction of FLUOS-labelled Papain collected from the release 
experiments was quantitatively determined using the spectrofluorimetry (as 
discussed in §  7.4.1.1). A typical, uncorrected fluorescence emission spectrum, 
obtained using the spectrofluorimetry, is depicted in Figure    7.7. The fluorescence 
emission was excited at a wavelength of 495 nm, with a Stoke shift anticipated to be 
between 10 nm and 13 nm (emission peak around 515 nm and 518 nm). As depicted 
in  Figure    7.7, the majority of the fraction of FLUOS-labelled Papain, from the 



















































Figure   7.7: Plot of the fluorescence emission intensity against the wavelength, excited at 495 nm, of 
device b2N07S62, after the passive release experiments in 37 °C () and 60 °C () for 24 hours. 
The concentration of the released FLUOS-labelled Papain was interpolated 
from the standard curve depicted in Figure   7.5. The interpolated concentration was 
then corrected as the measurement was performed using a more concentrated 
fraction, obtained after reconstitution of the freeze-dried Papain. The results are 
summarised in Table   7.4. The absolute quantity of FLUOS-labelled Papain was then 
estimated, based on a total volume of 6 mL (5 mL used in the specimen bottle and 1 7.4 Passive Release of Protein    227 
 
mL from the rinsing step), and summarised in Table    7.5. The amount of Papain 
released was significantly less than the estimated amount of Papain loaded into the 
PSi membrane. This is expected since the majority of the Papain, very likely bound 
to the surface of the PSi membrane, was removed during the leaching process (as 
depicted in Figure   7.6 (b)). However, importantly, it is clear, from both Table   7.4 and 
Table   7.5, that the passive release of Papain appeared to be enhanced at 60 °C, as all 
three devices, including the control, were found to have an increased amount of 
released Papain. Interestingly, the percent of Papain released (see Table   7.5), both at 
37 °C and at 60 °C, from the device with nanostructured PSi (b2P06S51 and 
b2N07S51), was relatively higher (> 5.2 %) than that obtained from the control 
device (< 3.5 %), which was without any PSi structure. Therefore, it is believed that 
the release profile from devices b2P06S51 and b2N07S51 are heterogeneous; Papain 
molecules that were bound on the surface and trapped inside the pores, both 
contributed to the release profile. It is postulated, based on the percent of Papain 
released, as summarised in Table   7.5, that the nanostructured PSi indeed enhances 
the release of Papain. 
Interpolated concentration (ng·mL-1) 
Device PSi  characteristics 
At 37 °C  At 60 °C  Difference 
b2P06S51 
Pore width: 111 nm ± 7 nm 
Pore depth: 545 nm ± 32 nm (include SiO2) 
Membrane size: ~ 2 mm x 4 mm 
4.851 5.303  0.452 
b2N07S62 
Pore width: 112 nm ± 10 nm 
Pore depth: 340 nm ± 36 nm 
Membrane size: 4 mm x 4 mm 
4.699 8.284  3.585 
b2N07S51 
Without PSi structure 
Membrane size: 4 mm x 4 mm 
3.226 6.439  3.213 
Table   7.4: The concentration (in ng·mL-1) of the FLUOS-labelled Papain obtained from the passive 
release experiments. The concentration was interpolated from the standard curve in Figure   7.5 and 
divided by 10 to take into account the concentration factor. 
Estimated Papain released (ng) 
Device 




b2P06S51  29.11 (5.3 %)  31.82 (5.8 %)  2.71  545* 
b2N07S62  28.20 (5.2 %)  49.71 (9.1 %)  21.51  545 
b2N07S51  19.36 (1.8 %)  38.64 (3.5 %)  19.28  1090 
Table   7.5: The estimated absolute quantity (in ng) of the FLUOS-labelled Papain obtained from the 
passive release experiments. The percent (%) released was based on the estimated Papain loaded 
into the device (see Table   7.3). * Device b2P06S51 was broken during the loading process; only half 
of the amount loaded was assumed in the calculation. 7.5 Conclusion    228 
 
7.5  Conclusion 
The proof of concept of using the fabricated PSi membrane device, for drug delivery, 
was demonstrated. Fluorescently labelled model protein, Papain (MW = 23 406 
Dalton), which has a similar molecular weight to the BMP-2 (MW ≈ 26 000 Dalton), 
was used. By using the impregnation method, with vacuum drying, the FLUOS-
labelled Papain was found to be predominantly bound to the surface, as 
demonstrated using the combined fluorescence microscopy and SEM (see Figure   7.2 
and Figure   7.3) techniques. The amount of protein loaded into the PSi membrane 
devices, however, could not be quantitatively determined by using these techniques; 
other alternative methods are needed. An improved loading strategy, perhaps by 
using other drying approaches or by surface functionalising the PSi structure [211, 
212], may be required to optimise the loading efficacy and improve the penetration of 
protein into the pores. 
A passive release, of the FLUOS-labelled Papain in DI water, was performed 
at 37 °C and at 60 °C, over 24 hours. Two interesting and promising findings were 
observed. Firstly, an increase in the concentration of FLUOS-labelled Papain, which 
was released at 60 °C, was observed in the three devices investigated (see Table   7.4 
and Table   7.5). This is a useful finding as the nanostructured PSi and the Papain 
appeared to respond to a thermal stimulus. Secondly, the nanostructured PSi is 
believed to enhance the release of Papain, both at 37 °C and at 60°C. This proposal is 
supported based on the increase in percentage of Papain released (> 5.2 %, see Table 
  7.5) by the devices with PSi structure (b2P06S51 and b2N07S62), as compared to the 
control device (< 3.5 %), which does not contain any PSi structure. 
Further investigations, to establish the impact of factors such as the pH level 
and type of release medium, the physical properties (porosity, pore sizes and pore 
depths) of the PSi and the dissolution kinetic of the PSi, on the release of Papain, 
will enhance the understanding of the PSi membrane device for drug delivery. The 
next step will be to study the controlled release of protein by active release using the 
integrated heater of the PSi membrane drug delivery device.  
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Chapter  8 
Conclusion and Suggestions for 
Future Work 
8.1  Thesis Summary and Conclusion 
The ability to deliver therapeutic agents, to a targeted site, in a controlled manner, is 
pivotal in achieving the full therapeutic potentials of many pharmaceuticals. Thus, 
the aim of this thesis work was to design and produce, using microfabrication 
technologies, a novel, integrated, electrically-addressable drug delivery device for the 
site-specific, controlled release of therapeutic agents. In particular, the device is 
designed to locally deliver bone morphogenetic protein-2 in a controlled manner, as 
the first step to an intelligent therapeutic system for skeletal regeneration. 
Ideally, for a localised delivery, the drug delivery microdevice should be 
implantable. In fact, based on a literature review, implantable drug delivery 
microdevices with integrated electronics, such as the microchip developed by Langer 
and co-workers [125], stand-out as the most promising candidates to offer a 
personalised, responsive and controlled delivery of therapeutic agents. These 
microdevices are equipped with one or more micromachined physical containers as 
drug reservoirs, which are usually capped with biocompatible membranes [125, 130]. 
A major concern of such a design is the potential for dose-dumping upon device 
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A porous drug reservoir, with better entrapment and retention of the drug 
molecules, could address this concern. In particular, porous silicon (PSi) is a 
promising candidate; PSi in particulate forms has been used as a drug delivery 
vehicle [54, 55]. PSi is biocompatible and can be made bioinert, bioactive or 
biodegradable depending on its microstructural properties (such as porosity and pore 
morphology) [60, 61, 207]. The biodegradable PSi can be readily and safely dissolved 
in the human body [62], thus introducing the therapeutic agents; while bioinert PSi 
can rely on the desorption or diffusion of drugs into the human body. These means of 
passive release form the basis of a sustainable drug delivery. By incorporating an 
active control mechanism into a porous drug reservoir, a controlled release can be 
realised. Hence, a novel drug delivery system with a silicon-based porous drug 
reservoir and an integrated, electro-thermal actuated active control mechanism was 
proposed. 
A prototype device based on a porous polysilicon (PPSi) drug reservoir was 
conceptualised by C. Kaminski [247]. In the design, a pair of electrodes was 
integrated into the device for electro-thermal actuation. By applying a current across 
the resistive PPSi drug reservoir, via the pair of electrodes, the entrapped drug could 
be released by Joule heating. The fabrication of the prototype device went swiftly 
until the formation of the PPSi structure; considerable amount of effort was put into 
creating a PPSi structure that is suitable as a drug reservoir.  
The initial studies included fabrication of a PPSi structure using a chemical 
stain etching method. The stain etching method was preferred over the conventional 
anodisation approach due to the straight-forward implementation and relatively 
inexpensive experimental setup. Various volume ratios of HF:HNO3:H2O and etching 
times were investigated; mixed results were obtained. By using 1.3:6:15 volume ratio 
of HF:HNO3:H2O, a PPSi structure, with random, branched pores of sizes estimated 
in the range of 30 nm to 50 nm and a porous film thickness of ~ 250 nm, was 
produced on a polysilicon substrate with a Rs of (28.67 ± 0.59) Ω/sq. In contrast, most 
samples prepared by the stain etching process, did not yield a PPSi film with distinct 
microstructural characteristics; hillocks, cracks and rough surfaces were observed 
when the produced PPSi structures were examined using SEM and AFM techniques. 
This study, like others [180, 225, 242, 249], demonstrated the poor reproducibility 
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The random pore structure, the self-limiting thickness of PPSi films and the 
lack of success in obtaining well-characterised PPSi structures formed by using the 
stain etching method prompted an investigation into using alternative fabrication 
approaches. In addition, the pore size range of 50 nm to 100 nm is deemed more 
suitable due to typical sizes of proteins and peptides, which are in the range of 5 nm 
to 20 nm [61, 228]; the protein of interest, the BMP-2, has dimensions of 7.0 nm x 3.5 
nm x 3.0 nm [28]. 
Two alternative, novel approaches to fabricate a more orderly, reproducible 
PPSi structure, with sizes between 50 nm and 100 nm, were investigated. Both 
approaches employ the concept of using a dry etching process through a well-defined 
masking template. The first approach used a porous anodic alumina (PAA) film as a 
template. In this approach, a thick (> 7 μm) aluminium layer was first deposited on 
top of a polysilicon surface by thermal evaporation. A PAA film was formed by 
electrochemical etching (anodisation) of the aluminium layer; here, a process 
developed by M. E. Nasir [288], which includes electrochemical polishing and 
multistep anodisation, was used. Due to non-uniformity in the thickness of the 
deposited aluminium, an uncharacteristic anodisation behaviour was observed. As a 
result, most PAA films were found to have detached from the polysilicon surface 
after the anodisation process. In addition, some of the pores were not vertical. 
Although a quasi-ordered PAA film with desirable pore dimensions (pore diameter ~ 
50 nm; interpore distance of ~ 100 nm) was obtained, due to the poor contact 
between the PAA film and the polysilicon surface, and the angled pore structure, the 
PAA film was considered to be non-ideal for the use as a masking template during 
the RIE of the polysilicon layer. 
The second approach employed the nanosphere lithography (NSL) technique 
to create the template. Nanospheres, of 500 nm or 200 nm in diameter, were first 
self-assembled on top of a polysilicon substrate to form a monolayer, hexagonally 
close-packed array. Next, the size of the nanospheres was reduced by a RIE process, 
thus creating a non-close-packed nanosphere array arranged in a hexagonal lattice. 
A thin metal film was then deposited. Subsequent removal (lift-off) of the 
nanospheres thus produced a metal film with array of holes. This metal film was 
used as a masking template for the RIE of the polysilicon to realise the PPSi 
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In principle, the NSL technique provides an inexpensive and practical 
approach for pattern generation of hexagonally-arranged holes, with tuneable 
diameter and spacing (or pitch size) of the holes – the initial size of the nanospheres 
defines the pitch size; while the size of the etched nanospheres determines the 
eventual diameter of the holes. In practise, however, there is a limit to the 
reasonable size that can be reduced; the smaller the size-reduced nanospheres, the 
thinner the metal mask has to be, so that the subsequent removal of nanospheres is 
possible. However, a thin metal mask limits the etch depth of the polysilicon using 
the RIE process. Therefore, a good compromise is needed; in most cases, the size of 
the nanospheres was not reduced (by RIE) by more than half the original size. A 
metal mask, with total thickness of 20 nm, was found to produce successful lift-off 
and yet, sufficiently robust during the RIE of the polysilicon layer.  
The RIE of the polysilicon was achieved using the “black silicon” process 
[383]. Typically, the RIE resulted in a positively tapered etch profile. For 
nanospheres with initial diameter of 500 nm, a tapered PPSi structure with pore 
width of, for instance, 370 nm ± 30 nm and pore depth around 417 nm were achieved. 
Although the quasi-ordered PPSi exhibited a tapered profile, this is the first 
demonstration of the fabrication of PPSi with ordered pores of sizes in the macropore 
range of ~ 370 nm. PPSi structures, which were fabricated using metal mask formed 
using the 200 nm initial-sized nanospheres, typically exhibited a microneedle-like, 
spiked triangular pyramidal shape, as a result of lateral through-etching between 
the pores at the upper surface. It was proposed that by using a silicon substrate 
(instead of polysilicon) or with different etching tools, the geometry of the pores could 
be improved, so that the sidewalls are straight. 
Subsequently, an improved, second generation, prototype drug delivery 
device, using a silicon membrane substrate, with an alternative electro-thermal 
actuation method, was proposed. The silicon membrane substrate consists of a 
nanostructured, quasi-ordered PSi drug reservoir, fabricated at the back-side of the 
membrane. An integrated heater and temperature sensor was designed at the front-
side of the silicon membrane. It was envisaged that, by Joule heating, the heater 
provide a rapid increase in temperature, for a short period of time, to the PSi 
structure, therefore promoting the release of the loaded therapeutic agents from the 
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A modified NSL technique, with an improved RIE of silicon using a STS LPX 
Pegasus system, was used to fabricate quasi-ordered, vertical, cylindrical PSi 
structures. Nanospheres with a mean diameter of 200 nm were used, thus resulting 
in the interpore distance of ~ 200 nm of the eventual PSi structures. The 
nanospheres were typically reduced to a diameter of 86 nm ± 3 nm by a one-minute 
O2 RIE process. To improve the success of the removal of nanospheres, a 10 nm thick 
Cr layer and an ultrasonication time of < 60 s, were used. By exploiting the LF 
process and the parameter ramping feature of the STS LPX Pegasus system, PSi 
structures with mean pore diameters between ~ 75 nm and ~ 120 nm, and a pore 
depth in the range of ~ 330 nm to 500 nm, were fabricated. The theoretical porosity 
was calculated to be between 12.8 % and 32.6 %. The aspect ratio was found to be < 
5:1; higher aspect ratios might potentially be achieved using an optimised process in 
the STS LPX Pegasus system. This novel nanofabrication technique is versatile and 
various other nanostructures, such as nanopillars (see Appendix E, §E.6) and 
nanowires (see Appendix E, §E.7), have been successfully fabricated. It is a 
“materials general” technique and has been successfully demonstrated on both p-
type and n-type silicon substrates; ordered PSi with cylindrical pores in 100 nm 
diameter range has been difficult to achieve using conventional electrochemical 
etching method. 
An integrated heater and temperature sensor was incorporated at the front-
side of the PSi membrane device. Three configurations (meander, spiral and coil) of 
the heater and temperature sensor were designed and fabricated using the lift-off 
method. Higher than simulated peak temperatures were first observed when the 
meander heater was actuated with voltages from 3 V to 5 V, with heater on-times of 
0.1 s to 1.0 s. This was believed to be due to a higher than desired deposited 
thickness of Ti and Au (hence, a reduced resistance) and the smaller than expected 
TCR values. A revised simulation, however, demonstrated a good agreement with 
the experimental result. Hence, it was proposed and verified, both by experiment 
and simulation, that an actuation voltage of 3 V and a heater on-time of 0.5 s was 
sufficient to provide a rapid local heating (up to 60 °C ± 10 °C) with minimal heat 
dissipation to the surrounding environment. 
The proof of concept of using the fabricated PSi membrane device, for drug 
delivery, was demonstrated. Fluorescently labelled model protein, Papain, which has 8.1 Thesis Summary and Conclusion    234 
 
similar molecular weight with BMP-2, was used. The FLUOS-labelled Papain was 
found to be predominantly bound to the surface; the amount of protein loaded into 
the pores of the nanostructured PSi drug reservoir could not be quantitatively 
determined. A passive release, of the FLUOS-labelled Papain in DI water, was 
performed at 37 °C and at 60 °C, over 24 hours. Two interesting and promising 
findings were observed – i) the nanostructured PSi and the Papain appeared to 
respond to a thermal stimulus since an increase in the concentration of FLUOS-
labelled Papain was observed at a release temperature of 60 °C; ii) the 
nanostructured PSi appeared to enhance the release of Papain, both at 37 °C and at 
60°C, as demonstrated by an increase in percentage of Papain released as compared 
to the control device (without PSi structure). 
The commercially available INFUSE® Bone Graft with ACS carrier (7.5 cm x 
10 cm in size), was demonstrated to accelerate open tibial fracture healing when 
used in a concentration of 1.50 mg·mL-1 (total dose of 12 mg) [20]. Hypothetically, the 
concentration of rhBMP-2 delivered, normalised to the area of the ACS carrier, 
amounts to 0.02 mg·mL-1·cm-2 (or 0.16 mg·cm-2). In comparison, the PSi membrane 
drug delivery device developed here, with a membrane size of 0.4 cm x 0.4 cm, is 
capable of passive delivery of ~ 4.7 ng·mL-1 (28.2 ng) model protein at 37 °C. The 
normalised concentration is calculated to be ~ 0.03 mg·mL-1·cm-2 (or ~ 0.18 mg·cm-2); 
this is comparable to the delivery capacity of the ACS carrier. However, the PSi 
membrane device is potentially capable of an active, controlled release, which is 
lacking in the ACS carrier. 
The proof-of-concept prototype drug delivery microchip device developed by 
Langer and co-workers was demonstrated to produce a pulsatile controlled release of 
microgram quantities of either single or multiple substances [125]. However, in order 
to provide a sustained release, the microchip has to be operated periodically; each of 
the drug reservoirs has to be actuated to maintain the plasma concentration. In 
contrast, the PSi membrane device developed here was designed to provide the 
sustained delivery by passive release. The active control mechanism could 
potentially be used as a bolus dose, when a higher concentration of therapeutic 
agents is required, thus realising the pulsatile controlled release. This, unlike the 
Langer’s device where the delivery of therapeutic agents has to be actuated, is a 
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issue of dose-dumping upon device failure (which could occur in Langer’s device) is of 
a lesser risk. The microchip by Langer was able to release multiple substances (due 
to individual loading of substances into each reservoir); this feature may be difficult 
to achieve with the current PSi membrane device developed here. 
In summary, it has been demonstrated that the NSL technique and an 
improved RIE process using the STS LPX Pegasus system can be used to fabricate a 
quasi-ordered PSi structure with cylindrical pores of ~ 100 nm in diameter. By 
incorporating the nanostructured PSi as a drug reservoir and an integrated heater 
and temperature sensor as an active control mechanism, a drug delivery device was 
realised. A passive release of an intermediate-sized model protein was demonstrated 
using the microdevice, and preliminary results suggested that an increment in 
release quantity was achieved by using the nanostructured PSi drug reservoir. 
8.2  Suggestions for Future Work 
The aim of the research is to fabricate an electrically-addressable drug delivery 
device; it is desirable to demonstrate the potential of this technology in skeletal 
regeneration, by using the BMP-2. This thesis has demonstrated the potential 
benefit of incorporating a PSi structure for the delivery of a model protein by passive 
desorption. Thus, the logical next step would be to demonstrate the full potential of 
the designed device by releasing the model protein using the active control 
mechanism. The integrated heater can be actuated periodically and the released 
protein can be monitored and quantified. These measurements can be compared with 
a device (as the control) operating under passive release condition. Subsequently, 
upon successful demonstration of the functionality of the PSi membrane drug 
delivery device, the actual BMP-2 can be used in conjunction with human 
mesenchymal stem cell, to demonstrate and optimise the use of the device, both by 
the passive release and active control mechanism. 
Currently, the driver circuit was designed to actuate the heater by passing a 
current (with an applied voltage) in a specific time frame. The heat generated, hence 
the resultant temperature, was therefore not modulated. Alternatively, a feedback 8.2 Suggestions for Future Work    236 
 
control with a simple proportional-integral-derivative (PID) and a comparator circuit 
can be devised to modulate the temperature; this ensures the heater is actuated to 
produce the required temperature within the time limit.  The electrical connection of 
the heater and the temperature sensor, to the external world, could also be improved 
by using wire bonding to a custom-made dual in-line package. 
An improved loading strategy is desirable to enhance the penetration of 
protein into the pores of the nanostructured PSi drug reservoir of the devices 
fabricated during this thesis. Other drying approaches, such as freeze-drying or 
supercritical drying, can be employed. Alternatively, by surface functionalisation of 
PSi structure [211, 212], the pores can be chemically modified to provide a suitable 
covalent attachment of the therapeutic agents. The quantification of drug loaded into 
the pores remains a challenge; a combination of analytical techniques may be 
required instead. Thermal analysis methods (such as thermogravimetry [429] and 
different scanning calorimetry [70, 429]), helium pycnometry [54] and N2 adsorption 
/ desorption methods [54], have been used to investigate the loading of model drugs 
into PSi microparticles, and can be potentially used here. Other techniques such as 
secondary-ions mass spectrometry (SIMS) can be used to provide qualitative 
determination of protein within the pores, by examining the cross-section of the PSi 
structure, as demonstrated by Prestidge et al. [216].  
This thesis work investigated the microstructural characteristics, primarily 
using the SEM, of the fabricated PPSi and PSi structures extensively. Based on the 
dimensions and theoretical porosity determined from these investigations, and a 
comparison to the literature [61, 208], the ordered PPSi and PSi structures could be 
bioinert. Therefore, it is desirable to experimentally establish the bioactivity and 
biocompatibility of these fabricated structures. In particular, the dissolution (or non-
dissolution) of these structures in the simulated body fluids, under an electro-
thermal stimulus from the integrated heater, could be an interesting investigation 
which can enhance the understanding of the drug release by these structures. 
The most studied property of PPSi and PSi is its photoluminescent behaviour 
[134, 145, 158, 176, 178-189] due to a great interest in integrating PSi and PPSi into 
optoelectronics devices. Hence, it would be very interesting to also interrogate the 
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conventionally fabricated PPSi and PSi structures. Temperature and power 
dependent PL and EL measurement, and reflectance and light scattering 
measurements using integrating sphere are two examples of many possible optical 
interrogations; findings from these optical characterisation will provide more insight 
into the potential of these ordered porous structures in the application of 
optoelectronics and as an anti-reflective layer for solar cell applications. 
The PSi membrane drug delivery device was fabricated satisfactorily; 
however, there is plenty of room for improvement. Three possible improvements to 
the current fabrication process are identified here. Firstly, the fabrication of the 
silicon membrane using TMAH timed-etch was not ideal. The timed-etch requires 
that the etch depth is measured, intermittently, during the etching process to 
estimated an etch rate and hence the total etch time needed; this is only feasible if 
the initial thickness of the wafer is known. Alternatively, an in-situ optical 
monitoring [385, 386] can be used to control the etching. A boron-doped layer can 
also be used as an etch stop or a SOI wafer can be used since the insulator layer 
readily providing the etch stop. Some fabrication issues were experienced post-
TMAH etch, which were believed to be caused by the cracking or pinholes on the 
fabricated silicon membrane. It was proposed that these undesirable cracking and 
pinholes were a result of the failure of the SiO2-Si3N4 masking layers, both at the 
front- and back-side of the wafers. Therefore, it is imperative that a good working 
practice is maintained to ensure the integrity of these masking layers during 
standard wafer handling processes. Thicker SiO2-Si3N4 layers can also be used to 
provide better protection during the TMAH etching. 
Secondly, the RIE using STS LPX Pegasus system produced PSi structures 
with mean pore diameters between ~ 75 nm and ~ 120 nm and a pore depth in the 
range of ~ 330 nm to 500 nm; the aspect ratio was < 5:1. In order to improve the 
retention capability, pores with higher aspect ratio will be ideal. The RIE process 
could be optimised to achieve that. Longer total process times can be used to increase 
the etch depth, hence the aspect ratio. In addition, when using the LF process, the 
pulsing generator feature can be explored; this feature was not used in the current 
fabrication process. A pulsing generator switches the platen on and off during the 
etch cycle, hence reducing the notching effect typically observed when etching SOI 
wafers. Thus it is proposed to explore the potential benefit of using a pulsing 8.2 Suggestions for Future Work    238 
 
generator, during the LF process, to improve the etch depth and the aspect ratio of 
the PSi structure. 
Lastly, the lift-off process to realise the integrated heater and temperature 
sensor can be better performed using alternative approaches. In the current 
fabrication process, the lift-off was performed using a thick photoresist with a 
subsequent surface modification step to provide the required undercut. However, a 
positive taper profile with shallow undercut was often obtained. Although a 
successful lift-off was demonstrated (in most samples), the fabricated heater and 
temperature sensor exhibited a curved edge that followed the taper profile of the 
photoresist. Therefore, alternative lift-off strategies can be used to provide a better 
undercut profile. These include using a bi-layer photoresist process, which uses a 
dedicated lift-off photoresist (such as MicroChem’s PMGI or LOR 10B) as a 
sacrificial layer, and a standard pattern-generation photoresist on top. The dedicated 
lift-off photoresist dissolves faster in the developer, hence creating an overhang with 
good undercut. An image reversal process [42] is also frequently used to change the 
taper profile (typically observed in positive tone photoresist) into an undercut profile 
that is suitable for lift-off process. 
The work presented in this thesis provides the basis for many exciting 
applications. In drug delivery, the PSi membrane device can be further developed to 
incorporate appropriate sensors, integrated electronics and non-biofouling 
packaging, and thus potentially realising an implantable, responsive and controlled 
release drug delivery system. The quasi-ordered PSi, fabricated using the NSL 
technique and Bosch-based RIE process, is uniquely interesting; its application could 
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A.1  Batch K2714s – Intelligent Drug Delivery 
Device 
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A.2  Silicon Membrane Device (at Chalmers 
University of Technology) 
 
No Description Count
1 Mask Writing (3 x 7" + 2 x 5" Mask Plates) 5
2 Title Page: Total 13 Wafers, Materials: Si Prime, DSP with Primary flat in accordance to 
SEMI standard. All wafers 150 mm dia., 525 μm ± 15 μm thick and in <100> orientation. 
Wafers breakdown:
SIX Si p-type, Boron, (1 - 10) Ωcm, #P01 - P06
SIX Si n-type, Phosphorus, (1 - 10) Ωcm, #N07 - N12
ONE TEST WAFER Si p-type, Boron, (1 - 10) Ωcm, #T01
13
3 RCA Clean (SC1 & SC2) 13
4 Dry Oxide 40 nm ± 5 nm (FRONT & BACK) 13
5 LPCVD Si3N4 160 nm ± 20 nm @ 770°C (Stoichiometric Standard Recipe) (FRONT & 
BACK)
13
*** START OF TEST WAFER (Evaluation of Al for PAA Template) ***
6P h o t o l i t h o g r a p h y  M a s k  UoS-TM-CFC-M2 (FRONT) - #T01
Dark Field: nom. 1.1 μm resist STANDARD [Align to flat]
USE SOFT CONTACT TO MINIMISE DAMAGE TO PHOTORESIST
1
7 Hardbake for dry etch (FRONT) - #T01 1
8 General Inspection - #T01
Inspect photolithography quality - resolution on alignment marks, for any damage to 
resist in large patterned areas
1
9 Etch nom. 160 nm Si3N4 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(FRONT) - #T01
1
10 Etch nom. 40 nm SiO2 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(FRONT) - #T01
1
11 Resist Strip Plasma O2 in the same chamber (FRONT) - #T01 1
12 Al Sputter 4 μm with Ar Plasma clean to remove native oxide (FRONT) - #T01 1
13 Etch nom. 160 nm Si3N4 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(BACK) - #T01
1
14 Etch nom. 40 nm SiO2 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(BACK) - #T01
1
15 Ti / Au Sputter 10 nm / 300 nm (BACK) - #T01 1
16 Spin resist for protection (FRONT) - #T01 1
17 Saw into 10 mm x 10 mm chips [follow the scribe line created with M2] - #T01 1
18 Optical inspections for surface smoothness and adhesion quality of Sputtered Al film 1 
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19 Send to Southampton for External Processing 1
*** END OF TEST WAFER *** 
Processing continues with Device Wafers (#P01-P06 & #N07-N12)
20 Photolithography Mask UoS-TM-CFC-M1 (BACK)
Dark Field: nom. 1.1 μm resist STANDARD
[Right reading on "Align to flat", wrong reading on Mask ID]
USE SOFT CONTACT TO MINIMISE DAMAGE TO PHOTORESIST
12
21 Hardbake for dry etch (BACK)  12
22 General Inspection
Inspect photolithography quality - resolution on alignment marks, for any damage to 
resist in large patterned areas
12
23 Etch nom. 160 nm Si3N4 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(BACK)
12
24 Etch nom. 40 nm SiO2 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(BACK)
12
25 Resist Strip Plasma O2 in the same chamber (BACK) 12
*** START OF DEVELOPMENT WAFER ***
26 TMAH Etch. Timed-etch (etch and measure) to achieve membrane thickness of 50 μm 
(BACK)
1
27 Ti / Au Sputter 10 nm / 300 nm (BACK) 1
28 Photolithography Mask UoS-TM-CFC-M2 (FRONT)
Dark Field: nom. 1.1 μm resist STANDARD
[Mask reads "Right Side Up"; Captured image reads "Wrong Side Up"]
USE HARD CONTACT / LOW VAC for Double-sided alignment
1
29 Hardbake for dry etch (FRONT) 1
30 General Inspection (FRONT)
Inspect photolithography quality - resolution on alignment marks, for any damage to 
resist in large patterned areas
1
31 Etch nom. 160 nm Si3N4 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(FRONT)
1
32 Etch nom. 40nm SiO2 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(FRONT)
1
33 Photoresist Strip with Plasma O2 in the same chamber (FRONT) 1
34 Spin resist for protection (FRONT) 1
35 Saw into Chips 1
36 Send to Southampton for External Processing 1
*** END OF DEVELOPMENT WAFER *** 
Processing continues with Device Wafers
37 TMAH Etch. Timed-etch based on development of Step 26 to achieve membrane 









38 Photolithography Mask UoS-TM-CFC-M2 (FRONT)
Dark Field: nom. 1.1 μm resist STANDARD
[Mask reads "Right Side Up"; Captured image reads "Wrong Side Up"]
USE HARD CONTACT / LOW VAC for Double-sided alignment
11
39 Hardbake for dry etch (FRONT) 11
40 General Inspection (FRONT)
Inspect photolithography quality - resolution on alignment marks, for any damage to 
resist in large patterned areas
11
41 Etch nom. 160 nm Si3N4 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(FRONT)
11
42 Etch nom. 40 nm SiO2 Aniso. D/F OPTICAL resists, CF4 + O2 plus short over etch 
(FRONT)
11
43 Photoresist Strip with Plasma O2 in the same chamber (FRONT) 11
*** START OF SPLIT BATCH (for PAA Template) (#P04-P06 & #N07-N09) ***
44 Ti / Au Sputter 10 nm / 300 nm (BACK) 6
45 Aluminium Sputter 4 μm with Ar Plasma clean to remove native oxide (FRONT) 6
46 Spin photoresist for protection (BACK) 6
47 Photolithography Mask UoS-TM-CFC-M3 (FRONT)
Dark Field: nom. 2.2 μm resist STANDARD
USE SOFT CONTACT TO MINIMISE DAMAGE TO PHOTORESIST
6
48 Postbake for wet etch (FRONT) 6
49 General Inspection (FRONT)
Inspect photolithography quality - for any defects or pin-holes on resist in device areas
6
50 Aluminium Wet Etch to reveal scribe lines 6
*** END OF SPLIT BATCH ***
51 Spin resist for protection (FRONT)  11
52 Saw into Chips 11
53 Completion of Listing / Section
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B.1  Batch K2714s – Intelligent Drug Delivery 
Device 
























Figure   B.1: Layout of mask KB35M-AA, showing the 6 mm diameter circular region, which defines 
the area for the fabrication of porous polysilicon. The samples were denoted by Sxx, where xx is 
their positions on the wafer, assumed from left to right and top to bottom. B.1 Batch K2714s – Intelligent Drug Delivery Device  244 
 
B.1.2  Mask 2 – KB35M-M1 
 










Figure   B.2: Layout of mask KB35M-M1, showing the various patterns of the electrodes. 
 




Figure   B.3: Layout of the revised, 3-inch emulsion mask (of KB35M-M1), used for the lift-off 
development in University of Manchester. B.2 Porous Silicon Membrane Drug Delivery Device  245 
 
B.2  Porous Silicon Membrane Drug Delivery 
Device  
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Figure   B.4: Layout of mask UoS-TM-CFC-M1, which defines the opening for TMAH etch, to realise 
the silicon membranes, at the back-side of the wafers. 
 
 





















200 m μ 240 m μ
 
(c) 
Figure   B.5: Detailed layout of mask UoS-TM-CFC-M1, showing (a) the wafer level alignment mark; 
(b) the TMAH etch-depth indicator; and (c) the chip level alignment mark and identification. 
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Chip ID (Sample  , 3 mm square membrane) S07
 
Figure   B.6: Layout of mask UoS-TM-CFC-M2, which defines the sawing tracks and opening of the 
front membrane, intended for the formation of PAA. The samples were denoted by Sxx, where xx is 
their positions on the wafer, assumed from left to right and top to bottom. 
 


















Figure   B.7: Detailed layout of mask UoS-TM-CFC-M2, showing (a) the M1 to M2; and (b) M2 to 
M3, wafer level alignment marks. 
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Figure   B.8: Layout of mask UoS-TM-CFC-M3, which defines the sawing tracks for the wet 
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Figure   B.9: Layout of mask UoS-TM-CFC-M4, which defines the various electrode designs and the 
integrated heater and temperature sensor designs. 
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C  Process Simulation – Example Input File used in Athena 
Appendix  C 
Process Simulation – Example 
Input File used in Athena 
C.1  Simulation with Boron Implantation of 5 x 
1015 cm-2 and Energy of 80 keV 
# ---------------------------------------------------------------  # 
#  Filename  :  k2714s_01.in       # 
# Description : Process simulation of batch K2714s Wafer 1-4   # 
# Author  : C. F. Chau (cfc03r@ecs.soton.ac.uk)      # 
#  Created  :  31  March  2006       # 
# Comment  : Using SIMS Verified Dual Pearson (SVDP)    # 
#       ion  implantation  model      # 












# Establish the grid locations and densities  
# ------------------------------------------ 
line x loc=0.00 spac=0.05 
line x loc=0.50 spac=0.01 C.1 Simulation with Boron Implatation of 5 x 1015 cm-2 and 80 keV  252 
 
line x loc=1.00 spac=0.05 
 
line y loc=0.00 spac=0.01 
line y loc=0.50 spac=0.05 
line y loc=1.00 spac=0.1 
line y loc=2.00 spac=0.5 
 
# Initialize the silicon wafer 
# ---------------------------- 
init silicon boron resistivity=25 orientation=100 two.d 
 
# Grow pad oxide layer 
# -------------------- 
method fermi grid.oxide=0.05 
 
diffuse time=15 temp=750 t.final=1000 dryo2 press=1.0 hcl.pc=0.0 
diffuse time=105 temp=1000 weto2 press=1.0 hcl.pc=0.0 
diffuse time=30 temp=1000 t.final=750 nitrogen press=1.0 hcl.pc=0.0 
 
extract name="Pad Oxide Thickness" thickness material="SiO~2" \ 
  mat.occno=1 x.val=$cutline datafile="k2714s_01_para.dat"  
 
# LPCVD Polysilicon 
# ----------------- 
deposit polysilicon thick=$poly_thick div=20 
 
extract name="Polysilicon Thickness" thickness material="Polysilicon" \ 
  mat.occno=1 x.val=$cutline datafile="k2714s_01_para.dat" 
 
# Dope Polysilicon with Ion Implantation  
# -------------------------------------- 
implant boron dose=$implant_dose energy=$implant_eneg tilt=0 rotation=0 \ 
  amorph unit.damage dam.factor=1.0 
 
struct outfile=$"prefix"_implant.str 
extract name="Simulated_dose" area from curve(depth, impurity="Boron" \ 
        material="Polysilicon" mat.occno=1 x.val=$cutline)*1e-4 \ 
 datafile="k2714s_01_para.dat" 
extract name="Percent diff" abs($Simulated_dose - $implant_dose)*\ 
 100/$implant_dose  datafile="k2714s_01_para.dat" 
extract name="Surface Conc after Implant" surf.conc impurity="Net Doping" \  
  material="Polysilicon" mat.occno=1 x.val=$cutline \ 
 datafile="k2714s_01_para.dat" 
extract name="Sheet_Res_after_implant" sheet.res material="Polysilicon" \ 
  mat.occno=1 x.val=$cutline semi.poly datafile="k2714s_01_para.dat" 
extract name="Polysi_Thick_after_implant" thickness material="Polysilicon" \ C.1 Simulation with Boron Implatation of 5 x 1015 cm-2 and 80 keV  253 
 
  mat.occno=1 x.val=$cutline datafile="k2714s_01_para.dat" 
extract name="Res after Implant (Ohm*cm)" \  
 $Sheet_Res_after_implant*$Polysi_Thick_after_implant/1e8  \ 
 datafile="k2714s_01_para.dat" 
 
# Deposit LTO to reduce stress of nitride layer 
# --------------------------------------------- 
deposit oxide thick=0.3 div=10 
 
extract name="LTO Thickness" thickness material="SiO~2" \ 








# LPCVD Silicon nitride 
# --------------------- 
deposit nitride thick=0.16 div=10 
 
struct outfile=$"prefix"_final.str 
extract name="Nitride Thickness" thickness material="Si~3N~4" \ 
  mat.occno=1 x.val=$cutline datafile="k2714s_01_para.dat" 
extract name="Surface Conc after Drive-in" surf.conc impurity="Net Doping" \  
  material="Polysilicon" mat.occno=1 x.val=$cutline \ 
 datafile="k2714s_01_para.dat" 
extract name="Sheet_Res_after_drivein" sheet.res material="Polysilicon" \ 
  mat.occno=1 x.val=$cutline semi.poly datafile="k2714s_01_para.dat" 
extract name="Polysi_Thick_after_drivein" thickness material="Polysilicon" \ 
  mat.occno=1 x.val=$cutline datafile="k2714s_01_para.dat" 
extract name="Res after Drive-in (Ohm*cm)" \  
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COMSOL Simulation 
D.1  AC / DC Module 
The AC / DC Module comprises several application modes aimed to solve the diverse 
problems in electromagnetic. The application modes can be divided into two main 
fields: electrostatic fields, and magnetostatic and quasi-static fields. The Conductive 
Media DC and Shell, Conductive Media DC application modes, used in this 
simulation, are part of the electrostatic fields. The following descriptions are adopted 
from COMSOL’s AC / DC Module User’s Guide [430]. 
D.1.1  Conductive Media DC Application Mode 
The Conductive Media DC application mode solves the following partial differential 
equation (PDE): 
( ) j
e V Q J = − ∇ ⋅ ∇ − σ       (   D.1) 
where V is the electrical potential, Je is an externally generated current density, and 
Qj is the current source. The σ is the electrical conductivity of the conductive media, 
which is the only governing material property. For a strongly coupled simulation, the 
conductivity is temperature-dependent, as described by the following equation: D.1 AC / DC Module    255 
 
() [] 0 0 1
1
T T − +
=
α ρ
σ       (   D.2) 
where ρ0 is the resistivity at the reference temperature T0, α is the temperature 
coefficient of resistivity (TCR), and T is the current temperature (in Joule heating 
multiphysics coupling, this is obtained from a heat transfer application mode). The 
relevant interface condition at the interface between two different media (1 and 2) is 
( ) 0 2 1 2 = − ⋅ J J n       (   D.3) 
where n is the normal vector. The equation D.3 is fulfilled by the following natural 
boundary condition: 
( ) ( ) [ ] ( ) 0 2 1 2 1 = − ⋅ − = − ∇ − − ∇ ⋅ J J n J J n
e e V V σ σ     (   D.4) 
Therefore, the boundary conditions typically used in this model include: 
Boundary Condition  Description 
n J = ⋅ − J n   Inward current flow 
0 = ⋅J n   Electrical insulation 
0 V V =   Electrical potential 
0 = V   Ground 
Table   D.1: The boundary conditions typically used in the Conductive Media DC application mode. 
D.1.2  Shell, Conductive Media DC Application Mode 
The Shell, Conductive Media DC application mode models thin layers of conductive 
media by solving the problem on 2D surfaces in a 3D geometry. It is similar to the 
2D Conductive Media DC application mode, as described by the following PDE: 
( ) j s
e
t s t d V d Q J = − ∇ ⋅ ∇ − σ      (   D.5) 
where ds is the thickness of the layer (or shell) and the operator  t ∇  represents the 
tangential derivative along the layer. D.2 Heat Transfer Module    256 
 
D.2  Heat Transfer Module 
The Heat Transfer Module covers all the fundamental mechanisms in heat transfer, 
including different combinations of conductive, convective and radiative heat 
transfer (with both surface-to-surface and surface-to-ambient radiation). The 
General Heat Transfer is the main application mode within this module. The 
following descriptions are adopted from COMSOL’s Heat Transfer Module User’s 
Guide [431]. 
D.2.1  General Heat Transfer Application Mode 




C Q ∇ ⋅ ∇ −
∂
∂
= ρ      (   D.6) 
where Q is the heat source, ρ is the density, C is the specific heat capacity, T is the 
temperature,  t i s  t i m e  a n d  k is the thermal conductivity. For the steady-state 
simulation, the first term containing ρ and C vanishes, and the only governing 
material property is the thermal conductivity, k. The boundary conditions available 
with this model include: 
Boundary Condition  Description 
() ( ) T T h q T k inf − + = ∇ − ⋅ − 0 n   Heat flux 
() 0 = ∇ ⋅ T k n   Insulation or symmetry 
0 T T =   Prescribed temperature 
() ( ) 0 = ∇ − ⋅ − ∇ − ⋅ − d d d u u u T k T k n n   Continuity for interior boundary 
Table   D.2: The boundary conditions available in the General Heat Transfer application mode. 
where q0 is the inward heat flux, h is the heat transfer coefficient and Tinf is the 
temperature of surrounding environment. n is the normal vector, with the subscripts 
u and d denote the upside and downside of the boundary, respectively. D.3 2D Simulation    257 
 
The  Highly Conductive Layers feature, of the General Heat Transfer 
application mode, provide efficient modelling of heat transfer in thin layers without 
the need to geometrically create a fine mesh for them. The feature assumes that no 
variations in temperature and in-plane heat flux exist along the direction of the 
thickness of the layer. In doing so, it simplifies the geometry and significantly 
reduces the required number of mesh elements. 
() Ω Ω ∂ − = ∇ − ⋅ ∇ +
∂
∂
q q T k d
t
T
C d t s s t s s sρ     (   D.7) 
( ) T T h q q inf − + = Ω ∂ 0       (   D.8) 
( ) u n CT T k q ρ + ∇ − ⋅ − = Ω      (   D.9) 
where ds is the layer thickness, ρs is the layer density, Cs is the layer specific heat 
capacity, ks is the layer thermal conductivity, q∂Ω is the heat flux from the boundary 
into the layer and qΩ is the heat flux from the layer into the subdomain. 
D.3  2D Simulation 
A 2D, steady-state simulation was performed to investigate the effect of the 
insulating layers (Si3N4 and SiO2), on the heat transfer of the silicon membrane 
device. The steady-state simulation used the application modes Conductive Media 
DC and General Heat Transfer to model the conductive heat transfer due to the Joule 
heating. The insulating layers (Si3N4 and SiO2) were modelled as one single 200 nm 
thick Si3N4 layer. For comparison, two simulations were performed – i) with the 
heater on the insulating layer; and ii) with the heater on the silicon membrane. 
D.3.1  Settings for Conductive Media DC Application 
Mode 
Only the gold heater was set to be active in this application mode. The conductivity 
of the gold heater was modelled using equation D.2 with properties that are D.3 2D Simulation    258 
 
summarised in Table   D.3. An inward current flow of 1.67 x 1011 A·m-2, which is based 
on an input current of 10 A, was used in the simulation. 
Parameter Value  Unit  Reference 
Resistivity, ρ0   2.2 x 10-8  Ωm  [389] 
Reference Temperature, T0  293.15 K  [389] 
TCR, α  0.00372  K-1 [388] 
Table   D.3: The properties of Au used in the subdomain settings of the Conductive Media DC 
application mode. 
D.3.2  Settings for General Heat Transfer Application 
Mode 
The thermal properties, for the various materials, used in the simulation are 
presented in Table   D.4. The PSi layer was assumed to be 25 % porous (porosity, P = 
0.25), and its thermal conductivity, kPSi and specific heat capacity, CPSi were 
assumed by the following [393]:  
( )
3 1 P k k exp PSi − × =       (   D.10) 
( ) P C C Si Si PSi PSi − × = 1 ρ ρ      (   D.11) 
where kexp is an experimentally determined fitting parameter (here assumed to be 
the thermal conductivity of the bulk silicon), ρPSi and ρSi are the density of porous 
silicon and the bulk silicon, respectively, and CSi is the specific heat capacity of the 
bulk silicon. The density of PSi was assumed to be the same as the density of silicon. 












Gold, Au  0.3  19300  317  129 
Silicon nitride, Si3N4 0.2  3100  20  700 
Silicon, Si  50  2330  163  703 
Porous silicon, PSi 0.5  2330  68.8  527.3 
Table   D.4: The thermal properties used in the 2D simulation. D.4 Revised 3D Simulation    259 
 
D.3.3  Results 
The 2D temperature distribution of both simulations was compared. A temperature 
line profile was made along the depth of the simulated device structure, for both of 
the simulations. It was observed that the simulated temperature gradient, at the 
heater layer, differs by about 3 °C; the model with the heater on the Si3N4 layer 
exhibits higher temperature at steady-state, as depicted in Figure   D.1. However, the 
temperature gradient at the silicon membrane layer (depth from -25.0 μm to 25.0 
μm) is very similar (with ~ 1 °C difference). At the PSi structure (depth from -25.5 
μm to -25.0 μm) the temperature gradients of both simulations are almost identical, 
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Figure   D.1: Simulated steady-state temperature profiles, along the depth of the simulated 2D 
device structure, of both simulations. 
D.4  Revised 3D Simulation 
For the revised simulation, the measured total thickness of the metal layers (Ti and 
Au) and the calculated TCR value were used. Therefore, for sample b2P02S51, the 
metal thickness (ds) of 443 nm and the TCR value of 0.003 K-1 were used. The D.4 Revised 3D Simulation    260 
 
natural convective heat transfer coefficients, hc of 20, 200, 1000 and 2000 were used. 
The actuation voltage was fixed at 3 V with a heater on-time of 0.5 s. It can be 
observed, from Figure   D.2, that the peak temperature and the cooling rate differ 





























hc = 2000 Increasing h c values
h c = 20
h c = 200
h c = 1000
h c = 2000
 
Figure   D.2: Simulated temperature profile over time, at the centre of the meander heater, after 
applying actuation voltages of 3 V, for 0.5 s, with hc values of 20 (♦), 200 (■), 1000 (▲) and 2000 (×). 
The metal thickness of 443 nm and the TCR value of 0.003 K-1 were used. 
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Appendix  E 
Additional SEM Micrographs of the 
Fabricated PSi Structures 
E.1  Sample P03S32 
Sample  P03S32 was used in the protein loading experiment and discussed in 







Figure   E.1: Cross-sectional view SEM micrograph of sample P03S32 after the RIE process using 
the STS LPX Pegasus system. E.2 Sample b2P06S51   262 
 
E.2  Sample b2P06S51 
Sample  b2P06S51 was used in the protein release experiment and discussed in 
Chapter 7, §7.4. The SEM micrographs were acquired with the SiO2 hard mask still 
intact. 
200 nm 200 nm
 
(a) (b) 
Figure   E.2: (a) Oblique, cross-sectional view and (b) plane-view SEM micrographs of sample 
b2P06S51 after the RIE process using the STS LPX Pegasus. The mean diameter of the pores was 
calculated to be 111 nm ± 7 nm, with a pore depth of 545 nm ± 32 nm (inclusive of the thickness of 
the SiO2 hard mask). 
E.3  Sample b2N07S62 
Sample  b2N07S62 was used in the protein release experiment and discussed in 
Chapter 7, §7.4. The SiO2 hard mask was etched before the SEM. 
200 nm 200 nm
 
(a) (b) 
Figure   E.3: (a) Oblique, cross-sectional view and (b) plane-view SEM micrographs of sample 
b2N07S62 after the RIE process using the STS LPX Pegasus. The mean diameter of the pores was 
calculated to be 112 nm ± 10 nm, with a pore depth of 340 nm ± 36 nm. E.4 Sample b2N07S43   263 
 
E.4  Sample b2N07S43 
These SEM micrographs of sample b2N07S43 were acquired with the SiO2 hard 
mask still intact. 
695 nm
111 nm 200 nm 1 m μ
 
(a) (b) 
Figure   E.4: (a) Oblique, cross-sectional view and (b) plane-view SEM micrographs of sample 
b2N07S43 after the RIE process using the STS LPX Pegasus. 
E.5  Sample b2P06S23 
These SEM micrographs of sample b2P07S23 were acquired with the SiO2 hard 
mask still intact. 
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500 nm 200 nm
 
(a) (b) 
Figure   E.5: (a) Oblique, cross-sectional view and (b) plane-view SEM micrographs of sample 
b2P06S23 after the RIE process using the STS LPX Pegasus. E.6 Sample b2P06S46   264 
 
E.6  Sample b2P02S46 
Sample b2P02S46 was deposited with nanospheres that were subsequently etched 
for 40 s using an O2 RIE process. The RIE of silicon using the STS LPX Pegasus was 
then performed for 10 minutes to realise the nanopillars. 
500 nm 500 nm
 
(a) (b) 
Figure   E.6: (a) Cross-sectional view and (b) plane-view SEM micrographs of sample b2P02S46 after 
the RIE of silicon. Nanopillars of ~ 107 nm in diameter and ~ 894 nm in length were fabricated. 
E.7  Sample b2P02S56 
Sample b2P02S56 was deposited with nanospheres that were subsequently etched 
for 50 s using an O2 RIE process. The RIE of silicon using the STS LPX Pegasus was 
then performed for 15 minutes to realise the nanowires. 
1 m μ 500 nm
 
(a) (b) 
Figure   E.7: (a) Oblique, cross-sectional view and (b) plane-view SEM micrographs of sample 
b2P02S56 after the RIE of silicon. Nanowires of ~ 97 nm in diameter and ~ 1369 nm in length were 
fabricated.  
265 
F  Publications 
Appendix  F 
Publications 
F.1  Journal and Conferences 
1)  C. F. Chau and T. Melvin, "The fabrication of macroporous polysilicon by 
nanosphere lithography," J. Micromech. Microeng., 18 (6), 064012 (9pp.), 2008. 
2)  C. F. Chau and T. Melvin, (Talk) "Fabrication of macroporous polysilicon using 
nanosphere lithography technique," in Biomimetic on the Nanoscale (IoP Day 
Meeting), Southampton, UK, Feb. 2008. 
3)  C. F. Chau and T. Melvin, (Poster) "Fabrication of macroporous polysilicon by 
using nanosphere lithography," in 18th Workshop on Micromachining, 
Micromechanics and Microsystems (MME 2007), Guimaraes, Portugal, pp. 273-
276, Sep. 2007. 
4)  C. F. Chau, T. Melvin, and B. Hamilton, (Poster) "Fabrication of a nanoporous 
polysilicon device for drug delivery," in Nanoscale Physics and Technology: the 
Interface with Medical and Biological Sciences (IoP Meeting), Southampton, UK, 
Mar. 2007. 
5)  S. Mohmad, C. F. Chau, T. Melvin, S. Atri, and C. Kaminski, (Talk) "Nano-
porous polysilicon fabrication for micro electro mechanical system (MEMS) drug 
delivery device," IFMBE for the 3rd Kuala Lumpur International Conference on F.2 Supporting Publications    266 
 
Biomedical Engineering 2006 (Biomed 2006), Kuala Lumpur, Malaysia, Dec. 
2006. 
F.2  Supporting Publications 
1)  C. F. Chau and T. Melvin, (Talk) "Design and fabrication of passive mixing 
channels to be incorporated into a centrifugally driven microfluidic lab-on-a-
disc," in 7th Postgraduate Research Conference in Electronics, Photonics, 
Communications and Software (PREP 2005), Lancaster, UK, 2005. 
2)  B. Mills, C. F. Chau, E. T. F. Rogers, J. Grant-Jacob, S. L. Stebbings, M. 
P r a e g e r ,  A .  M .  D e  P a u l a ,  C .  A .  F r o u d ,  R .  T .  C h a p m a n ,  T .  J .  B u t c h e r ,  J .  J .  
Baumberg, W. S. Brocklesby and J. G. Frey, "Direct measurement of the 
complex refractive index in the extreme ultraviolet spectral region using 
diffraction from a nanosphere array," Appl. Phys. Lett., 93 (23), 231103 (3pp.), 
2008. 
3)  B. Mills, C. F. Chau, E. T. F. Rogers, J. Grant-Jacob, S. L. Stebbings, M. 
Praeger, C. A. Froud, R. T. Chapman, T .  J .  B u t c h e r ,  D .  C .  H a n n a ,  J .  J .  
Baumberg, W. S. Brocklesby and J. G. Frey, (Talk) "XUV diffraction from a self-
assembled 2D array of close-packed 200nm diameter PMMA spheres," in Optics 
and Photonics Conf. 2008 (Photon 08), Edinburg, UK, August 2008. 
4)  B. Mills, C. F. Chau, E. T. F. Rogers, J. Grant-Jacob, S. L. Stebbings, M. 
Praeger, C. A. Froud, R. T. Chapman, T .  J .  B u t c h e r ,  D .  C .  H a n n a ,  J .  J .  
Baumberg, W. S. Brocklesby and J. G. Frey, (Talk) "XUV diffraction from a self-
assembled 2D array of close-packed 200nm diameter PMMA spheres," in 





[1]  C. Holroyd, C. Cooper and E. Dennison, "Epidemiology of osteoporosis," Best Pract. Res. 
Clin. Endocrinol. Metab., 22 (5), pp. 671-685, 2008. 
[2]  National Osteoporosis Society England, The NOS Menifesto 2009: Protecting fragile bones 
- A strategy to reduce the impact of osteoporosis and fragility fractures in England, 
http://www.nos.org.uk/NetCommunity/Document.Doc?id=490, last accessed in Jul. 2009. 
[3] S.  Parrott,  The economic cost of hip fracture in the UK. A paper commissioned by Health 
Promotion England on behalf of the Department of Trade and Industry York, UK: Centre 
for Health Economics, University of York, Jun. 2000. 
[4]  T. P. van Staa, E. M. Dennison, H. G. M. Leufkens and C. Cooper, "Epidemiology of 
fractures in England and Wales," Bone, 29 (6), pp. 517-522, 2001. 
[5]  G. F. Muschler, C. Nakamoto and L. G. Griffith, "Engineering principles of clinical cell-
based tissue engineering," J. Bone Joint Surg. Am., 86 (7), pp. 1541-1558, 2004. 
[6]  P. V. Giannoudis, T. A. Einhorn and D. Marsh, "Fracture healing: The diamond concept," 
Injury, Int. J. Care Injured, 38 (Supplement 4), pp. S3-S6, 2007. 
[7]  S. B. Trippel, R. D. Coutts, T. A. Einhorn, G. R. Mundy and R. G. Rosenfeld, "Instructional 
Course Lectures, The American Academy of Orthopaedic Surgeons - Growth factors as 
therapeutic agents," J. Bone Joint Surg. Am., 78A (8), pp. 1272-1286, 1996. 
[8]  S. R. Winn, H. Uludag and J. O. Hollinger, "Sustained release emphasizing recombinant 
human bone morphogenetic protein-2," Adv. Drug Deliv. Rev., 31 (3), pp. 303-318, 1998. 
[9]  M. R. Urist, "Bone: Formation by autoinduction," Science, 150 (3698), pp. 893-899, 1965. 
[10]  M. R. Urist and B. S. Strates, "Bone morphogenetic protein," J. Dent. Res., 50 (6), pp. 
1392-1406, 1971. 
[11]  H. Cheng, W. Jiang, F. M. Phillips, R. C. Haydon, Y. Peng, L. Zhou, H. H. Luu, N. An, B. 
Breyer, P. Vanichakarn, et al., "Osteogenic activity of the fourteen types of human bone 
morphogenetic proteins (BMPs)," J. Bone Joint Surg. Am., 85A (8), pp. 1544-1552, 2003. 
[12]  O. P. Gautschi, S. P. Frey and R. Zellweger, "Bone morphogenetic proteins in clinical 
applications," ANZ J. Surg., 77 (8), pp. 626-631, 2007. 
[13]  D. Chen, M. Zhao and G. R. Mundy, "Bone morphogenetic proteins," Growth Factors, 22 
(4), pp. 233 - 241, 2004. 
[14]  M. F. Termaat, F. C. Den Boer, F. C. Bakker, P. Patka and H. J. T. M. Haarman, "Bone 
Morphogenetic Proteins. Development and clinical efficacy in the treatment of fractures 
and bone defects," J. Bone Joint Surg. Am., 87 (6), pp. 1367-1378, 2005. References   268 
 
[15]  W. F. McKay, S. M. Peckham and J. M. Badura, "A comprehensive clinical review of 
recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft)," Int. Orthop., 
31 (6), pp. 729-734, 2007. 
[16]  G. Schmidmaier, P. Schwabe, B. Wildemann and N. P. Haas, "Use of bone morphogenetic 
proteins for treatment of non-unions and future perspectives," Injury, Int. J. Care Injured, 
38 (Supplement 4), pp. S35-S41, 2007. 
[17]  J. M. Schmitt, K. Hwang, S. R. Winn and J. O. Hollinger, "Bone morphogenetic proteins: 
An update on basic biology and clinical relevance," J. Orthop. Res., 17 (2), pp. 269-278, 
1999. 
[18]  J. K. Burkus, M. F. Gornet, C. A. Dickman and T. A. Zdeblick, "Anterior lumbar interbody 
fusion using rhBMP-2 with tapered interbody cages," J. Spinal Disord. Tech., 15 (5), pp. 
337-349, 2002. 
[19]  G. E. Friedlaender, C. R. Perry, J. D. Cole, S. D. Cook, G. Cierny, G. F. Muschler, G. A. 
Zych, J. H. Calhoun, A. J. LaForte and S. Yin, "Osteogenic protein-1 (bone morphogenetic 
protein-7) in the treatment of tibial nonunions: A prospective, randomized clinical trial 
comparing rhOP-1 with fresh bone autograft," J. Bone Joint Surg. Am., 83A (Supp. 1, Part 
2), pp. S151-S158, 2001. 
[20]  BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group, S. Govender, C. 
Csimma, H. K. Genant, A. Valentin-Opran, Y. Amit, R. Arbel, H. Aro, D. Atar, M. Bishay, 
et al., "Recombinant human bone morphogenetic protein-2 for treatment of open tibial 
fractures: A prospective, controlled, randomized study of four hundred and fifty patients," 
J. Bone Joint Surg. Am., 84A (12), pp. 2123-2134, 2002. 
[21]  H. Seeherman and J. M. Wozney, "Delivery of bone morphogenetic proteins for orthopedic 
tissue regeneration," Cytokine Growth Factor Rev., 16 (3), pp. 329-345, 2005. 
[22]  G. Schmidmaier, P. Schwabe, C. Strobel and B. Wildemann, "Carrier systems and 
application of growth factors in orthopaedics," Injury, Int. J. Care Injured, 39 (Supplement 
2), pp. S37-S43, 2008. 
[23]  E. Anitua, M. Sánchez, G. Orive and I. Andia, "Delivering growth factors for therapeutics," 
Trends Pharmacol. Sci., 29 (1), pp. 37-41, 2008. 
[24]  M. Geiger, R. H. Li and W. Friess, "Collagen sponges for bone regeneration with rhBMP-
2," Adv. Drug Deliv. Rev., 55 (12), pp. 1613-1629, 2003. 
[25]  W. G. De Long, Jr., T. A. Einhorn, K. Koval, M. McKee, W. Smith, R. Sanders and T. 
Watson, "Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical 
analysis," J. Bone Joint Surg. Am., 89 (3), pp. 649-658, 2007. 
[26]  B. McKay and H. S. Sandhu, "Use of recombinant human bone morphogenetic protein-2 in 
spinal fusion applications," Spine, 27 (16S), pp. S66-S85, 2002. 
[27]  R. Ruppert, E. Hoffmann and W. Sebald, "Human bone morphogenetic protein 2 contains a 
Heparin-binding site which modifies its biological activity," Eur. J. Biochem., 237 (1), pp. 
295-302, 1996. 
[28]  C. Scheufler, W. Sebald and M. Hülsmeyer, "Crystal structure of human bone 
morphogenetic protein-2 at 2.7 Å resolution," J. Mol. Biol., 287 (1), pp. 103-115, 1999. 
[29]  M. Laub, H. P. Jennissen, T. Seul and E. Schmachtenberg, "Molecular modelling of bone 
morphogenetic protein-2 (BMP-2) by 3D-rapid prototyping," Materwiss. Werksttech.,  32 
(12), pp. 926-930, 2001. References   269 
 
[30]  H. Ohta, S. Wakitani, K. Tensho, H. Horiuchi, S. Wakabayashi, N. Saito, Y. Nakamura, K. 
Nozaki, Y. Imai and K. Takaoka, "The effects of heat on the biological activity of 
recombinant human bone morphogenetic protein-2," J. Bone Miner. Metab., 23  (6), pp. 
420-425, 2005. 
[31]  R. D'Aquino, "Good drug therapy: It's not just the molecule - It's the delivery," in Chem. 
Eng. Prog. magazine, 100 (2), pp. 15S-17S, 2004. 
[32]  J. T. Santini, A. C. Richards, R. Scheidt, M. J. Cima and R. Langer, "Microchips as 
controlled drug-delivered devices," Angew. Chem. Int. Ed., 39 (14), pp. 2397-2407, 2000. 
[33]  F. J. Martin and C. Grove, "Microfabricated drug delivery systems: Concepts to improve 
clinical benefit," Biomed. Microdevices, 3 (2), pp. 97-108, 2001. 
[34]  S. Sharma, A. J. Nijdam, P. M. Sinha, R. J. Walczak, X. Liu, M. M. C. Cheng and M. 
Ferrari, "Controlled-release microchips," Expert Opin. Drug Deliv.,  3  (3), pp. 379-394, 
2006. 
[35]  J. Z. Hilt and N. A. Peppas, "Microfabricated drug delivery devices," Int. J. Pharm., 306 
(1-2), pp. 15-23, 2005. 
[36]  S. Zafar Razzacki, P. K. Thwar, M. Yang, V. M. Ugaz and M. A. Burns, "Integrated 
microsystems for controlled drug delivery," Adv. Drug Deliv. Rev., 56  (2), pp. 185-198, 
2004. 
[37]  O. H. Chan and B. H. Stewart, "Physicochemical and drug-delivery considerations for oral 
drug bioavailability," Drug Discov. Today, 1 (11), pp. 461-473, 1996. 
[38]  L. F. Chasseaud and T. Taylor, "Bioavailability of drugs from formulations after oral 
administration," Annu. Rev. of Pharmacol., 14, pp. 35-46, 1974. 
[39]  G. Walsh, "Biopharmaceuticals: Recent approvals and likely directions," Trends 
Biotechnol., 23 (11), pp. 553-558, 2005. 
[40]  S. D. Senturia, Microsystem Design, Boston, USA: Kluwer Academic, 2002. 
[41]  G. T. A. Kovacs, Micromachined Transducers Sourcebook, Boston, USA: McGraw-Hill, 
1998. 
[42]  M. J. Madou, Fundamentals of Microfabrication: The Science of Miniaturization, 2nd ed., 
Boca Raton , USA: CRC Press, 2002. 
[43]  M. Hu and R. Zengerle, "Microfabricated devices for controlled biochemical release," in 
10th International Conference on New Actuators and the 4th International Exhibition on 
Smart Actuators and Drive Systems (Actuator 2006), Bremen, Germany, pp. 263-271, Jun. 
2006. 
[44]  A. C. Richards Grayson, R. S. Shawgo, Y. Li and M. J. Cima, "Electronic MEMS for 
triggered delivery," Adv. Drug Deliv. Rev., 56 (2), pp. 173-184, 2004. 
[45]  M. L. Reed and W.-K. Lye, "Microsystems for drug and gene delivery," Proc. IEEE, 92 (1), 
pp. 56-75, 2004. 
[46]  D. A. LaVan, T. McGuire and R. Langer, "Small-scale systems for in vivo drug delivery," 
Nat. Biotechnol., 21 (10), pp. 1184-1191, 2003. 
[47]  R. S. Shawgo, A. C. R. Grayson, Y. Li and M. J. Cima, "BioMEMS for drug delivery," Curr. 
Opin. Solid State Mater. Sci., 6 (4), pp. 329-334, 2002. References   270 
 
[48]  A. C. Richards Grayson, R. S. Shawgo, A. M. Johnson, N. T. Flynn, Y. Li, M. J. Cima and 
R. Langer, "A BioMEMS review: MEMS technology for physiologically integrated devices," 
Proc. IEEE, 92 (1), pp. 6-21, 2004. 
[49]  M. Staples, K. Daniel, M. J. Cima and R. Langer, "Application of micro- and nano-
electromechanical devices to drug delivery," Pharm. Res., 23 (5), pp. 847-863, 2006. 
[50]  S. L. Tao and T. A. Desai, "Microfabricated drug delivery systems: From particles to 
pores," Adv. Drug Deliv. Rev., 55 (3), pp. 315-328, 2003. 
[51]  D. T. Birnbaum and L. Brannon-Peppas, "Microparticle drug delivery systems," in Drug 
Delivery Systems in Cancer Therapy, D. M. Brown (Ed.), Totowa, NJ, USA: Humana Press, 
2004, pp. 117-136. 
[52]  M. N. V. Ravi Kumar, "Nano and microparticles as controlled drug delivery devices," J. 
Pharm. Pharm. Sci., 3 (2), pp. 234-258, 2000. 
[53]  G. A. Hughes, "Nanostructure-mediated drug delivery," Nanomed. Nanotechnol. Biol. 
Med., 1 (1), pp. 22-30, 2005. 
[54]  J. Salonen, A. M. Kaukonen, J. Hirvonen and V.-P. Lehto, "Mesoporous silicon in drug 
delivery applications," J. Pharm. Sci., 97 (2), pp. 632-653, 2008. 
[55]  E. J. Anglin, L. Cheng, W. R. Freeman and M. J. Sailor, "Porous silicon in drug delivery 
devices and materials," Adv. Drug Deliv. Rev., 60 (11), pp. 1266-1277, 2008. 
[56]  M. Ferrari, "Cancer nanotechnology: Opportunities and challenges," Nat. Rev. Cancer, 5 
(3), pp. 161-171, 2007. 
[57]  W. R. Sanhai, J. H. Sakamoto, R. Canady and M. Ferrari, "Seven challenges for 
nanomedicine," Nat. Nanotechnol., 3 (5), pp. 242-244, 2008. 
[58]  C. E. Webb, "Chip shots," in IEEE Spectrum magazine, 41 (10), pp. 48-53, 2004. 
[59]  S. K. Deo, E. A. Moschou, S. F. Peteu, L. G. Bachas, S. Daunert, P. E. Eisenhardt and M. 
J. Madou, "Responsive drug delivery systems," Anal. Chem., 75 (9), pp. 206A-213A, 2003. 
[60]  L. T. Canham, "Bioactive silicon structure fabrication through nanoetching techniques," 
Adv. Mater., 7 (12), pp. 1033-1037, 1995. 
[61]  ---, "Biomedical applications of porous silicon," in Properties of Porous Silicon (EMIS 
Datareview Series No. 18), L. T. Canham (Ed.), London, UK: INSPEC, the Institution of 
Electrical Engineers, 1997, pp. 371-376. 
[62]  S. H. C. Anderson, H. Elliott, D. J. Walllis, L. T. Canham and J. J. Powell, "Dissolution of 
different forms of partially porous silicon wafers under simulated physiological 
conditions," Phys. Status Solidi A, 197 (2), pp. 331-5, 2003. 
[63]  S. L. Tao and T. A. Desai, "Micromachined devices: The impact of controlled geometry 
from cell-targeting to bioavailability," J. Controlled Release, 109 (1-3), pp. 127-138, 2005. 
[64]  K. M. Ainslie, C. M. Kraning and T. A. Desai, "Microfabrication of an asymmetric, multi-
layered microdevice for controlled release of orally delivered therapeutics," Lab Chip, 8 (7), 
pp. 1042-1047, 2008. 
[65]  A. Ahmed, C. Bonner and T. A. Desai, "Bioadhesive microdevices with multiple reservoirs: 
a new platform for oral drug delivery," J. Controlled Release, 81 (3), pp. 291-306, 2002. References   271 
 
[66]  S. L. Tao and T. A. Desai, "Micromachined polymeric devices for applications in targeted 
drug delivery," JALA J. Assoc. Lab. Autom., 9 (3), pp. 155-8, 2004. 
[67]  ---, "Microfabrication of multilayer, asymmetric, polymeric devices for drug delivery," Adv. 
Mater., 17 (13), pp. 1625-1630, 2005. 
[68]  M. H. Cohen, K. Melnik, A. A. Boiarski, M. Ferrari and F. J. Martin, "Microfabrication of 
silicon-based nanoporous particulates for medical applications," Biomed. Microdevices, 5 
(3), pp. 253-259, 2003. 
[69]  A. B. Foraker, R. J. Walczak, M. H. Cohen, T. A. Boiarski, C. F. Grove and P. W. Swaan, 
"Microfabricated porous silicon particles enhance paracellular delivery of insulin across 
intestinal Caco-2 cell monolayers," Pharm. Res., 20 (1), pp. 110-116, 2003. 
[70]  J. Salonen, L. Laitinen, A. M. Kaukonen, J. Tuura, M. Björkqvist, T. Heikkilä, K. Vähä-
Heikkilä, J. Hirvonen and V.-P. Lehto, "Mesoporous silicon microparticles for oral drug 
delivery: Loading and release of five model drugs," J. Controlled Release, 108 (2-3), pp. 
362-374, 2005. 
[71]  E. Tasciotti, X. Liu, R. Bhavane, K. Plant, A. D. Leonard, B. K. Price, M. M.-C. Cheng, P. 
Decuzzi, J. M. Tour, F. Robertson, et al., "Mesoporous silicon particles as a multistage 
delivery system for imaging and therapeutic applications," Nat. Nanotechnol., 3 (3), pp. 
151-157, 2008. 
[72]  L. Brown and R. Langer, "Transdermal delivery of drugs," Ann. Rev. Med., 39, pp. 221-
229, 1988. 
[73]  R. B. Stoughton, "Percutaneous Absorption of Drugs," Annu. Rev. Pharmacol Toxicol, 29, 
pp. 55-69, 1989. 
[74]  V. V. Ranade, "Drug delivery systems. 6. Transdermal drug delivery," J. Clin. Pharmacol., 
31 (5), pp. 401-418, 1991. 
[75]  R. Kumar and A. Philip, "Modified transdermal technologies: Breaking the barriers of 
drug permeation via the skin," Trop. J. Pharm. Res., 6 (1), pp. 633-644, 2007. 
[76]  M. R. Prausnitz, S. Mitragotri and R. Langer, "Current status and future potential of 
transdermal drug delivery," Nat Rev Drug Discov, 3 (2), pp. 115-124, 2004. 
[77]  C. H. Dublin, "Transdermal delivery becoming more active," in Drug Deliv. Technol. 
magazine, 8 (7), pp. 38-43, 2008. 
[78]  T. Tanner and R. Marks, "Delivering drugs by the transdermal route: Review and 
comment," Skin Res. Technol., 14 (3), pp. 249-260, 2008. 
[79]  K. Chiarello, "Breaking the barrier: Advances in transdermal technology," in Pharm. 
Technol. magazine, 28 (10), pp. 46-56, 2004. 
[80]  M. R. Prausnitz, "Microneedles for transdermal drug delivery," Adv. Drug Deliv. Rev., 56 
(5), pp. 581-587, 2004. 
[81]  D. V. McAllister, M. G. Allen and M. R. Prausnitz, "Microfabricated microneedles for gene 
and drug delivery," Annu. Rev. Biomed. Eng., 2, pp. 289-313, 2000. 
[82]  J. C. Birchall, "Microneedle array technology: the time is right but is the science ready?," 
Expert Rev. Med. Devices, 3 (1), pp. 1-4, 2006. References   272 
 
[83]  H. S. Gill and M. R. Prausnitz, "Coated microneedles for transdermal delivery," J. 
Controlled Release, 117 (2), pp. 227-237, 2007. 
[84]  D. V. McAllister, P. M. Wang, S. P. Davis, J.-H. Park, P. J. Canatella, M. G. Allen and M. 
R. Prausnitz, "Microfabricated needles for transdermal delivery of macromolecules and 
nanoparticles: Fabrication methods and transport studies," Proc. Natl. Acad. Sci. USA, 
100 (24), pp. 13755-13760, 2003. 
[85]  S. Mitragotri, "Immunization without needles," Nat. Rev. Immunol., 5 (12), pp. 905-916, 
2005. 
[86]  K. D. Wise, J. B. Angell and A. Starr, "An integrated-circuit approach to extracellular 
microelectrodes," IEEE Trans. Biomed. Eng., 17 (3), pp. 238-247, 1970. 
[87]  J. Chen, K. D. Wise, J. F. Hetke and S. C. Bledsoe, Jr., "A multichannel neural probe for 
selective chemical delivery at the cellular level," IEEE Trans. Biomed. Eng., 44 (8), pp. 
760-769, 1997. 
[88]  L. Lin and A. P. Pisano, "Silicon-processed microneedles," J. Microelectromech. Syst., 8 (1), 
pp. 78-84, 1999. 
[89]  J. D. Zahn, A. Deshmukh, A. P. Pisano and D. Liepmann, "Continuous on-chip 
micropumping for microneedle enhanced drug delivery," Biomed. Microdevices, 6 (3), pp. 
183-90, 2004. 
[90]  S. Henry, D. V. McAllister, M. G. Allen and M. R. Prausnitz, "Microfabricated 
microneedles: A novel approach to transdermal drug delivery," J. Pharm. Sci., 87 (8), pp. 
922-925, 1998. 
[91]  H. Jansen, M. de Boer, R. Legtenberg and M. Elwenspoek, "The Black Silicon method: A 
universal method for determining the parameter setting of a fluorine-based reactive ion 
etcher in deep silicon trench etching with profile control," J. Micromech. Microeng., 5 (2), 
pp. 115-120, 1995. 
[92]  S. Kaushik, A. H. Hord, D. D. Denson, D. V. McAllister, S. Smitra, M. G. Allen and M. R. 
Prausnitz, "Lack of pain associated with microfabricated microneedles," Anesth. Analg., 92 
(2), pp. 502-504, 2001. 
[93]  D. P. Wermeling, S. L. Banks, D. A. Hudson, H. S. Gill, J. Gupta, M. R. Prausnitz and A. 
L. Stinchcomb, "Microneedles permit transdermal delivery of a skin-impermeant 
medication to humans," Proc. Natl. Acad. Sci. USA, 105 (6), pp. 2058-2063, 2008. 
[94]  B. Stoeber and D. Liepmann, "Arrays of hollow out-of-plane microneedles for drug 
delivery," J. Microelectromech. Syst., 14 (3), pp. 472-479, 2005. 
[95]  F. Lärmer and A. Schilp, "Method of Anisotropically Etching Silicon." Robert Bosch 
GmbH, Stuttgart, Germany: U.S. Patent 5501893, 1996. 
[96]  P. Griss and G. Stemme, "Side-opened out-of-plane microneedles for microfluidic 
transdermal liquid transfer," J. Microelectromech. Syst., 12 (3), pp. 296-301, 2003. 
[97]  H. J. G. E. Gardeniers, R. Luttge, E. J. W. Berenschot, M. J. de Boer, S. Y. Yeshurun, M. 
Hefetz, R. van't Oever and A. van den Berg, "Silicon micromachined hollow microneedles 
for transdermal liquid transport," J. Microelectromech. Syst., 12 (6), pp. 855-62, 2003. 
[98]  W. Lin, M. Cormier, A. Samiee, A. Griffin, B. Johnson, C.-L. Teng, G. E. Hardee and P. E. 
Daddona, "Transdermal delivery of antisense oligonucleotides with microprojection patch 
(Macroflux®) technology," Pharm. Res., 18 (12), pp. 1789-1793, 2001. References   273 
 
[99]  G. Widera, J. Johnson, L. Kim, L. Libiran ,  K .  N ya m ,  P .  E .  D a d d o n a  a n d  M.  C o rm i e r,  
"Effect of delivery parameters on immunization to ovalbumin following intracutaneous 
administration by a coated microneedle array patch system," Vaccine, 24 (10), pp. 1653-
1664, 2006. 
[100]  J. A. Matriano, M. Cormier, J. Johnson, W. A. Young, M. Buttery, K. Nyam and P. E. 
Daddona, "Macroflux® microprojection array patch technology: A new and efficient 
approach for intracutaneous immunization," Pharm. Res., 19 (1), pp. 63-70, 2002. 
[101]  J. W. Lee, J.-H. Park and M. R. Prausnitz, "Dissolving microneedles for transdermal drug 
delivery," Biomaterials, 29 (13), pp. 2113-24, 2008. 
[102]  S. P. Sullivan, N. Murthy and M. R. Prausnitz, "Minimally invasive protein delivery with 
rapidly dissolving polymer microneedles," Adv. Mater., 20 (5), pp. 933-938, 2008. 
[103]  J.-H. Park, M. Allen and M. Prausnitz, "Polymer microneedles for controlled-release drug 
delivery," Pharm. Res., 23 (5), pp. 1008-1019, 2006. 
[104]  J.-H. Park, M. G. Allen and M. R. Prausnitz, "Biodegradable polymer microneedles: 
Fabrication, mechanics and transdermal drug delivery," J. Controlled Release, 104 (1), pp. 
51-66, 2005. 
[105]  J. H. Park, Y. K. Yoon, S. O. Choi, M. R. Prausnitz and M. G. Allen, "Tapered conical 
polymer microneedles fabricated using an integrated lens technique for transdermal drug 
delivery," IEEE Trans. Biomed. Eng., 54 (5), pp. 903-913, 2007. 
[106]  T. Miyano, Y. Tobinaga, T. Kanno, Y. Matsuzaki, H. Takeda, M. Wakui and K. Hanada, 
"Sugar micro needles as transdermic drug delivery system," Biomed. Microdevices, 7 (3), 
pp. 185-188, 2005. 
[107]  J. Ji, F. E. H. Tay, J. Miao and C. Iliescu, "Microfabricated microneedle with porous tip for 
drug delivery," J. Micromech. Microeng., 16 (5), pp. 958-964, 2006. 
[108]  J. Ji, F. E. H. Tay, M. Jianmin and C. Iliescu, "Microfabricated silicon microneedle array 
for transdermal drug delivery," in International MEMS Conference 2006, Singapore, pp. 
1127-31, May 2006. 
[109]  B. Chen, J. Wei, F. E. H. Tay, Y. T. Wong and C. Iliescu, "Silicon microneedle array with 
biodegradable tips for transdermal drug delivery," Microsyst. Technol., 14 (7), pp. 1015-
1019, 2008. 
[110]  V. V. Ranade, "Drug delivery systems. 4. Implants in drug delivery," J. Clin. Pharmacol., 
30 (10), pp. 871-889, 1990. 
[111]  N.-C. Tsai and C.-Y. Sue, "Review of MEMS-based drug delivery and dosing systems," 
Sens. Actuators A, 134 (2), pp. 555-64, 2007. 
[112]  A. Nisar, N. Afzulpurkar, B. Mahaisavariya and A. Tuantranont, "MEMS-based 
micropumps in drug delivery and biomedical applications," Sens. Actuators B, 130 (2), pp. 
917-942, 2008. 
[113]  J. T. Santini, A. C. Richards, R. A. Scheidt, M. J. Cima and R. S. Langer, "Microchip 
technology in drug delivery," Ann. Med., 32 (6), pp. 377 - 379, 2000. 
[114]  N.-T. Nguyen and S. T. Wereley, Fundamentals and Applications of Microfluidics, Boston, 
USA: Artech House, 2002. 
[115] B.  Husband,  The Design and Fabrication of a Magnetically Actuated Microfluidic 
Dispensing Device, Ph.D. Dissertation, University of Southampton, 2007. References   274 
 
[116]  A. Geipel, F. Goldschmidtboeing, P. Jantscheff, N. Esser, U. Massing and P. Woias, 
"Design of an implantable active microport system for patient specific drug release," 
Biomed. Microdevices, 10 (4), pp. 469-478, 2008. 
[117]  A. Geipel, A. Doll, F. Goldschmidtboing, P. Jantscheff, N. Esser, U. Massing and P. Woias, 
"Pressure-independent micropump with piezoelectric valves for low flow drug delivery 
systems," in Proc. 19th IEEE International Conference on Micro Electro Mechanical 
Systems (MEMS 2006), Istanbul, Turkey, pp. 786-789, Jan. 2006. 
[118]  A. Geipel, A. Doll, P. Jantscheff, N. Esser, U. Massing, P. Woias and F. 
Goldschmidtboeing, "A novel two-stage backpressure-independent micropump: Modeling 
and characterization," J. Micromech. Microeng., 17 (5), pp. 949-59, 2007. 
[119]  D. Maillefer, S. Gamper, B. Frehner, P. Balmer, H. Van Lintel and P. Renaud, "A high-
performance silicon micropump for disposable drug delivery systems," in Tech. Digest 14th 
IEEE International Conference on Micro Electro Mechanical Systems (MEMS 2001), 
Interlaken, Switzerland, pp. 413-417, Jan. 2001. 
[120]  D. Maillefer, H. van Lintel, G. Rey-Mermet and R. Hirschi, "A high-performance silicon 
micropump for an implantable drug delivery system," in Proc. 12th IEEE International 
Conference on Micro Electro Mechanical Systems (MEMS 1999), Orlando, FL, USA, pp. 
541-546, Jan. 1999. 
[121]  Y.-C. Su and L. Lin, "A water-powered micro drug delivery system," J. Microelectromech. 
Syst., 13 (1), pp. 75-82, 2004. 
[122]  W. Ryu, Z. Huang, F. B. Prinz, S. B. Goodman and R. Fasching, "Biodegradable micro-
osmotic pump for long-term and controlled release of basic fibroblast growth factor," J. 
Controlled Release, 124 (1-2), pp. 98-105, 2007. 
[123]  Viadur
® Press Release (12 Dec. 2007), 
http://www.bayerviadur.com/pdfs/Final_Press_Release_Viadur_122007.pdf, last accessed 
in Sep. 2008. 
[124]  DUROS
® Fact Sheet, http://www.durect.com/pdf/duros_fact_sheet2001.pdf, last accessed in 
Sep. 2008. 
[125]  J. T. Santini, M. J. Cima and R. Langer, "A controlled-release microchip," Nature, 397 
(6717), pp. 335-338, 1999. 
[126]  J. M. Maloney, S. A. Uhland, B. F. Polito, N. F. Sheppard Jr, C. M. Pelta and J. T. Santini 
Jr, "Electrothermally activated microchips for implantable drug delivery and biosensing," 
J. Controlled Release, 109 (1-3), pp. 244-255, 2005. 
[127]  J. Prescott, T. Krieger, S. Lipka and M. Staples, "Dosage form development, in vitro 
release kinetics, and in vitro–in vivo correlation for Leuprolide released from an 
implantable multi-reservoir array," Pharm. Res., 24 (7), pp. 1252-1261, 2007. 
[128]  J. H. Prescott, S. Lipka, S. Baldwin, N. F. Sheppard, J. M. Maloney, J. Coppeta, B. 
Yomtov, M. A. Staples and J. T. Santini, "Chronic, programmed polypeptide delivery from 
an implanted, multireservoir microchip device," Nat. Biotechnol., 24 (4), pp. 437-438, 2006. 
[129]  E. R. Proos, J. H. Prescott and M. A. Staples, "Long-term stability and in vitro release of 
hPTH(1–34) from a multi-reservoir array," Pharm. Res., 25 (6), pp. 1387-1395, 2008. 
[130]  A. C. Richards Grayson, I. S. Choi, B. M. Tyler, P. P. Wang, H. Brem, M. J. Cima and R. 
Langer, "Multi-pulse drug delivery from a resorbable polymeric microchip device," Nat. 
Mater., 2 (11), pp. 767-772, 2003. References   275 
 
[131]  F. Martin, R. Walczak, A. Boiarski, M. Cohen, T. West, C. Cosentino, J. Shapiro and M. 
Ferrari, "Tailoring width of microfabricated nanochannels to solute size can be used to 
control diffusion kinetics," J. Controlled Release, 102 (1), pp. 123-133, 2005. 
[132]  P. M. Sinha, G. Valco, S. Sharma, L. Xuewu and M. Ferrari, "Nanoengineered device for 
drug delivery application," Nanotechnology, 15 (10), pp. 585-9, 2004. 
[133]  G. B. Lesinski, S. Sadhana, K. A. Varker, P. Sinha, M. Ferrari and I. I. I. W. Carson, 
"Release of biologically functional interferon-alpha from a nanochannel delivery system," 
Biomed. Microdevices, 7 (1), pp. 71-9, 2005. 
[134]  L. T. Canham, "Silicon quantum wire array fabrication by electrochemical and chemical 
dissolution of wafers," Appl. Phys. Lett., 57 (10), pp. 1046-50, 1990. 
[135]  V. Lehmann and U. Gösele, "Porous silicon formation: A quantum wire effect," Appl. Phys. 
Lett., 58 (8), pp. 856-858, 1991. 
[136]  J. Salonen and V.-P. Lehto, "Fabrication and chemical surface modification of mesoporous 
silicon for biomedical applications," Chem. Eng. J., 137 (1), pp. 162-172, 2008. 
[137]  A. G. Cullis, L. T. Canham and P. D. J. Calcott, "The structural and luminescence 
properties of porous silicon," J. Appl. Phys., 82 (3), pp. 909-965, 1997. 
[138]  V. Lehmann, "Trends in fabrication and applications of macroporous silicon," Phys. Status 
Solidi A, 197, pp. 13-15, 2003. 
[139]  M. J. Sailor, "Sensor applications of porous silicon," in Properties of Porous Silicon (EMIS 
Datareview Series No. 18), L. T. Canham (Ed.), London, UK: INSPEC, the Institution of 
Electrical Engineers, 1997, pp. 364-370. 
[140]  E. Lorenzo, C. J. Oton, N. E. Capuj, M. Ghulinyan, D. Navarro-Urrios, Z. Gaburro and L. 
Pavesi, "Porous silicon-based rugate filters," Appl. Opt., 44 (26), pp. 5415-5421, 2005. 
[141]  A. Janshoff, K.-P. S. Dancil, C. Steinem, D. P. Greiner, V. S.-Y. Lin, C. Gurtner, K. 
Motesharei, M. J. Sailor and M. R. Ghadiri, "Macroporous p-type silicon Fabry-Pérot 
layers. Fabrication, characterization, and applications in biosensing," J. Am. Chem. Soc., 
120 (46), pp. 12108-12116, 1998. 
[142]  M. Thönissen, M. Krüger, G. Lerondel and R. Romestain, "Optical applications of porous 
silicon," in Properties of Porous Silicon (EMIS Datareview Series No. 18), L. T. Canham 
(Ed.), London, UK: INSPEC, the Institution of Electrical Engineers, 1997, pp. 349-355. 
[143]  V. P. Bondarenko and V. A. Yakovtseva, "Optoelectronic applications of porous silicon," in 
Properties of Porous Silicon (EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, 
UK: INSPEC, the Institution of Electrical Engineers, 1997, pp. 356-363. 
[144]  N. M. Kalkhoran, F. Namavar and H. P. Maruska, "Optoelectronic applications of porous 
polycrystalline silicon," Appl. Phys. Lett., 63 (19), pp. 2661-2663, 1993. 
[145]  V. Lehmann, B. Jobst, T. Muschik, A. Kux and V. Petrova-Koch, "Correlation between 
optical properties and crystallite size in porous silicon," Jpn. J. Appl. Phys., Part 1 Regul. 
Pap. Short Note Rev. Pap., 32 (5A), pp. 2095-2099, 1993. 
[146]  S. Gardelis, U. Bangert and B. Hamilton, "Correlation between structural and optical 
properties of luminescent porous silicon," Thin Solid Films, 255 (1-2), pp. 167-170, 1995. 
[147]  J. Z. Wallner and P. L. Bergstrom, "A porous silicon based particle filter for 
microsystems," Phys. Status Solidi A, 204 (5), pp. 1469-1473, 2007. References   276 
 
[148]  X. G. Zhang, "Morphology and formation mechanisms of porous silicon," J. Electrochem. 
Soc., 151 (1), pp. C69-C80, 2004. 
[149]  V. N. Tondare, B. C. Gierhart, D. G. Howitt, R. L. Smith, S. J. Chen and S. D. Collins, "An 
electron microscopy investigation of the structure of porous silicon by oxide replication," 
Nanotechnology, 19 (22), pp. 225301 (4 pp), 2008. 
[150]  J. Dian, A. Macek, D. Nižňanský, I. Němec, V. Vrkoslav, T. Chvojka and I. Jelínek, "SEM 
and HRTEM study of porous silicon - Relationship between fabrication, morphology and 
optical properties," Appl. Surf. Sci., 238 (1-4), pp. 169-174, 2004. 
[151]  R. J. Martín-Palma, P. Herrero, R. Guerrero-Lemus, J. D. Moreno and J. M. Martínez-
Duart, "Cross-section TEM and optical characterization of porous silicon multilayer 
stacks," J. Mater. Sci. Lett., 17 (10), pp. 845-847, 1998. 
[152]  S. Shih, K. H. Jung, R. Z. Qian and D. L. Kwong, "Transmission electron microscopy study 
of chemically etched porous Si," Appl. Phys. Lett., 62 (5), pp. 467-469, 1993. 
[153]  R. Hérino, "Pore size distribution in porous silicon," in Properties of Porous Silicon (EMIS 
Datareview Series No. 18), L. T. Canham (Ed.), London, UK: INSPEC, the Institution of 
Electrical Engineers, 1997, pp. 89-96. 
[154]  R. Hérino, G. Bomchil, K. Barla, C. Bertrand and J. L. Ginoux, "Porosity and pore size 
distributions of porous silicon layers," J. Electrochem. Soc., 134 (8), pp. 1994-2000, 1987. 
[155]  G. Bomchil, R. Hérino, K. Barla and J. C. Pfister, "Pore size distribution in porous silicon 
studied by adsorption isotherms," J. Electrochem. Soc., 130 (7), pp. 1611-14, 1983. 
[156]  P. G. Abramof, A. F. Beloto, A. Y. Ueta and N. G. Ferreira, "X-ray investigation of 
nanostructured stain-etched porous silicon," J. Appl. Phys., 99 (2), pp. 24304(5pp), 2006. 
[157]  S. Gardelis, U. Bangert, A. J. Harvey and B. Hamilton, "Double-crystal X-ray diffraction, 
electron diffraction, and high resolution electron microscopy of luminescent porous 
silicon," J. Electrochem. Soc., 142 (6), pp. 2094-2101, 1995. 
[158]  T. K. Sham, D. T. Jiang, I. Coulthard, J. W. Lorimer, X. H. Feng, K. H. Tan, S. P. Frigo, R. 
A. Rosenberg, D. C. Houghton and B. Bryskiewicz, "Origin of luminescence from porous 
silicon deduced by synchrotron-light-induced optical luminescence," Nature, 363 (6427), 
pp. 331-334, 1993. 
[159]  P. G. Abramof, N. G. Ferreira, A. F. Beloto and A. Y. Ueta, "Investigation of 
nanostructured porous silicon by Raman spectroscopy and atomic force microscopy," J. 
Non-Cryst. Solids, 338-340, pp. 139-142, 2004. 
[160]  R. J. Martín-Palma, L. Vázquez, P. Herrero, J. M. Martínez-Duart, M. Schnell and S. 
Schaefer, "Morphological, optical and electrical characterization of antireflective porous 
silicon coatings for solar cells," Opt. Mater., 17 (1-2), pp. 75-78, 2001. 
[161]  C. Wongmanerod, S. Zangooie and H. Arwin, "Determination of pore size distribution and 
surface area of thin porous silicon layers by spectroscopic ellipsometry," Appl. Surf. Sci., 
172 (1-2), pp. 117-125, 2001. 
[162]  W. J. Salcedo, F. J. Ramirez Fernandez and E. Galeazzo, "Structural characterization of 
photoluminescent porous silicon with FTIR spectroscopy," Braz. J. Phys., 27A (4), pp. 158-
161, 1997. 
[163]  J. Rouquérol, D. Avnir, C. W. Fairbridge, D. H. Everett, J. H. Haynes, N. Pernicone, J. D. 
F. Ramsay, K. S. W. Sing and K. K. Unger, "Recommendations for the characterization of 
porous solids (IUPAC Technical Report)," Pure Appl. Chem., 66 (8), pp. 1739-1758, 1994. References   277 
 
[164]  K. S. W. Sing, D. H. Everett, R. A. W. Haul, L. Moscou, R. A. Pierotti, J. Rouquérol and T. 
Siemieniewska, "Reporting physisorption data for gas/solid systems with special reference 
to the determination of surface area and porosity (IUPAC Recommendations 1984)," Pure 
Appl. Chem., 57 (4), pp. 603-619, 1985. 
[165]  H. Föll, M. Christophersen, J. Carstensen and G. Hasse, "Formation and application of 
porous silicon," Mater. Sci. Eng. R Rep., R39 (4), pp. 93-141, 2002. 
[166]  A. F. Vyatkin, "Macroporous silicon: Material science and technology," in Proc. SPIE - 
Micro- and Nanoelectronics 2003, Zvenigorod, Russia, pp. 187-191, Oct. 2003. 
[167]  V. Lehmann and U. Gösele, "The limits of macropore array fabrication," Thin Solid Films, 
297 (1-2), pp. 13-17, 1997. 
[168]  H. Föll, J. Carstensen and S. Frey, "Porous and nanoporous semiconductors and emerging 
applications," J. Nanomater., 2006, pp. 91635 (10pp), 2006. 
[169]  L. Santinacci and T. Djenizian, "Electrochemical pore formation onto semiconductor 
surfaces," C. R. Chimie, 11 (9), pp. 964-983, 2008. 
[170]  L. T. Canham, "Pore type, shape, size, volume and surface area in porous silicon," in 
Properties of Porous Silicon (EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, 
UK: INSPEC, the Institution of Electrical Engineers, 1997, pp. 83-88. 
[171]  E. S. Kooij and J. J. Kelly, "Chemiluminescence from porous silicon," in Properties of 
Porous Silicon (EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, UK: 
INSPEC, the Institution of Electrical Engineers, 1997, pp. 276-279. 
[172]  X. G. Zhang, "Mechanism of pore formation on n-type silicon," J. Electrochem. Soc., 138 
(12), pp. 3750-3756, 1991. 
[173]  C. Lévy-Clément, A. Lagoubi and M. Tomkiewicz, "Morphology of porous n-type silicon 
obtained by photoelectrochemical etching," J. Electrochem. Soc.,  141  (4), pp. 958-967, 
1994. 
[174]  C. Pickering, M. I. J. Beale, D. J. Robbins, P. J. Pearson and R. Greef, "Optical studies of 
the structure of porous silicon films formed in p-type degenerate and non-degenerate 
silicon," J. Phys. C: Solid State Phys., 17 (35), pp. 6535-6552, 1984. 
[175]  M. du Plessis, "Relationship between specific surface area and pore dimension of high 
porosity nanoporous silicon - Model and experiment," Phys. Status Solidi A, 204 (7), pp. 
23219-28, 2007. 
[176]  K. H. Jung, S. Shih and D. L. Kwong, "Developments in luminescent porous Si," J. 
Electrochem. Soc., 140 (10), pp. 3046-3064, 1993. 
[177] B.  Hamilton,  "Porous silicon," Semicond. Sci. Technol., 10 (9), pp. 1187-1207, 1995. 
[178]  A. G. Cullis and L. T. Canham, "Visible light emission due to quantum size effects in 
highly porous crystalline silicon," Nature, 353 (6342), pp. 335-338, 1991. 
[179]  S. Gardelis, J. S. Rimmer, P. Dawson, B. Hamilton, R. A. Kubiak, T. E. Whall and E. H. C. 
Parker, "Evidence for quantum confinement in the photoluminescence of porous Si and 
SiGe," Appl. Phys. Lett., 59 (17), pp. 2118-2220, 1991. 
[180]  R. W. Fathauer, T. George, A. Ksendzov and R. P. Vasquez, "Visible luminescence from 
silicon wafers subjected to stain etches," Appl. Phys. Lett., 60 (8), pp. 995-997, 1992. References   278 
 
[181]  J. Sarathy, S. Shih, K. Jung, C. Tsai, K. H. Li, D. L. Kwong, J. C. Campbell, Y. Shueh-Lin 
and A. J. Bard, "Demonstration of photoluminescence in nonanodized silicon," Appl. Phys. 
Lett., 60 (13), pp. 1532-1534, 1992. 
[182]  A. J. Steckl, J. Xu and H. C. Mogul, "Photoluminescence from stain-etched polycrystalline 
Si thin films," Appl. Phys. Lett., 62 (17), pp. 2111-2113, 1993. 
[183]  A. G. Cullis, L. T. Canham, G. M. Williams, P. W. Smith and O. D. Dosser, "Correlation of 
the structural and optical properties of luminescent, highly oxidized porous silicon," J. 
Appl. Phys., 75 (1), pp. 493-501, 1994. 
[184]  Y. Gao, D. G. Uttamchandani and B. Culshaw, "Comparative study on photoluminescence 
of porous silicon fabricated by different methods," in Proc. SPIE - 2nd International 
Conference on Optoelectronic Science and Engineering '94, Beijing, China, pp. 68-70, Aug. 
1994. 
[185]  S. Gardelis and B. Hamilton, "The effect of surface modification on the luminescence of 
porous silicon," J. Appl. Phys., 76 (9), pp. 5327-5333, 1994. 
[186]  U. Gösele and V. Lehmann, "Light-emitting porous silicon," Mater. Chem. Phys., 40 (4), pp. 
253-259, 1995. 
[187]  D. Dimova-Malinovska, M. Sendova-Vassileva, M. Kamenova, N. Tzenov and M. Tzolov, 
"On the origin of the visible luminescence from porous silicon," Vacuum, 47 (9), pp. 1133-
1138, 1996. 
[188]  W. N. Huang, K. Y. Tong and P. W. Chan, "Photoluminescence in porous sputtered 
polysilicon films formed by chemical etching," Semicond. Sci. Technol., 12 (2), pp. 228-233, 
1997. 
[189]  S. Cheylan, T. Trifonov, A. Rodriguez, L. F. Marsal, J. Pallares, R. Alcubilla and G. 
Badenes, "Visible light emission from macroporous Si," Opt. Mater., 29 (2-3), pp. 262-267, 
2006. 
[190]  G. M. Williams, "Cathodoluminescence properties of porous silicon," in Properties of 
Porous Silicon (EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, UK: 
INSPEC, the Institution of Electrical Engineers, 1997, pp. 270-275. 
[191]  A. Biaggi-Labiosa, L. F. Fonseca, O. Resto and I. Balberg, "Tuning the 
cathodoluminescence of porous silicon films," J. Lumin., 128 (3), pp. 321-327, 2008. 
[192]  L. T. Canham, W. Y. Leong, M. I. J. Beale, T. I. Cox and L. Taylor, "Efficient visible 
electroluminescence from highly porous silicon under cathodic bias," Appl. Phys. Lett., 61 
(21), pp. 2563-2565, 1992. 
[193]  S. Lazarouk, V. Bondarenko, P. Jaguiro, N. Lacquaniti, S. La Monica, G. Maiello, G. 
Masini and A. Ferrari, "Electrical characterization of visible emitting electroluminescent 
Schottky diodes based on n-type porous silicon and on highly doped n-type porous 
polysilicon," J. Non-Cryst. Solids, 198-200 (Part 2), pp. 973-976, 1996. 
[194]  N. Yamamoto, A. Sumiya and H. Takai, "Electroluminescence (EL) from photo-chemically 
etched silicon," Mater. Sci. Eng. B Solid-State Mater. Adv. Technol., 69-70, pp. 205-209, 
2000. 
[195]  E. S. Kooij, R. W. Despo and J. J. Kelly, "Electroluminescence from porous silicon due to 
electron injection from solution," Appl. Phys. Lett., 66 (19), pp. 2552-2554, 1995. 
[196]  W. N. Huang, K. Y. Tong and P. W. Chan, "Electroluminescence in porous polycrystalline 
silicon," Int. J. Electron., 85 (4), pp. 419-423, 1998. References   279 
 
[197]  J. Xu and A. J. Steckl, "Visible electroluminescence from stain-etched porous Si diodes," 
IEEE Electron Device Lett., 15 (12), pp. 507-509, 1994. 
[198]  E. S. Kooij, K. Butter and J. J. Kelly, "Hole injection at the silicon/aqueous electrolyte 
interface: A possible mechanism for chemiluminescence from porous silicon," J. 
Electrochem. Soc., 145 (4), pp. 1232-1238, 1998. 
[199]  L. T. Canham, "Storage of porous silicon," in Properties of Porous Silicon (EMIS 
Datareview Series No. 18), L. T. Canham (Ed.), London, UK: INSPEC, the Institution of 
Electrical Engineers, 1997, pp. 44-50. 
[200]  S. Godefroo, M. Hayne, M. Jivanescu, A. Stesmans, M. Zacharias, O. I. Lebedev, G. Van 
Tendeloo and V. V. Moshchalkov, "Classification and control of the origin of 
photoluminescence from Si nanocrystals," Nat. Nanotechnol., 3 (3), pp. 174-178, 2008. 
[201]  C. L. Curtis, V. V. Doan, G. M. Credo and M. J. Sailor, "Observation of optical cavity 
modes in photoluminescent porous silicon films," J. Electrochem. Soc., 140 (12), pp. 3492-
3494, 1993. 
[202]  J. D. Birchall, "The essentiality of silicon in biology," Chem. Soc. Rev., 24 (5), pp. 351-357, 
1995. 
[203]  C. Pacholski, M. Sartor, M. J. Sailor, F. Cunin and G. M. Miskelly, "Biosensing using 
porous silicon double-layer interferometers: Reflective interferometric fourier transform 
spectroscopy," J. Am. Chem. Soc., 127, pp. 11636-11645, 2005. 
[204]  E. J. Anglin, M. P. Schwartz, V. P. Ng, L. A. Perelman and M. J. Sailor, "Engineering the 
chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of 
a steroid," Langmuir, 20 (25), pp. 11264-11269, 2004. 
[205]  D. F. Williams, "On the mechanisms of biocompatibility," Biomaterials, 29 (20), pp. 2941-
53, 2008. 
[206]  B. D. Ratner and S. J. Bryant, "BIOMATERIALS: Where we have been and where we are 
going," Annu. Rev. Biomed. Eng., 6 (1), pp. 41-75, 2004. 
[207]  L. T. Canham, C. L. Reeves, J. P. Newey, M. R. Houlton, T. I. Cox, J. M. Buriak and M. P. 
Stewart, "Derivatized mesoporous silicon with dramatically improved stability in 
simulated human blood plasma," Adv. Mater., 11 (18), pp. 1505-1507, 1999. 
[208]  M. Arroyo-Hernández, J. Pérez-Rigueiro, M. Manso-Silván and J. M. Martínez-Duart, 
"Bioactivity test for amine-based functionalized meso- and macro-porous silicon 
substrates," Mater. Sci. Eng. C, Biomin. Supramol. Syst., 27 (5-8), pp. 1211-14, 2007. 
[209]  L. T. Canham, "Nanoscale semiconducting silicon as a nutritional food additive," 
Nanotechnology, 18 (18), pp. 185704, 2007. 
[210]  W. Y. Leong, A. Loni and L. T. Canham, "Electrically enhanced erosion of porous Si 
material in electrolyte by pH modulation and its application in chronotherapy," Phys. 
Status Solidi A, 204 (5), pp. 1486-90, 2007. 
[211]  J.-N. Chazalviel and F. Ozanam, "Surface modification of porous silicon," in Properties of 
Porous Silicon (EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, UK: 
INSPEC, the Institution of Electrical Engineers, 1997, pp. 59-65. 
[212]  J. H. Song and M. J. Sailor, "Chemical modification of crystalline porous silicon surfaces," 
Comments Inorg. Chem., 21 (1), pp. 69-84, 1999. References   280 
 
[213]  L. Vaccari, D. Canton, N. Zaffaroni, R. Villa, M. Tormen and E. Fabrizio, "Porous silicon as 
drug carrier for controlled delivery of doxorubicin anticancer agent," Microelectron. Eng., 
83 (4-9), pp. 1598-1601, 2006. 
[214]  A. M. Kaukonen, L. Laitinen, J. Salonen, J. Tuura, T. Heikkilä, T. Limnell, J. Hirvonen 
and V.-P. Lehto, "Enhanced in vitro permeation of furosemide loaded into thermally 
carbonized mesoporous silicon (TCPSi) microparticles," Eur. J. Pharm. Biopharm, 66 (3), 
pp. 348-356, 2007. 
[215]  C. A. Prestidge, T. J. Barnes, A. Mierczynska-Vasilev, W. Skinner, F. Peddie and C. 
Barnett, "Loading and release of a model protein from porous silicon powders," Phys. 
Status Solidi A, 204 (10), pp. 3361-3366, 2007. 
[216]  C. A. Prestidge, T. J. Barnes, A. Mierczynska-Vasilev, I. Kempson, F. Peddie and C. 
Barnett, "Peptide and protein loading into porous silicon wafers," Phys. Status Solidi A, 
205 (2), pp. 311-315, 2008. 
[217]  J. C. Thomas, C. Pacholski and M. J. Sailor, "Delivery of nanogram payloads using 
magnetic porous silicon microcarriers," Lab Chip, 6 (6), pp. 782-7, 2006. 
[218]  Y. Koh, S. Jang, J. Kim, S. Kim, Y. C. Ko, S. Cho and H. Sohn, "DBR PSi/PMMA composite 
materials for smart patch application," Colloids Surf. A Physicochem. Eng. Asp., 313-314, 
pp. 328-331, 2008. 
[219]  W. Sun, J. E. Puzas, T.-J. Sheu, X. Liu and P. M. Fauchet, "Nano- to microscale porous 
silicon as a cell interface for bone-tissue engineering," Adv. Mater., 19 (7), pp. 921-924, 
2007. 
[220]  W. Sun, J. E. Puzas, T.-J. Sheu and P. M. Fauchet, "Porous silicon as a cell interface for 
bone tissue engineering," Phys. Status Solidi A, 204 (5), pp. 1429-33, 2007. 
[221]  A. S.-W. Goh, A. Y.-F. Chung, R. H.-G. Lo, T.-N. Lau, S. W.-K. Yu, M. Chng, S. 
Satchithanantham, S. L.-E. Loong, D. C.-E. Ng, B.-C. Lim, et al., "A novel approach to 
brachytherapy in hepatocellular carcinoma using a phosphorous32 ( 32P) brachytherapy 
delivery device - A first-in-man study," Int. J. Radiation Oncology Biol. Phys., 67 (3), pp. 
786-792, 2007. 
[222]  A. Uhlir, "Electrolytic shaping of germanium and silicon," Bell Syst. Tech. J., 35 (2), pp. 
333-347, 1956. 
[223]  C. S. Fuller and J. A. Ditzenberger, "Diffusion of donor and acceptor elements in silicon," 
J. Appl. Phys., 27 (5), pp. 544-553, 1956. 
[224]  D. R. Turner, "Electropolishing silicon in hydrofluoric acid solutions," J. Electrochem. Soc., 
105 (7), pp. 402-408, 1958. 
[225]  R. J. Archer, "Stain films on silicon," J. Phys. Chem. Solids, 14, pp. 104-110, 1960. 
[226]  Y. Watanabe, Y. Arita, T. Yokoyama and Y. Igarashi, "Formation and properties of porous 
silicon and its application," J. Electrochem. Soc., 122 (10), pp. 1351-1355, 1975. 
[227]  A. Halimaoui, "Porous silicon formation by anodisation," in Properties of Porous Silicon 
(EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, UK: INSPEC, the 
Institution of Electrical Engineers, 1997, pp. 12-22. 
[228] V.  Lehmann,  Electrochemistry of Silicon: Instrumentation, Science, Materials and 
Applications, Verlag, Germany: Wiley-VCH, 2002. References   281 
 
[229]  V. Lehmann, R. Stengl and A. Luigart, "On the morphology and the electrochemical 
formation mechanism of mesoporous silicon," Mater. Sci. Eng. B Solid-State Mater. Adv. 
Technol., 69, pp. 11-22, 2000. 
[230]  M. L. Ngan, K. C. Lee and K. W. Cheah, "Photochemical etching of silicon," J. Porous 
Mater., 7 (1-3), pp. 41-45, 2000. 
[231]  K. W. Kolasinski, D. Mills and M. Nahidi, "Laser assisted and wet chemical etching of 
silicon nanostructures," J. Vac. Sci. Technol. A, 24 (4), pp. 1474-1479, 2006. 
[232]  Q. Chen, J. Zhu, X. G. Li and C. G. Fan, "Photoluminescence in porous silicon obtained by 
hydrothermal etching," Phys. Lett. A, 220 (4-5), pp. 293-296, 1996. 
[233]  E. A. De Vasconcelos, E. F. Da Silva Jr, B. E. C. A. Dos Santos, W. M. De Azevedo and J. 
A. K. Freire, "A new method for luminescent porous silicon formation: Reaction-induced 
vapor-phase stain etch," Phys. Status Solidi A, 202 (8), pp. 1539-1542, 2005. 
[234]  C. M. A. Ashruf, P. J. French, P. M. M. C. Bressers and J. J. Kelly, "Galvanic porous 
silicon formation without external contacts," Sens. Actuators A,  74  (1-3), pp. 118-122, 
1999. 
[235]  X. Li and P. W. Bonn, "Metal-assisted chemical etching in HF/H2O2 produces porous 
silicon," Appl. Phys. Lett., 77 (16), pp. 2572-2574, 2000. 
[236]  A. Splinter, J. Stüermann and W. Benecke, "Novel porous silicon formation without 
external contact," in Proc. SPIE - Micromachining and Microfabrication Process 
Technology VI, Santa Clara, CA, USA, pp. 398-405, Sep. 2000. 
[237]  ---, "New porous silicon formation technology using internal current generation with 
galvanic elements," Sens. Actuators A, 92 (1-3), pp. 394-399, 2001. 
[238]  K. Tsujino and M. Matsumura, "Boring deep cylindrical nanoholes in silicon using silver 
nanoparticles as a catalyst," Adv. Mater., 17 (8), pp. 1045-1047, 2005. 
[239]  P. Allongue, "Porous silicon formation mechanisms," in Properties of Porous Silicon (EMIS 
Datareview Series No. 18), L. T. Canham (Ed.), London, UK: INSPEC, the Institution of 
Electrical Engineers, 1997, pp. 3-11. 
[240]  X. G. Zhang, "Porous Silicon," in Electrochemistry of Silicon and Its Oxide, New York, 
USA: Kluwer Academic / Plenum, 2001, pp. 353-439. 
[241]  J. L. Coffer, "Porous silicon formation by stain etching," in Properties of Porous Silicon 
(EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, UK: INSPEC, the 
Institution of Electrical Engineers, 1997, pp. 23-29. 
[242]  S. Shih, K. H. Jung, T. Y. Hsieh, J. Sarathy, J. C. Campbell and D. L. Kwong, 
"Photoluminescence and formation mechanism of chemically etched silicon," Appl. Phys. 
Lett., 60 (15), pp. 1863-1865, 1992. 
[243]  D. R. Turner, "On the mechanism of chemically etching Germanium and Silicon," J. 
Electrochem. Soc., 107 (10), pp. 810-816, 1960. 
[244]  M. T. Kelly, J. K. M. Chun and A. B. Bocarsly, "High efficiency chemical etchant for the 
formation of luminescent porous silicon," Appl. Phys. Lett., 64 (13), pp. 1693-1695, 1994. 
[245]  É. Vázsonyi, E. Szilágyi, P. Petrik, Z. E. Horváth, T. Lohner, M. Fried and G. Jalsovszky, 
"Porous silicon formation by stain etching," Thin Solid Films, 388 (1-2), pp. 295-302, 2001. References   282 
 
[246]  E. A. Starostina, V. V. Starkov and A. F. Vyatkin, "Porous-silicon formation in HF-HNO3-
H2O etchants," Russ. Microelectron., 31 (2), pp. 88-96, 2002. 
[247] C.  Kaminski,  Intelligent Drug Delivery Device from Nanoporous Silicon, Diploma 
Dissertation, Universität Karlsruhe (TH, Germany) and University of Southampton (UK), 
2004. 
[248]  M. I. J. Beale, J. D. Benjamin, M. J. Uren, N. G. Chew and A. G. Cullis, "The formation of 
porous silicon by chemical stain etches," J. Cryst. Growth, 75 (3), pp. 408-414, 1986. 
[249]  A. J. Steckl, J. Xu, H. C. Mogul and S. Mogren, "Doping-induced selective area 
photoluminescence in porous silicon," Appl. Phys. Lett., 62 (16), pp. 1982-1984, 1993. 
[250]  J. Xu and A. J. Steckl, "Fabrication of visibly photoluminescent Si microstructures by 
focused ion beam implantation and wet etching," Appl. Phys. Lett., 65 (16), pp. 2081-2083, 
1994. 
[251]  M. Nahidi and K. W. Kolasinski, "Effects of stain etchant composition on the 
photoluminescence and morphology of porous silicon," J. Electrochem. Soc., 153 (1), pp. 
C19-C26, 2006. 
[252]  B. González-Díaz, R. Guerrero-Lemus, N. Marrero, C. Hernández-Rodríguez, F. A. Ben-
Hander and J. M. Martínez-Duart, "Anisotropic textured silicon obtained by stain-etching 
at low etching rates," J. Phys. D: Appl. Phys., 39 (4), pp. 631-634, 2006. 
[253]  T. I. Kamins, "Structure and properties of LPCVD silicon films," J. Electrochem. Soc., 127 
(3), pp. 686-690, 1980. 
[254] ---,  Polycrystalline Silicon for Integrated Circuit Applications   Boston, USA: Kluwer 
Acedemic Publishers, 1988. 
[255]  C. A. Zorman and M. Mehregany, "Materials for Microelectromechanical Systems," in The 
MEMS Handbook: Volume II - MEMS: Design and Fabrication, M. Gad-el-Hak (Ed.), 2nd 
ed., Boca Raton, USA: CRC Press, 2006, pp. 2-3-2-9. 
[256]  T. I. Kamins, "Resistivity of LPCVD polycrystalline-silicon films," J. Electrochem. Soc., 
126 (5), pp. 833-837, 1979. 
[257]  L. T. Canham, C. L. Reeves, D. O. King, P. J. Branfield, J. G. Crabb and M. C. L. Ward, 
"Bioactive polycrystalline silicon," Adv. Mater., 8 (10), pp. 850-852, 1996. 
[258]  R. C. Anderson, R. S. Muller and C. W. Tobias, "Porous polycrystalline silicon: A new 
material for MEMS," J. Microelectromech. Syst., 3 (1), pp. 10-18, 1994. 
[259]  S.-C. Bae and S.-Y. Choi, "Efficient and stable field emission from the oxidized porous 
polysilicon using Pt/Ti multilayer electrode," J. Mater. Sci., 42 (4), pp. 1369-1375, 2007. 
[260]  R. He and C.-J. Kim, "On-wafer monolithic encapsulation by surface micromachining with 
porous polysilicon shell," J. Microelectromech. Syst., 16 (2), pp. 462-472, 2007. 
[261]  E. J. Connolly, H. T. M. Pham, P. M. Sarro, P. J. French and G. M. O'Halloran, 
"Comparison of porous silicon, porous polysilicon and porous silicon carbide as materials 
for humidity sensing applications," Sens. Actuators A, 99 (1-2), pp. 25-30, 2002. 
[262]  P. G. Han, H. Wong and M. C. Poon, "Sensitivity and stability of porous polycrystalline 
silicon gas sensor," Colloids Surf. A Physicochem. Eng. Asp., 179 (2-3), pp. 171-175, 2001. References   283 
 
[263]  K. H. Jung, S. Shih, D. L. Kwong, G. G. Cho and B. E. Gnade, "Visible photoluminescence 
from porous Si formed by annealing and chemically etching amorphous Si," Appl. Phys. 
Lett., 61 (20), pp. 2467-2469, 1992. 
[264]  A. J. Steckl and H. C. Mogul, "Crystallinity and photoluminescence in stain-etched porous 
Si," J. Electrochem. Soc., 141 (3), pp. 674-679, 1994. 
[265]  A. J. Steckl, J. Xu, H. C. Mogul and S. M. Prokes, "Si oxyhydrides on stain-etched porous 
Si thin films and correlation with crystallinity and photoluminescence," J. Electrochem. 
Soc., 142 (5), pp. 69-71, 1995. 
[266]  K. Higa, T. Asano and T. Miyasato, "Variation of photoluminescence properties of stain-
etched Si with crystallinity of starting polycrystalline Si films," Jpn. J. Appl. Phys., Part 2 
Lett., 33 (12B), pp. L1733-L1736, 1994. 
[267]  P. G. Han, H. Wong, A. H. P. Chan and M. C. Poon, "A novel approach for fabricating 
light-emitting porous polysilicon films," Microelectron. Reliab., 42 (6), pp. 929-933, 2002. 
[268]  G. M. Dougherty, A. P. Pisano and T. Sands, "Processing and morphology of permeable 
polycrystalline silicon thin films," J. Mater. Res., 17 (9), pp. 2235-2242, 2002. 
[269]  G. M. Dougherty, T. D. Sands and A. P. Pisano, "Microfabrication using one-step LPCVD 
porous polysilicon films," J. Microelectromech. Syst., 12 (4), pp. 418-424, 2003. 
[270]  H. Kahn, S. Stemmer, K. Nandakumar, A. H. Heuer, R. L. Mullen, R. Ballarini and M. A. 
Huff, "Mechanical properties of thick, surface micromachined polysilicon films," in Proc. 
9th IEEE International Workshop on Micro Electro Mechanical Systems (MEMS 1996), San 
Diego, CA, USA, pp. 343-348, Feb. 1996. 
[271]  P. Guyader, P. Joubert, M. Guendouz, C. Beau and M. Sarret, "Effect of grain boundaries 
on the formation of luminescent porous silicon from polycrystalline silicon films," Appl. 
Phys. Lett., 65 (14), pp. 1787-1789, 1994. 
[272]  S. Beeby, G. J. Ensell, M. Kraft and N. White, MEMS Mechanical Sensors, 2nd ed., 
London, UK: Artech House, 2004. 
[273]  W. Kern and D. A. Poutinen, "Cleaning solution based on hydrogen peroxide for use in 
silicon semiconductor technology," RCA Rev., 31, pp. 187-206, 1970. 
[274]  G. S. May and S. M. Sze, Fundamentals of Semiconductor Fabrication, New York, USA: 
John Wiley & Sons, Inc., 2004. 
[275]  S. M. Sze, Semiconductor Devices: Physics and Technology, 2nd ed., New York, USA: John 
Wiley & Sons, Inc., 2002. 
[276] S.  Mohmad,  Intelligent Bio-Sensing and Drug Delivery from Nanoporous Silicon, MSc. 
Dissertation, University of Southampton, 2004. 
[277] SILVACO  International,  ATHENA User's Manual, Santa Clara, USA, 2006. 
[278] ---,  Virtual Wafer FAB (VWF) Interactive Tools User's Manual, Santa Clara, USA, 2005. 
[279]  V. V. Doan and M. J. Sailor, "Luminescent color image generation on porous silicon," 
Science, 256 (5065), pp. 1791-1792, 1992. 
[280]  J. I. Goldstein, D. E. Newbury, D. C. Joy, C. E. Lyman, P. Echlin, E. Lifshin, L. Sawyer 
and J. R. Michael, Scanning Electron Microscopy and X-Ray Microanalysis, 3rd ed., New 
York, USA: Springer, 2003. References   284 
 
[281]  A. Grosman and C. Ortega, "Chemical composition of 'fresh' porous silicon," in Properties 
of Porous Silicon (EMIS Datareview Series No. 18), L. T. Canham (Ed.), London, UK: 
INSPEC, the Institution of Electrical Engineers, 1997, pp. 145-153. 
[282]  R. Guerrero-Lemus, F. A. Ben-Hander, J. L. G. Fierro, C. Hernández-Rodríguez and J. M. 
Martínez-Duart, "Compositional and photoluminescent properties of anodically and stain 
etched porous silicon," Phys. Status Solidi A, 197 (1), pp. 137-143, 2003. 
[283]  S. D. Campbell, L. A. Jones, E. Nakamichi, F. X. Wei, L. D. Zajchowski and D. F. Thomas, 
"Spectral and structural features of porous silicon prepared by chemical and 
electrochemical etching processes," J. Vac. Sci. Technol. B Microelectron. Nanometer. 
Struct., 13 (3), pp. 1184-1189, 1995. 
[284]  G. Binnig, C. F. Quate and C. Gerber, "Atomic force microscope," Phys. Rev. Lett., 56 (9), 
pp. 930-933, 1986. 
[285]  Veeco Instruments Inc., A Practical Guide to SPM: Scanning Probe Microscopy, 
http://www.veeco.com/pdfs.php/166, last accessed in Nov. 2008. 
[286]  G. Mauckner, T. Walter, T. Baier, K. Thonke, R. Sauer, R. Houbertz, U. Memmert and R. 
J. Behm, "Luminescence properties and surface topography of porous silicon," J. Lumin., 
57 (1-6), pp. 211-215, 1993. 
[287]  M. Hatzakis, B. J. Canavello and J. M. Shaw, "Single-step optical lift-off process," IBM J. 
Res. Dev., 24 (4), pp. 452-460, 1980. 
[288]  M. E. Nasir, Fabrication and Spectroscopy of Nanostructured Surfaces on Silicon, Ph.D. 
Dissertation, University of Manchester, 2008. 
[289]  Y. Tao and M. Esashi, "Local formation of macroporous silicon through a mask," J. 
Micromech. Microeng., 14 (10), pp. 1411-1415, 2004. 
[290]  V. Lehmann, "Physics of macroporous silicon formation," Thin Solid Films, 255 (1-2), pp. 
1-4, 1995. 
[291]  S. Shingubara, "Fabrication of nanomaterials using porous alumina templates," J. 
Nanoparticle Res., 5 (1-2), pp. 17-30, 2003. 
[292]  H. Asoh and S. Ono, "Fabrication of ordered anodic nanoporous alumina layers and their 
application to nanotechnology," in Electrocrystallization in Nanotechnology, G. T. Staikov 
(Ed.), Weinheim, Germany: Wiley-VCH Verlag, 2007, pp. 138-166. 
[293]  G. D. Sulka, "Highly ordered anodic porous alumina formation by self-organized 
anodizing," in Nanostructured Materials in Electrochemistry, A. Eftekhari (Ed.), 
Weinheim, Germany: Wiley-VCH Verlag, 2008, pp. 1-116. 
[294]  Y. Xia, B. Gates, Y. Yin and Y. Lu, "Monodispersed colloidal spheres: Old materials with 
new applications," Adv. Mater., 12 (10), pp. 693-713, 2000. 
[295]  S.-M. Yang, S. G. Jang, D.-G. Choi, S. Kim and H. K. Yu, "Nanomachining by colloidal 
lithography," Small, 2 (4), pp. 458-475, 2006. 
[296]  H. Masuda and K. Fukuda, "Ordered metal nanohole arrays made by a two-step 
replication of honeycomb structures of anodic alumina," Science,  268  (5216), pp. 1466-
1468, 1995. 
[297]  A. D. Franklin, M. R. Maschmann, M. DaSilva, D. B. Janes, T. S. Fisher and T. D. Sands, 
"In-place fabrication of nanowire electrode arrays for vertical nanoelectronics on Si References   285 
 
substrates," J. Vac. Sci. Technol. B Microelectron. Nanometer. Struct., 25 (2), pp. 343-347, 
2007. 
[298]  S. Mátéfi-Tempfli, M. Mátéfi-Tempfli, A. Vlad, V. Antohe and L. Piraux, "Nanowires and 
nanostructures fabrication using template methods: a step forward to real devices 
combining electrochemical synthesis with lithographic techniques," J. Mater. Sci. Mater. 
Electron., 20 (Supp. 1), pp. S249-S254, 2009. 
[299]  J. Liang, H. Chik and J. Xu, "Nonlithographic fabrication of lateral superlattices for 
nanometric electromagnetic-optic applications," IEEE J. Sel. Top. Quantum. Electron., 8 
(5), pp. 998-1008, 2002. 
[300]  S.-K. Hwang, J. Lee, S.-H. Jeong, P.-S. Lee and K.-H. Lee, "Fabrication of carbon nanotube 
emitters in an anodic aluminium oxide nanotemplate on a Si wafer by multi-step 
anodization," Nanotechnology, 16 (6), pp. 850-858, 2005. 
[301]  H. Masuda and K. Nishio, "Synthesis and applications of highly ordered anodic porous 
alumina," in Self-Organized Nanoscale Materials, M. Adachi and D. J. Lockwood (Eds.), 
New York, USA: Springer, 2006, pp. 296-312. 
[302]  D. T. Crouse, Y.-H. Lo, A. E. Miller and M. M. Crouse, "Self-ordered pore structure of 
anodized aluminum on silicon and pattern transfer," Appl. Phys. Lett., 76 (1), pp. 49-51, 
2000. 
[303]  J. P. O'Sullivan and G. C. Wood, "The morphology and mechanism of formation of porous 
anodic films on aluminium," Proc. R. Soc. Lond. A Math. Phys. Sci., 317 (1531), pp. 511-
543, 1970. 
[304]  O. Jessensky, F. Müller and U. Gösele, "Self-organized formation of hexagonal pore 
structures in anodic alumina," J. Electrochem. Soc., 145 (11), pp. 3735-3740, 1998. 
[305]  M. Kokonou, A. G. Nassiopoulou and K. P. Giannakopoulos, "Ultra-thin porous anodic 
alumina films with self-ordered cylindrical vertical pores on a p-type silicon substrate," 
Nanotechnology, 16 (1), pp. 103-106, 2005. 
[306]  L. E. Fratila-Apachitei, H. Terryn, P. Skeldon, G. E. Thompson, J. Duszczyk and L. 
Katgerman, "Influence of substrate microstructure on the growth of anodic oxide layers," 
Electrochim. Acta., 49 (7), pp. 1127-1140, 2004. 
[307]  A. Cai, H. Zhang, H. Hua and Z. Zhang, "Direct formation of self-assembled nanoporous 
aluminium oxide on SiO2 and Si substrates," Nanotechnology, 13 (5), pp. 627-630, 2002. 
[308]  S.-K. Hwang, S.-H. Jeong, H.-Y. Hwang, O.-J. Lee and K.-H. Lee, "Fabrication of highly 
ordered pore array in anodic alumina oxide," Korean J. Chem. Eng., 19 (3), pp. 467-473, 
2002. 
[309]  F. Li, L. Zhang and R. M. Metzger, "On the growth of highly ordered pores in anodized 
aluminum oxide," Chem. Mater., 10 (9), pp. 2470-2480, 1998. 
[310]  A. Yin, M. Tzolov, D. Cardimona, L. Guo and J. Xu, "Fabrication of highly ordered anodic 
aluminium oxide templates on silicon substrates," IET Circuits Devices Syst., 1 (3), pp. 
205-209, 2007. 
[311]  S.-Z. Chu, K. Wada, S. Inoue, M. Isogai and A. Yasumori, "Fabrication of ideally ordered 
nanoporous alumina films and integrated alumina nanotubule arrays by high field 
anodization," Adv. Mater., 17 (17), pp. 2115-2119, 2005. References   286 
 
[312]  A. P. Li, F. Müller, A. Birner, K. Nielsch and U. Gösele, "Hexagonal pore arrays with a 50–
420 nm interpore distance formed by self-organization in anodic alumina," J. Appl. Phys., 
84 (11), pp. 6023-6026, 1998. 
[313]  M. M. Crouse, A. E. Miller, D. T. Crouse and A. A. Ikram, "Nanoporous alumina template 
with in situ barrier oxide removal, synthesized from a multilayer thin film precursor," J. 
Electrochem. Soc., 152 (10), pp. D167-D172, 2005. 
[314]  K. Nielsch, J. Choi, K. Schwirn, R. B. Wehrspohn and U. Gosele, "Self-ordering regimes of 
porous alumina: The 10% porosity rule," Nano Lett., 2 (7), pp. 677-680, 2002. 
[315]  H. Masuda, F. Hasegwa and S. Ono, "Self-ordering of cell arrangement of anodic porous 
alumina formed in sulfuric acid solution," J. Electrochem. Soc., 144 (5), pp. L127-L130, 
1997. 
[316]  H. Masuda and M. Satoh, "Fabrication of gold nanodot array using anodic porous alumina 
as an evaporation mask," Jpn. J. Appl. Phys. Part 2 Lett., 35 (1B), pp. L126-L129, 1996. 
[317]  H. Masuda, K. Yada and A. Osaka, "Self-ordering of cell configuration of anodic porous 
alumina with large-size pores in phosphoric acid solution," Jpn. J. Appl. Phys. Part 2 Lett., 
37 (11A), pp. L1340-L1342, 1998. 
[318]  A. P. Li, F. Müller and U. Gösele, "Polycrystalline and monocrystalline pore arrays with 
large interpore distance in anodic alumina," Electrochem. Solid-State Lett., 3 (3), pp. 131-
134, 2000. 
[319]  Y. Li, M. Zheng, L. Ma and W. Shen, "Fabrication of highly ordered nanoporous alumina 
films by stable high-field anodization," Nanotechnology, 17 (20), pp. 5101-5105, 2006. 
[320]  W. Lee, R. Ji, U. Gösele and K. Nielsch, "Fast fabrication of long-range ordered porous 
alumina membranes by hard anodization," Nature Mater., 5 (9), pp. 741-747, 2006. 
[321]  Y. Li, Z. Y. Ling, S. S. Chen and J. C. Wang, "Fabrication of novel porous anodic alumina 
membranes by two-step hard anodization," Nanotechnology,  19  (22), pp. 225604 (6pp), 
2008. 
[322]  K. Schwirn, W. Lee, R. Hillebrand, M. Steinhart, K. Nielsch and U. Gösele, "Self-ordered 
anodic aluminum oxide formed by H2SO4 hard anodization," ACS Nano, 2 (2), pp. 302-310, 
2008. 
[323]  H. Masuda, K. Kanezawa and K. Nishio, "Fabrication of ideally ordered nanohole arrays 
in anodic porous alumina based on nanoindentation using scanning probe microscope," 
Chem. Lett., 31 (12), pp. 1218-1219, 2002. 
[324]  C. Y. Liu, A. Datta and Y. L. Wang, "Ordered anodic alumina nanochannels on focused-
ion-beam-prepatterned aluminum surfaces," Appl. Phys. Lett., 78 (1), pp. 120-122, 2001. 
[325]  S.-H. Hong, K.-S. Han, H. Lee, J. U. Cho and Y. K. Kim, "Fabrication of nano-porous 
structure on silicon substrate using nanoimprint lithography with an anodic aluminum 
oxide nano-template," Jpn. J. Appl. Phys., Part 1 Regul. Pap. Short Note Rev. Pap., 46 
(9B), pp. 6375-6377, 2007. 
[326]  H. Masuda, H. Yamada, M. Satoh, H. Asoh, M. Nakao and T. Tamamura, "Highly ordered 
nanochannel-array architecture in anodic alumina," Appl. Phys. Lett., 71 (19), pp. 2770-
2772, 1997. 
[327]  Y. Matsui, K. Nishio and H. Masuda, "Highly ordered anodic porous alumina with 13-nm 
hole intervals using a 2D array of monodisperse nanoparticles as a template," Small, 2 (4), 
pp. 522-525, 2006. References   287 
 
[328]  J. Zou, X. Qi, L. Tan and B. J. H. Stadler, "Large-scale ordering of porous Si using anodic 
aluminum oxide grown by directed self-assembly," Appl. Phys. Lett., 89 (9), pp. 093106 
(3pp), 2006. 
[329]  F. Zacharatos, V. Gianneta and A. G. Nassiopoulou, "Highly ordered hexagonally arranged 
nanostructures on silicon through a self-assembled silicon-integrated porous anodic 
alumina masking layer," Nanotechnology, 19 (49), pp. 495306 (5 pp), 2008. 
[330]  H. Asoh, K. Sasaki and S. Ono, "Electrochemical etching of silicon through anodic porous 
alumina," Electrochem. Commun., 7 (9), pp. 953-956, 2005. 
[331]  A. Oide, H. Asoh and S. Ono, "Natural lithography of Si surfaces using localized 
anodization and subsequent chemical etching," Electrochem. Solid-State Lett., 8 (7), pp. 
G172-G175, 2005. 
[332]  H. Asoh, M. Matsuo, M. Yoshihama and S. Ono, "Transfer of nanoporous pattern of anodic 
porous alumina into Si substrate," Appl. Phys. Lett., 83 (21), pp. 4408-4410, 2003. 
[333]  S. Z. Chu, K. Wada, S. Inoue and S. Todoroki, "Formation and microstructures of anodic 
alumina films from aluminum sputtered on glass substrate," J. Electrochem. Soc., 149 (7), 
pp. B321-B327, 2002. 
[334]  B. Das, "Investigation of nanoporous thin-film alumina templates," J. Electrochem. Soc., 
151 (6), pp. D46-D50, 2004. 
[335]  P. G. Miney, P. E. Colavita, M. V. Schiza, Ryan J. Priore, F. G. Haibach and M. L. Myrick, 
"Growth and characterization of a porous aluminum oxide film formed on an electrically 
insulating support," Electrochem. Solid-State Lett., 6 (10), pp. B42-B45, 2003. 
[336]  S. K. Thamida and H.-C. Chang, "Nanoscale pore formation dynamics during aluminum 
anodization," Chaos, 12 (1), pp. 240-251, 2002. 
[337]  V. P. Parkhutik and V. I. Shershulsky, "Theoretical modelling of porous oxide growth on 
aluminium," J. Phys. D Appl. Phys., 25 (8), pp. 1258-1263, 1992. 
[338]  Z. Wu, C. Richter and L. Menon, "A study of anodization process during pore formation in 
nanoporous alumina templates," J. Electrochem. Soc., 154 (1), pp. E8-E12, 2007. 
[339]  M. Kokonou and A. G. Nassiopoulou, "Nanostructuring Si surface and Si/SiO2 interface 
using porous-alumina-on-Si template technology. Electrical characterization of Si/SiO2 
interface," Physica E, 38 (1-2), pp. 1-5, 2007. 
[340]  S. Ono, A. Oide and H. Asoh, "Nanopatterning of silicon with use of self-organized porous 
alumina and colloidal crystals as mask," Electrochim. Acta., 52 (8), pp. 2898-2904, 2007. 
[341]  S.-J. Hwang, Y.-D. Lee, Y.-B. Park, J.-H. Lee, C.-O. Jeong and Y.-C. Joo, "In situ study of 
stress relaxation mechanisms of pure Al thin films during isothermal annealing," Scr. 
Mater., 54 (11), pp. 1841-1846, 2006. 
[342]  K. A. Koh and S. J. Chua, "Electromigration in aluminum/silicon/copper metallization due 
to the presence of a thin oxide layer," Journal of Electronic Materials, 26 (9), pp. 1070-
1075, 1997. 
[343]  A. Yin, R. S. Guico and J. Xu, "Fabrication of anodic aluminium oxide templates on curved 
surfaces," Nanotechnology, 18 (3), pp. 035304 (6pp), 2007. 
[344]  H. W. Deckman and J. H. Dunsmuir, "Natural lithography," Appl. Phys. Lett., 41 (4), pp. 
377-379, 1982. References   288 
 
[345]  J. C. Hulteen and R. P. Van Duyne, "Nanosphere lithography: A materials general 
fabrication process for periodic particle array surfaces," J. Vac. Sci. Technol. A, 13 (3 pt 2), 
pp. 1553-1553, 1995. 
[346]  J. C. Hulteen, D. A. Treichel, M. T. Smith, M. L. Duval, T. R. Jensen and R. P. Van Duyne, 
"Nanosphere lithography: Size-tunable silver nanoparticle and surface cluster arrays," J. 
Phys. Chem. B, 103 (19), pp. 3854-3863, 1999. 
[347]  T. R. Jensen, M. D. Malinsky, C. L. Haynes and R. P. Van Duyne, "Nanosphere 
lithography: Tunable localized surface plasmon resonance spectra of silver nanoparticles," 
J. Phys. Chem. B, 104 (45), pp. 10549-10556, 2000. 
[348]  C. L. Haynes and R. P. Van Duyne, "Nanosphere lithography: A versatile nanofabrication 
tool for studies of size-dependent nanoparticle optics," J. Phys. Chem. B, 105  (24), pp. 
5599-5611, 2001. 
[349]  C. L. Haynes, A. D. McFarland, M. T. Smith, J. C. Hulteen and R. P. Van Duyne, "Angle-
resolved nanosphere lithography: Manipulation of nanoparticle size, shape, and 
interparticle spacing," J. Phys. Chem. B, 106 (8), pp. 1898-1902, 2002. 
[350]  A. D. Ormonde, E. C. M. Hicks, J. Castillo and R. P. Van Duyne, "Nanosphere lithography: 
Fabrication of large-area Ag nanoparticle arrays by convective self-assembly and their 
characterization by scanning UV - Visible extinction spectroscopy," Langmuir, 20 (16), pp. 
6927-6931, 2004. 
[351]  X. Zhang, A. V. Whitney, J. Zhao, E. M. Hicks and R. P. Van Duyne, "Advances in 
contemporary nanosphere lithographic techniques," J. Nanosci. Nanotechnol., 6 (7), pp. 
1920-1934, 2006. 
[352]  Z. P. Huang, D. L. Carnahan, J. Rybczynski, M. Giersig, M. Sennett, D. Z. Wang, J. G. 
Wen, K. Kempa and Z. F. Ren, "Growth of large periodic arrays of carbon nanotubes," 
Appl. Phys. Lett., 82 (3), pp. 460-462, 2003. 
[353]  A. Kosiorek, W. Kandulski, H. Glaczynska and M. Giersig, "Fabrication of nanoscale rings, 
dots, and rods by combining shadow nanosphere lithography and annealed polystyrene 
nanosphere masks," Small, 1 (4), pp. 439-444, 2005. 
[354]  Y. Li, W. Cai, B. Cao, G. Duan, C. Li, F. Sun and H. Zeng, "Morphology-controlled 2D 
ordered arrays by heating-induced deformation of 2D colloidal monolayer," J. Mater. 
Chem., 16 (6), pp. 609-612, 2006. 
[355]  C. L. Cheung, R. J. Nikolic, C. E. Reinhardt and T. F. Wang, "Fabrication of nanopillars by 
nanosphere lithography," Nanotechnology, 17 (5), pp. 1339-1343, 2006. 
[356]  K. Seeger and R. E. Palmer, "Fabrication of ordered arrays of silicon nanopillars," J. Phys. 
D: Appl. Phys., 32 (24), pp. L129-L132, 1999. 
[357]  A. Sinitskii, S. Neumeier, J. Nelles, M. Fischler and U. Simon, "Ordered arrays of silicon 
pillars with controlled height and aspect ratio," Nanotechnology, 18 (30), pp. 305307 (6 
pp), 2007. 
[358]  C. Haginoya, M. Ishibashi and K. Koike, "Nanostructure array fabrication with a size-
controllable natural lithography," Appl. Phys. Lett., 71 (20), pp. 2934-2936, 1997. 
[359]  N. Nagy, A. E. Pap, E. Horváth, J. Volk, I. Bársony, A. Deák and Z. Hórvölgyi, "Large area 
self-assembled masking for photonic applications," Appl. Phys. Lett.,  89  (6), pp. 63104 
(3pp), 2006. References   289 
 
[360]  M. Manso Silván, M. Arroyo Hernández, V. Torres Costa, R. J. Martín-Palma and J. M. 
Martínez-Duart, "Structured porous silicon sub-micrometer wells grown by colloidal 
lithography," Europhy. Lett., 76 (4), pp. 690-695, 2006. 
[361]  D. F. Liu, Y. J. Xiang, Q. Liao, J. P. Zhang, X. C. Wu, Z. X. Zhang, L. F. Liu, W. J. Ma, J. 
Shen, W. Y. Zhou, et al., "A simple route to scalable fabrication of perfectly ordered ZnO 
nanorod arrays," Nanotechnology, 18 (40), pp. 405303 (5pp), 2007. 
[362]  K. Peng, M. Zhang, A. Lu, N.-B. Wong, R. Zhang and S.-T. Lee, "Ordered silicon nanowire 
arrays via nanosphere lithography and metal-induced etching," Appl. Phys. Lett., 90 (16), 
pp. 163123 (3pp), 2007. 
[363]  K. Kempa, B. Kimball, J. Rybczynski, Z. P. Huang, P. F. Wu, D. Steeves, M. Sennett, M. 
Giersig, D. V. G. L. N. Rao, D. L. Carnahan, et al., "Photonic crystals based on periodic 
arrays of aligned carbon nanotubes," Nano Lett., 3 (1), pp. 13-18, 2003. 
[364]  N. D. Denkov, O. D. Velev, P. A. Kralchevsky, I. B. Ivanov, H. Yoshimura and K. 
Nagayama, "Mechanism of formation of two-dimensional crystals from latex particles on 
substrates," Langmuir, 8 (12), pp. 3183-3190, 1992. 
[365]  N. D. Denkov, O. D. Velev, P. A. Kralchevsky, I. B. Ivanov, H. Yoshimura, K. Nagayama, 
T. Enoch, A. Carr and P. Nurse, "Two-dimensional crystallization," Nature, 361 (6407), pp. 
26, 1993. 
[366]  A. S. Dimitrov and K. Nagayama, "Continuous convective assembling of fine particles into 
two-dimensional arrays on solid surfaces," Langmuir, 12 (5), pp. 1303-1311, 1996. 
[367]  C. D. Dushkin, H. Yoshimura and K. Nagayama, "Nucleation and growth of two-
dimensional colloidal crystals," Chem. Phys. Lett., 204 (5-6), pp. 455-460, 1993. 
[368]  K. Nagayama, "Two-dimensional self-assembly of colloids in thin liquid films," Colloids 
Surf. A Physicochem. Eng. Asp., 109, pp. 363-374, 1996. 
[369]  R. Micheletto, H. Fukuda and M. Ohtsu, "A simple method for the production of a two-
dimensional, ordered array of small latex particles," Langmuir,  11  (9), pp. 3333-3336, 
1995. 
[370]  V. Ng, Y. V. Lee, B. T. Chen and A. O. Adeyeye, "Nanostructure array fabrication with 
temperature-controlled self-assembly techniques," Nanotechnology,  13  (5), pp. 554-558, 
2002. 
[371]  L. M. Goldenberg, J. Wagner, J. Stumpe, B.-R. Paulke and E. Görnitz, "Ordered arrays of 
large latex particles organized by vertical deposition," Langmuir, 18 (8), pp. 3319-3323, 
2002. 
[372]  L. K. Teh, N. K. Tan, C. C. Wong and S. Li, "Growth imperfections in three-dimensional 
colloidal self-assembly," Appl. Phys. A, 81 (7), pp. 1399-1404, 2005. 
[373]  Z. Zheng, X. Liu, Y. Luo, B. Cheng, D. Zhang, Q. Meng and Y. Wang, "Pressure controlled 
self-assembly of high quality three-dimensional colloidal photonic crystals," Appl. Phys. 
Lett., 90 (5), pp. 051910 (3 pp), 2007. 
[374]  B. J. Y. Tan, C. H. Sow, K. Y. Lim, F. C. Cheong, G. L. Chong, A. T. S. Wee and C. K. Ong, 
"Fabrication of a two-dimensional periodic non-close-packed array of polystyrene 
particles," J. Phys. Chem. B, 108 (48), pp. 18575-18579, 2004. 
[375]  P. Jiang and M. J. McFarland, "Large-scale fabrication of wafer-size colloidal crystals, 
macroporous polymers and nanocomposites by spin-coating," J. Am. Chem. Soc., 126 (42), 
pp. 13778-13786, 2004. References   290 
 
[376]  R. Aveyard, J. H. Clint, D. Nees and V. N. Paunov, "Compression and structure of 
monolayers of charged latex particles at air/water and octane/water interfaces," Langmuir, 
16 (4), pp. 1969-1979, 2000. 
[377]  J. Rybczynski, U. Ebels and M. Giersig, "Large-scale, 2D arrays of magnetic 
nanoparticles," Colloids Surf. A Physicochem. Eng. Asp., 219 (1-3), pp. 1-6, 2003. 
[378]  S. M. Weekes, F. Y. Ogrin, W. A. Murray and P. S. Keatley, "Macroscopic arrays of 
magnetic nanostructures from self-assembled nanosphere templates," Langmuir, 23 (3), 
pp. 1057-1060, 2007. 
[379]  L. M. Goldenberg, J. Wagner, J. Stumpe, B.-R. Paulke and E. Görnitz, "Simple method for 
the preparation of colloidal particle monolayers at the water/alkane interface," Langmuir, 
18 (14), pp. 5627-5629, 2002. 
[380]  M. G. Nikolaides, A. R. Bausch, M. F. Hsu, A. D. Dinsmore, M. P. Brenner, C. Gay and D. 
Weltz, "Electric-field-induced capillary attraction between like-charged particles at liquid 
interfaces," Nature, 420 (6913), pp. 299-301, 2002. 
[381]  W. Chen, S. Tan, T.-K. Ng, W. T. Ford and P. Tong, "Long-ranged attraction between 
charged polystyrene spheres at aqueous interfaces," Phys. Rev. Lett., 95 (21), pp. 218301 
(4pp), 2005. 
[382]  M. E. Abdelsalam, P. N. Bartlett, J. J. Baumberg and S. Coyle, "Preparation of arrays of 
isolated spherical cavities by self-assembly of polystyrene spheres on self-assembled pre-
patterned macroporous films," Adv. Mater., 16 (1), pp. 90-93, 2004. 
[383]  R. Legtenberg, H. V. Jansen, M. J. de Boer and M. Elwenspoek, "Anisotropic reactive ion 
etching of silicon using SF6/O2/CHF3 gas mixtures," J. Electrochem. Soc., 142 (6), pp. 2020-
2028, 1995. 
[384]  B. S. Flavel, J. G. Shapter and J. S. Quinton, "Nanosphere lithography using thermal 
evaporation of gold," in Proc. SPIE - Micro- and Nanotechnology: Materials, Processes, 
Packaging, and Systems III Adelaide, Australia, pp. 64151J (8 pp), Dec. 2006. 
[385]  U. M. Mescheder and C. Koetter, "Optical monitoring and control of Si wet etching," 
Sensors and Actuators A: Physical, 76 (1-3), pp. 425-430, 1999. 
[386]  H. Tosaka, K. Minami and M. Esashi, "Optical in situ monitoring of silicon diaphragm 
thickness during wet etching," Journal of Micromechanics and Microengineering, 5 (1), pp. 
41-46, 1995. 
[387]  M. W. Dewhirst, B. L. Viglianti, M. Lora-Michiels, M. Hanson and P. J. Hoopes, "Basic 
principles of thermal dosimetry and thermal thresholds for tissue damage from 
hyperthermia," International Journal of Hyperthermia, 19 (3), pp. 267 - 294, 2003. 
[388]  T. R. Kuphaldt, Lessons in Electric Circuits: Volume V - Reference, 
http://www.ibiblio.org/kuphaldt/electricCircuits/, last accessed in Mar. 2009 
[389]  E. A. Brandes and G. B. Brook (Eds.), Smithells Metals Reference Book, 7th ed. Oxford, UK: 
Butterworth-Heinemann, 1992. 
[390]  F. P. Incropera, D. P. DeWitt, T. L. Bergman and A. S. Lavine, Fundamentals of Heat and 
Mass Transfer, 6th ed., New York, USA: John Wiley & Sons, Inc., 2007. 
[391]  P. Yuan, "Numerical analysis of an equivalent heat transfer coefficient in a porous model 
for simulating a biological tissue in a hyperthermia therapy," International Journal of 
Heat and Mass Transfer, 52 (7-8), pp. 1734-1740, 2009. References   291 
 
[392]  V. Lehmann, F. Hofmann, F. Möeller and U. Grüening, "Resistivity of porous silicon: A 
surface effect," Thin Solid Films, 255 (1-2), pp. 20-22, 1995. 
[393]  A. Wolf and R. Brendel, "Thermal conductivity of sintered porous silicon films," Thin Solid 
Films, 513 (1-2), pp. 385-390, 2006. 
[394]  C. Chang, Y.-F. Wang, Y. Kanamori, J.-J. Shih, Y. Kawai, C.-K. Lee, K.-C. Wu and M. 
Esashi, "Etching submicrometer trenches by using the Bosch process and its application to 
the fabrication of antireflection structures," J. Micromech. Microeng., 15 (3), pp. 580-585, 
2005. 
[395]  X. Wang, W. Zeng, G. Lu, O. L. Russo and E. Eisenbraun, "High aspect ratio Bosch etching 
of sub-0.25 μm trenches for hyperintegration applications," Journal of Vacuum Science & 
Technology B: Microelectronics and Nanometer Structures, 25 (4), pp. 1376-1381, 2007. 
[396]  Y.-F. Chang, Q.-R. Chou, J.-Y. Lin and C.-H. Lee, "Fabrication of high-aspect-ratio silicon 
nanopillar arrays with the conventional reactive ion etching technique," Appl. Phys. A 
Mater. Sci. Processing, 86 (2), pp. 193-196, 2007. 
[397]  A. Tserepi, E. Gogolides, C. Cardinaud, L. Rolland and G. Turban, "Highly anisotropic 
silicon and polysilicon room-temperature etching using fluorine-based high density 
plasmas," Microelectron. Eng., 41-42, pp. 411-414, 1998. 
[398]  L. Petrossian, S. J. Wilk, P. Joshi, S. Hihath, S. M. Goodnick and T. J. Thornton, 
"Fabrication of cylindrical nanopores and nanopore arrays in silicon-on-insulator 
substrates," J. Microelectromech. Syst., 16 (6), pp. 1419-1428, 2007. 
[399]  M. J. de Boer, H. V. Jansen, E. Smulders, M.-J. Gilde, G. Roelofs, J. N. Sasserath, M. 
Elwenspoek and J. G. E. Gardeniers, "Guidelines for etching silicon MEMS structures 
using fluorine high-density plasmas at cryogenic temperatures," J. Microelectromech. 
Syst., 11 (4), pp. 385-401, 2002. 
[400]  N. Maluf and K. Williams, An Introduction to Microelectromechanical Systems 
Engineering, 2nd ed., London, UK: Artech House, 2004. 
[401]  J. K. Bhardwaj, H. Ashraf and A. McQuarrie, "Dry etching for MEMS," in Proc. 
Symposium on Microstructures and Microfabricated Systems at the Annual Meeting of the 
Electrochemical Society, Montreal, Quebac, Canada, May 1997. 
[402]  H. V. Jansen, M. J. de Boer, S. Unnikrishnan, M. C. Louwerse and M. C. Elwenspoek, 
"Black silicon method X: a review on high speed and selective plasma etching of silicon 
with profile control: an in-depth comparison between Bosch and cryostat DRIE processes 
as a roadmap to next generation equipment," J. Micromech. Microeng., 19 (3), pp. 033001 
(41pp), 2009. 
[403]  M. Wasilik and A. P. Pisano, "Low-frequency process for silicon-on-insulator deep reactive 
ion etching," in Proc. SPIE - Device and Process Technologies for MEMS and 
Microelectronics II, Adelaide, Australia, pp. 462-472, Dec. 2001. 
[404]  J. Hopkins, H. Ashraf, J. K. Bhardwaj, A. M. Hynes, I. Johnston and J. N. Shepherd, "The 
benefits of process parameter ramping during the plasma etching of high aspect ratio 
silicon structures," in Proc. Mater. Res. Soc. Fall Meeting - Symposium AA: Materials 
Science of Microelectromechanical Systems (MEMS) Devices, Boston, MA, USA, pp. 63-68, 
Dec. 1998. 
[405] M.  Bahrami,  Micro-Opto-Fluidic Device for PCR Application, Ph.D. Dissertation, 
University of Southampton, 2006. References   292 
 
[406]  F. Warkusz, "The size effect and the temperature coefficient of resistance in thin films," J. 
Phys. D: Appl. Phys., 11 (5), pp. 689-694, 1978. 
[407]  A. L. Doadrio, E. M. B. Sousa, J. C. Doadrio, J. Pérez Pariente, I. Izquierdo-Barba and M. 
Vallet-Regí, "Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug 
delivery," J. Controlled Release, 97 (1), pp. 125-132, 2004. 
[408]  S. W. Song, K. Hidajat and S. Kawi, "Functionalized SBA-15 materials as carriers for 
controlled drug delivery: Influence of surface properties on matrix-drug interactions," 
Langmuir, 21 (21), pp. 9568-9575, 2005. 
[409]  C. Charnay, S. Bégu, C. Tourné-Péteilh, L. Nicole, D. A. Lerner and J. M. Devoisselle, 
"Inclusion of ibuprofen in mesoporous templated silica: Drug loading and release 
property," Eur. J. Pharm. Biopharm, 57 (3), pp. 533-540, 2004. 
[410]  M. Vallet-Regí, A. Rámila, R. P. del Real and J. Pérez Pariente, "A new property of MCM-
41: Drug delivery system," Chem. Mater., 13 (2), pp. 308-311, 2001. 
[411]  L. M. Karlsson, P. Tengvall, I. Lundstrom and H. Arwin, "Penetration and loading of 
human serum albumin in porous silicon layers with different pore sizes and thicknesses," 
J. Colloid Interface Sci., 266 (1), pp. 40-47, 2003. 
[412]  I. Batra, J. L. Coffer and L. T. Canham, "Electronically-responsive delivery from a calcified 
mesoporous silicon structure," Biomed. Microdevices, 8 (2), pp. 93-97, 2006. 
[413]  K. L. Holmes and L. M. Lantz, "Protein labeling with fluorescent probes," in Methods in 
Cell Biology, vol. 63: Cytometry Part 1, Z. Darzynkiewicz, H. A. Crissman and J. P. 
Robinson (Eds.), New York, USA: Academic Press, 2001, pp. 185-204. 
[414]  T. H. The and T. E. W. Feltkamp, "Conjugation of fluorescein isothiocyanate to antibodies 
I. Experiments on the conditions of conjugation," Immunology, 18 (6), pp. 865-873, 1970. 
[415]  R. E. J. Mitchel, I. M. Chaiken and E. L. Smith, "The complete amino acid sequence of 
Papain. (ADDITIONS AND CORRECTIONS)," J. Biol. Chem., 245 (14), pp. 3485-3492, 
1970. 
[416]  R. Arnon, "Papain," in Methods in Enzymology, vol. 19: Proteolytic Enzymes, E. P. 
Gertrude and L. Laszlo (Eds.), New York, USA: Academic Press, 1970, pp. 226-244. 
[417]  A. N. Glazer and E. L. Smith, "Phenolic hydroxyl ionization in Papain," J. Biol. Chem., 
236 (11), pp. 2948-2951, 1961. 
[418] Sigma-Aldrich  Inc.,  Product Information Sheet: Papain (Product No. P 4762), 
http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/datasheet5/p4762dat.pdf, last 
accessed in Apr. 2009. 
[419]  A. Kilara, K. M. Shahani and F. W. Wagner, "Preparation and properties of immobilized 
papain and lipase," Biotechnol. Bioeng., 19 (11), pp. 1703-1714, 1977. 
[420]  P. R. Banks and D. M. Paquette, "Comparison of three common amine reactive fluorescent 
probes used for conjugation to biomolecules by capillary zone electrophoresis," Bioconjug. 
Chem., 6 (4), pp. 447-458, 1995. 
[421]  Roche Applied Science, "Product Information Sheet: Fluorescein Labeling Kit (Cat. No. 
11386093001)," 2005. 
[422]  Thermo Fischer Scientific Inc., Product Instructions: NHS-Fluorescein (Product No. 46409 
and 46410), http://www.piercenet.com/files/2082as4.pdf, last accessed in Apr. 2009. References   293 
 
[423]  C. V. Sapan, R. L. Lundblad and N. C. Price, "Colorimetric protein assay techniques," 
Biotechnol. Appl. Biochem., 29 (Part 2), pp. 99-108, 1999. 
[424]  C. M. Stoscheck, "Quantitation of Protein," in Methods in Enzymology, vol. 182: Guide to 
Protein Purification, M. P. Deutscher (Ed.), New York, USA: Academic Press, 1990, pp. 50-
68. 
[425]  T. J. Mantle and D. A. Harris, "Spectrophotometric Assays," in Spectrophotometry and 
Spetrofluorimetry: A Practical Approach, M. G. Gore (Ed.), 2nd ed., Oxford, UK: Oxford 
University Press, 2000, pp. 183-208. 
[426]  G. R. Grimsley and C. N. Pace, "Spectrophotometry determination of protein 
concentration," in Current Protocols in Protein Science, J. E. Coligan, B. M. Dunn, D. W. 
Speicher and P. T. Wingfield (Eds.), New York, USA: John Wiley & Sons, Inc., 2003, pp. 
Unit 3.1 (9 pp). 
[427]  T. Okubo, D. Onoshima and A. Tsuchida, "Drying dissipative patterns of biological 
polyelectrolyte solutions," Colloid Polymer Sci., 285 (9), pp. 999-1007, 2007. 
[428]  J. Stoer and R. Bulirsch, Introduction to Numerical Analysis (translated from Einführung 
in die Numerische Mathematik), 2nd ed., New York, USA: Springer-Verlag, 1993. 
[429]  V.-P. Lehto, K. Vaha-Heikkila, J. Paski and J. Salonen, "Use of thermoanalytical methods 
in quantification of drug load in mesoporous silicon microparticles," J. Therm. Anal. 
Calor., 80 (2), pp. 393-397, 2005. 
[430] COMSOL  AB,  AC / DC Module User's Guide, Stockholm, Sweden, 2006. 
[431] ---,  Heat Transfer Module User's Guide, Stockholm, Sweden, 2006. 
 
 
 